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Summary
The sepsis syndrome is the systemic response of the body to infection. It develops 
from the earliest stage, Systemic Inflammatory Response Syndrome sepsis, to severe 
sepsis, septic shock and multi-organ dysfunction syndrome. The incidence of sepsis 
is growing and globally accounts for one in ten admissions to Intensive Care Units. 
The mortality rate for severe sepsis ranges from 25% to 67%. People with cancer are 
ten times more likely to develop sepsis and having developed it have a higher 
mortality rate.
Early recognition and treatment of sepsis has been demonstrated to improve 
outcomes. This study sought to improve early recognition of sepsis in cancer patients 
receiving acute treatment. Nurses and patient assessment were the focus of this 
study. The design was a prospective multi-method observational study with two 
interventions: a teaching session for 177 nurses; the introduction of a bedside test -  
Procalcitonin (PCT-Q), an immunological marker of sepsis. PCT has been shown to 
be a reliable marker of sepsis. The PCT-Q, has been used since the late 1990s but 
never by ward nurses. ;
Methods used were: qualitative interviews of ten nurses and a questionnaire survey 
of 177 nurses pre and post intervention; and a patient database with the PCT-Q test 
being used 416 times in 320 patients to diagnose sepsis. The study showed that 
nurses and patients recognise the early changes of deterioration before their 
observations change. Nurses recognise these changes because they know their 
patients well. Nurses’ knowledge improved in several areas during the study and 
they used PCT-Q appropriately, diagnosing sepsis at an early stage in 66% of cases. 
Ordinal multi-regression analysis demonstrated that PCT was more reliable than 
CRP and, used together with a low WBC and high lactate, accurately predicts sepsis.
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Chapter 1 Introduction
1.1 Introduction
The study, described in this thesis, which is part of a doctorate in nursing science, 
was concerned with improving practice in the acute care of people with cancer. The 
study aimed to improve both the early nursing assessment of a cancer patient 
deteriorating with sepsis and the associated multi-professional communication and 
rescue. The researcher was a Nurse Consultant in Cancer: Critical Care working in a 
major comprehensive cancer centre in the U.K.
People with cancer are more susceptible to sepsis and have a high mortality once it 
has developed (Groeger 1991, Aisenberg et al 2004, Cone et al 2004). There is 
evidence that the early treatment of sepsis reduces mortality and morbidity and 
improves quality of life (Gattinoni et al 1995, Rivers et al 2001, Dellinger et al 
2004, 2008, Rhodes et al 2004, Trzeciak et al 2007, Ferrer et al 2008). To treat 
patients early necessitates early diagnosis. In the inpatient acute setting it is nurses 
who are most frequently in contact with patients and are best placed to notice the 
early signs of deterioration or listen to patients themselves who can identify that a 
change is taking place (Coyle and Wenhold 2001, Colson et al 2004, Green and 
Hacker 2004).
This study was therefore designed to investigate the nurses’ role in the early 
diagnosis of sepsis and to provide nurses with a new objective tool and dedicated 
education to improve early diagnosis and rescue.
1.1.2. Theoretical Framework
The theoretical framework underpinning this study, is as follows and is explored in 
detail in the following chapters:
1. The vulnerability of the cancer patients’ immune system and increased 
susceptibility to sepsis (chapter two);
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2. The evidence that early diagnosis and treatment reduces morbidity and 
mortality in sepsis (chapter three);
3. Nurses’ ability to intuit subtle change pre-cognitively which causes 
discomfort and a stimulus to act (chapter four);
4. Education and its ability to raise awareness of risk (chapter four and five);
5. Packaging of information using an objective test to aid effective multi 
professional communication and rescue (chapter two and four).
The study was designed to improve practice as it exists in the reality of everyday life 
on wards. An experimental design was therefore rejected in favour of a pragmatic 
practice development approach. The study was designed from the outset to have five 
linked stages as demonstrated in the research framework outlined below in Table 
1. 1:
Table 1.1: Research Framework with subsidiary research aims and associated 
research stages 1-5.
No. Subsidiary Research aims Research stages
1. Pre-intervention
1. The experience of caring for cancer patients 
deteriorating with sepsis.
2. The experience of communicating with and 
mobilising the multi-professional team about a 
patient deteriorating with sepsis.
3. The introduction to a new bedside blood test that 
may help in identifying sepsis earlier.
Post intervention
4. Experience of the patient deteriorating from sepsis.
5. The experience of using the PCT-Q in practice
6. Nurses’ accounts of the optimal ways of learning 
and developing their practice.
7. How nurses think an effective multi-professional 
response with a deteriorating patient can be
Pre and post - 
intervention 
qualitative 
interviews with 10 
nurses of varying 
cancer and critical 
care experience.
Post-intervention 
qualitative 
interviews with 8 of 
the 10 nurses 
previously 
interviewed.
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improved.
8. Nurses’ recommendations to improve the early 
detection and treatment of cancer patients 
developing sepsis.
2. Pre-intervention
1. Raising awareness of sepsis.
2. The nurses’ knowledge of sepsis: incidence, 
mortality risk, early diagnostic tests, procalcitonin 
and its role in the early diagnosis of sepsis.
3. Introduction to the bedside procalcitonin test (PCT-
Q).
4. Examples of patients deteriorating with sepsis and 
nurses finding it difficult to convince the team.
Post intervention
5. Changes in nurses’ awareness and knowledge 
regarding sepsis: incidence, mortality risk, early 
diagnostic tests, procalcitonin and its role in the 
early diagnosis of sepsis.
6. The nurses’ experience of using the PCT-Q in 
practice.
7. The nurses experience of thinking that a patient was 
deteriorating but finding it difficult to convince other 
nurses/doctors or other health care professionals. 
Examples from practice.
Pre and post 
intervention 
questionnaires to 
177 nurses across 
the hospital.
Post-intervention 
questionnaires 
completed by 85 of 
the original 177 
nurses.
3 a. 1. Ward teaching sessions on the cancer patient and 
sepsis, associated risks and mortality rate, the 
evidence on early diagnosis and treatment and 
assessment tools including procalcitonin.
2. Introduction to the use of the PCT-Q bedside test.
Intervention (1)
3b. 1. Introduction of the bedside test PCT-Q in the 
hospital for the first time. PCT-Q bedside blood test 
used on all patients that nurses assess as showing 
early signs of sepsis.
2. Each patient recruited for the PCT-Q test to have all 
other infection markers mapped to be able to 
compare the efficacy of the PCT-Q test to those 
usually used in the hospital.
Intervention (2)
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3. All patients entered into the study to have episode 
and hospital outcomes mapped with the objective of 
comparing outcomes of those who had PCT-Q 
measured in the study year to outcomes in the three 
previous years when the PCT-Q test was not 
available.
Archival notes 
review used to 
compare historical 
data with study data.
4. 1. Assess if the PCT-Q is used appropriately.
2. Assess if using the PCT-Q in sepsis assessment 
means that sepsis is diagnosed earlier.
3. The performance of the PCT-Q compared to the 
sepsis predictive markers already used by the 
hospital: White Blood Cell count, C-reactive protein, 
blood lactate, altered physiological parameters 
particularly mean arterial blood pressure.
4. The effect of introducing the two interventions: 
education and the PCT-Q on sepsis episodes and 
outcomes compared to the three previous years.
PCT-Q patient 
survey with 320 
patients and 416 
sepsis episodes in 
patients receiving 
acute care across the 
hospital.
5. Overall Research Aim
1. To investigate the nurses’ role in the early diagnosis 
of sepsis and to provide nurses with a new objective 
tool and dedicated education to improve early 
diagnosis and rescue.
Integration 
of all
qualitative 
data and 
comparison 
with
quantitative
data.
The primary objective was to diagnose patients' sepsis at an earlier stage, 
recognising that nurses report a difficulty in convincing colleagues, an objective 
bedside test was to be introduced to improve multi-professional communication and 
therefore rescue. The secondary objectives were to:
1. Learn more about nurses’ experience of the cancer patient deteriorating with 
sepsis and any barriers to effective communication and rescue;
2. Gain an in-depth understanding of nurses’ awareness of sepsis and its assessment 
and management and how this could be improved, particularly how nurses felt 
they learnt optimally;
3. Explore whether nurses’ judgement about the patient developing sepsis was 
accurate and whether they could use the PCT-Q appropriately;
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4. Gain an in-depth understanding from the nurses how they felt the use of the 
PCT-Q has impacted upon practice and how easy in practice it was to use;
5. Assess whether in the nurses’ hands and with cancer patients the PCT-Q was 
reliable in identifying sepsis compared to WBC, lactate, CRP and mean arterial 
pressure falls;
6. Evaluate if the use of the PCT-Q as part of clinical nursing assessment and 
communication resulted in earlier referrals and improved outcomes;
7. Compare the outcomes of patients during the study year to three previous years;
8. Evaluate whether the dedicated education session improved awareness and 
knowledge about the cancer patient with sepsis.
The research was undertaken on the acute wards and Critical Care Unit (CCU) of the 
cancer hospital. The patients had a variety of types of cancer and were all being 
actively treated as inpatients. The anti-cancer treatments were either single therapy 
or a combination of chemotherapy, radiotherapy, surgery, blood or marrow 
transplantation (BMT). The patients were receiving their first treatment or later 
treatment following relapse. Any patients entering the study needed to be eligible for 
full active treatment and not be in the terminal phase of their illness.
Experience and the literature show that identification of the early stages of sepsis is 
often delayed, with patients sustaining multi-organ failure before referral to the CCU 
team (Cioffi 2000a, DH 2003, Bellomo et al 2004). Discussion with nurses revealed 
that they recognise the signs of deterioration but lack the confidence or tools to 
persuade themselves or others to take action. This research was undertaken to 
improve both the early detection of sepsis and the mobilisation of the multi­
professional team.
1.2 The burden of cancer
Cancer is recognised as a global health problem. In the Western world cancer is, 
after heart disease, the second most common cause of death (La Vecchia et al 2003). 
Worldwide, it is estimated that there are 10.9 million new cases of cancer a year, 22 
million people live with it and 6.9 million people die from it (Parkin 2001, Cancer 
Research UK 2005, 2006). These estimates represent an increase of approximately
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22% since the estimates of Parkin et al in 1990 (Parkin et al 1999). Cancer in the 
Western world is a disease that mainly affects older people, with a peak in incidence 
(59%) in people over the age of 65 (Cancer Research UK 2005). There are some 
cancers, for example Leukaemia, which peak in incidence at birth up to four years 
and then range across the age span. In the UK in 2001 there were approximately
225.000 new cases of cancer. The incidence is increasing, with approximately
289.000 new cases in the UK in 2005 and 154,162 people dying from cancer in 2006 
(DH 2004, Cancer Research UK 2005, 2006).
All cancer patients are susceptible to sepsis (Table 1.1, Williams et al 2002, 
Williams et al 2004b). Some cancer patients are more vulnerable because their 
disease, sited in the bone marrow, directly affects the body’s immune response 
(Cherif et al 2003). The definitive treatment for these cancers is ablation of the bone 
marrow with chemo/radiotherapy and then replacement with a stem cell or bone 
marrow transplant from another person (allogeneic) or from themselves 
(autologous). Some cancer patients with solid tumours, for example teratoma, may 
receive the same marrow ablative chemotherapy. The mortality rate for patients 
receiving a transplant who develop severe sepsis is quoted as being between 65% 
and 85% (Groeger 1991, Chemecky and Berger 1998, Aisenberg et al 2004, Cone et 
al 2004). In some patients, such as those with leukaemia, sepsis is the major reason 
for transplant-associated death in the first six weeks of therapy (Williamson et al 
1999, Pastores et al 2002, Uys et al 2007, Merz et al 2008, Scales et al 2008).
There are times in the patient’s cancer journey when they are more at risk from 
sepsis (see chapter two). In general, this is during periods of active treatment of the 
disease. For most patients this is the first treatment period after diagnosis, and then at 
times of active treatment for relapse.
Table 1.2: Risks of infection and sepsis for the person with cancer
Characteristic Reason for greater risk of sepsis
Repeated hospitalisations. Increase in nosocomial (hospital acquired) 
infections.
Repeated invasive therapy using short or long 
term central venous access devices (CVAD).
Increased exposure to CVAD associated 
infections.
Bone marrow suppression due to disease Bone marrow suppression results in
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infiltration of the marrow or metastatic disease 
involving the bone.
pancytopaenia with a resultant lowering of the 
white cell count, the platelet count and the red 
cell count. The white cells are the body's first 
and most important response to infection.
Bone marrow suppression as a result of 
treatment, either chemo or radiotherapy.
The resultant neutropenia (reduction in the 
absolute neutrophil count (ANC)) renders the 
body susceptible to infections.
Malnutrition associated with disease or treatment Poor immunity and resistance to infection.
Predominantly older population more likely to 
have co-morbid conditions.
Generally frail health, likely to be less resistant 
to infections.
Increased exposure to transfused blood and its 
components, either as a result of repeated surgery 
or the disease and chemo/radiotherapy.
The transfusion of donated blood and its 
components such as platelets, clotting factors 
and fibrinogen carry the risk of transmitting 
donor infections.
For any patient who develops sepsis and multi-organ failure the experience is 
frightening, uncomfortable and often life threatening. Patients are hospitalised and 
need immediate invasive therapy and admission to the Critical Care Unit.
1.3 The focus of research in sepsis and cancer care
In cancer and sepsis research, much work has focused on the treatment of infection 
and the management of sepsis, especially in the following areas:
• improved anti-microbial agents;
• improved agents to reverse the immunological sequelae associated with sepsis 
and severe sepsis (Pastores et al 2002, Vincent and Jacobs 2003); and
• agents to support the host's defence against infection (Wheeler et al 1999,
Yan et al 2001, Dolan et al 2005).
1.4 Overall aim of this research study and rationale
This study was designed to tackle sepsis from another angle, that of the early 
identification of sepsis. The overall aim of the study was to investigate the nurses’
14 o f 355
role in the early diagnosis of sepsis and to provide nurses with a new objective tool 
and dedicated education to improve early diagnosis and rescue.
The sepsis syndrome has been defined as having four stages, with one being the 
earliest and fourth the latest and worst. Diagnosis and treatment at an earlier stage 
has been demonstrated to improve morbidity and mortality (Gattinoni et al 1995, 
Rivers et al 2001, Dellinger et al 2004, Rhodes et al 2004, Trzeciak et al 2007, 
Dellinger 2008. Each stage has defining characteristics and is described further in 
chapter three (Bone et al 1992, Dellinger et al 2004,2008).
The four stages of the sepsis syndrome are:
1. Systemic Inflammatory Response Syndrome (SIRS);
2. Sepsis;
3. Severe Sepsis; and
4. Septic Shock and Multi-Organ Dysfunction Syndrome (MODS).
1.5 Rapid deterioration of the person with cancer who 
develops sepsis
In those patients who have cancer and are immune compromised, the time from the 
onset of SIRS to the development of sepsis may be short. It is therefore essential to 
identify patients early to minimise the chance of further deterioration. The rationale 
for this study, therefore, is the rapidity with which patients deteriorate and the 
importance of nurses being attuned to the risks and early signs of sepsis.
1.6 The role of the nurse in identifying sepsis
Nurses in the acute hospital setting are the healthcare professionals who spend the 
most time with a patient. For the nurse working in a cancer centre, one of the key 
parts of their monitoring role is to work with the patient and teach them to recognise 
and report key changes in their condition that may indicate sepsis or other cancer 
emergencies (Shannon-Dorcy 2002). The early changes associated with the first part 
of the sepsis continuum, SIRS, can be subtle and difficult to quantify. Nurses,
15 o f 355
patients and their families can often identify a change, although there may be few 
visible or measurable changes in the patient’s physiological parameters 
(Eggenberger et al 2004). One of the most important aspects of this study is the 
development of nurses’ awareness of the “at risk” patient and their sensitivity to 
early subtle changes or triggers.
Early signs may be the result of changes in biological parameters, but are manifest 
by subtle changes in the patient’s behaviour or appearance that the nurse notices 
because she/he has cared for the patient before. It is these early changes in a patient 
that can be used alongside an increased awareness and knowledge of the sepsis 
syndrome to aid in early recognition and so improve outcomes for patients (Cioffi 
2000a, b, Andrews and Waterman 2005).
1.7 The expert patient and intuition
An important philosophy underpinning this study is the “cancer patient as an expert” 
who understands their illness experience (Costain Shou 1999). Despite acute illness, 
patients with cancer are often able to recognise symptoms and changes which 
provide an early warning of sepsis. These subjective experiences (for example 
increased malaise, feelings of cold or flu-like symptoms, “not being as well”) are an 
important contribution to the early recognition and diagnosis of sepsis. Intuition 
experienced by the patient or nurse is an important part of the theoretical framework 
of this study where recognition of subtle change is so important. For this study it is 
explicitly Bemadetto Croce’s (1872) model of intuition that is being used and this is 
explored in detail in chapter four.
1.8 Development of the research idea
As the Nurse Consultant for Cancer: Critical Care, the researcher’s responsibility 
was to lead a comprehensive critical care service from CCU. There is recognition 
across the world that patients are referred late to critical care services. The evidence 
shows that ward patients are referred late, are sicker than other admissions, stay 
longer, and have a higher morbidity and mortality rate (McQuillan et al 1998,
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McGloin et al 1999, Goldhill et al 1999 Chellel et al 2002, Clarke and Aiken 2003, 
DH 2003, Goldhill 2005, Hillman et al 2005, Robson and Daniels 2008). In 2000, 
the researcher decided to use the 50% clinical practice element of the Nurse 
Consultant role to develop a critical care outreach service. This initiative was 
supported by the National Service Framework for Critical Care (DH 2000a). On 
developing the outreach service two issues were quickly apparent: sepsis was the 
most common non-elective reason for admission and patients were referred to CCU 
too late. Listening to the ward nurses it was apparent that they identified a problem 
but this was not translated into a referral. Reasons provided for delayed referral were 
lack of confidence by the nurse, self-identified gaps in their knowledge, inability to 
convince others -  usually junior doctors - and difficulty in recognition of acute 
illness. Patients also described knowing they were getting worse but said they had 
found it difficult to convince both nursing and medical staff. Finally, there were also 
examples of deterioration accompanied by organisational delays in mobilising 
appropriate rescue. Working closely with clinical teams, the researcher knew that to 
achieve sustained practice improvement the study would need to be designed in a 
way that recognised real practice as it happens every day on busy wards, where 
nurses and junior doctors have competing roles and imperatives and may be short 
staffed.
Further discussion with nurses and junior doctors revealed two key problems: first, a 
lack of knowledge of the dangers of sepsis and the speed of its development in the 
cancer patient; and secondly a gap in communication between nurses and junior 
doctors. Nurses felt that doctors listened more to numbers or objective data. Nurses 
knew the patient was deteriorating but felt they needed something more objective in 
order to convince others. This clinical experience led to the formulation of the 
research idea and the design of the study. The overall aim and subsidiary aims and 
objectives were developed from the theoretical framework that earlier diagnosis and 
optimal management of sepsis leads to decreased mortality. In practice that timely 
assessment would translate into earlier referral to critical care outreach, reduction in 
late admissions to CCU and therefore a decrease in morbidity and mortality. The 
emphasis of the study was to improve practice as it happens in reality and to 
integrate the research with nurses’ daily practice in an imperfect environment.
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Two interventions were identified: a targeted teaching initiative to be delivered to 
nurses working on the acute wards; and the introduction of a bedside tool to give 
nurses an objective measure that they could use to convince themselves and others of 
the need to act. The dedicated teaching session on the sepsis syndrome, early 
diagnosis and assessment, and the use of the predictive blood test (see appendix 6 for 
lesson plan) was provided to 177 ward and critical care nurses. Nurses and junior 
doctors typically use several blood tests as sepsis indicators: white blood cell (WBC) 
count, C-reactive protein (CRP) and arterial blood lactate. The bedside tool -  the 
PCT-Q -  was a new blood test to measure Procalcitonin (PCT, an early indicator of 
sepsis described further in chapter three). The PCT-Q had only previously been used 
worldwide in the CCU setting, but by definition patients in the CCU are already 
critically ill and the aim here was to identify deterioration at a much earlier stage. 
This was the first time in the world that the PCT-Q was used by ward nurses.
Junior doctors in the study hospital are composed of Senior House Officers (SHOs) 
and Specialist Registrars. The former rotate to the hospital for six months, have 
minimal cancer knowledge and have not established a relationship with the nurses. 
These junior doctors did not feel they could change practice on anything other than 
objective data and also identified that they lacked knowledge of the acutely 
deteriorating cancer patient. Although not the subject of this study, additions were 
made to their induction and mandatory training programme in collaboration with the 
clinical tutor.
1.9 Relevance and contribution to nursing practice
Medical cancer research is aimed at improving curative cancer therapies. Nursing 
cancer research has predominantly concentrated on describing the patient 
experience, reducing symptomatology, information giving and helping patients to 
live with long-term effects of cancer and its treatment “(Davidson et al 2006, Pattison 
et al 2007, Faithfull and White 2008). This study aimed to reduce the risk of a life- 
threatening event during acute cancer treatment, in an area not previously researched 
in the cancer literature. There is a growing body of research in the critical care 
literature on the early diagnosis and interventions for sepsis (Gattinoni et al 1995,
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Rivers et al 2001, Dellinger et al 2004, 2008, Rhodes et al 2004, Trzeciak et al 
2007).
Severe sepsis is most likely to develop when the person is neutropenic but can occur 
at any time (Ellerhorst-Ryan 2000, Vidal 2004, Safdar et al 2006,). The person with 
cancer is susceptible to infection and sepsis for many reasons, but particularly due to 
changes in their immune system (Tervit and Phillips 2006). Having developed 
sepsis, the person with cancer is also more likely to die from it (Groeger 1991, 
Aisenberg et al 2004, Cone et al 2004).
The justification for the study was the imperative to raise nurses’ awareness of sepsis 
and particularly to improve the earlier identification of the patient who is developing 
sepsis. As discussed in chapter three there is a growing body of evidence that early 
identification of sepsis followed by appropriate action leads to reduced morbidity 
and mortality rates (Gattinoni et al 1995, Rivers et al 2001, Dellinger et al 2004, 
Rhodes et al 2004, Trzeciak et al 2007, Dellinger 2008).
When severe sepsis is established the organs fail and the patient is critically ill. In 
the early stages of the syndrome, however, there are often few hard clinical signs, 
and yet it is at this stage that multi-organ failure may be averted by prompt action, 
described in the literature as rescue or early goal directed therapy (Gattinoni et al 
1995, Rivers et al 2001, Dellinger et al 2004, Goldhill and McNarry 2004, Rhodes et 
al 2004, Ridley 2005, Trzeciak et al 2007).
1.10 Failure to rescue
Clinicians working in acute areas often report that the patient, their family and the 
nurses working with them knew there was something wrong, but for a variety of 
reasons the appropriate rescue package was delayed (Benner et al 1999, Clarke and 
Aiken 2003, Goldhill 2005). This experience is corroborated by many publications 
and studies over the last 10 years. Publications reveal several reasons for delay in the 
appropriate management of patients: lack of communication throughout the team and 
between teams, lack of education and experience regarding acute care, and a 
reluctance to refer to more senior colleagues and/or other teams (McQuillan et al
19 o f 355
1998, McGloin et al 1999, Goldhill et al 1999, Chellel et al 2002, Clarke and Aiken 
2003, DH 2003, Goldhill et al 2005).
1.11 The context of care
This study was undertaken at a time of growing challenges for the ward nurse, who 
has to navigate a complex array of professionals, agencies, and patient and family 
needs. Ward nurses are caring for increasingly ill patients who are likely to 
deteriorate quickly, against a background of an acute nursing shortage (Finlayson et 
a\ 2002, Meleis 2005). There are also growing technological changes, particularly in 
cancer care, and an increase in the public’s expectations of care. Finally, people with 
cancer, in common with other people experiencing chronic illness, are often well 
educated about their disease, its monitoring and treatment. This patient knowledge is 
important when encouraging active participation in care but can also be daunting for 
the nurse or doctor who is new to cancer care (Tattersall 2002, DH 2002, Mechanic
2004).
The role of the nurse working with people who have cancer on a general ward or a 
haematology unit is diverse, but for this study it was their role as it applies to the 
assessment and rescue of the patient deteriorating which was of interest. One of the 
problems highlighted by staff nurses is their inability to convince others of the 
results of their assessment, observation and monitoring. During this study, one of the 
areas explored in interviews was whether the nurses found it difficult to convince 
others of their findings. Liaschenko (1998) suggests that those nursing testimonies 
that are regarded as legitimate are those that are within the normal boundaries of 
scientific medicine (Liaschenko 1998, p. 11). In practice, examples of those 
observations that are easily assimilated are a temperature recording or a 12 lead 
Electrocardiogram (ECG), other observations such as a subtle change in behaviour 
or appearance may not be credible (Cioffi 2000a).
Nurses often describe the difference in effect when a more senior member of the 
team provides information to members of another discipline or indeed within 
nursing. It is part of our behaviour of working with others that we constantly make 
judgements about oral testimony and its relative value based on our previous
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experience of the narrator. If, previously, we have found a nurse to have been 
accurate in her assessment, this will colour our judgement for further interactions; 
the opposite is also true. This judgement may be based on seniority, previous 
interaction or because during the oral testimony we are convinced by the teller. 
There may also, however, be something else at work here. One of the skills learnt by 
nurses whose work involves crossing professional boundaries is that of speaking or 
providing information in a particular form or style. Chase (1995) and Andrews and 
Waterman (2005) describe this as “packaging information”. This may be almost 
unconscious, but if made overt can be reflected upon and taught so that 
communication between disciplines is more effective. An example of this may be the 
attempt to describe how a patient is “not quite right” or “not the same as they were 
earlier” although there is little “objective” scientific data to support this perceived 
change (Smith 1988, Daffum et al 1994, Cioffi 2000a, b). In many of these 
situations, nurses recount frustration that they cannot communicate this change. It is 
only when the person starts to deteriorate and there are measurable changes in their 
blood pressure, for example, that others are convinced (Cioffi 2000a, b, Andrews 
and Waterman 2005).
Staff nurses do describe finding ways around this problem: asking a more senior 
nurse to come and make an assessment and then to speak to the team, or approaching 
a more senior doctor who they know, or calling the Critical Care Outreach team.
1.12 Critical Care Outreach and Medical Emergency 
Teams: a method of improving communication and 
“rescue”
Following research in the UK and Australia recognising “failure to rescue” on 
general wards, the Department of Health (DH) in its national service framework for 
critical care described the need for a critical care service integrated with the whole 
hospital (DH 2000a). Critical Care Outreach Teams (CCOT) were to provide the link 
between wards and the critical care service by providing the following roles (DH 
2000a):
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1. “To avert admissions by identifying patients who are deteriorating 
and either helping them to prevent admission or ensuring that 
admission to a critical care bed happens in a timely manner to 
ensure best outcome.
2. To enable discharge by supporting the continuing recovery of 
discharged patients on wards and post discharge from hospital, 
and their relatives and friends.
3. To share critical care skills with staff in wards and the community 
ensuring enhancement of training opportunities and skills practice 
and to use information gathered from the ward and community to 
improve critical care services for patients and relatives” (DH 
2000a).
The UK Intensive Care Society (ICS 2002) added two further roles in 2002:
“To promote continuity of care.
To ensure thorough audit and evaluation of outreach services” (ICS 
2002).
The DH also recommended, in Comprehensive Critical Care (2000a), that hospitals 
use a system of physiologically-based Early Warning Score (EWS) or Modified 
Early Warning Score (MEWS) to identify and monitor patients. These tools, which 
award points for degrees of physiological abnormality, are used by nurses to 
communicate with doctors and the multidisciplinary team. Several studies since 
2000 have investigated the efficacy of the CCOT and the MEWS in improving 
communication, care and outcome. The studies investigating the provision of the 
CCOT have been hampered by methodological difficulties, but several have shown 
that the CCOT reduce mortality and cardiac arrests on general wards (Buist et al 
2002, Kern et al 2002, Bellomo et al 2003, Bellomo et al 2004, Priestley et al 2004). 
Ball et al (2003) demonstrated some decrease in readmission rates to critical care 
whereas Leary and Ridley (2003) were unable to demonstrate this. A high MEWS 
score (3 or more abnormalities equalled 21.3% mortality n=433 ward patients) has 
been shown to correlate strongly with 30-day hospital mortality (Goldhill and 
McNarry 2004) and in one study to increase confidence and effective 
communication between nurses and doctors (Andrews and Waterman 2005). Subbe
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et al (2003) found that the introduction of the MEWS did not improve 
communication or patient outcomes. The MEWS is sensitive in predicting critical 
illness and can be a useful adjunct to communication (Ryan et al 2004). Other 
factors that have been shown to improve nursing confidence and effectiveness in 
communicating and managing acute deterioration are:
1. Applied clinical knowledge of pathophysiology and physical assessment 
skills (McArthur-Rouse 2001, Smith 2001, Coombs and Morse 2002, Adams 
and Bond 2003b, Andrews and Waterman 2005).
2. The stability of nursing teams (Adams and Bond 2003a).
3. The nurse-to-patient ratio (Silber et al 1995, Aiken et al 2002, Needleman et 
al 2002, Adams and Bond 2003b, Curtin 2003).
4. Appropriate skill mix for patient dependency (McArthur-Rouse 2001, Adams 
and Bond 2003b, Clarke and Aiken 2003, Curtin 2003, Lankshear et al 
2005).
It is important that nurses continue to lobby to improve the four factors cited above. 
In practice, however, nurses are working in sub-optimal environments and tools such 
as the MEWS or, as in this study, the PCT-Q may help simplify patient assessment 
and aid in communication.
1.13 Study design
The study was composed of five stages: the first two were pre and post-intervention 
and consisted of 10 qualitative interviews with nurses from different specialties and 
varying levels of experience, and a pre and post intervention questionnaire survey to 
177 nurses from all acute wards. The third stage was the introduction of the two 
interventions: a dedicated teaching session on sepsis and an introduction to the sepsis
marker blood test the PCT-Q. The fourth stage was the use of the PCT-Q Q in 416
*
sepsis episodes in 320 acutely ill cancer patients alongside other predictive markers 
already used in the hospital. In order to retain sufficient power for multivariate 
regression to compare predictors of sepsis, a total of 400 episodes was planned. 
Finally the fifth stage was the integration of the qualitative data from the interviews
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and the open question in the questionnaires and comparison with the quantitative 
data.
1.14 Overview of chapters two to eleven
Chapters two and three provide the cancer and sepsis literature that forms the 
background to the study, the rationale for the development in practice, and the choice 
of sepsis marker. Chapter four focuses in detail on nurses’ clinical practice, 
particularly their sensitivity to patient deterioration and the knowledge they use 
when assessing the acutely unwell cancer patient. Chapter five provides the 
explanation for the choice of design and the methodological approach to the study. 
The findings are presented in chapters six, seven and eight: first, the findings from 
the interviews with the nurses and the free text from the nurse questionnaire, 
secondly the data from the pre and post-questionnaire survey of bedside nurses 
across the trust, and finally the patient data. Chapter nine discusses the findings in 
relation to the literature and clinical practice. Lastly, chapter ten provides the 
conclusion to the thesis and implications for future research.
1.15 Conclusion
This study was therefore designed to investigate the nurses’ role in the early 
diagnosis of sepsis and to provide nurses with a new objective tool and dedicated 
education to improve early diagnosis and rescue. The primary objective was to 
diagnose patients' sepsis at an earlier stage, recognising that nurses report a difficulty 
in convincing colleagues, an objective bedside test was to be introduced to improve 
multi-professional communication and therefore rescue. There were eight secondary 
objectives designed to achieve the overall and subsidiary aims of the study. The 
design of the study with its five stages is explained in more detail in chapter five.
The whole of the study was underpinned by a five part theoretical framework: the 
vulnerability of cancer patients to developing sepsis; early diagnosis and treatment 
reduce mortality and morbidity; nurses intuit subtle change which can be a stimulus 
to act; the awareness of risk highlighted by education; and information packaged as 
an objective test aids effective multi-professional communication and rescue.
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Chapter 2 Cancer and vulnerability to 
infection and sepsis
2.1 Introduction
The immune system is responsible for protecting the body from infection and 
disease, and for maintaining a stable environment. It also plays an important role in 
carcinogenesis. This chapter discusses cancer and its effect on the immune system, 
and explains why people with cancer are so vulnerable to infection and hence why 
this study is so important.
2.2 What is cancer?
Cancer is a term that covers over 200 different types of disease resulting from the 
abnormal proliferation of cells which either mass together and form a tumour or, in 
the haematological cancers, stay in the blood or lymphatic system. Some cancers are 
rapidly growing, whilst others are indolent, taking years to become clinically 
significant. Cancer affects all ages but is more common in the older person. Cancers 
can be superficially divided into the solid tumours and the haematological cancers. 
Solid tumours are treated by a single therapy or more commonly by a combination of 
chemotherapy, surgery, radiotherapy, and hormonal, targeted and genetic therapies. 
The haematological cancers leukaemia, myeloma and lymphoma change the 
constitution of the blood, bone marrow and lymphatic system and thus require 
treatments that replace the diseased marrow, for example blood or marrow 
transplantation.
2.3 Epidemiology of cancer
There are national and international variations in the incidence and mortality of 
cancer related to income, lifestyle, genetic influence and access to prevention, 
screening and treatment. Across the world, incidence and mortality is higher in men 
than in women (Parkin et al 2001). In sub-Saharan Africa reduced life expectancy 
due to infectious diseases such as HIV and AIDS, tuberculosis and malaria means
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that cancer is less prevalent (Murray et al 1997). By 2020, however, it is predicted 
that tobacco-related cancers such as lung cancer will feature in the 15 leading causes 
of death across the world (Evans et al 2006). Across Europe approximately one in 
four deaths are due to cancer and there are over one million deaths per annum 
(Cancer Research UK 2005).
Across the UK, the incidence of cancer increases in areas of social deprivation 
associated with higher tobacco use, poorer diet, delayed diagnosis and delays in 
treatment, particularly for some cancers such as oesophageal (DH 2004, Quinn et al
2005).
Growth in incidence of the rarer cancers is relevant to this study, as it is the 
haematological and gastrointestinal cancers that are particularly associated with the 
risk of sepsis and with poorer outcomes once it has developed. The age-standardised 
incidence rate for the haematological cancers is rising, for example the incidence of 
non-Hodgkin’s lymphomas is increasing by an average of 1.2% a year (Cancer 
Research UK 2005). Oesophageal cancer incidence is also rising, with the UK rates 
being some of the highest in Europe (Gilbert et al 2002). In the UK the highest rates 
of oesophageal cancer are seen in Scotland and urban areas of north-west England 
and Wales (Quinn et al 2005). The general rise in the age-standardised incidence of 
oesophageal cancer, from 11.3 per 100,000 in 1975 to 18 per 100,000 in 2002 
(Cancer Research UK 2005), affects admissions to all cancer centres. Due to changes 
in demographics, treatment regimens, incidence increase and cancer services 
reconfiguration there is a growing population of patients in cancer centres who are at 
risk of developing sepsis.
2.4 Immunology and cancer
The primary function of the immune system is to protect against infective micro 
organisms and against cells that have transformed and become infected, such as 
cancer cells, cells received from donation or transplant (blood or marrow) and cells 
which die (Moore 2006). The body’s immunity against infection is achieved through 
a complex networking of innate and acquired immunity.
26 o f355
2.4.1 Innate (non-specific) immunity
This is the system of mechanisms responsible for the killing and removal of foreign 
macromolecules and pathogens (Moore 2006). Innate immunity relies on the 
following mechanisms:
1. Barriers;
2. Inflammation;
3. Phagocytosis and complement activity;
4. Complement;
5. Natural Killer (NK) cells;
6. Antimicrobial proteins.
2.4.2 Acquired immunity
Acquired, adaptive or specific immunity is the system of mechanisms that 
recognises, immobilises, destroys and eliminates foreign micro organisms, abnormal 
body cells and pathogens (Marieb 2008). Acquired immunity is mediated by two 
classes of lymphocytes: B and T lymphocytes, known respectively as B cells and T 
cells. B and T cells derive from the pluripotent stem cells of the bone marrow. B 
cells kill pathogens indirectly through the production of antibodies that kill the 
pathogen either directly or indirectly by controlling other immune mechanisms 
(Thibodeau and Patton 2003, Moore 2006). T cells have a direct action on 
pathogens, and their mechanism is therefore known as cell mediated immunity 
(Moore 2006). Acquired immunity depends on an immunological memory 
developed once the body has been exposed to a foreign antigen. B and T cells 
express unique surface markers that are different from each other (Thibodeau and 
Patton 2003). The international classification system for surface markers is the 
Cluster Designation (CD) system followed by a number. The helper T cell expresses 
CD4 and the cytotoxic T cell CD 8 surface markers (Moore 2006).
Specific acquired immunity defences are:
1. Antigens;
2. Major Histocompatability Complex (MHC) molecules;
3. B lymphocytes;
27 o f355
4. T Lymphocytes, Helper T lymphocytes,Cytotoxic T lymphocytes; and
5. Antibodies (Cheng et al 2000, Janeway et al 2001, Marieb 2001, Moore 
2006).
The immune response to an antigen is therefore a complex network of mechanisms 
that may include both innate and acquired responses.
2.5 Inflammatory response to an infection: the beginning of the 
sepsis syndrome
An infection will result in an inflammatory response, including the activation of 
polymorphonuclear cells and complement, acute phase proteins, the clotting cascade 
and kinins, phagocytosis, production of cytokines and activation of macrophages and 
Natural Killer (NK) cells. If the micro organism is not stopped by the inflammatory 
response then a specific immune response will be initiated, often with both T and B 
cell response (Staines et al 1993, Moore 2006). The immune system is also closely 
related to cancer, with some tumours being associated with immunosupression: 
Kaposi’s sarcoma and lymphoma are linked to HIV (Tulpule et al 1999, Cannon et 
a /2000).
The patients with the highest potential risk of sepsis are those whose bone marrow 
has become disrupted due to either the disease or the cancer treatment. Major 
disruption of the bone marrow myelosuppression results in the loss of the 
polymorphonuclear cells, one of the major defences against infection. A summary of 
the normal function of the bone marrow as it relates to infection is therefore 
provided.
2.6 Normal function of the bone marrow related to infection
The bone marrow produces the myeloid cell line generating red blood cells, white 
blood cells and platelets. These cells are responsible for the carriage of oxygen, 
protection from infection and the ability of the blood to clot (Traynor 2006). Cancer 
or the treatment of cancer results in alterations to the function of the bone marrow, 
and depending on the severity and duration of this malfunction the person will be 
severely debilitated and may face severe life-threatening complications (Dolan 
2006).
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Haematopoiesis (blood cell production) is an important function for this study as 
patients who have a cancer affecting their bone marrow or have received marrow 
ablative chemotherapy need to wait for cell maturation to achieve immunity to 
infection. These patients are therefore vulnerable to infection and sepsis for days or 
weeks. Cell production occurs in the red bone marrow of the axial skeleton and 
girdles and in the proximal epiphyses of the humerus and femur (Marieb 2008). 
Haematopoiesis is controlled by a complex network of growth factors, cytokines, 
and chemokines (Janowska-Wieczorek et al 2001). Cells are formed at a different 
rate depending on the changing needs of the body and the regulation of each cell. All 
of the cells originate from the same source, the pluripotent stem cell, but then go on 
to mature along different pathways signalled by membrane surface receptors that 
respond to particular growth factors or hormones (see figure 2.1). Each cell has a 
distinct function as it reaches maturity (Traynor 2006, Marieb 2008).
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Figure 2.1: Haematopoiesis
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Key:
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Leukocytes or white blood cells (WBC) account for only 1% of the total blood 
volume and function extravascularly (Traynor 2006). WBC are essential as a host 
defence against disease including infections, poisons and tumour cells. There are 
4,000-11,000 WBC per cubic millimetre of blood. To mount an inflammatory or 
immune response the body accelerates their production, so a high WBC count is a 
useful clinical indicator of infection. There are five types of WBC (see table 2.1) 
with the neutrophils being the most numerous and the most important group in 
fighting infections, particularly bacterial and fungal. Neutrophils respond to 
chemotactic factors released from damaged tissues and bacteria and move to 
infective sites. The endotoxin of a gram negative bacterial infection causes a 
neutropenia until the healthy marrow responds causing a neutrophilia (Babior and 
Golde 2001, Marieb 2001, Traynor 2006).
Table 2.1: Types of white blood cells
Type of cell Number of cells 
in the blood 
(mm3)
Life span Function
Neutrophil 3000-7000 6 hours to a few 
days
Bacterial kill
Eosinophil 100-400 8-12 days Kill parasitic worms, 
destroy antigen-antibody 
complexes, inactivate 
some of the inflammatory 
chemicals of allergy
Basophil 20-50 Probably a few 
hours to a few days
The release of histamine 
and other mediators of 
inflammation
Lymphocyte 1500-3000 Hours to years Immune response by direct 
cell attack or via antibodies
Monocyte 100-700 Months Phagocytosis
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2.7 Myelosuppression
Myelosuppression is the most common and potentially life-threatening effect of 
cancer and its treatment (Tervit and Phillips 2006). The three blood cells that are 
affected by myelosuppression are the erythrocyte (red blood cell) leukocyte (white 
blood cell) and thrombocyte (platelet) (see figure 2.1). Severe myelosupression will 
diminish ability to transport oxygen (erythrocytes) and clot the blood (platelets), 
both important factors in the development of multi-organ failure, but it is the effect 
on immunity that is most important for this study. Risk factors for developing 
myelosuppression can be divided into three areas: patient characteristics, treatment 
and patient risk history (Lyman et al 2003).
2.7.1 Patient characteristics
A patient risk framework has been developed from the evidence of several studies. 
Lyman et al (2003) looked at 577 patients with lymphoma receiving combination 
chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisolone). They 
found that patients aged 65 years and over were twice as likely to experience 
myelosuppression. In a study of patients with non-Hodgkins lymphoma, 
Intragumtomchai et al (2003) showed that a raised serum lactate dehydrogenase 
(LDH), lowered serum albumin and tumour involvement of the bone marrow all 
contributed to a greater risk. Therefore patient risk factors are: age greater than 65 
years, female, lowered albumin, raised LDH and decreased performance status and 
weight (Lyman et al 2003).
2.7.2 Treatment cycle-related risk factors
In a study of 175 breast cancer patients, Silber et al (1998) found that patients 
receiving both chemotherapy and radiotherapy were at higher risk, as well as those 
patients whose absolute neutrophil count (ANC) dropped during the first cycle of 
chemotherapy. Rivera et al (2002) validated the Silber study with another cohort of 
breast cancer patients.
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2.7.3 Treatment-related risk factors
Chemotherapy drugs and regimens have different potentials for myelosuppression 
(Beveridge et al 2003, Dolan et al 2005). Patients who undergo a bone marrow 
transplant (BMT) or peripheral blood stem cell transplant (PBST) receive high doses 
of chemotherapy, often in combination with radiotherapy, and are therefore at the 
highest risk of treatment-induced myelosuppression (Outhwaite 2000, Dolan 2005).
The haematological cancers are associated with a greater risk of myelosuppression as 
the cancer located in the bone marrow disrupts normal cell distribution. At diagnosis 
the patient with an acute leukaemia, for example acute myeloid leukaemia (AML), 
may present with bone marrow failure resulting in infection, bleeding, anaemia or all 
three (Howard and Hamilton 2002). Solid cancers, particularly breast, prostate, lung 
and adenocarcinoma, can metastasise to the bone marrow with resultant 
myelosupression, although usually not to such a degree as the haematological 
cancers (Howard and Hamilton 2002).
Treatment-induced myelosuppression can be understood in terms of how 
chemotherapy affects both the malignant and the normal cell cycle. Chemotherapy 
interferes with the synthesis of deoxynucleic acid (DNA), ribonucleic acid (RNA) 
and proteins and leads to cell death. Some drugs are specific to phases of the cell 
cycle and some are effective throughout the cycle (Tervit and Phillips 2006). 
Chemotherapy is directed at rapidly dividing malignant cells, but normal cells that 
have similar rapid cell doubling times such as bone marrow, hair follicles and 
epithelial cells of the gastrointestinal tract and gonads are also affected by 
chemotherapy (Tortorice 2000). Unlike cancer cells, normal cells have the ability to 
repair, therefore gastrointestinal toxicity, myelotoxicity and alopecia are usually 
reversible (Wujcik 1992, Tervit and Phillips 2006).
Radiotherapy damages all cells indiscriminately, both directly by the gamma or x- 
rays breaking the chemical bonds of the cellular DNA and indirectly by biological 
damage to chromosomes (Bomford and Kunkler 2003, Cule and Butters 2006). Bone 
marrow is highly sensitive to radiation with damage to the bone marrow dependent 
on the treatment field. The pelvic area is the most vulnerable to damage, as about 
40% of the marrow-producing bone is located in this area (Souhami and Tobias
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1998). If the radiotherapy doses are small the unaffected bone marrow sites will 
compensate, but in the case of patients who are receiving total body irradiation 
(haemato-oncology) or total pelvic or splenic radiation there is a higher risk of 
myelosuppression (Quinn and Stephens 2006).
Two further factors are essential in identifying risk for myelosuppression: the impact 
of multimodality treatment, for example patients receiving chemotherapy whose 
bone marrow has previously been subjected to radiotherapy (Camp-Sorrell 2000); 
and the cumulative effect that successive chemotherapy cycles have on bone marrow 
suppression (Camp-Sorrell 2000, Dolan et al 2005, Smith et al 2006).
2.8 Effects of myelosuppression on the person with cancer
Some patients develop a generalised bone marrow suppression with all three blood 
cells affected, others have one or two cell lines affected. All three lines are essential 
to health, but for this study the most important are those that protect the body from 
infection -  the white blood cells and particularly the neutrophils.
The patient is usually unaware that their WBC count has fallen to a dangerous level. 
As the neutrophils are the most important in terms of infection, it is usually the 
neutrophil count that is used to monitor the patient’s clinical condition. The severity 
of the neutropenia is defined according to the National Cancer Institute (NCI) 
grading system (see figure 2.2):
Figure 2.2: NCI grading of neutropenia (NCI CTEP (1999) Common Toxicity 
Criteria: Neutropenia)
Grade 1 2 3 4
Mild Moderate Severe Life-threatening
Absolute
Neutrophil
Count
<2.0-1.5x 107L <1.5-1 x 107L <1.0-0.5 x 109/L < 0.5 x 10 Vl
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A lowered neutrophil count exposes the patient to infections that can be life 
threatening. Infection is the major cause of death in patients who are neutropenic 
(Ellerhorst-Ryan 2000, Vidal 2004, Dolan et al 2005, 2006, Safdar et al 2006). The 
incidence of infection is associated with the severity and duration of neutropenia 
(Bodey 1966, Meza et al 2002, Lyman, 2003, 2005). Patients who have experienced 
neutropenic infections have a higher chance of developing another event during 
subsequent neutropenic periods (Leonard et al 2003). Severe neutropenia with WBC 
count of <1.0 exposes the patient to life-threatening opportunistic infections from 
microorganisms that usually pose no threat (Offidani et al 2004). The common sites 
of infection in patients with a low neutrophil count are the lungs, skin and soft tissue, 
urinary tract, periodonteum, gastrointestinal tract, blood and perineum (Urabe 2004). 
Neutropenia is the most common reason for chemotherapy dose limitation or a delay 
which may affect the patient’s overall outcome (Bonadonna 1995, Budman et al 
1998, Link et al 2001, Dolan et al 2005, Smith et al 2006). Assessment of 
neutropenia risk is made using a full blood count coupled with patient risk 
modelling: patient characteristics, type of cancer and treatment. Education about risk 
and minimising infection for the patient, family, and nursing and medical teams is an 
important aspect of care.
2.9 Management of lowered WBC
The aim is to minimise the risk of neutropenic events such as sepsis. An essential 
treatment is the use of Granulocyte-Colony Stimulating Factor (G-CSF) to reduce 
the duration and depth of neutropenia (Ozer et al 2000, Dolan et al 2005, Smith et al 
2006).
Naturally occurring G-CSF is produced by endothelium, macrophages and other 
immune cells. Mouse G-CSF was first identified in 1983 and cloned for clinical use 
in 1986. G-CSF is a glycoprotein that stimulates the bone marrow to produce 
granulocytes, while also stimulating the differentiation, proliferation and survival of 
neutrophils. American Society of Clinical Oncology guidelines recommend using 
primary (prophylactic) administration of G-CSF if the patient is at high risk due to 
age above 65, medical history, disease characteristics, and the myelotoxicity of the 
chemotherapy regimen (Smith et al 2006). The European Organisation for the
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Research and Treatment of Cancer guidelines also recommend proactive treatment 
with G-CSF in the person over 65 who is receiving myelotoxic therapy for non- 
Hodgkins lymphoma, small cell lung cancer or urothelial cancer (Lyman et al 2003, 
Repetto et al 2003, Aapro et al 2006, Smith et al 2006).
2.10 Treatment of cancer
With over 200 different types of cancer and many approaches to cancer treatment it 
is impossible here to describe a typical cancer treatment regimen. To provide the 
context, especially the risk of sepsis, two specific treatment examples are provided 
for two of the dominant cancers represented in the research study: leukaemia and 
oesophageal cancer.
2.10.1 Leukaemia
The leukaemias are a heterogenous group of malignant blood diseases including 
acute and chronic forms and further subdivided depending on morphology, 
cytogenetics, molecular genetics and immunological markers (Jaffe et al 2001, 
Atkinson and Richardson 2006). The four most common types of leukaemia are 
acute and chronic myeloid leukaemia and acute and chronic lymphoblastic 
leukaemia (Atkinson and Richardson 2006). Each type of leukaemia is managed 
differently; the treatment presented here is for a subtype that forms a large 
percentage of the study sample: acute myeloid leukaemia (AML).
The treatment for AML is chemotherapy +/- radiotherapy +/- a transplant to achieve 
a complete remission, defined as less than 5% blasts in the bone marrow and 
eradication of any disease in the central nervous system (Howard and Hamilton 
2002, Sheinberg et al 2005). The treatment is divided into two phases: induction (to 
achieve remission) and postremission consolidation treatment (to avoid relapse). The 
treatment for AML is intensive hospital treatment for several weeks in a designated 
haematology centre accredited to perform BMT.
[
i
Induction chemotherapy and radiotherapy is followed by either an allogeneic or an 
i autologous transplant. In AML, autologous transplant has been shown to be less
effective (Soutar and King 1995, Atkinson and Richardson 2006) and research has
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therefore focused on allogeneic transplantation (NICE 2004). Allogeneic transplants 
achieve longer disease-free survival but are associated with greater toxicity from 
sepsis, acute graft versus host disease (aGvHD), venus occlusive disease (VOD) and 
pneumonitis (Balsdon and Craig 2003). More recently, non-myeloblative reduced 
intensity or mini allogeneic transplants have been tried, especially in the frail patient. 
There is less toxicity but relapse is a significant risk (Richardson and Atkinson
2006).
Many toxicities are associated with the treatment for AML, but important for this 
study is the severe myelosuppression that begins five to seven days following 
transplantation and lasts for two to four weeks depending on the patient, disease and 
treatment regimen (Richardson and Atkinson 2006). Having ablated the patient’s 
diseased marrow with drugs and radiotherapy the patient is pancytopenic until 
donated marrow cells have reached the bone marrow and normal haematopoiesis has 
begun. It is during this acute pancytopenic period that patients are at risk of life- 
threatening bleeds and sepsis.
Severe infections and sepsis are the major cause of death in the transplant period 
(Williamson et al 1999, Pastores et al 2002), hence the impetus for the current 
research study. To minimise the risk, patients are nursed in isolation with or without 
hepa-filtration and lamina air flow. Studies into isolation techniques for allogeneic 
transplant are not conclusive and practice varies (Parker 1999, Richardson and 
Atkinson 2006). Patients are closely monitored for signs of infection and are 
commenced on empirical broad spectrum antimicrobial therapy (Whedon and 
Wujcik 1997, Richardson and Atkinson 2006). It is during this period that patients 
with AML who develop sepsis are referred to the critical care outreach team and, if 
they deteriorate, to the CCU. Following this acute phase of treatment the patient is 
supported to recover and then after about six weeks is discharged home. Acute 
hospitalisation is followed by months of outpatient care monitoring haematological 
markers, levels of anti-rejection drugs and treatment with prophylactic 
antimicrobials (Whedon and Wujcik 1997, Richardson and Atkinson 2006).
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2.10.2 Oesophageal cancer
Oesophageal cancer now accounts for 2.2% of all cancers and the incidence is 
increasing (Malthaner et al 2006). Many patients present late with widespread 
metastases and oesophageal cancer is the sixth most frequent reason for cancer 
death, annually causing over 286,000 deaths worldwide (Pisani et al 1999). Where 
treatment is possible the patient faces complex invasive therapy that requires 
hospitalisation in a recognised cancer centre (DH 2001). Oesophageal cancer is 
histologically usually either adenocarcinoma or squamous cell cancer (Thompson 
and Wells 2006).
For patients who are potentially curable, multidisciplinary assessment is essential to 
plan a complex combination of surgery, chemotherapy and radiotherapy (Thompson 
and Wells 2006). For localised disease, surgery is the treatment choice with cure 
achieved in only 15% to 39% of patients (Law et al 1992, Lerut et al 1992, Orringer 
1993, Lieberman et al 1995). To improve survival several studies have investigated 
preoperative chemotherapy. Reviews conducted by Malthaner et al (2003), 
Kaklamanos et al (2003), Chong and Cunningham (2005) and Malthaner et al (2006) 
concluded that there may be a small survival benefit but that further evidence is 
needed. The survival benefit is balanced against the risk of added toxicity. A meta­
analysis of five studies comparing preoperative radiotherapy with no preoperative 
radiotherapy in 1147 patients demonstrated a small absolute survival advantage of 
3% to 4% (95% Cl 0.78-1.01) (Amott et al 2005). Finally, for non-resectable 
oesophageal cancer combined chemotherapy and radiotherapy as opposed to 
radiotherapy alone in a review of nineteen randomised trials demonstrated a modest 
absolute survival benefit of 9% (95% Cl 5% to 12%) (Wong and Malthaner 2006).
Toxicities of treatment for oesophageal cancer are dependent on the patient, their 
comorbid disease, the cancer and the treatment regimen. As oesophageal cancer is 
associated with smoking and is more commonly found in men over the age of 50, 
patients often have co-existing ischeamic heart disease, chronic pulmonary disease 
and diabetes (Zambon et al 2000, Zeka et al 2003). Around 40% of patients 
undergoing surgery or multimodality treatment develop respiratory and cardiac 
complications (Gilbert et al 2002). Other complications are anastomotic leaks, deep 
vein thrombosis, and wound infection (Thompson and Wells 2006). Patients who
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have undergone chemotherapy and oesophagogastrectomy are admitted to CCU with 
a postoperative course that is often interrupted by severe pulmonary or abdominal 
infection leading to the possibility of sepsis. Patients undergoing multimodality 
therapy for oesophageal cancer are at increased risk from sepsis. Recovery from 
acute treatment may take several months while the patient learns to eat again and to 
restore their weight loss.
2.11 Conclusion
Cancer is a heterogenous disease with over 200 types requiring a large range of 
treatment modalities. There is an important relationship between the immune system 
and cancer. Many people with cancer will at some stage require treatment in 
hospital, during which they may be immunosuppressed as a result of the disease, the 
treatment or both. From the literature it is apparent that people who are 
immunosuppressed are more vulnerable to developing infections. People with 
haematological cancers or upper gastrointestinal cancer are more at risk of 
developing life-threatening infections. There is therefore a higher incidence of sepsis 
in cancer patients and a higher resulting mortality rate. Patients have more chance of 
surviving life-threatening infections if they are diagnosed early and this is the major 
objective of this study. In the next chapter, the link between sepsis, its epidemiology 
and cancer will be made.
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Chapter 3 Literature review: 
epidemiology, incidence and pathophysiology 
of sepsis, Procalcitonin
3.1 Introduction
The previous chapter described the biology of cancer, with particular emphasis on 
the importance of immunology. This chapter describes the sepsis syndrome, 
beginning with details of the systematic approach taken in this study to reviewing 
the published literature on the epidemiology of sepsis, and incidence and early 
diagnosis of sepsis. The early diagnosis of sepsis is a relatively new field with 
limited publications and even fewer applied to the person with cancer. Following 
this review of the literature, there is a summary of the relevant pathophysiology of 
sepsis, highlighting the altered immune response. Finally, the chapter concludes with 
a review of the predictive immunological markers of sepsis, with an emphasis on the 
rationale for choosing Procalcitonin (PCT).
3.2 Collecting the evidence
The modem study of sepsis dates from the seminal meeting in 1992 of the American 
College of Chest Physicians and the Society of Critical Care Medicine 
(ACCP/SCCM) (Bone 1992). This therefore provides the start date for the literature 
review. For the period 1992 to 2008, searches were conducted of the databases of 
Medline, Embase, Cinahl, The British Nursing Index and the Cochrane library. 
Manual searches of the following journals for the same period were also undertaken:
• Critical Care Medicine;
• Critical Care;
• Chest;
• Intensive and Critical Care Nursing;
• Journal of Advanced Nursing;
• European Journal of Cancer Care;
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• European Journal of Cancer.
A structured review of the literature based on a systematic approach to generating 
and selecting research-based literature was undertaken (Higgins et al 2008). All 
articles formally reviewed also had searches conducted of their reference lists.
Inclusion and exclusion criteria were identified to define and refine the parameters 
for the search. Abstracts of all papers conforming to the broad inclusion guidelines 
were reviewed and some papers immediately included. Where the abstract did not 
provide enough information the whole paper was reviewed before inclusion. Full 
papers were obtained of all material conforming to the inclusion criteria, which were 
then critically analysed before deciding on inclusion. As the search progressed more 
overlapping areas were found so that, by search four, although 950 papers were 
identified only 48 were new to the search and included. Duplicate references were 
removed. The papers were not graded for their level of evidence although they were 
all appraised.
3.3 Sepsis definition
In 1992, the ACCP and SCCM met in a consensus conference to define the sepsis 
syndrome for clinicians and researchers (Bone 1992). Following this seminal 
meeting over 3000 papers were published in English between 1992 and 2008, which 
focused on the identification and diagnosis, epidemiology, microbiology, definitions 
and management strategies for sepsis. Of the papers published during this period, 
459 focused on the adult with cancer who develops sepsis. For the purposes of this 
review, publications for review were limited to those that concentrate on the 
epidemiology, diagnosis, risk factors and predictive markers of sepsis. The initial 
review was not limited to papers focused on sepsis and cancer, as this would have 
limited its scope.
3.4 Inclusion and exclusion criteria
3.4.1 Inclusion criteria
1. Research papers focusing on adults
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2. International publications available in English
3. Research papers focusing on sepsis, severe sepsis and septic shock
4. Research papers focusing on the epidemiology of sepsis
5. Research papers on the diagnosis of sepsis
6. Research papers on sepsis and cancer
7. Research papers on the early diagnosis of sepsis.
3.4.2 Exclusion criteria
1. Research papers on children
2. Research not published or translated into English
3. Research before 1992
4. Review articles, commentaries, case studies
5. * Papers focusing on the treatment of sepsis, especially pharmaceutical 
studies
6. Papers focusing on sepsis following trauma
7. Papers focusing on sepsis following tropical disease
8. Papers focusing on sepsis following cardiac surgery
9. Papers focusing on sepsis following bum injuries.
* Papers focusing on the treatment of sepsis in the cancer setting were not included, 
as treatment is outside the remit of this study.
3.5 The epidemiology of sepsis
There were 30 hits for articles on the epidemiology of sepsis. Of these, 14 had 
epidemiology as their primary focus. Another five articles were found by using the 
reference list from one of the most recent overview articles (Linde-Zwirble et al 
2004). One study was rejected as it concerned the epidemiology of sepsis associated 
with blunt or penetrating injury and was therefore outside the scope of this study 
(Osborn et al 2004). The 18 articles are listed in appendix 1.
These 18 studies provide a useful overview of the epidemiology and impact of 
sepsis. Each study has been given a number (1-18) for identification in the following 
summary. Studies 17 and 18 are the only papers looking at the epidemiology of
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sepsis in malignancy and are therefore analysed separately (Williams et al 2004b, 
Danai et al 2006). Although a wide variety of countries are represented, there are no 
studies from the low-resourced countries. Taken together the studies represent a 
sample of 12,342,424 patients with sepsis, 303,042 with severe sepsis and 12,334 
with septic shock, from 33 countries. The time periods surveyed vary from 24 hours 
to 22 years. The studies have varying endpoints: the progression of sepsis (Rangel- 
Frausto et al 1995), the incidence of infections and their outcome in ITU (Alberti et 
al 2002), and the incidence cost and outcome across a whole country (Angus 2001). 
The study samples were heterogenous but 13 (76%) of the studies (n=17) used the 
1992 ACCP/SCCM consensus conference definitions for SIRS, sepsis, severe sepsis 
and septic shock (Bone 1992). The United States studies all use the International 
Classification of Diseases Ninth Revision-Clinical Modification (ICD-9-CM) (Deyo 
et al 1992) with one study (16) using both the ICD-9-CM and the ACCP/SCCM 
criteria.
3.6 Incidence of sepsis
Twelve of the studies measured incidence from ITU admission statistics, with the 
other six using hospital admission figures. The incidence of sepsis in the ITU 
admission studies, generally expressed as number of cases per 100 ITU patients (3, 
4, 5, 6, 7, 8, 9, 12, 13, 14), ranged from 7.76% to 37%. Six of those studies (4, 5, 7, 
8, 9, 13) had more homogenous rates between 7.76% and 14.6%, an average of one 
in 10 ITU admissions. The Dutch study calculated a one-day incidence at 31.42% 
with an annual incidence of 11% (van Gestel et al 2004, 158). Eight studies (3, 4, 5, 
6, 10, 11, 12, 14) generated population incidence rates with a range from 0.5 to 1.5 
cases per 1000 people.
The difference in incidence rates can be explained by the different research designs 
but also by the unequal distribution of ITU beds across the world. The UK and 
Brazil, for example (8, 12), have fewer ITU beds per population, therefore patients 
tend to be much sicker before gaining admission (Rowan et al 1993, Pappachan et al 
1999, Padkin et al 2003, Silva et al 2004). Linde and Zwirble (2004) argue that it 
would be more accurate to use the term used by oncologists -  “treated incidence” -  
as 12 out of the 18 studies reflect the epidemiology of those admitted to ITUs
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(Linde-Zwirble 2004, p. 223). Using “treated incidence” would more accurately 
reflect two problems with the data: first, the difference in ITU provision, and 
secondly the decision making about whether patients are admitted for treatment.
Finally, four authors looked at incidence of sepsis over time (3, 7, 10, 11). These 
studies all describe a rising incidence of sepsis that is confirmed by other studies not 
described here (McBean et al 2001, Hugonnet et al 2003). Three describe a 
significant fall in mortality rates over time, which the authors ascribe to improved 
treatments and access to ITU (3, 10, 11).
3.7 Characteristics of sample with sepsis or severe sepsis
Eight studies (3, 8, 9, 10, 11, 12, 14, 15) showed that both the incidence and the 
mortality from sepsis increased with age. Those studies that looked at progression 
over age showed an increase in incidence, for example from 4.1% in patients below 
20 increasing to 10.2% in patients over 80 (Wichmann et al 1999) and from <1/1000 
at 50 years to 8.7/1000 in those over 80 (Flaatten et al 2004). In all samples that 
measured it, hospital mortality was higher at older ages and greatest in patients over 
80. This is important for the present study as the incidence of cancer also increases 
with age.
3.8 Mortality rates
The ITU mortality rates for sepsis ranged from the low 16% in the early Rangel- 
Frausto study (1995) to 27% in the recent Vincent et al study (2006). As expected, 
mortality rates were higher for severe sepsis, from 20% (16) to 35.6% (13), and 
septic shock, 46% (16) to 65.5% (15). Predictors for mortality are shown in table 3.1 
which is on the following page.
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Table 3.1: Predictors of mortality
No Author Date Predictors of mortality and significance where 
provided
1 Vincent et al 2006 Number of organ failures; Methicillin Resistant 
Staphylococcus Aureus (MRSA), Pseudomonas and 
Candida Albicans infections; female gender (95% Cl 
p=0.013); older age (95%CI p<0.001); comorbid 
diseases; haematological cancer(95% Cl p<0.001); 
cirrhosis (95% Cl p=0.01); medical admissions (95% 
Cl p=0.007); use of pulmonary artery catheters (95% 
Cl p<0.001), mechanical ventilation (95% Cl 
pO.OOl), haemodialysis (95% Cl p=0.009); positive 
accumulative fluid balance (95% Cl p<0.001)
3 Dombrovskiy 
et al
2005 Older age; number of organs failing
4 Brun-Buisson 
et al
2004 Older age (pO.OOOl); congestive heart failure 
(p=0.0002); chronic liver insufficiency (p=0.0002); 
organ failures -  renal, cardiac, neurological 
(pO.OOOl), respiratory, haematological (p<0.001) and 
hepatic failure (p<0.013)
6 Flaatten et al 2004 Increasing organ dysfunction
7 Laupland et al 2004 APACHE II score (95%CI pO.OOOl); chronic organ 
insufficiency (95%CI p<0.1)
8 Silva et al 2004 Increasing age; comorbidities; number and severity of 
organ dysfunctions
10 Annane et al 2003 Comorbidity or immune suppression; multiresistant 
bacteria; organ failure and life-support therapies
11 Martin et al 2003 Organ failure
12 Padkin et al 2003 Increasing age; medical and emergency surgical 
admissions; renal dysfunction
14 Angus et al 2001 Increasing age; comorbidities; medical conditions;
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organ failure
15 Wichmann et 
al
1999 Increasing age; increasing organ failure
As can be seen from this table, across the 11 studies (n=18) that looked at mortality 
predictors the most important predictors in order of significance were:
1. Increasing age;
2. Organ failures;
3. Comorbidities;
4. Multi-resistant organisms;
5. Medical conditions; and
6. Surgical emergencies.
Finally, the studies by Danai et al (2006) and Williams et al (2004b) describe the 
epidemiology of sepsis in malignancy. In Danai’s study 854 million acute care 
hospitalisations of 8.9 million cancer patients were reviewed from 1979 to 2001 
using a nationally representative sample of non-federal acute care hospitalisations in 
the United States. The authors used the International Classification Disease-Ninth 
edition-Clinical Modification (ICD-9-CM) and the National Cancer Institute 
Epidemiology and End Results (SEER) databases. The SEER programme collects 
cancer incidence, prevalence and survival data from 14 population-based cancer 
registries and three supplemental registries representing approximately 26% of the 
Unites States population (National Cancer Institute 2005).
Sepsis occurred in 2.3 % of all cancer patients admitted to hospital. The incidence of 
sepsis in cancer patients increased from 24,150 in 1997 to 87,160 in 2001, an 
increase of 261% over 23 years. Over the 23 years of the study there were 1,781,445 
cases of sepsis giving a mean annual incidence rate of 1465 cases per 100,000 
patients. If this is compared to the rates noted previously for non-cancer patients 
(150 cases per 100,000 non-cancer US population), then cancer patients in this study 
were shown to be at 9.8 times increased risk of sepsis. The mean age for cancer 
patients with sepsis was significantly higher than for those without cancer: 62.8
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years compared to 58.1 (p<0.001). Incidence rates per 100,000 population in the 
various cancer subtypes are shown in table 3.2.
Table 3.2: Incidence rates for sepsis in cancer sub types
No. Cancer sub type Cases per 100,000 
population
1. Pancreatic cancer 14,468
2. Multiple Myeloma 10,601
3. Leukaemia 10,501
4. Lung cancer 4,604
5. Lymphoma 3,764
6. Brain cancer 2,146
7. Breast cancer 323
8. Skin cancer 335
Source: Williams (2004b), Danai (2006)
Williams et al (2004b) retrospectively analysed over one year (1999) the patient 
discharge databases from six state hospitals in the United States (Florida, 
Massachusetts, New Jersey, New York, Virginia and Washington). This data was 
then merged with US Census data, Centers for Disease Control vital statistics, and 
National Cancer Institute SEER data. The ICD-9-CM codes for severe sepsis were 
also used in this study. The incidence of severe sepsis was 4.9% of all cancer 
admissions, with a higher rate in those admitted for medical (5.5%) rather than 
surgical (3.8%) reasons. As in the Danai study the cohort of patients with sepsis and 
cancer was older than the non-cancer patients (68.2 years versus 66.2 years). There 
were also more males than females with cancer who developed severe sepsis (55.6% 
versus 49.9%) After adjusting for age and gender, people with cancer are more likely 
to be hospitalised with severe sepsis (relative risk 3.96 Cl 95%, 3.94-3.99). Williams 
et al estimated that nationally there are 126,200 cases of severe sepsis in the cancer 
population annually. The mortality rate for cancer patients with sepsis was 52% 
higher than for non-cancer patients (37.8% versus 24.9%).
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3.9 Summary of sepsis epidemiology and incidence
The incidence of sepsis cases per annum worldwide is 1.8 million, but with problems 
in diagnosis and monitoring in many countries this is likely to be an underestimation 
(Slade et al 2003). The authors of Surviving Sepsis Campaign estimate that with an 
incidence of 3 in 1000 per population a more accurate incidence per annum may 
reach 18 million, with a mortality rate of between 30% and 70% for sepsis, severe 
sepsis and septic shock, and higher in people with a chronic disease (Dellinger et al 
2008). Sepsis therefore, is a leading cause of death worldwide and the commonest 
cause of death in non-coronary ITUs (Angus et al 2001, Hoyert et al 2001, Aird
2003, Alberti et al 2003, Angus et al 2003, Bochud 2003, Padkin et al 2003, Decker
2004, Dellinger et al 2004, 2008). The elderly are more susceptible to sepsis and 
have a higher associated mortality, so as their numbers increase it is predicted that 
the incidence will continue to grow (Slade 2003). Other influences on growth are 
increases in nosocomial infections and antimicrobial resistance (Wenzel 2000, 
Annane et al 2003, Vincent et al 2006). In order to understand the challenges of 
diagnosis and the lack of progress in reducing mortality rates, it is important to 
understand the pathophysiology of the sepsis syndrome. The next section therefore 
explores the current understanding of the syndrome.
3.10 Pathophysiology of the sepsis syndrome
The sepsis syndrome is a complex systemic inflammatory syndrome associated with 
infection (Almog 2003). It is not the infective pathogen that directly causes multi­
organ failure and high mortality, but the host response to that pathogen (Aird 2003). 
To understand the syndrome it is useful to divide the complicated pathophysiology 
into four main areas:
1. The individual host response;
2. The role of the endothelium;
3. The disequilibrium of the proinflammatory and antinflammatory 
mechanisms; and
4. Activation of the coagulation pathways.
48 o f355
For any nurse who works with people critically ill from sepsis, it is clear that there is 
a heterogeneity of response to infection. Nurses working with the acutely ill cancer 
patient will have witnessed two patients with identical microbiology but variant 
responses to infection: one improves following a course of antimicrobials while the 
other develops severe sepsis and dies. The large clinical trials conducted in the late 
1990s investigating the use of anti-endotoxin antibodies demonstrated that solely 
targeting the infecting pathogen does not work (McCloskey et al 1994, Angus et al 
2001, Aird 2003, Riedemann et al 2003).
3.11 Role of the endothelium
The endothelium is responsible for many vital roles in maintaining health, which 
include:
• Regulation of cellular and nutrient trafficking;
• Generation of new blood vessels;
• Maintenance of the fluidity of blood;
• Vasomotor tone; and
• A contribution to the local balance of proinflammatory and anti­
inflammatory mediators (Rosenberg and Aird 1999, Gross and Aird 2000, 
Aird 2001, Stevens et al 2001, Aird 2003).
It is the interaction of the endothelium with the local environment, for example the 
invasion of bacteria that is important to this study. Invasion of bacteria causes local 
endothelial cells to release inflammatory mediators, leucocytes and the activation of 
the clotting cascade. This endothelial action is a part of the normal healthy response 
of the body to an invading pathogen. In severe sepsis, however, the endothelial 
response is dysfunctional with an excessive, sustained and generalised activation of 
the endothelium (Aird 2003, Bochud 2003). The endothelium of the person with 
sepsis may be phenotypically altered by several different mechanisms: pathogenic 
infection of the endothelial cells (Bochud 2003) and/or activation by the host’s cell 
mediators such as cytokines, chemokines, proteases, fibrin, activated platelets and 
leucocytes, hyperglycemia, changes in oxygenation and blood flow (Volk and Kox 
2000, Faure et al 2001, Henneke and Golenbock 2002, Zhao et al 2001, Aird 2003).
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There is also a heterogeneity of response depending on individual patient factors 
such as age, genetics, comorbidities, gender, the type of pathogen and the area of the 
body most affected (Westendorp et al 1997, Hermans et al 1999, Kumar et al 1999, 
Mira et al 1999, Arbour et al 2000, Mavrommatis et al 2001, Amalich et al 2002, 
Cariou et al 2002, Nadel 2002, Yamamoto et al 2002, Aird 2003, Knobl 2005). The 
function of the endothelium is also affected by: changes in the hemostatic balance 
resulting in a procoagulant state (Yamamoto and Loskutoff 1996, Weiler et al 2001, 
Yanada et al 2002); cell adhesion and leucocyte trafficking (Aird 2003); vasomotor 
tone with a resultant decrease in mean arterial pressure (McCuskey et al 1996); barrier 
function with increased vascular permeability (Ferro et al 2000); and an increased rate 
of apoptosis (Fujita et al 1998, Bombeli et al 1999, Kawasaki et al 2000, Aird 2003).
3.12 Summary of altered inflammatory response in sepsis
In health the host endothelium responds to insults locally, but in sepsis there is a 
generalised host response that can no longer be regulated by local negative feedback 
mechanisms (Munford and Pugin 2001, Bochkov et al 2002). This generalised 
response results in a severe disequilibrium of inflammatory response, which causes 
generalised tissue injury, vascular permeability, shock and multi-organ failure 
(Decker 2004, Dolan 2006, Dellinger et al 2008). The patient thus develops multi­
organ failure necessitating admission to intensive care.
3.13 The early diagnosis of sepsis
There is robust evidence that earlier diagnosis with appropriate monitoring and 
treatment correlates with improved outcomes. There are, however, challenges to 
diagnosing sepsis early and thus the experience of many critical care clinicians is 
that referrals are often received too late. The early diagnosis of sepsis has been 
shown to reduce mortality rates as it allows prompt treatment: either antimicrobial 
therapy, or, where possible, removal of the sepsis source such as the gangrenous gut, 
or the removal of an infected skin tunnelled catheter (Bota et al 2003). Several 
studies have also illustrated the increased mortality associated with a delay in 
diagnosis (Aube et al 1992, Leibovici et al 1997, Weinstein et al 1997). Work over
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the last 10 years has concentrated on early recognition and therapy for sepsis in an 
attempt to prevent the systemic sequelae of generalised inflammatory change, tissue 
damage, increased cell permeability, shock and organ damage described previously 
(Rady et al 1996, Rivers et al 2001, Vincent et al 2002, Dellinger et al 2004, 2008).
The challenge for nurses and healthcare teams is that the early clinical signs are 
often subtle and difficult to recognise. Some of the clinical, biochemical and 
haematological signs of sepsis are also indicators of non-sepsis conditions such as 
pancreatitis, cerebral haemorrhage or other major shock conditions (Circiumaru et al 
1999, Bota et al 2003). To reduce mortality rates, evidence and experience indicate 
that the earlier the person is identified and then monitored the more chance there is 
of preventing a critical illness (Rivers et al 2001, Dellinger et al 2004, 2008). As 
nurses work so intimately with people who are at the highest risk of developing 
sepsis, they are key members of the multidisciplinary team, and this study is 
designed to help them to identify at-risk patients and those who are deteriorating at 
an earlier stage (Ruffell 2004). There are over 42 early predictors of sepsis described 
in the literature since 1992. Seven of these indicators are clinical signs such as a 
raised or lowered temperature, a raised respiratory rate and changes in the Glasgow 
coma scale (GCS). There are two severity of illness scores: SOFA and APACHE II. 
The remaining 33 indicators are different blood indicators. A table of these early 
indicators of sepsis can be found in appendix 2.
3.14 Procalcitonin (PCT)
The predictive marker most commonly studied between 1992 and 2007 for its utility 
in sepsis diagnosis, prediction of the course of illness and mortality is procalcitonin 
(PCT). PCT is the prohormone of calcitonin (CT), a hormone that was discovered in 
1961 to be involved in lowering serum calcium (Copp et al 1961). CT was isolated 
in the thyroid gland (Hirsch et al 1963) within the parafollicular cells (Foster et al 
1964, Meyer et al 1968). These parafollicular cells came to be known as C cells and 
are neuroendocrine cells (LeDouarin 1970). It was the demonstration in the late 
1960s and 1970s that these C cells were involved in medullary thyroid cancer 
(MTC) that led to the isolation of human CT (Byfield et al 1969). CT continues in 
2008 to be the classical clinical marker of MTC (Becker et al 2004). CT is
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biosynthesised from the polypeptide precursor prohormone, procalcitonin (Singer et 
al 1974, Roos et al 1974, Mouktar et al 1975, Moya et al 1975, Goodman et al 1979, 
Becker et al 2004). CT is therefore characterised as a mature hormone that has been 
derived from a larger precursor prohormone (Becker et al 2004). Procalcitonin 
(PCT) is a 116-amino acid comprised of three constituent peptides (LeMoullec 
1984).
PCT continues to be studied for its sensitivity as a marker for MTC, although as yet 
it has not been determined whether it is as sensitive as CT (Becker 2004). There are 
also non-cancer conditions that are associated with higher levels of PCT; these are 
all conditions characterised by involvement of the pulmonary neuroendocrine cells: 
chronic obstructive pulmonary disease, tuberculosis, inhalational bums or chemical 
irritant (Becker et al 1984, Becker et al 2004). It is the increase of PCT that occurs 
with sepsis that is key to this study. PCT in sepsis has been shown to be harmful and 
immunoneutralisation may be a potential effective therapy (Nylen et al 1998, Becker 
et al 2004).
3.15 History and discovery of PCT’s role in sepsis
In 1983 two articles linked CT with sepsis. One was a letter to the Lancet (Mallet et 
al 1983) concerning a meningitis outbreak in children; the other was concerned with 
adults with the staphylococcal toxic-shock syndrome (Chesney et al 1983). In both 
cases CT was found to be markedly elevated, and later work revealed that the 
immunoreactive CT was of a large molecular weight corresponding to PCT and the 
carboxyterminus peptide 1 (CT CCP-1) (Becker et al 2004). This work led to interest 
in an assay that could predict the severity and even outcome of sepsis and severe 
sepsis. Several proinflammatory cytokines associated with the severe inflammation 
of sepsis are raised in the blood, for example Interleukin 6 (IL-6), Interleukin -10 
(IL-10), Tumour Necrosis Factor alpha (TNFa) but only intermittently, PCT 
however increases and remains high.
By 2008, after many subsequent studies, PCT physiology was better understood. 
PCT is synthesised by thyroid C cells, but in sepsis originates from many areas 
throughout the body outside the thyroid, even in patients who have had a previous
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thyroidectomy (Nishikura 1999). Using gel filtration chromatography, substantially 
increased levels of PCT were found in the major organs (liver, lung, kidney, 
pancreas, brain, heart and small intestine) of septic hamsters (Muller et al 2001, 
Becker 2004). In experimental studies following intravenous injection of endotoxin 
to healthy volunteers, serum PCT is detectable at four hours and maintains a plateau 
through eight to 24 hours following an increase of proinflammatory cytokines such 
as TNFa and IL-6 (Dandona et al 1994). Four assays have been created to measure 
PCT in the blood. In Europe the assays are available from BRAHMS Diagnostica 
and include several assays including a sensitive tracer technology Kryptor assay 
which may be useful in detecting infection earlier (Nylen et al 2003).
3.16 The PCT bedside kit: the PCT-Q
In 1999 a bedside kit was developed: a semi-quantitative immunochromatographic 
dipstick test which can be used at the bedside as opposed to the laboratory and 
provides a result in 30 minutes. The PCT is detected by binding to a mouse 
monoclonal antibody complexed to colloidal gold. By capillary flow the bound 
complex travels through the strip and turns it red. The concentration of the colour 
correlates with three different PCT concentrations (Meisner et al 2000c). This is the 
first time a sepsis marker has been available in a bedside form, and its use is 
described in more detail in chapter five.
3.17 Procalcitonin as a predictive marker of sepsis and 
severe sepsis
Ten years after the letter to the Lancet about CT (Mallet et al 1983), a group of 
French scientists working with children from newborn to 12 years of age 
prospectively examined the blood of 79 children admitted to hospital with suspected 
infections (Assicot et al 1993). This early study found that the 19 patients with 
severe bacterial infection on admission had high serum concentrations of PCT (6-53 
ng/ml),whereas children who were found to have no signs of infection had serum 
PCT levels less than 0.1 ng/ml. The authors of this paper concluded that the serum 
concentrations of PCT seemed to correlate with the severity of microbial invasion
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(Assicot et al 1993). Three years later a group of researchers working in Germany, 
having read Assicot’s work designed a prospective study to investigate 337 adult 
patients who were hospitalised and fulfilled the SIRS criteria (Al-Nawas et al 1996). 
Al-Nawas, Krammer and Shah measured the serum PCT levels on admission and 
then for nine days. They demonstrated that patients with microbiologically 
documented infection showed peak PCT values of 30 ng/ml at day three while those 
adults without sepsis had baseline PCT values of 0.1 ng/ml or lower.
There are over 1034 publications on PCT, but many of these are in populations or for 
indications that are outside the scope of the present study. A systematic review of the 
literature was undertaken with the same methodology described earlier. The review 
was limited to studies concerned with adults, associated with sepsis and written in 
English. These inclusion criteria reduced the field to 104 studies, 10 of which were 
meta-analysis.
3.18 Summary of PCT review
PCT has been shown to have an important place in the early diagnosis of infection, 
sepsis, the monitoring of sepsis and the prediction of mortality. There is no evidence 
that PCT or any other marker of sepsis is reliable in 100% of patients with sepsis. 
There is evidence, however, to show that PCT is superior to C-reactive Protein 
(CRP) in identifying sepsis (Whicher et al 2001, Simon et al 2004, Mitaka et al 
2005, Uzzan et al 2006). Several studies support the use of PCT-Q in practice as an 
adjunct to effective clinical care including risk awareness, medical history and 
physical examination (Levy et al 2003, Uzzan et al 2006). There is also evidence to 
support the combined use of markers of sepsis as part of the clinical assessment. 
Finally, the cut off value for PCT should be applied with careful regard to the 
clinical context of the patient (Whicher et al 2001, Rau et al 2004). In other words, 
increased PCT indicates a SIRS response to infection and is not a “gold standard” for 
infection, but may make the diagnosis easier when combined with other clinical 
assessments (Whicher et al 2001, Rau et al 2004, Meisner et al 2005).
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3.19 Conclusion
From the literature review it is clear that sepsis is the systemic response to infection 
and is defined as having four stages that worsen from the early stage of Systemic 
Inflammatory Response Syndrome (SIRS) to Severe Sepsis when the patient is 
critically ill receiving multi-organ support. There is a high mortality rate associated 
with cancer and severe sepsis. Diagnosing and treating sepsis at an early stage 
SIRS/Sepsis results in increased survival. Diagnosing sepsis early is challenging as 
there can be few physical manifestations, however at a cellular level there are 
changes and early blood markers / indicators of sepsis have been developed. Of these 
early indicators procalcitonin and its bedside test the PCT-Q has been demonstrated 
to be valid and reliable in cancer patients.
No marker of sepsis is useful without clinical awareness and sensitivity to the 
possible changes in a patient’s condition. In acute cancer care, this awareness and 
then effective action are essential. Unfortunately, the evidence and clinical 
experience demonstrates that clues are missed and an effective response is limited, 
with vulnerable patients reaching a stage of sepsis when Intensive Therapy Unit 
(ITU) admission is inevitable and mortality rates are too high (McQuillan et al 1998, 
McGloin et al 1999, Goldhill et al 1999 Chellel et al 2002, Clarke and Aiken 2003, 
DH 2003, Goldhill et al 2005). The next chapter therefore explores the literature 
relating to the sensitivity triggers for nurses working in acute care.
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Chapter 4 Literature review: sensitivity 
to patient change/deterioration
4.1 Introduction
Previous chapters have emphasised the risk of sepsis for the cancer patient and the 
imperative to diagnose and treat early if a high mortality rate is to be reduced (Danai 
et al 2006). Nurses are the healthcare professionals who are most often with the 
patient day and night. Therefore, nurses are key in recognising early signs of change 
ensuring that recognition is translated into action: contacting others and mobilising 
an appropriate and timely response. It is essential, that nurses are sensitised to the 
dangers of sepsis and early changes and that they have the knowledge, skills and 
confidence to recognise change and mobilise the team.
There is considerable evidence, both empirical and anecdotal, that nurses are able to 
detect subtle changes in a patient’s condition even when overt signs of deterioration 
are not obvious. Coffee room anecdotes talk of nurses having gut feelings or 
hunches, or “just knowing” that a patient was “not right”, while more formal 
accounts in the literature talk of intuition. The work of Patricia Benner and her 
account of the ability of the expert nurse rapidly to assess the patient's condition and 
make rapid decisions about the need for action is important here (Benner 1984, 1987, 
1992, 1999). Many nursing authors discuss the value of intuition in the rapid 
detection of the deteriorating patient (Rew 1988, Benner 1992, 1999, Ruth-Sahd 
1993 Cioffi 1997, McCutcheon and Pincombe 2001, Smith et al 2004). Intuition has 
had both a positive and a critical press but its role in crisis recognition is important to 
examine for this study.
It would seem reasonable to assume that most nursing practice is not random or 
capricious and that the decisions of nurses are based on some body of theory and 
knowledge, even if this is not always articulated. Flemming and Fenton (2002)
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identify knowledge and experience as major influences in nursing practice. Of 
particular interest for this study is the way nurses respond to subtle changes in the 
patient and the action they then take. Ruth-Sahd describes intuition as a way of 
knowing that “allows the nurse to anticipate what may happen in the immediate 
future, plan ahead, prepare and mobilize others before a crisis occurs” (Ruth-Sahd 
2003, p. 130). Intuition has been described in the nursing literature for over twenty 
years and in this chapter is discussed as it applies to the care of the cancer patient at 
risk across all wards and with all nurses from the ‘novice’ newly qualified nurse 
through to the ‘expert’ senior practitioner.
4.2 Intuition and recognising change
As described in chapter three, the early changes shown by the patient who is 
developing sepsis may be minimal and difficult to quantify. The cancer patient with 
severe sepsis will eventually develop marked changes in their vital signs and gross 
manifestations of deterioration such as change in consciousness, respiratory 
difficulty, absence of urine, but before these late changes there is an opportunity for 
the bedside nurse to note subtle change and to raise the alarm early. The patient 
themselves may express that “they don’t feel as well” or the nurse may notice a 
change in the appearance, demeanour or behaviour of the patient. It is this early 
stage before the vital signs have changed that is important for the early recognition 
of sepsis and thus for the present study. The changes that the patient or nurse 
recognise are caused by a physiological alteration that can be detected using the 
PCT-Q but the nurse needs to notice and act on this “change” to initiate its use.
There are several steps that are necessary to make the nurse’s intervention in the 
early stages of sepsis successful. First there is the recognition of change either by the 
nurse or the patient. Change is a variation in the status quo or the norm. There is 
evidence that it is easier to recognise subtle change if the nurse “knows” the patient 
sufficiently well to see an alteration (Noddings and Shore 1984, Logan and Boss 
1993, Smith et al 2004). For the patient’s voice to be effective the nurse needs to 
listen actively to the patient and respect their view despite there being no objective
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evidence of alteration. There is then a need having noticed a change to follow it 
through with action. John Dewey in his work “How we think” (1910) describes the 
way change makes us uncomfortable and disturbs the equilibrium making the 
reflective thinker take steps to formulate a plan, or consider a solution:
The data at hand cannot supply the solution; they can only suggest it. What 
then are the sources of the suggestion? Clearly past experience and prior 
knowledge. If the person has had some acquaintance with similar situations, 
if he has dealt with material of the same sort before, suggestions more or less 
apt and helpful are likely to arise (Dewey 1910, p. 12).
Dewey contrasts inertia with active intellectual curiosity that is seeking for answers. 
In acute cancer nursing this kind of proactive curiosity coupled with a moral intent to 
improve the patient’s situation is essential. Questioning about change is followed by 
a sifting of prior knowledge in the effort to find a solution. This discomfort followed 
by a search for further data has been linked with intuition. Intuition is an important 
phenomenon in this study where acute sudden change needs to be recognised and 
followed by action. The nurse having been disturbed by intuiting a change has then 
to be motivated to do something quickly. The nurse’s decision involves making a 
likelihood judgement about whether this patient is going to deteriorate; searching for 
further data and comparing with similar events experienced previously. Intuition has 
been described by spiritual leaders, philosophers and artists for thousands of years 
and has several different definitions in the Oxford English Dictionary. For this study 
the most relevant definition is the following:
“The immediate apprehension of an object by the mind without the intervention of 
any reasoning process; a particular act of such apprehension” (OED 2009)
It is the quality of immediacy and understanding that is important to this study where 
rapidity of detection is so important. Intuition has been described variously by many 
philosophers, but the description by the Italian philosopher Benadetto Croce (1866- 
1952 cited in Patankar 1962) is particularly useful. Croce described intuition as the 
process of consciousness whereby the myriad of objects, images and sensations that 
are constantly presenting themselves are constructed into forms or structures that
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make them intelligible and identifiable and that intuition makes this new 
consciousness expressible to others (Patankar 1962). For this study it is this rapid 
identification of change and the ability to translate concern to others that makes 
Croce’s definition of intuition so useful. The Croce definition of intuition therefore 
consists of three stages:
1. The apprehension or recognition of the phenomenon
2. The cognitive process of classification
3. A choice about what to do with this data, much of it will be discarded, some 
may be acted upon.
The theoretical assumptions underpinning this study are that people with cancer are 
susceptible to sepsis and once they have developed it are much more likely to die 
from it; survival from sepsis is increased the earlier it is diagnosed and treated; the 
early signs of sepsis are subtle and therefore the nurse needs to be prepared or 
sensitised to these sudden subtle deviations from the norm. The subtle deviations 
may not even be consciously recognised and articulated, but there is rather a sense of 
discomfort of the sort that Dewey describes -  the nurse intuits change but must then 
work out what has changed and what the significance of this might be. Croce’s 
model of intuition is therefore useful to this study where rapid detection is important, 
the nurse is faced with many competing stimuli and needs to work with others to 
help the patient.
4.3 Intuition and Nursing
Nursing authors have recognised intuition as an important type of clinical knowledge 
and have taken a variety of approaches to its study (see table 4.1.) Nurse researchers 
however do not seem to have related their discussions to the classical definitions of 
intuition discussed previously. Rather than describing the fundamental process of 
recognition or apprehension followed by cognitive processing and then the choice to 
act or not, intuition in the nursing literature has progressed from Benner in 1984 
along a different path.
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One definition often quoted is “understanding without rationale” (Benner and Tanner 
1987), but many authors have described how the process of intuitive judgement may 
lead to an analysis of cues and further data. Muir (2004) argues that intuition is about 
pattern recognition, where each new patient or situation will be compared with 
previous circumstances stored in the nurse’s memory and then compared (Muir 
2004, p. 52); this links directly with Dewey’s reference to past knowledge and 
experience.
In their review of research on nurse intuition, King and Appleton (1997) provide a 
comprehensive literature review up to the mid 1990s. They describe one of the 
earliest research studies describing the intuitive component of critical care nurses’ 
decision making (Pyles and Stem 1983). In that study, intuition was not described by 
the nurses but rather “gut feelings” particularly associated with something that was 
going to happen, usually deterioration. They described patients “falling out of the 
pattern”, where their progress or observations varied from what the nurse would 
have expected (Pyles and Stem 1983, p. 54). This theme of an early warning of 
imminent deterioration runs throughout the nursing literature on intuition (Benner 
and Tanner 1987, Smith 1988, Truman 2003, Rovithis and Parissopoulos 2005). 
Schraeder and Fisher (1987) like Ruth-Sahd (1993) include the preparatory nature of 
intuition linking perceptions from the past with an anticipated future. Over ten years 
later, Benner and colleagues (1999) also describe intuition when exploring the work 
of critical care nurses as being able to be used as “clinical forethought” so that nurses 
prepare the environment anticipating possible clinical sequelae that they have 
encountered previously (Benner et al 1999, p. 64). In 2008 the National Patient 
Safety Agency (NPSA) designed a patient safety initiative to encourage nurses to use 
forethought or foresight in reducing errors and increasing safety (NPSA 2008). 
Therefore in the nursing literature there is a concentration on intuition being 
associated with risk or preventing something negative whereas in the classical 
literature, intuition is not associated with good or bad but recognition.
4.4 Intuition and uncertainty
There are more studies associated with critical care nurses and intuition than any 
other specialty of nursing (Pyles and Stem 1983, Smith 1988, Rew 1988, Rew 1990,
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Benner et al 1992, Polge 1995, Elcock 1997, Benner et al 1999, King and Macleod 
Clark 2002, Aitken 2003). This may be because of the association between intuition 
and uncertainty and rapidity of decision making (Noddings and Shore 1984, Rew 
1986, Benner 1992, Eraut 1994, Easen and Wilcockson 1996, Parker et al 1997). It 
is not just speed of decision making that these studies have in common, but the fact 
that the patient is in danger. Cioffi (1997) cites Benner and Wrubel (1982) and 
Benner and Tanner (1987), who demonstrated that nurses use intuition most when 
patients are at risk. This directly relates to the present study and the patient with 
cancer and sepsis who is in danger of deteriorating. Before proceeding to look at the 
research studies examining intuition, King and Appleton review several author’s 
attempts to describe the defining attributes of intuition. These are listed in table 4.1 
with definitions from later authors.
Table 4.1: Definitions of intuition as applied to clinical nursing practice
No Definition Date Authors
1 “Intuitive perception in nursing practice is the 
ability to experience the elements of a clinical 
situation as a whole, to solve a problem or reach a 
decision with limited concrete information” (p. 
161)
1986 Schraeder and 
Fischer
2 “knowledge of a fact or truth, as a whole; 
immediate possession of knowledge; and 
knowledge independent of the linear reasoning 
process” (p. 60)
1987 Rew and Barrow
3 “Understanding without a rationale” (p. 23) 1987 Benner and 
Tanner
4 “A perception of possibilities, meanings, and 
relationships by way of insight” (p. 63)
1987 Gerrity
5 “process whereby the nurse knows something 
about a patient that cannot be verbalised, that is 
verbalised with difficulty or for which the source 
of knowledge cannot be determined” (p. 52)
1987 Young
6 Six key aspects: “pattern recognition, similarity 1988 Dreyfus and
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recognition, commonsense understanding, skilled 
know-how, sense of salience and deliberative 
rationality” (p. 23)
Dreyfus
7 “knowing the patient or client and being involved 
with his /her care are also key elements which 
strengthen the nurses’ intuition”
1996 Benner et al
8 “a process of making sense of a situation which 
often leads to a decision. This process is non- 
conscious by-passing linear methods of reasoning 
and, by western cultural standards, is considered to 
be irrational. Intuition involves the use of a sound, 
rational, relevant knowledge base in situations 
that, through experience, are so familiar the person 
has learned how to recognise and act on 
appropriate patterns”
(p. 671)
1996 Easen and 
Wilcockson
9 “ lacking underlying conscious processes and as 
not being able to be explained in a tangible 
manner”
(p. 204)
1997 Cioffi
10 “Unconscious competence” (p. 305) 1999 Turnbull
11 “intuition is a function of experience where cue 
patterns become so well associated with desired 
responses (treatment or intervention classes) that 
the classes are automatically brought to mind, i.e. 
there is no conscious rule following and rapid 
association obscures the exact nature of the 
initiating cues”
(p. 996)
2000 Buckingham and 
Adams
12 “It is intuition that allows the nurse to anticipate 
what may happen in the immediate future, plan 
ahead, prepare and mobilize others before a crisis 
occurs” (p. 130)
2003 Ruth-Sahd
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13 “Intuition occurs in response to knowledge and is 2005 Rovithis and
a trigger for nursing action and reflection. Paissopoulos
Subsequently it has a direct bearing on analytical
processes in patient care. If intuition continues to
be ignored it will be at the peril of the nursing
profession. Practitioners will become entrenched
in standardized procedures and routines of care
and there will be little opportunity for the flare and
skill of nursing judgement to flourish” (p. 6)
Benner and colleagues (1992) used a sample of 105 critical care nurses from 
neonatal, paediatric and adult units in different hospitals to explore the use of 
intuition. They grouped nurses into focus groups by their length of experience and 
expected expertise. In these groups the nurses provided narrative descriptions of 
episodes in their practice, and some were directly observed in practice. Data was also 
collected on the nurses’ perceptions of their educational experience and careers. The 
study drew on the model of skills acquisition developed by Dreyfus and Dreyfus 
(1988) and also on Benner’s own work on domains of practice (1984). Benner says 
the findings of the 1992 study highlight the ability of the expert nurse to use intuition 
in perceiving a situation rapidly and that the expert nurse has an increased ability to 
use perception and emotion to undertake expert clinical judgement. In this paper 
Benner likens the nurses’ crisis anticipation to Dreyfus and Dreyfus (1985) six key 
aspects of intuition that is pattern recognition, similarity recognition, commonsense 
understanding, skilled know-how, sense of salience and deliberative rationality. 
Although the link with pattern recognition is key to this study there is a problem 
with the exclusivity of intuition and the “expert nurse”. As previously described 
Croce’s interpretation of intuition is available to anyone as to intuit is to perceive 
and then interpret. It would therefore seem likely that the novice nurse would have 
the faculty to intuit change but will not have the abundance of patterns or previous 
experience that the “expert” nurse has. As the novice nurse is often the one at the 
bedside it is important that the novice nurse is encouraged to have confidence in 
their intuition of change and to call for help.
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4.5 Intuition and somatic feelings
In a further study with 25 critical care nurses from five different hospitals, Rew 
(1990) found that nurses described intuition using the following terms: knowing, gut 
feeling, sixth sense, perception and ability to anticipate (Rew 1990). The mystical 
sense of intuition described in Rew’s study as “sixth sense” is often quoted in the 
literature and may be associated with a cognitive inference where visual and other 
cues are so rapidly or subliminally assimilated that they are not articulated and hence 
attributed to something mystical. For this study intuition is used fundamentally and 
prosaically as the prepared nurse intuiting change and then using past experience to 
guide present care. This “sixth sense” and “gut feeling” described by nurses in 
Rew’s study are however important in that they are often used by nurses to describe 
this phenomenon. The somatic feeling associated with intuition especially pre crisis 
is often quoted and may be because the nurse recognises signs that have previously 
led to a sudden deterioration, cardiac arrest or death. To return to the Croce 
definition the somatic feeling often associated with intuition happens immediately 
after the apprehension of change during the process of cognitive evaluation or 
classification when a physical feeling often described as “gut feeling” or “skin 
crawling” is part of the making sense or probability judgements being made. 
Dewey advocated a heightened awareness of somatic feelings and paying attention to 
the self (Dewey 1932).
4.6 Psychological aspects of intuition
Rew (1988) studied nurses’ use of intuition in clinical practice and, with 56 nurses 
from critical care, wards and a health centre, looked at their use of intuition as part of 
the nursing process. Rew grouped the way nurses described the use of intuition into 
three themed areas: cognitive inference, gestalt intuition and precognitive function 
(Rew 1988). Rew then looked at the consequent actions nurses took following their 
intuition, which included searching for more data, validation and corroboration with 
another nurse, reporting on specific findings and/or interventions (Rew 1988,). This 
nursing gestalt or knowing the patient has been described by other authors as a 
preconscious understanding gained from nurse-patient interactions that are then used 
in practice (Benner 1984, Pyles and Stem 1993, Hicks 2001).
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Cioffi (1997) examines the use of heuristics from cognitive psychology as an 
important element of intuition. Throughout her paper she uses the work of the 
cognitive psychologists Kahneman and Tversky (1982) on “subjective probability 
judgements” (heuristics) as a partial explanation for the intuitive judgements of 
nurses (Cioffi 1997, p. 2). Cioffi suggests that nurses’ clinical experience gives them 
heuristic knowledge of common and unusual clinical issues, visual memories of 
patients with particular conditions, and particular clinical events that are memorable 
because they are out of the ordinary. This knowledge is the nurse’s baseline upon 
which, in their assessments, they base their subjective probability judgement. Thus 
Cioffi’s explanation is that nurses working in an uncertain and complex environment 
use probability assessments rapidly, computing previous events, likely causality and 
assessment of available associations or exemplars (Cioffi 1997, p. 5). For Cioffi, 
heuristics are therefore at least a partial explanation of the intuitive judgements of 
clinical nurses. Similarly, Thompson (1999) describes several authors’ work on 
probability theory in the decision making of nurses, using the hypothesis that nurses 
use formal or informal probability estimates of “diagnostic fit” as well as data from 
the particular context of the patient (Thompson 1999, p. 1225). Useful for this study 
is the link all of these authors make between this psychological perception of the 
patient but then the need to collect more data. The intuitive phase is therefore an 
introduction or perhaps a first step that leads to gathering and analysis of more data 
in an effort to help the patient.
4.7 Intuition and experience: Expert to novice nurses
Tertiary referral specialist cancer centres have a greater number than is perhaps 
typical throughout the UK of expert cancer nurses. These cancer nurses may not feel 
themselves to be skilled in acute care such as the recognition and understanding of 
sepsis. Conversely, the proficient critical care nurse may not understand the 
particular vulnerability of the person with cancer. Research on intuition has focused 
mainly on experienced nurses (Benner 1984, Schraeder and Fischer 1987, Rew 1988, 
Easen and Wilcockson 1996). King and Macleod Clark (2002) sought to explore 
intuition in nurses with different levels of expertise and educational background and 
recruited 30 nurses from acute surgical wards and 31 from two intensive care units.
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The study was in three stages: the first was conducted by a nonparticipant researcher 
observing practice and recording field notes; the second a semi-structured interview 
based on the nurses’ reflexive account of patient episodes, and finally the nurses’ 
perceptions of the development of their expertise and the way that they made 
decisions (King and Macleod Clark 2002, p. 324). In summary, nurses included 
intuitive and analytical components in their clinical judgements throughout the 
different levels of expertise. Expert nurses were confident in their clinical decision 
making even in rapidly changing situations, and had the ability to use unconscious 
recognition of very subtle changes in the patient. These expert nurses were also able 
to stand back and take their intuitive reasoning further and look for concrete or 
measurable evidence to support their suspicions (King and Macleod Clark 2002, p. 
327). For the novices, their intuitive feelings of concern did not so readily lead to an 
identification of the problem or relevant analysis because of lack of knowledge and 
experience. For King and Macleod Clark, the difference between nurses was the way 
they used intuition to analyse and then organise timely and effective 
multidisciplinary care (King and Macleod Clark 2002, p. 327).
There are limitations to this study in that the conclusions were based on the nurse’s 
self reports and represent just one episode of care. Nonetheless, the comparison 
between nursing groups is useful, especially the recognition that the novice nurses 
did experience intuition. One area that doesn’t seem to have been reported in the 
literature but is evident in practice is the issue of expert nurses who have become 
less motivated to notice change. Experience shows that expertise or long experience 
can also negatively affect the ability to see a situation afresh and to intuit small 
change. There are occasions when the novice nurse entering a new field is more 
observant reacting quickly to change because they are not comfortable in the area. 
This links with Dewey’s description of the inertia that is the antithesis of intuition.
A key factor in the early recognition of the patient with sepsis is the ability for the 
most junior nurse to be empowered in their clinical practice. Patient emergencies 
such as sepsis occur at any time of the day or night and it is often the staff nurse or 
the patient themselves who first notice a change. Several studies have revealed that 
student nurses have intuitive feelings or “gut feelings” about the patients with whom 
they work (Orme and Maggs 1993, McCormack 1993, Tabak et al 1996, Brooks and
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Thomas 1997, King and McCleod- Clark 2002, Ruth-Sahd 2003, Smith et al 2004). 
In a specialist cancer centre there are very few student nurses, there are, however, an 
increasing number of newly qualified nurses. Research evidence about the novice 
nurse is therefore both relevant and important to understand. McCutcheon and 
Pincombe (2001) in a study involving 264 registered nurses reported that novice 
nurses stated that although they had intuitive feelings they were often afraid to raise 
them due to their inexperience. Novice nurses also reported that the environment 
within which they were working would either encourage or discourage or discourage 
their use of intuition (McCutcheon and Pincombe 2001, p.347). Smith, Thurkettle 
and dela Cruz (2004) in a study exploring the use of a psychometric instrument to 
test the intuition of final year student nurses (n=349) concluded that student nurses 
understood and used / or experienced intuition in a similar way to more experienced 
nurses. Although the study relied on self report and only 349 (35%) (n= 1000) of 
questionnaires were returned this study repeats other’s findings that novice nurses do 
and can use intuition, they just have a limited frame of reference. Rolfe (2006b, p. 
41) argues that novice nurses can be taught to think and act reflexively and reason 
about their practice. Much, therefore, may depend on the training of the novice nurse 
and the environment within which they work.
4.8 Intuition and the patient
The intuition of the patient is another theme in the literature and is of major 
importance to this study. It is essential that people with cancer who are likely to 
become septic and may be in hospital or at home are able to recognise the early signs 
of deterioration and raise the alarm. It is also important that the nurses and multi­
professional team working with the patient listen and respect the patient’s intuitive 
feelings. Several studies support the use of nurse and patient intuition (Orme and 
Maggs 1993, McCormack 1993, King and Appleton 1997). Broom (2009) 
demonstrated that cancer patients use a wide range of knowledge when managing the 
plurality of treatments including intuition and embodied knowledge. In interviews in 
their own homes 20 medical oncology patients were interviewed about their decision 
making and intuition was repeatedly raised as a critical source of knowledge Broom 
2009, p. 1053). Although a small study and focusing on treatment options its
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relevance to this review is the way patients talked about knowing their bodies, 
having gut feelings and intuition about choices.
4.9 Involvement or engagement
Easen and Wilcockson (1996) cite the work of Dreyfus and Dreyfus (1988), arguing 
that intuition requires the “deep involvement” of the person in the environment. 
Benner refers to the expert nurse who has a deep understanding of the total 
circumstances (1984), and Easen and Wilcockson (1996) introduce Noddings and 
Shore’s work (1984), which links intuition with a direct contact with the whole 
problem. It seems that this correlation of a deep understanding of the problem or 
situation of the patient/client is an important key to understanding this aspect of 
nursing knowledge. Logan and Boss (1993) found a relationship between 
engagement in care, commitment of the nurse and the use of intuition. Parker and 
colleagues (1999) corroborate this aspect of being able to appreciate the larger 
picture in their review of perioperative nurses’ clinical decision making process. 
Indeed, their study showed that, in spite of brief nurse-patient relationships, expert 
perioperative nurses were able to combine a highly developed intuitive decision 
making process with overt caring and concern for their patients. Elcock (1997) 
supports this view that an important part of the nurse-patient relationship is the 
ability to connect rapidly with a patient, with this process being accelerated if the 
situation is critical (Elcock 1997, p. 140). A confounding view of involvement was 
found by McCutcheon and Pincombe (2001) whose findings varied between those 
who thought a relationship was essential, those who did not, and those who thought 
intuitive ability would be improved by a relationship (McCutcheon and Pincombe 
2001, p. 346)
The involvement with the patient and the environment does not consist solely of 
knowledge of the patient, but also the nurse’s awareness of the self. Central to this 
involvement is the ability of the nurse to have a heightened awareness of the cues 
patients present because of the nurse’s willingness and ability to become involved in 
the relationship with the patient. When intuition is described as non-rational or 
mystical, it is perhaps because it is not viewed as a part of the whole process of 
patient assessment and care. For intuition to be useful in clinical practice it needs to
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be linked to a sound knowledge base and the ability to recognise patterns or 
deviations in the situation or behaviour. This thought processing, although rapid in 
onset, does contain rational and deliberative sorting of information to aid the nurse in 
clinical judgements.
4.10 The environment
Several studies cited above refer to the environment and its influence on nurses’ 
ability to develop intuitive clinical practice. These studies refer to the ability of 
nurses to learn from each other, especially more senior colleagues (Rolfe 1998b, 
Hansten and Washburn 2000, McCutcheon and Pincombe 2001, King and Macleod 
Clark 2002, Aitken 2003). Oral corroboration is an important aspect of reducing the 
risk that is inherent in practice and will depend on the clinical and organisational 
milieu within which the nurse is working. In Hedberg and Larsson’s study (2003) 
looking at the experience of six nurses working in a medical ward, a geriatric 
rehabilitation ward and a primary care centre, participants used collegial verification 
to validate the patient cues they observed. The nurses also recognised the value of 
being able to corroborate with more competent colleagues, which mainly took the
form of oral testimony (Hedberg and Larsson 2003, p. 219). Manley (2000)
describes much of this work as critical companionship and acknowledges that 
clinical leadership and an empowered organisation are key to such activities.
More recently, the term “community of practice” has been developed from learning 
theory. Wenger defines the necessary components of such a community as follows:
• Communities of practice enable practitioners to take collective 
responsibility for managing the knowledge they need, recognizing that, 
given the proper structure, they are in the best position to do this.
• Communities among practitioners create a direct link between learning 
and performance, because the same people participate in communities 
of practice and in teams and business units.
• Practitioners can address the tacit and dynamic aspects of knowledge
creation and sharing, as well as the more explicit aspects.
Communities are not limited by formal structures: they create connections among 
people across organizational and geographic boundaries” (Wenger et al 2002, p. 28).
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There remains a lively debate in the literature about whether intuition is an 
appropriate knowledge area for nursing. In its clinical community and in much of the 
evidence, however, intuition is seen as a highly valued part of nursing knowledge. 
Intuition has been described, classified and researched across environments and is 
part of the art of nursing that alongside other nursing knowledge can be consciously 
shared, honed and practised in a community of nursing practice as described by 
Wenger (2002). This sense of a learning community across an organisation or a ward 
may be useful in challenging barriers between education, practice and research. To 
make the community a reality other educational components such as personal 
reflection and supervision are also important and are discussed below.
4.11 Learning about intuition for practice
Demystifying and understanding intuition as a part of the nurse’s (or nurses') 
decision making is essential for clinical practice for three major reasons: first, so that 
nurses can develop intuitive processing and thus benefit patients; secondly, to aid 
transparency and understanding for other health care professionals, and thirdly so 
that the practice of nursing is made transparent (Rolfe 1998a).
Linked with intuition in the nursing literature is a sensitivity, preparedness and 
reflection on past experience. Johns’ (1998) description of “reflection-within-the- 
moment” is cited as a practice that can be used by the individual nurse during 
practice, so that the nurse is consciously monitoring themselves during practice. 
Several authors recommend using scenarios or “stories” from clinical practice to 
help themselves and learning nurses understand intuitive practice. This presentation 
of cases together with a deconstruction of the process of decision making can make 
conscious and overt that which is hidden in practice, so that nurses can develop and 
teach other skills (Rolfe 1998, Hansten & Washburn 2000). McCutcheon and 
Pincombe (2001) ask the more experienced nurse to act as a role model in practice, 
working alongside a learner nurse to consciously explain how in a particular 
situation they have used intuition. They recognise, however, that in their study of 
262 registered nurses there was a lack of reporting of intuition being wrong or 
misplaced (McCutcheon and Pincombe 2001, p. 347). King and Macleod Clark
(2002) also describe how novice nurses worked with more experienced nurses, who
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helped them to deconstruct their intuitive concerns and interpret their importance for 
the patient in relation to other clinical signs and then, importantly, how they might 
react appropriately to this new analysis (King and Macleod Clark 2002, p. 327). 
Aitken (2003) recommends the use of professional development coaching, utilising 
strategies such as teaching rounds and patient case presentations (Aitken 2003, p. 
483). Taking clinical education into the classroom, Ruth-Sahd (2003) argues for 
educators to share their intuitive experiences with their students, to create a climate 
of creativity and curiosity, and to design learning objectives that concentrate on 
process and skilled pattern recognition as well as content (Ruth-Sahd 2003, p. 133).
In a tertiary cancer centre where patients are treated actively and there is a high 
degree of complex treatments all carrying the risk of deterioration it is important that 
nurses are coached and supported to be aware of their importance in the early 
detection of cancer. Intuition is an important part of this recognition process and can 
be taught and encouraged through reflective practice, clinical supervision and 
sharing experience in formal teaching sessions.
4.12 Conclusion
In order to achieve early recognition of deterioration, nurses need to be aware of the 
dangers of sepsis in the cancer patient and be sensitised to the early changes of 
deterioration in their patients. Having recognised the change, nurses then need to 
instigate further assessment and where necessary alert the multi-professional team 
and ensure early rescue. In this chapter the literature on nurse and patient intuition, 
pattern recognition, heuristics, engagement and the therapeutic environment has been 
explored together with ideas on coaching and education. Each encounter that the 
nurse has with a person with cancer is unique, but the encounter can perhaps be 
helped by reflection on relevant literature and previous experience of care. The nurse 
at the bedside uses all these sources of knowledge to test the live hypothesis: “Is this 
patient developing sepsis?” The aim of this study was to increase awareness by 
providing a teaching session that highlighted the dangers of sepsis and then to aid in 
an early and appropriate response by providing nurses with a tool that could translate 
their intuitive concerns about the patient to others. Intuition is acknowledged as an 
important aspect of clinical nursing knowledge and has been variously described by
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many nursing authors as a type of consciousness, psychological perception and 
gestalt, probability judgements, a preparedness, clinical forethought and pattern 
recognition. The use of intuition is also recognised to be affected by experience, the 
environment and the involvement with the patient and situation.
In summary, it would seem that intuition is highly important in this study. Intuition 
here is not seen as something mystical or something that can only be experienced by 
the most experienced nurse. For this study it is explicitly Croce’s model of intuition 
that is being used (Croce 1872) and Dewey’s (1931) description of change: 
consisting of a sequence of events: intuiting the presence of phenomena, the 
evaluative classification process and then a choice regarding response to the new 
data. From the literature review, intuition is described as immediate apprehension or 
recognition, followed by a cognitive classification and understanding perhaps 
coupled with somatic feelings, then a decision whether to act on the new data. In the 
particular context of nursing nurses intuit a large amount of data that they need to 
process, some will be gross some will be subtle and difficult to articulate. The 
change that is intuited causes a disturbance or perplexity that then leads to a further 
examination of the data and reflection on past events / patterns, much new data will 
be rejected as irrelevant but some may be chosen to act upon. To pursue the quest 
for further data requires motivation, intellectual engagement and sensitivity to the 
situation.
This study applies Croce’s model of intuition to the nurse who is caring for the 
person with cancer who is in danger of sepsis. The nurse caring for the patient with 
cancer intuits a change; this change may be subtle but because the patient is known 
or there is full engagement the nurse is disturbed by it and may experience somatic 
feelings. The nurse engages with the patient, listening to them and performing a 
physical examination and starts the process of evaluation, action and calling for help. 
For intuition to be used effectively in the early detection of sepsis the nurse needs to 
be prepared and sensitised to the patient and their particular situation, and to be 
motivated with the moral intent to help. Experience and a mileu where this type of 
knowledge is welcomed make it easier for a nurse to openly express their intuitive 
feelings. Novice nurses do intuit change and should be encouraged to openly voice
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their thoughts whilst the experienced nurse must be encouraged to remain alive and 
motivated to the rapid deterioration of patients. The overall aim of this research was 
to improve practice in the acute care of people with cancer and specifically to 
investigate the nurses’ role in the early diagnosis of sepsis. The theoretical 
framework that cancer patients are vulnerable to sepsis and that early diagnosis and 
treatment reduces morbidity and mortality provided the rationale for designing a 
study that could harness nurses’ use of intuition, as described by Croce, and provide 
them with an objective tool and education to improve their awareness and 
recognition of sepsis. The objective tool was also used not just to aid the nurses’ 
assessment but also to help them in communicating with the multidisciplinary team 
and improving early rescue. The next chapter provides details of the methodology 
used and interventions employed.
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Chapter 5 Methodology
5.1 Introduction
The research reported in this thesis was conceived as a single study with a single 
clear focus; the improvement of nursing practice in the care of cancer patients who 
develop sepsis. However, nursing practice is what might be called a complex 
intervention (MRC Craig et al 2008) and, in order to understand and improve 
nursing practice and patient outcomes in this area, five separate stages of the study 
were developed. These were not five separate studies, but rather formed an 
integrated whole, bringing together nurses' ability to intuit subtle changes in patients' 
condition, to recognise these changes as possible early indications of the onset of 
sepsis, and to present this to other members of the multi-professional team with the 
support of a confirmatory blood test. The theoretical framework underpinning this 
study, as introduced in chapter one, is as follows:
1. The vulnerability of the cancer patients’ immune system and increased 
susceptibility to sepsis;
2. The evidence that early diagnosis and treatment reduces morbidity and 
mortality in sepsis;
3. Nurses’ ability to intuit subtle change pre-cognitively which causes 
discomfort and a stimulus to act;
4. Education and its ability to raise awareness of risk;
5. Packaging of information using an objective test to aid effective multi 
professional communication and rescue.
The early recognition and treatment of sepsis therefore consists of three elements: 
the nurse’s knowledge of and commitment to her patient, nurses’ knowledge of 
sepsis, and the tools to allow nurses to mobilise the multi professional team. This 
chapter describes the methodology chosen for this study and the way that the 
theoretical framework affected the choice of both design and interventions. Choices
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about design and methodology were based on the need to develop and improve 
practice in the clinical environment and to reflect the complexity of clinical practice. 
A multiple methods design was chosen to address the research aims and objectives. 
The chapter first describes the aims of the study and then the rationale for the design 
chosen and those rejected.
The theoretical assumptions underpinning the research drawing from the literature 
and clinical experience, were that:
1. Cancer and its treatment make a person more vulnerable to the development 
of sepsis;
2. Cancer patients are likely to develop sepsis and have a higher mortality rate 
from it than patients without cancer;
3. Early recognition of developing sepsis is essential if patients are to survive;
4. Early recognition can only lead to improved survival if it is acted on with 
early and appropriate treatment;
5. The early signs and symptoms of sepsis may be subtle and may not always 
manifest through measurable changes in vital signs;
6. Nurses are capable of intuiting and recognising subtle changes in the 
patient’s condition but do not always articulate these as signs of early sepsis;
7. When nurses intuit subtle changes but lack objective evidence of the onset of 
sepsis others may be reluctant to act with the necessary urgency.
Based on these assumptions, the study aimed to investigate the nurses’ role in the 
early diagnosis of sepsis and to provide nurses with a new objective tool and 
dedicated education to improve early diagnosis and rescue. The overall and 
subsidiary aims, as introduced in chapter one, from each of the five stages of the 
research are illustrated below in table 5.1. together with the two interventions.
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Table 5.1: Subsidiary and overall research aims linked to each research stage
No. Subsidiary Research aims Research stages
1. Pre-intervention
1. The experience of caring for cancer patients 
deteriorating with sepsis.
2. The experience of communicating with and 
mobilising the multi-professional team about a 
patient deteriorating with sepsis.
3. The introduction to a new bedside blood test that 
may help in identifying sepsis earlier.
Post intervention
4. Experience of the patient deteriorating from sepsis.
5. The experience of using the PCT-Q in practice
6. Nurses’ accounts of the optimal ways of learning 
and developing their practice.
7. How nurses think an effective multi-professional 
response with a deteriorating patient can be 
improved.
8. Nurses’ recommendations to improve the early 
detection and treatment of cancer patients 
developing sepsis.
Pre and post - 
intervention 
qualitative 
interviews with 10 
nurses of varying 
cancer and critical 
care experience.
Post-intervention 
qualitative 
interviews with 8 of 
the 10 nurses 
previously 
interviewed.
2. Pre-intervention
1. Raising awareness of sepsis.
2. The nurses’ knowledge of sepsis: incidence, 
mortality risk, early diagnostic tests, procalcitonin 
and its role in the early diagnosis of sepsis.
3. Introduction to the bedside procalcitonin test (PCT-
Q)-
4. Examples of patients deteriorating with sepsis and 
nurses finding it difficult to convince the team.
Post intervention
5. Changes in nurses’ awareness and knowledge 
regarding sepsis: incidence, mortality risk, early 
diagnostic tests, procalcitonin and its role in the
Pre and post 
intervention 
questionnaires to 
177 nurses across 
the hospital.
Post-intervention
questionnaires
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early diagnosis of sepsis.
6. The nurses’ experience of using the PCT-Q in 
practice.
7. The nurses experience of thinking that a patient was 
deteriorating but finding it difficult to convince other 
nurses/doctors or other health care professionals. 
Examples from practice.
completed by 85 of 
the original 177 
nurses.
3 a. 1. Ward teaching sessions on the cancer patient and 
sepsis, associated risks and mortality rate, the 
evidence on early diagnosis and treatment and 
assessment tools including procalcitonin.
2. Introduction to the use of the PCT-Q bedside test.
Intervention (1)
3b. 1. Introduction of the bedside test PCT-Q in the 
hospital for the first time. PCT-Q bedside blood test 
used on all patients that nurses assess as showing 
early signs of sepsis.
2. Each patient recruited for the PCT-Q test to have all 
other infection markers mapped to be able to 
compare the efficacy of the PCT-Q test to those 
usually used in the hospital.
3. All patients entered into the study to have episode 
and hospital outcomes mapped with the objective of 
comparing outcomes of those who had PCT-Q 
measured in the study year to outcomes in the three 
previous years when the PCT-Q test was not 
available.
Intervention (2)
Archival notes 
review used to 
compare historical 
data with study data.
4. 1. Assess if the PCT-Q is used appropriately.
2. Assess if using the PCT-Q in sepsis assessment 
means that sepsis is diagnosed earlier.
3. The performance of the PCT-Q compared to the 
sepsis predictive markers already used by the 
hospital: White Blood Cell count, C-reactive protein, 
blood lactate, altered physiological parameters 
particularly mean arterial blood pressure.
4. The effect of introducing the two interventions: 
education and the PCT-Q on sepsis episodes and 
outcomes compared to the three previous years.
PCT-Q patient 
survey with 320 
patients and 416 
sepsis episodes in 
patients receiving 
acute care across the 
hospital.
5. Overall Research Aim
1. To investigate the nurses’ role in the early diagnosis
Integration 
of all
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of sepsis and to provide nurses with a new objective qualitative
tool and dedicated education to improve early data and
diagnosis and rescue. comparison
with
quantitative
data.
5.2 Primary and Secondary objectives
In chapter three the literature explaining the subtle early signs of sepsis was 
described together with the evidence that early detection and treatment of sepsis 
reduces morbidity and mortality and increases survival (Dellinger et al 2004, 2008). 
The primary objective was therefore to diagnose patients' sepsis at an earlier stage, 
recognising that nurses report a difficulty in convincing colleagues, an objective 
bedside test was to be introduced to improve multi-professional communication and 
therefore rescue.
The secondary objectives were to:
1. Learn more about nurses’ experience of the cancer patient deteriorating with 
sepsis and any barriers to effective communication and rescue;
2. Gain an in-depth understanding on nurses awareness of sepsis and its 
assessment and management and how this could be improved, particularly 
how nurses felt they learnt optimally;
3. Explore whether nurses’ judgement about the patient developing sepsis was 
accurate and whether they could use the PCT-Q appropriately;
4. Gain an in-depth understanding from the nurses about how they felt the use 
of the PCT-Q has impacted upon practice and ;how easy in practice it was to 
use;
5. Assess whether in the nurses’ hands and on cancer patients the PCT-Q was 
reliable in identifying sepsis compared to WBC, lactate, CRP and mean 
arterial pressure falls;
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6. Evaluate if the use of the PCT-Q as part of clinical nursing assessment and 
communication resulted in earlier referrals and improved outcomes;
7. Compare the outcomes of patients during the study year to three previous 
years;
8. Evaluate whether the dedicated education session improved awareness and 
knowledge about the cancer patient with sepsis.
The primary endpoint of the study was an increase in referrals at an early as opposed 
to late stage of sepsis. The secondary endpoints were: nurses’ increased awareness 
and knowledge of sepsis as measured by the post-intervention questionnaire; 
appropriate use of the PCT-Q by ward nurses; an increased understanding of nurses’ 
experience of patient deterioration; and mobilising help from other nurses and 
multidisciplinary colleagues. Finally, archival data would be examined to look for 
evidence of improvement in mortality rates for sepsis during the study period.
5.3 Overall study design
This study focused on improving clinical practice and used a research framework 
with five stages. The different stages were:
1. Qualitative in-depth interviews, pre and post the introduction of the PCT- 
Q to gain an in-depth understanding of the nurses’ experience both with 
and without the PCT-Q.
2. Pre and post-intervention questionnaire survey;
3. Two interventions:
3(a) Dedicated education session on sepsis, its assessment, management and 
predictive markers including procalcitonin and the PCT-Q;
3(b) The introduction of a new bedside blood test the PCT-Q to aid in the 
early assessment and communication re sepsis.
4. Collection of clinical data on patients who were thought to be developing 
sepsis and had a PCT-Q test performed and an archival notes review to 
compare pre and peri-study mortality rates.
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5. Integration o f  all qualitative results and com parison with quantitative 
findings.
The diagram below illustrates schem atically how the five stages o f  the study were 
designed and implemented.
Figure 5.1: Study Design
Simultaneous actions
Simultaneous actions
I Qualitative 
interviews
Post-intervention
questionnaires
Interventions: 
Teaching session 
& PCT-Q 
introduction
Commence Patient 
Recruitment: PCT-Q
Pre-intervention
questionnaires
10 Qualitative 
interviews
Compare qualitative and 
quantitative findings in 
the discussion
Analyse all data 
separately
Integrate all 
qualitative data
5.4 Rationale for study approach
W hile research suggests that nurses can recognise subtle early changes in a patient's 
condition, the literature (e.g. Cioffi 2000) and clinical experience suggest this alone 
may be insufficient to persuade other clinical staff to act. A tool, the PCT-Q, was 
identified that would enable ward nurses to approach other colleagues with objective 
evidence o f  the early onset o f sepsis. The PCT-Q is a bedside test which in 35 
minutes provides a PCT level between 0 and 10 ngs/ ml. A PCT-Q value o f  0.5 
ngs/ml is indicative that the patient has the Systemic Inflamm atory Response
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Syndrome (SIRS); a value of 2 indicates sepsis, and 5 to 10 indicates severe sepsis. 
The rationale for introducing the tool was, first, to give the nurse more confidence in 
alerting other colleagues; secondly, there is evidence that other colleagues are more 
affected by quantitative change rather than description (Koubel 2006). The Critical 
Care Outreach Team (CCOT) were included in the process of measuring the PCT-Q 
and would therefore be informed early of a deteriorating patient.
The researcher was keen to improve practice in all areas of the hospital where 
patients were at risk from sepsis, therefore a large number of patients and nurses 
were recruited to the study. All patients during the intervention period who 
consented were eligible, and those who demonstrated early signs of sepsis were 
recruited into the study. In order to reach all wards a questionnaire was used with 
177 nurses. To gain an in-depth understanding of the nurses’ experience both with 
and without the PCT-Q a qualitative interview was conducted pre and post 
intervention, with ten nurses pre and eight post intervention. The three elements of 
the study, the investigation of nurses' experience of recognising changes in patients' 
condition, the raising of knowledge levels and the implementation of the PCT-Q test, 
each demanded different methodological approaches, and the study could therefore 
be described as employing multiple methods.
5.5 Multiple method research design
Priorities for nursing research need to be able to reduce the theory-practice gap and 
nursing research needs to investigate practice-based questions (Cull-Wilby and Pepin 
1987, Im and Meleis 1999, Doane 2003, Rolfe 2006b). In a practice-based discipline 
such as nursing where the questions that need to be asked are complex and multi­
factorial, it may be necessary to combine methods to answer a question successfully 
or improve practice. In the past such a combining of methods would have been 
questioned, but increasingly it is recognised that such an approach is beneficial to the 
development of nursing (Weaver and Olson 2006).
5.5.1 Historical background of multiple methods research
Many authors attribute multiple methods design to the psychology research of 
Campbell and Fiske in 1959. In their work validating psychological traits, Campbell
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and Fiske used a multimethod matrix using more than one quantitative research 
method, and they encouraged other researchers to use multiple data collection 
methods. Campbell and Fiske decided to use several methods in an attempt to make 
sure that the variance in their study was accounted for by a particular trait. More 
researchers then started to combine methods such as interviews and surveys, which 
had previously only existed separately. Finally, the term triangulation was used by 
researchers who were keen to use the strengths of different methods to limit the bias 
in a single method and provide greater illumination of a question or hypothesis 
(Denzin 1978). Denzin (1978) is credited with first using the term triangulation in 
his book on sociological methods. Authors who describe the use of mixed designs 
emphasise the need to be clear about the framework that informs each type of 
method, analysis, or approach (Duffy 1987, Coward 1990, Mason 2002). Creswell
(2003) recommends that all researchers who plan to use a multiple methods design 
answer four questions before deciding on their research strategy:
1. What is the implementation sequence of the quantitative and 
qualitative data collection in the proposed study?
2. What priority will be given to the quantitative and qualitative data 
collection and analysis?
3. At what stage in the research project will the quantitative and 
qualitative data and findings be integrated?
4. Will an overall theoretical perspective (e.g. gender, race/ethnicity, 
lifestyle, class) be used in the study?” (Creswell 2003, p. 211)
For the current study, using both qualitative and quantitative methodologies, the 
researcher’s decisions were as follows:
1. The implementation sequence was based on a pragmatic need to ask some 
questions before designing the post-intervention questionnaire;
2. There was no priority given to any of the research methods, they were all 
seen as equally important;
3. The analysis of the pre-intervention qualitative interviews informed the 
questions in the post-intervention qualitative interviews;
4. The overall theoretical perspective used is one of a pragmatic approach to 
improving a particular part of nursing practice.
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5.5.2 Integration of the data
A common theme in the literature is concern regarding the combination of different 
paradigms or philosophies. Morse (1991) for this reason recommends independent 
analysis for all methods before merging the data (Morse 1991, p. 121). The 
challenge to the integration of the data lies primarily in the different paradigms or 
epistemologies associated with the research design. In qualitative analysis the 
researcher typically is trying to gain a clearer understanding of the way that a 
participant constructs their world: a constructivist philosophy (Pearson 1997). 
Silverman describes this as the researcher “being interested in the precise particulars 
of ...people’s understandings and interactions” (Silverman 2005, p.9).
Morse (1994) suggests that following qualitative data collection “four cognitive 
processes are integral to all qualitative analysis: comprehending, synthesising, 
theorising and recontextualising (Morse 1994, p. 25). Pearson (1997) adds that these 
stages often occur in an iterative loop, with the researcher returning to an earlier 
stage again when new questions arise from the analysis (Pearson 1997, p.69). In 
contrast, quantitative data is analysed in an essentially deductive way, usually 
involving the testing of one or several hypotheses. The analysis is concerned mainly 
with the parameters of the findings, for example the number of the same data and 
then the generalisability of the findings, whether they have occurred by chance, and 
whether they are representative and able to be applied to another group. Statistical 
tests are then used to explore the probabilities of the data occurring in a specific 
population or environment (Polit and Hungler 1999).
5.5.3 Integration of the findings in the present study
The present study accumulated knowledge from each method in an attempt to further 
understand and improve practice. This approach reflected the essential granularity of 
nursing practice with its complex combination of propositional and practical 
knowledge (Wainwright 2003). For example, a nurse needs to understand the 
pathophysiology of sepsis and safely administer complex antimicrobial therapy 
while being able to comfort the patient who senses a deterioration in their overall 
condition. In the same way, the different methods were respected but the findings 
used together to answer a question that was based on multi-layered clinical practice.
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Complex integration was not a problem for the current study. The qualitative 
findings from the interviews and the open question in the questionnaire were 
integrated but were clearly from the same paradigm. The two parts of the study 
involving quantitative data were analysed completely separately and their findings 
not integrated. Therefore this study which was designed to improve practice used 
multiple methods but did not require integration of the data.
5.5.4 Advantages and disadvantages of multiple methods research
Johnstone used a mixed methods approach to explore the process and organisational 
consequences of new surgical techniques in five Australian hospitals and describes 
the advantages of a “thick” description of the phenomenon being studied (Johnstone 
2004, p. 264). For many researchers, multiple methods research increases the scope, 
rigour, credibility and analytic power of research studies (Erlandson et al 1993, 
Hassard 1993, Sandelowski 2000). Creswell and colleagues (2004) explain that there 
is a logical and pragmatic benefit of using a multiple methods design in primary care 
when neither quantitative nor qualitative approaches are sufficient on their own to 
fully capture the trends and details of the phenomenon. When the two methods are 
used together they complement each other and provide a more complete analysis 
(Creswell et al 2004, p.7). Finally, Sandelowski (2000) suggests that researchers 
make choices not by fashion or fad but on the needs of the research question 
(Sandelowski 2000, p. 254). For the present study the researcher had observed a gap 
in practice and wanted to both understand the gap and improve practice during the 
research. The research question was deliberately set in the reality of clinical practice 
and the design was chosen to be able to answer a complex question embedded in 
clinical practice with all its variables.
Practical difficulties for the researcher using a multiple methods design are: a longer 
period of data collection, generation of a large amount of data and integration. 
Multiple methods research may take longer overall and require more resources. 
There may also be problems for researchers who wish to publish and editors who 
prefer to publish only one method or paradigm (Sandelowski 2000, p.254).
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5.6 Study setting
The study was set in a tertiary comprehensive cancer centre in England. The centre is 
a hospital with two sites focusing exclusively on children and adults with cancer. 
The centre sees approximately 40,000 patients a year with any type of cancer and, as 
a tertiary centre, receives referrals from the local population but also from across the 
UK and internationally. The centre is joined to a major translational research 
institute, developing therapy in the laboratory that is trialled for the first time in 
humans on the wards. The centre does not provide undergraduate nursing or medical 
training but does specialise in postgraduate cancer training for nurses, doctors and 
allied health professionals. There are about 2,000 people employed in the centre with 
approximately 760 of these being nurses.
5.6.1 Introduction to the researcher
The researcher is a clinician engaged in research in her own organisation. The 
researcher has worked with the critically ill person for 23 years, for the last 16 with 
the critically ill person with cancer. During this time the researcher has always 
worked clinically, valuing colleagues in the multidisciplinary team and especially 
fellow nurses. Since 2001, because of the development of Critical Care Outreach 
Teams the researcher has increasingly worked with ward nursing teams. Working 
with ward teams she has been conscious of the challenges in everyday clinical 
practice for nurses working with many patients and families, with fewer nurses and 
higher expectations placed upon them. The researcher also coordinates several 
educational modules and therefore works with the most junior clinical nurses in the 
organisation, as a module leader and teacher but also as a fellow student sharing the 
challenge of deadlines and balancing work, study and life. The researcher is a 
passionate enthusiast for nursing and the way it can change people’s lives, both 
during acute illness and also in the chronic setting. As a practising clinical nurse the 
researcher is however absolutely realistic about the muddle of clinical practice and 
the delays and difficulties in a system that is being constantly stretched with less 
resource.
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5.7 Individual m ethods
The following sections describe the three m ethods that form the study in the order, 
that they comm enced: qualitative interviews first; then the questionnaire survey and 
then the patient PCT-Q part o f the study, the two interventions are also described. 
Each o f  the three m ethods was informed by the theoretical fram ework and 
assum ptions underpinning the study and are illustrated in the diagram below:
Figure 5.2: Study Design: Theoretical Framework, Research Questions and 
Analysis
Theory Stage 1: The threat of sepsis 
fo r patients with cancer
1 P a ten ts  with cancer are more 
vulnerable to sepsis due to the d isease 
and treatment effects on their immune 
system
2 Cancer p a ten ts  are more su scep tb le  
to sepsis and to die from it
Theory stage 2: Early recognition of 
sepsis
1 Early recogniton of sepsis is essenbal 
if p a ten ts  are to survive
2 Early recogniton can only lead to 
improved survival if it is acted on with 
early and appropriate treatm ent
3 Early signs of sepsis are subtle and 
may not manifest through m easurable 
changes in vital signs
Theory stage 3 , 4 ,5  -  Intuition: 
Croce's model of intuition informs 
nurses assessment of sepsis and  
comm unication and m obilisation of 
the m ulti-professional team
1. Nurses intuit subtle change pre- 
cognitively this causes discomfort and a 
stimulus to act.
2 Education is important for nurses to be 
aware of the risk of sepsis 
3. To communicate with the multi­
professional team  effectively nurses need 
to package information an objective test 
aids communication and rescue
Intervention 1
Educational session  to raise 
aw areness and improve 
knowledge about sepsis 
its diagnosis and the use 
of the PCT-Q
Intervention 2
Introduction of the PCT-Q 
part of the nurses' 
assessm en t and an objective aid to 
communication of the 
deteriorating 
cancer patient
Research Aim s 1
1 Experience of caring for patients 
deteriorating with sepsis
2 Experience of communicating with and 
mobilising the multi-professional team 
about a patient deteriorating with sepsis
3 Introduction of a new bedside blood 
test the PCT-Q that may help in 
identifying sepsis eariier
4 Experience of using the PCT-Q in 
practice
5 Nurses' accounts of optimal ways of 
learning and teaching re  sepsis
6 How nurses think early detechon. multi- 
professional rescue and treatm ent of 
sepsis can be improved
Research Aims 2
1 Raising aw areness of sepsis
2 Nurses' knowledge of sepsis incidence, 
mortality risk, early diagnosbc tests, 
procalcitonin and its role in the early 
diagnosis of sepsis and any improvement 
in knowledge post educabonal 
intervention
3 Introduction to the PCT-Q and  then 
experience in practice
4 Examples of p a ten ts  deteriorating with 
sepsis and nurses finding it difficult to 
convince the team
Research Aims 3 ,4 ,5
1 A ssess if the PCT-Q used 
appropriately
2 A ssess if use  of the PCT-Q meant 
sepsis diagnosed earlier
3 The performance of the PCT-Q 
against markers| WBC. Lactate, CRP 
and lowered MAP
4 The effect of introducing the 2 
interventions on sepsis episodes and 
outcom es com pared to three previous 
years
Research M ethod 1
Qualitative Interviews 
pre and post the 
introduction of the 
PCT-Q
10 nurses then 8 
nurses
Analysis 1
1. Qualitative analysis 
informed by grounded theory
2 Constant comparative 
technique
3 Them es generated, 
concepts identified
Research M ethod 2
Questionnaire Survey 
pre and post 
educational intervention
177 nurses then 84 
nurses
Research M ethod 3
PCT- Q used  along 
with CRP, WBC, 
Lactate and 
physiological 
param eters to a s se s s  
the patient who was 
showing the early signs 
of sepsis
320 patients, 416 
episodes of sepsis
Analysis 2
1 Descriptive statistics to 
explore the data
2 Paired data com pared using 
M cNemar's test
N.B 3 Open question: 
qualitative data analysed as 
Analysis 1 above
Analysis 3
1 PCT value correlated with 
sepsis stage analysed using 
chi square
2 Validity of sepsis markers 
tested  individually using 
univanate ordinal logistic 
regression analysis and then 
combined using multivanate 
ordinal logistic regression 
anaylsis
3. Sepsis episode and hospital 
outcome in the study year 
com pared with three previous 
years
5.7.1 Nurse Qualitative Interviews pre and post intervention 
(research stage one)
Approximately 760 nurses are employed at the host hospital, with 440 nurses who 
work on the ch ildren 's wards, outpatient departm ents and theatres excluded from the 
Nurse Interview study, as were advanced nurse practitioners. A purposive sample o f
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10 nurses was selected, from a population of 320 nurses working across the trust 
who actively work with inpatients receiving acute care, from the most junior staff 
nurse to senior charge nurse or outreach sister. These nurses were interviewed pre 
and post the educational and PCT-Q interventions. A purposive sample was chosen 
to explore the experience of a range of nurses, from the novice cancer nurse to the 
very experienced. Nurses were also recruited from different wards/units to cover all 
types of cancer (see appendix 3). Nurses were also recruited from the CCU and 
Critical Care Outreach Team. The number of nurses was limited to 10 for primarily 
practical reasons (Thome 2001, Guest et al 2006). In this study the interviews were 
repeated, thus providing 20 transcripts available for analysis. The roles chosen were 
not selected to be representative of all cancer nurses, more to reflect the diversity of 
nursing experience, knowledge and nursing activity involved in the care of the 
cancer patient developing sepsis.
Table 5.2: Inclusion and exclusion criteria for the nurse interviews and the 
nurse questionnaire samples.
No Inclusion criteria Exclusion criteria
1 Registered nurses Student nurses
2 Working in an inpatient ward or critical 
care unit
Nurses working in outpatient areas
3 Likely to be at the hospital six to eight 
months later.
Nurses working on the children’s unit, 
children’s day care
4 Theatre nurses
5 Advanced practice nurses who do not 
have a bedside role with the inpatient 
population
6 Nurses working in the palliative care 
setting.
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5.7.2 Nurse recruitment plan
Nurses recruited for interview were initially alerted to the study by advertisements 
on each ward. Advertisements were used to try to avoid any undue influence by the 
researcher over the participants. The researcher was not in a line management role 
with any participants but was senior in the organisation, and it was important that 
she did not exert any overt pressure. From all nurses who volunteered (n=34), 10 
were selected because of their role, experience and ward (each ward at the host 
hospital reflects a different cancer). These 10 were then sent an invitation letter and 
Nurse Information Sheet (see appendix 4). Each nurse, according to the National 
Research Ethics Service (NRES) (2006) good practice guidelines, was given at least 
24 hours to think about the study and their participation. Nurses were then 
questioned by the researcher to ensure that they understood the information sheet 
and the time commitment over two interviews. One nurse then decided not to 
participate as she was leaving the hospital within two months; another nurse was 
recruited from the original 24 volunteers and all participants signed a formal consent 
form.
5.7.3 Qualitative interviews with nurses
The rationale for the qualitative interviews with nurses was to gain their in-depth 
experience of working clinically with people with cancer who may be developing 
sepsis. Each qualitative interview was conducted in private, away from the busy 
ward areas, in protected time agreed by the nurse’s line manager. Each interview 
session was taped using a purpose-designed transcription unit, with participants 
double consented before and after each interview. Each participant provided written 
consent and retained a copy of the participant information sheet and a copy of their 
consent form. A second copy of their consent form was kept in the research office 
(see appendix 9a). Each tape was then transcribed, with each transcript being 
anonymised using a number for identification so that when the post-intervention 
interviews were conducted the results could be compared and analysed. The tapes 
and transcripts were stored in a locked cabinet in the research office to ensure 
confidentiality and safety. The post-intervention interviews were consented and 
conducted in the same way.
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5.7.4 Objectives of the qualitative interviews
The objectives of the qualitative interviews were to gain an in-depth 
understanding of the following aspects of the nurses’ individual experiences of 
caring for a patient deteriorating with sepsis:
1. Nurses’ individual overall experience of caring for patients deteriorating with 
sepsis
2. Barriers to effective communication and rescue, and their previous experience of 
informing and mobilising the multi professional team;
3. Nurses’ awareness of sepsis and its assessment and management and how this 
could be improved, particularly how nurses felt they learnt optimally and could 
teach others;
4. How nurses felt the use of the PCT-Q impacted upon practice and how easy in 
practice it was to use.
The post-intervention interviews were to be conducted with the same 10 nurses who 
had been previously interviewed. Two of the nurses had left the hospital, leaving 
eight post-intervention interviews. The rationale for the post intervention interviews 
was to interview the nurses post the introduction of the PCT-Q to obtain richer data 
about its introduction. Themes or questions that were generated from the analysis of 
the first transcripts were also explored. There was no intent to compare pre and post 
interviews but rather to integrate all the findings to better understand the lived 
experience of the nurses. As previously, the eight nurses provided written consent 
pre and post interview.
5.7.5 Qualitative interviews
Qualitative interviews vary in their epistemological and methodological approach to 
the collection of data, from the quantitative structured interview to the unstructured 
qualitative interview, with the semi-structured interview including elements of both 
paradigms (Parahoo 1997, p. 283-296). The interviews used in this study were 
qualitative: broad cues gave some form to the interview but, unlike a semi-structured 
interview, the researcher was keen to have flexibility and less domination. Parahoo
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would describe the interviews used in this study as focused qualitative interviews 
(Parahoo 1997, p.295). The qualitative research interview is of a particular 
construction resulting in a specific theory and knowledge generation. The 
information gained from a qualitative interview is actively constructed at the time of 
the interview by the researcher and the participant (Holstein and Gubrium 1995). 
The researcher is recognised in qualitative interviews to influence the dialogue and is 
a part of the interactions that are studied (Fontana & Frey 2000, p.663). 
Acknowledging the active role of the researcher in unstructured or focused 
qualitative interviews means that trust, establishing a meaningful rapport, and 
reflexivity are essential requirements (Cicourel 1974, Fontana and Frey 2000).
In the sepsis study, in an effort to promote trust and rapport, the researcher reminded 
participants that their data would be anonymised and that nothing they could say 
would be “wrong”. The researcher repeated to each participant that she was keen to 
learn from their experience. Some of the participants had previously been taught by 
the researcher and she was therefore keen to monitor her own behaviour during the 
interview and ensure that the participants felt at ease, especially when talking about 
their knowledge and skills.
5. 7.6 Analysis plan for qualitative interviews
The transcripts from the pre-and post-intervention interviews and the qualitative data 
from the questionnaires were analysed using a qualitative technique utilising a 
constant comparative strategy (Glaser 1992, Strauss and Corbin 1998, May 1998). 
The aim of the analysis was to translate the rich and lengthy data from the transcripts 
into a coherent account linked to theory. Miles and Huberman (1994) describe this 
process as a sharpening, focusing and organising of the data. The researcher’s 
critical application to this process has been described as an essential prerequisite, 
carefully and critically reflecting on the data while reading and coding. May 
describes this as ‘a highly focused and selective kind of reading’ (May 1998, p.69). 
The researcher was also influenced by Morse’s work on comprehending, 
synthesizing, theorising and recontextualising (1994). During the analysis the 
transcripts were read and re-read in detail and common examples of events or 
accounts across narratives noted and highlighted using a highlighter pen (for an 
example see appendix 15).
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The emergent themes from the transcripts were then organised and coded using the 
model described by Tesch (1990) and sorted into general themes, unique and then 
left over themes and given a numerical key. These codes were collated and indexed 
on a simple paper grid such as that cited by May (1998) and used by Sirur (1997). 
The transcripts were then re-read and the codes applied across all transcripts, with 
more codes being added or previous ones subtracted as appropriate. The 18 
interviews provided a large amount of data and the mechanistic use of a grid helped 
with the process of organising and analysing the data. The process used was 
therefore inductive and iterative with a constant movement between the transcripts 
and the grid with frequent additions, subtractions and alterations.
Having performed these steps, the codes were focused further into key themes and 
concepts. During this analysis deviant or extraordinary cases emerged and were 
highlighted to be considered as part of the analysis (Silverman 1993). Finally, the 
data was transformed into key concepts. The process was an iterative one with a 
constant interaction between the researcher and the data, so that ideas developed as 
the researcher constantly asked questions of and explored the data. During this 
process the researcher also asked her primary supervisor to examine the themes and 
to comment on the emergent themes from the transcripts.
During the whole analytic process a research journal was kept for three main 
reasons: first, to help the researcher remember issues and ideas that occurred during 
the reading and coding for the analysis, secondly, to record any key decisions 
regarding coding or analysis, and thirdly to form part of an audit trail which several 
authors recommend to ensure rigour and to make overt the researcher’s thoughts, 
decisions and influences on the data (Lincoln and Guba 1985, Koch 1994, Koch 
1999, May 1998, Playle 2000, Rolfe 2006c).
5.7.7 Nurse sample to participate in the pre-and post-questionnaire 
survey (research stages two and five)
For the questionnaire and educational intervention a sample of 177 registered nurses 
employed as permanent or bank staff was recruited, from all adult inpatient wards at 
both sites of the hospital. This sample 177 (n=320) represents 55.3% (177/320) of
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the “bedside” ward and CCU nurses and included representation from both sites and 
all inpatient ward areas. The inclusion and exclusion criteria were the same as for 
the interview participants (see table 5.1).
5.7.8 Recruitment plan for questionnaire survey
Ward sisters were given copies of the questionnaire nurse information sheet (see 
appendix 5) and a verbal explanation of the aims of the study and details of the 
interventions. The researcher then met with large groups of ward staff on their ward, 
in open meetings and in the school of nursing to explain the study, distribute nurse 
information sheets and ask nurses to think about participating. The week before each 
teaching session the researcher visited the ward again and distributed more nurse 
information sheets. The researcher then arranged teaching sessions with the ward 
sister/charge nurse on the wards at an appropriate time of day, night or weekend. At 
the time of the teaching intervention the researcher asked all nurses present if they 
had read and understood the information sheet and were willing to complete the pre 
and post-intervention questionnaires. On each occasion it was emphasised that they 
were under no obligation to participate. Willing nurses then formally consented. 
Over the six month recruitment period, 14 nurses (n=T77) did not consent because 
they knew they would be leaving; 12 of these did attend the teaching session.
5.7.9 The formal education intervention (research stage three)
The formal education session was provided to 177 nurses across the hospital. The 
aim of the education session was threefold:
1. To heighten awareness of sepsis among nurses directly caring for 
patients at risk;
2. To ensure nurses were aware of recent evidence about early diagnosis 
and treatment of sepsis;
3. To teach nurses when and how to use the PCT-Q.
The session was standardised using a PowerPoint presentation that was easily 
transported and shown in wards by the researcher on her laptop computer (see 
appendix 7). Each education session took place on a ward or clinical department in 
the nursing office or in a designated quiet area on the ward. All teaching sessions
92 o f355
were pre-booked to integrate with ward teaching sessions. The researcher was, 
however, flexible and responsive to the ward’s needs: some sessions were cancelled 
and others were provided at short notice. All sessions were provided by the 
researcher and, although standardised, different questions and interactions with 
groups of nurses meant that each session was unique. The summary of the lesson is 
illustrated in figure 5.2 and provided as a lesson plan in appendix 6.
Figure 5.3: Summary of intervention: education session
1. Incidence and mortality rates worldwide for healthy people and cancer patients 
who develop severe sepsis;
2. The different stages of the sepsis syndrome: Systemic Inflammatory Response 
Syndrome (SIRS), sepsis, septic shock, severe sepsis;
3. The pathophysiology of the inflammatory response and severe sepsis;
4. The evidence regarding early diagnosis and treatment;
5. Early predictors of sepsis including procalcitonin;
6. Practical steps for using the PCT-Q.
5.7.10 Questionnaire survey
Before the teaching session any nurse that had consented to the questionnaire survey 
completed the pre-intervention questionnaire (see appendix 10). The questionnaire 
was designed to encourage participants to think about and test their knowledge 
regarding the sepsis syndrome. As no validated questionnaires that could be utilised 
in the study could be found one was designed for the study. The questionnaire was 
not designed to measure a concept or behaviour or be generalised to another 
population. It was explicitly to be used by nurses in order to test their individual 
knowledge and then for the researcher to assess whether individual knowledge 
improved following the teaching intervention. The outcome of interest therefore was
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the change within the person and the explanatory variable was time and the impact 
of the teaching session.
5.7.11 Questionnaire design
Before designing the questionnaire the researcher looked at the primary and 
secondary aims of the research and informed by the literature review, compiled into 
a list of the information to be gained from the participants. The overall aim of the 
questionnaire was to give the nurses an opportunity to reflect on their own 
knowledge before the dedicated teaching session, and for the researcher to see what 
level of knowledge the nurses had before and after the teaching intervention. The 
questionnaire was constructed to address the following areas:
1. Biographical data including experience and educational qualifications in 
cancer nursing;
2. The nurse’s confidence in her current knowledge;
3. The standard definitions for the sepsis cascade (this was important as the 
overall aim of the study was to diagnose sepsis, earlier and the researcher 
therefore wanted to ensure that the nurses were aware of the four stages of 
the sepsis syndrome);
4. The mortality rate for severe sepsis in healthy adults and then in cancer 
patients;
5. How the nurse would describe the early signs of sepsis;
6. The immunological blood indicators of sepsis, particularly CRP, WBC, 
lactate and PCT;
7. The members of the multidisciplinary team that the nurse would contact if 
concerned about a patient deteriorating;
8. Whether the nurse had had experience of nursing a patient with sepsis; and
9. Whether the nurse had ever had difficulty in convincing others.
These nine areas were then organised into 15 questions presented in four sections, 
with a logical sequence to each group of questions (Burgess 2001):
1. Biographical details of the nurse including experience and educational 
qualifications;
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2. General questions about the sepsis syndrome including mortality rates in the 
healthy and cancer patient;
3. Immunological blood indicators of sepsis and PCT;
4. Mobilising the rescue for the patient who has developed sepsis.
Having determined the questions that needed answering, the format of the questions 
was addressed. Short, simple and precise questions were chosen, asking for only one 
piece of information at a time (Leung 2001). The questionnaire was semi-structured 
with a combination of closed and open questions. As the questionnaire was to be 
administered on the ward with clinical time pressures, the questions were short and 
precise with eight closed questions (n=15) and two questions that provided a third 
choice: “not sure”. Two further questions asked the participant to insert the mortality 
rate for sepsis in healthy adults and those with cancer. The remaining five questions 
were open, the first four asking the participant to list relevant responses, and the fifth 
asking for experience of a clinical scenario. With closed questions testing knowledge 
there is the possibility of successfully guessing the answer, therefore these questions 
were open (Bowling 2006). The questionnaire was deliberately kept simple and 
short, avoiding any complex branching of questions. All of the closed questions were 
single item measures to aid both the participant and the analysis. The order of the 
questions was shaped by asking the easiest questions first and progressing down to 
specific questions regarding experience (McColl et al 2001). The researcher was 
keen to achieve a good response rate, particularly with the postal response from the 
post-intervention survey, and was aware that the longer and more complex the
questionnaire the less likely it was this would be achieved (Dorman et al 1997,
Leung 2001, Bowling 2006). The researcher recognised the limitations of this 
questionnaire in that it did not attempt to explore aspects of knowledge acquisition 
or the individual aptitude of the participant. As the post-intervention questionnaire 
was designed to measure change in knowledge over time, the questions were the 
same, without the addition of the last question inviting the description of a clinical 
scenario (see appendix 11).
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5.7.12 Piloting o f the questionnaire
The internal validity of the questionnaire was tested by piloting, first with senior 
CCU colleagues, to determine whether it made sense and whether there were any 
missing questions. No additions or corrections were made at this first pilot stage. 
The questionnaire was then piloted on members of the CCOT who would not be part 
of the study group and one alteration was suggested: in question eight the word 
“blood” was added to make it clear that the immunological tests were blood tests. 
The questionnaire was not, however, pre-tested on the ward nurses. Following 
analysis it was recognised that one question (question four) was worded in a way 
that many ward staff did not recognise. Retrospectively, it was clear that it would 
have been better to pilot the questionnaire on a small number of ward nurses.
5.7.13 Questionnaire survey pre- and post-intervention
All nurses were reassured that the researcher was not interested in individual nurses’ 
answers but rather trends in the data. Each questionnaire was coded with a 
participant number and stored on the database so that relevant nurses could be 
contacted for their post-intervention questionnaires. Having previously consented, 
the nurses were again provided with a chance not to take part when they arrived for 
the formal education session. If they agreed to stay they received the pre-intervention 
questionnaire and were asked to complete it immediately before the education 
session. Each nurse then put a pre-allotted code on the top of her paper along with 
the ward and date, handed the completed questionnaire to the researcher and the 
teaching session began. Nurses took about 10 to 15 minutes to complete the 
questionnaire depending on their knowledge, skills and confidence level.
5.7.14 Post-intervention questionnaires
The post-intervention questionnaires (see appendix 11) were sent out to all nurses 
who received the teaching sessions and may have used the PCT-Q test. The 
questionnaires were sent, using the coded database, to every nurse who took part in 
an education session and completed a pre-intervention questionnaire. The post­
intervention questionnaire was designed to discover whether there had been a change 
in awareness and knowledge regarding the sepsis syndrome and its early diagnosis,
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and also find out about the nurses’ experience of using the PCT-Q. These 
questionnaires were sent out approximately six months after the formal teaching 
session.
5.7.15 Analysis plan for questionnaire data
The quantitative data from the questionnaires was analysed using the Statistical 
Package for Social Scientists version 15 (SPSS 15). The demographic data from the 
first two questions was summarised using frequency tables and pie charts. The two 
groups contained different numbers (first data set n=177 and second n=85). Two sets 
of nominal questions regarding biographical data were analysed using frequency 
tables and pie charts individually, and then compared using only the nurses in both 
groups, as the groups contained different numbers (first data set n=177, second data 
set n=85). The next two sections of the questionnaire were analysed independently 
using frequency tables and non-parametric statistical tests, and then the paired data 
compared using McNemar’s test. McNemar’s test is used to evaluate categorical 
measurements taken from the same participants on two occasions, and measures 
whether there is a significant difference in proportions over time. For this type of 
analysis the outcome of interest is the within person change, and there may or may 
not be an explanatory variable. In this study it was time post intervention and 
possible improvement in knowledge (Peat and Barton 2005). The paired data that 
could be analysed was only 85 nurses as the remaining 82 nurses did not complete a 
second questionnaire. The frequency data from the first questionnaire are therefore 
based on large numbers (n=177) but the paired data relies on smaller numbers 
(n=85).
5.7.16 Patient sample: introduction of the PCT-Q (research 
stage four)
The primary objective of the study as discussed in chapter one was to diagnose 
sepsis at an earlier stage. The PCT-Q stage of the study was designed with a sample 
size and regression model to test this. The intention in the PCT-Q arm was to recruit 
all adult inpatients at the host hospital receiving acute therapy who developed two or 
more of the indicators of SIRS or sepsis using the ACCP/SCCM classification (see 
table 5.2) during the study. This sample was chosen for the following reasons
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1. All inpatients at the host hospital have cancer;
2. Previous studies have not achieved large samples of adult cancer 
patients;
3. It was important to study both neutropenic and non-neutropenic patients, 
as all are at risk of developing severe sepsis and dying.
All patients at the hospital have cancer and all are vulnerable to sepsis, with some 
being at much greater risk: those who are neutropeanic, have comorbid conditions, 
are elderly, have a low albumin, have high LDH, are undergoing complex 
multimodality therapy or have been in hospital for a prolonged period (Lyman et al 
2003, 2005). Over the study period of one year the target population was all 
inpatients (approximately 651) who were receiving acute treatment and were 
therefore eligible for rescue therapy. During this period 320 patients were recruited. 
Each successive patient who was eligible and demonstrated the early signs of sepsis 
was recruited into the study. Some patients had more than one episode of sepsis 
during a prolonged neutropenic episode, prolonged CCU stay or separate hospital 
admission. A second or third episode was characterised as being a new sepsis 
following a period of stability when physiological parameters and blood tests had 
returned to normal for at least seven days. At the end of the study period, archival 
data was used to compare episiode and hospital mortality rates.
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Table 5.3: Diagnostic signs of SIRS and sepsis
Signs of SIRS Signs of Sepsis
1 Temperature >38°C or <36°C SIRS plus a documented infection 
site
2 Heart rate > 90 beats / minute Blood cultures do not need to be 
positive
3 Respiration > 20/minute or PaC02 
< 32mmHg
4 Leukocyte count >12,000/mm'3, < 
4,000/mm3 or >10% immature 
(band) cells
Source: American College of Chest Physicians (1992)
The inclusion/exclusion criteria for the patient study are given in table 5.3.
Table 5.4: Inclusion and exclusion criteria for the patient study
Inclusion criteria Exclusion criteria
1 Patients with cancer over the age of 
18
Patients under 18 years of age
2 Inpatients Outpatients, ward attenders
3 Patients who were for all active 
treatment
Patients in the terminal stage of 
their illness
4 Patients who had signs of SIRS or 
sepsis
Patients who did not have any of 
the signs of SIRS or sepsis
5.7.17 Patients recruited for PCT-Q stage of the study
Any patient who developed signs of SIRS or sepsis (see table 5.2) and who fulfilled 
the inclusion criteria (see table 5.3) was eligible for recruitment into the study. The 
patient would be identified either because they triggered the Modified Early Warning 
System (MEWS) or because their nurse was concerned about them. The ward or 
CCU nurse would then contact the CCOT, researcher, night nurse practitioner or
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nurse researcher critical care nursing, who would see the patient, explain the study, 
provide a patient information sheet, gain consent and take blood for centrifuging. As 
the study continued, other members of the multi-disciplinary team contacted the 
CCOT to measure the PCT, particularly doctors from the haemato-oncology team 
and consultant intensivists. All patients who were recruited were then added to the 
patient database and the patient data set collected. This database included clinical 
parameters, markers of infection such as a raised or lowered temperature, lowered 
mean arterial pressure or raised respiratory rate, predictive indicators of infection 
including WBC, CRP, lactate, the dependent variable their PCT-Q levels, actual 
microbiological findings, and the clinical course of their illness and final outcome 
(see appendix 14 for patient data sheet).
5.7.18 Use of the PCT-Q as a tool in the early screening of the 
cancer patient developing early signs of sepsis
Before the study began, the PCT-Q had not been used in the host hospital. 
Assessment of the patient developing sepsis was based on patient history, physical 
examination, bloods for CRP, WBC and biochemistry, a chest x-ray and an arterial 
or venous blood gas. Finally, a septic screen was performed sending blood, urine, 
sputum and wound drainage for microbiology. The use of the PCT-Q bedside test 
was a new intervention and was introduced to ward and CCU nurses using the 
teaching session intervention. Although nurses would be using the test, it was 
important that relevant medical staff were aware of it and understand the rationale 
for its use and how the procalcitonin values relate to the different stages of the sepsis 
syndrome. The researcher therefore informed key medical staff at the Medical 
Advisory Committee, multidisciplinary team meetings, journal clubs and teaching 
sessions. Two of the consultant intensivists who had worked in Australia or attended 
recent international ITU conferences were aware of the PCT-Q and the relevant 
evidence.
The CCOT, CCU research nurse and nurse night practitioners were taught to use the 
PCT-Q so that they, with the researcher, were an added resource for ward and CCU 
nurses. The boxes of the PCT-Q test strips were located on each of the acute wards 
next to the centrifuge and in the critical care units to facilitate quick and easy access. 
Any nurse who had received the education session could inform the patient about the
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study and, if they consented, proceed to taking a sample of their blood and using the 
PCT-Q. A minority of patients (32) were too unwell to consent and are discussed in 
the section in this chapter on consent and ethical issues (5.11). As best practice, all 
cancer patients who demonstrate the early signs of sepsis have blood taken from 
their central venous catheters or peripheral veins for microbiological culture; this 
blood test was taken at the same time. The ward nurse then alerted the CCOT or 
night nurse practitioner to take the blood for centrifuging. The host hospital has a 
high percentage of patients engaged in clinical trials; there are therefore several 
centrifuges located in clinical areas to facilitate pharmacokinetics. The researcher 
was aware that ward nurses would not have time to take the blood to another ward to 
centrifuge, hence the provision of the extra nursing resource noted above. It was also 
important for the CCOT or night nurse practitioner to be aware of patients who 
might be deteriorating.
A standard operating procedure for the preparation of the blood for the PCT-Q test 
was displayed on the wall by every centrifuge (see appendix 8). Having centrifuged 
the blood and separated the red cells from the plasma, the nurse then returned the 
blood tube to the relevant ward and, together with the ward nurse, placed six drops 
from the plasma into the relevant area on the PCT-Q test (see figure 5.3). The test 
takes 30 minutes and the result was documented in the nursing and medical notes, 
and the relevant multidisciplinary team members were informed of the result. The 
PCT-Q result was also entered into the patient research database (see appendix 14).
F igure: 5.4: The PCT-Q bedside monitoring kit
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The patient data, including cardiovascular, respiratory, blood param eters and PCT-Q 
results, were recorded in the research study data m onitoring sheet kept on the CCU 
and Step Up Unit (see appendix 14). In recognition that ward nurses would not have 
time for this extra docum entation, the CCOS, night nurse practitioner, critical care 
research sister and the researcher completed m ost o f  this data sheet. The patient’s 
consent form was filed in their own medical notes, with a copy in the research study 
file (see appendix 13).
5.7.19 Power calculation and sample size justification
The sample size and power calculation was then established. The study had to be 
sufficiently powered to determine the primary endpoint that is, can the PCT-Q help 
to increase referrals at an early as opposed to late stage o f  sepsis. The appropriate 
sample size helps to avoid type I and type II errors.
However, there were practical constraints to the tim ing and duration o f data 
collection period (12 months). A bio-statistician at the Royal M arsden was consulted 
to perform an appropriate power calculation. W ith 400 incidents, a 95%  confidence
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interval for the early detection rate (as a proportion of all diagnosis) can be 
calculated with a width of at most 10%.
If the early detection rate as reflected in the literature is at worst 50%, then with a 
total of 400 episodes the study will have at least 95% power to detect an increase 
from the published rate of at least 10%, using an exact two-sided binomial test. If the 
early detection rate in the literature differs from 50%, then the overall power will 
increase. However, in order to retain sufficient power for multivariate regression to 
identify predictors of sepsis, a total of 400 episodes was planned. The early detection 
of sepsis rate is quoted in different studies as being between 10% and 55% ( chapter 
three). Having established the necessary sample size to achieve statistical 
significance (400 PCT-Q episodes), a statistical plan was formulated.
The patient data was analysed using SPSS 15. The data was firstly summarised using 
frequency tables and then using histograms examined for normality. The data 
comparing PCT value with stage of sepsis and patient variables with sepsis were 
analysed using chi square tests. The validity of the inflammatory markers WBC, 
lactate, CRP and PCT were tested individually using univariate ordinal logistic 
regression analysis and then combined with each other using multivariate ordinal 
logistic regression analysis.
Table 5.5: Patient data
Variable name Alternative name/s Axis for plots, data analysis 
and tables
Outcome variables: Stage of 
Sepsis e.g. SIRS versus Sepsis
Early versus late stage 
of sepsis
Y axis, columns
Intervening variables: outcome 
of sepsis episode and hospital 
stay, inflammatory predictors -  
PCT-Q, WBC, CRP, lactate
Y axis, columns
Explanatory variables: cancer 
diagnosis, type of treatment, 
vital signs
X axis, rows
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Having decided on the variables, the next stage was to classify them as shown in 
table 5.6.
Table 5.6: Patient data: classification of variables
Variable label Type SPSS measure Classification for analysis 
decisions
ID Numeric Scale Not used in analysis
Gender Numeric Nominal Categorical / non-ordered
Age Numeric Ordinal Continuous
Type of cancer Numeric Nominal Categorical / non-ordered
Cancer treatment Numeric Nominal Categorical/ non-ordered
Stage of sepsis 
syndrome at 
diagnosis
Numeric Ordinal Continuous
Outcome of sepsis 
episode
Numeric Nominal Categorical / non-ordered
Hospital outcome Numeric Nominal Categorical / non-ordered
Highest 
temperature in 
past 24 hours
Numeric Interval Continuous
Lowest MAP in 
24 hours
Numeric Interval Continuous
WBC Numeric Ratio Continuous
CRP Numeric Ratio Continuous
Lactate Numeric Ratio Continuous
PCT-Q Numeric Interval Continuous
Having classified the variables, any missing variables were coded as 999. It may, 
however, have been preferable to use a full stop. Peat and Barton (2005) recommend 
using a full stop rather than numbers as these can be mistakenly used in the analysis 
(Peat & Barton 2005, p. 12).
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The next stage was to decide which statistical tests would be used in the analysis. 
This decision is based on two factors: the type of variable (as shown in table 5.6). 
and whether the data was normally distributed. To decide on the distribution each set 
of data was plotted onto a histogram using a “frequency” test and then the normal 
distribution curve applied. This would determine whether parametric or non- 
parametric statistical tests were appropriate. As expected, much of the data was not 
normally distributed and therefore non-parametric tests were used (Fowler et al 
2002).
The main aim of this study was to improve the early detection of patients who were 
deteriorating from sepsis. The blood tests used to detect sepsis were therefore 
important. In the hospital, before this study, CRP and WBC were the most 
commonly used indicators, with the critical care team also using lactate 
measurements. Procalcitonin (PCT) had not previously been used and neither had the 
PCT-Q -  the bedside test. It was essential therefore to be able to compare the blood 
tests and their reliability and specificity at predicting sepsis. The PCT-Q test had 
been previously validated, so this study was not designed to test the accuracy of PCT 
in diagnosing sepsis. The aim was to confirm that, in our patient population, the 
results of diagnostic tests including PCT-Q were a useful predictor of sepsis stage at 
diagnosis. It was first thought that a binary logistic regression analysis should be 
used to test for predictive reliability. However, this was not an appropriate test as all 
but 11 patient episodes describe the presence of sepsis and the tests needed were 
therefore to assess early versus late stage diagnosis in a common group. As the 
outcome variable of interest was the sepsis stage, ranked as 1=SIRS, 2=sepsis, 
3=severe sepsis or worse (septic shock, MODS), and as such could be treated as an 
ordinal variable with ranking equating to severity of illness, an ordinal regression 
model was finally chosen in which candidate predictive variables would be used to 
predict for stage of sepsis at diagnosis. The hypothesis being tested here was that the 
null model is as good at predicting sepsis stage as the model using the candidate 
predictive variable. The 11 patients who did not have sepsis and the four patients 
with missing endpoint data were excluded from this analysis.
The dependant variable was the stage of sepsis at diagnosis as defined above. 
Candidate-independent predictor variables were included in separate analyses
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initially. The logit link function was used, since the data were relatively evenly 
distributed across the three stages of sepsis. Odds ratios for an increased stage of 
sepsis at diagnosis were calculated for each candidate-independent variable and the 
95% confidence interval for the ratio calculated from the standard error of the 
coefficient, as illustrated in chapter eight.
Variables that were significant predictors of sepsis stage in univariate analysis were 
then combined in a multivariate model. Initially, all parameters significant on 
univariate analysis were included in the model, then the change in model fit 
(assessed using the change in log-likelihood tested against a chi-squared distribution 
with degrees of freedom equal to the change in number of parameters between the 
model) was examined for the reduced model, with each parameter removed singly in 
turn. The model with the fewest parameters for which the overall model fit was not 
significantly worse was chosen as the best model overall.
5.7.20 Comparison of sepsis related episode and hospital 
outcomes in the study year to those in the three previous years when 
PCT-Q not available.
In the study year all patients recruited were entered onto a patient database and a 
patient data set collected. The database included clinical parameters, markers of 
infection such as a raised or lowered temperature, lowered mean arterial pressure or 
raised respiratory rate, predictive indicators of infection including WBC, CRP, 
lactate, the dependent variable their PCT-Q levels, actual microbiological findings, 
and the clinical course of their illness and final outcome (see appendix 14 for patient 
data sheet).
This patient database was then compared to the archived notes for all patients who 
were recorded on the hospital, Step Up or Critical Care Unit Admission database as 
referred due to sepsis for the previous three years. The clinical course of the illness, 
referrals to CCU, episode and then hospital outcomes were recorded. Where there 
was missing data about a patient on the databases the medical records, nursing care 
plans and in some cases death certificates were also used.
The data was then compared between the study year and the three previous years 
with particular reference to any change in overall outcomes. The data was checked
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by the researcher and a colleague (Nurse Researcher Critical Care) independently to 
ensure accuracy. The data for the three previous years was not complete and there 
were also changes to the delivery of critical care during the years leading up the 
study year so there are limitations to the interpretation of this data.
5.8 Ethical and research governance considerations
-There are important ethical considerations for all research studies with nurses and 
patients as participants. For the present study the first ethical issue was the 
acceptability of asking vulnerable patients to consent to the use of their blood in this 
study. Most of the patients recruited into the study were awake, alert and orientated, 
and able to enter into a discussion about the study having read the Patient 
Information Sheet (PIS) (see appendix 12). A small minority of patients had 
deteriorated rapidly, or were already sedated and mechanically ventilated on the 
CCU, and were unable to provide consent. It was important to recognise that all 
patients recruited were potentially going to deteriorate and might be frightened; they 
were all vulnerable adults.
There are two major factors that the researcher considered regarding the ethics of 
this study. The first was the legal standing of emergency research and research with 
incapacitated adults, the second the principles of research ethics and Good Clinical 
Practice (GCP).
On 1 May 2004 the European Clinical Trials Directive (2001/20/EC) became law as 
the Medicines for Human Use (Clinical Trials) Regulations. Although these laws 
only apply to interventional medicines or medical devices trials and there is no 
current legislation that governs non-medicines studies, it is thought that any 
Department of Health developments will take as their basis the current medicines 
legislation (Coats and Shakur 2005). The particular part of the law relevant to this 
study is found in schedules 1 and 2 in part 5 entitled “Conditions and principles 
which apply in relation to an incapacitated adult” (HMSO, Medicines for Human 
Use 2004). The 2004 legislation takes a stepped approach to consent for medical 
research as follows:
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If the person can consent they should be asked to give their informed consent. To 
have the competence, the person must be able to:
1. Comprehend and retain the information;
2. Believe it;
3. Weigh it up in order to make a choice (HMSO, Medicines for Human 
Use 2004).
If the patient is unable to perform the above and is therefore legally incapacitated, 
then for the first time in English law pertaining to adults another person can consent 
for them. The person is called the personal legal representative and they can be either 
a family member of friend who, because of their knowledge of the person, can act 
for them or a professional legal representative, either a doctor unconnected with the 
trial or another healthcare professional again unconnected with the trial. In 2005 the 
Mental Capacity Act made it clear that once an appropriate assessment had been 
undertaken the patient could be provided with care that is judged to be in their best 
interest (Whitcher 2008). In summary, therefore, a minority of patients involved in 
this study (35, n=320) were legally incapacitated, but in all cases at least one family 
member or friend was regularly on the CCU with them. In these cases the family 
member was informed about the study and asked if they felt that their relative would 
have consented to have the blood test and for the result to be used in the study. It 
should be emphasised here that the legal directive is only one part of the ethical 
consent process. The other areas that were addressed were the risk/benefit balance 
for the individual patient, the potential for harm and the strength of the scientific 
evidence supporting the study (Coats and Shakur 2005).
In this study the risk to the patient was minimal. The only intervention was a blood 
test that would be taken at the same time as other tests and in the majority of cases, 
especially in CCU, from a central venous access device or arterial cannula. The 
potential benefit to the patient was another test, supported by many studies as having 
good reliability and specificity for sepsis, to aid in their diagnosis and treatment. 
Another good clinical practice issue in research ethics is that patients will usually 
have more than 24 hours to decide on participation. In emergency research this is 
impractical it is therefore important that the benefits outweigh the risks for the 
patient. Finally, all the patient data was anonymised. Several cancer patients who
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were well informed and highly involved with their treatment, on developing signs of 
sepsis a second or third time, asked the CCOT to measure their PCT. On a few 
occasions a normal PCT was able to reassure the patient.
It was equally important to ensure that nurses were appropriately invited to 
participate. The researcher was well known and a senior nursing figure in the trust, 
she only had line responsibility for the CCOT but was aware that she was not 
without influence. The nurses were, therefore, recruited by their ward teams. They 
were given time to think about whether they wanted to take part in the study and 
their time commitment (the teaching session and pre- and post-questionnaire or two 
qualitative interviews) was made clear verbally and on the Nurse Information Sheet 
(see appendices 4 and 5). It was made clear to all nurses that there was absolutely no 
obligation to take part. Formal signed consent was taken from all nurses recruited 
into the study (see appendix 9, a and b). In practice, as the study gained momentum 
across what is a small hospital, nurses on different wards regularly asked the 
researcher when they were going to be invited or why they had not been asked yet.
The study was reviewed by the hospital’s Committee for Clinical Research and the 
Local Research Ethics Committee (protocol number CCR/ LREC 2372).
5.9 Research in own practice area
The challenges associated with conducting research in one’s own organisation are 
recognised. They include the disclosure of information, power and issues such as 
bias or compromised data that will be discussed in the section on rigour (5.10). 
Although there are dangers to research on home territory, the researcher was keen to 
conduct the research in her own organisation for two reasons: first, to improve 
practice in her own hospital, and secondly, the practical reality of trying to reach 177 
nurses in the teaching sessions. The researcher was aware that researchers may be 
accused of exploiting participants to achieve their own end, in this case an 
educational qualification. The researcher was however clear that there was an 
important rationale for the study that of improving practice to reduce the impact of 
sepsis in the person with cancer.
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Oakley (1981) describes most traditional in-depth interviewing as unethical, either 
deliberately or not, and says that the various techniques used are methods of 
manipulating the participants. In seeking to counteract this and other perceived 
exploitations, feminist researchers have sought to work in a way that is more 
participatory and democratic, with researchers who aim to build collaborative, 
trusting and friendly relationships with participants (Benmayor 1991). For this study 
the researcher was aware that the ward and CCU nurses were keen to learn more 
about sepsis, and she was used to working clinically with nurses on shifts in an open 
and democratic way. The researcher was, however, mindful of dangers such as bias 
and collusion and took steps throughout the research to avoid these.
5.10 Issues of rigour
5.10.1 Quantitative research
There were two areas of quantitative research: the questionnaire survey and the PCT- 
Q patient research therefore issues of validity and reliability are discussed for both. 
The design of the questionnaire its advantages and limitations have been discussed 
previously. Its content validity was satisfied in some degree by the pilot. The 
external validity of the questionnaire survey is satisfied by the random sample of 177 
nurses out of the total possible population of 320 nurses. The internal validity of the 
questionnaire survey was satisfied by the inclusion and exclusion criteria and 
variables such as the teaching intervention and teacher were controlled. It must be 
noted that the questionnaire survey only sought to raise awareness of sepsis and 
increase knowledge in a limited area. Finally the statistical test chosen to analyse the 
paired data McNemars test was justified as it measures change over time in paired 
categorical data sets.
The construct validity of the PCT-Q test was satisfied as it was demonstrated in the 
literature review that procalcitonin and the PCT-Q are a valid and reliable tool for 
the early diagnosis of sepsis in the neutropenic and non neutropenic adult. External 
validity was satisfied in that all patients who met the inclusion criteria and exhibited
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the early signs of sepsis were recruited to the study. These cancer patients were 
representative of the total population that is all cancer patients receiving acute 
potentially curative cancer treatment at the study hospital over one year. Internal 
validity was satisfied by raising nurses’ awareness of sepsis and the PCT-Q therefore 
increasing active recruitment to the study, and utilising the other markers of sepsis 
commonly used in the hospital.
The stage of sepsis and PCT-Q level was correlated using the chi square test. The 
stage of sepsis is internationally defined (Dellinger et al 2004, 8). The validity and 
reliability of the PCT-Q, lactate, WBC and changes in Blood Pressure in diagnosing 
sepsis were tested using univariate ordinal logistic regression analysis and then in a 
combined model using multivariate logistic regression analysis. The reliability of the 
PCT-Q in the hands of ward nurses was demonstrated with 11 (n=416) PCT-Q tests 
measured erroneously in patients who never developed sepsis, and 11 patients 
(n=416) developing sepsis who had not had a PCT-Q performed.
5.10.2 Qualitative data
Issues of rigour are important in all research. Qualitative researchers rejects terms 
such as validity, reliability and generalisability in favour of plausibility and 
trustworthiness, and reflexivity (Popay et al 1998, Lincoln and Guba 2005, Mays 
and Pope 2000, Donovan and Saunders 2006, Morse 2006c). Rolfe (2006c), Koch 
and Harrington (1998) and Sandelowski and Barroso (2002) recommend that 
judgements about the plausibility of qualitative research are made according to the 
sense that the author but also the reader can make of the final research report, and 
not to preordained rules. Rolfe also encourages judgements to be made from the 
perspective of practice with all of its complexity (Rolfe 2006c, p.309).
5.10.3 Plausibility or trustworthiness of interpretation of the
data.
Guba and Lincoln (1989) in the pursuit of “trustworthiness” recommend the criteria 
of credibility, transferability and dependability. Thus anyone reading the research 
should be able to recognise the presented phenomena or, if it departs from 
expectation, be able to see how the researcher has arrived there. Other researchers
111 o f355
have challenged these criteria, concerned that Guba and Lincoln have tried to 
introduce criteria to equal those used in quantitative research (Smith 1993, Bloor 
1997, Sparks 2001, Silverman 2005).
In the present study, the key themes emerging from the data have been clearly 
described. The data itself has also been presented alongside the analysis as further 
evidence and an example of an interview transcript is included at Appendix 15. The 
themes are generated from two different sets of data collection and then integrated 
where possible. The integration of the findings has been used to obtain a greater 
understanding of phenomena such as the experience of nurses contacting the 
multidisciplinary team. The data has also been analysed with reference to previous 
research, particularly that pertaining to the Medical Emergency Teams and Critical 
Care Outreach (Cioffi, 2000a,b, Bellomo et al 2003, Bellomo et al 2004, Ryan et al 
2004, Goldhill et al 2005). In this study the researcher decided not to undertake 
member validation for two main reasons: first, the practical difficulty of contacting 
187 nurses, and secondly, the debate in the literature about the efficacy of this 
strategy (Gallagher 1995, Silverman 2005, Tobin and Begley 2004, Donovan and 
Sanders 2006).
5.10.4 The audit trail
Key techniques used to ensure plausibility in qualitative data are openness, 
transparency of analysis, and the provision of an audit trail (Lincoln and Guba 1999, 
Mays and Pope 2000). In the present study the researcher has clearly and 
systematically described the process of the analysis. There is also an audit trail 
described in the findings chapters that the reader can follow. Another process that 
has been used with qualitative research is for the coding to be open to scrutiny by 
others to discuss and refine codes and categories (Barbour 2001). In this study the 
coding was read and discussed with the researcher’s main supervisor and after 
discussion two themes were changed and combined.
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5.10.5 Reflexivity
In qualitative research the qualities and experience of the researcher and the role they 
play in the research are regarded as important. In much qualitative research the 
author provides a biography and a reflexive account of their attitude to and effect on 
the research. The researcher in this study was familiar with the clinical area and there 
was therefore at potential risk of being biased. The researcher therefore kept a 
reflexive diary and constantly appraised her role in the study, informed by reading 
about Gadamer’s model of the hermeneutic circle. For Gadamer as described by 
Rundell (1995), hermeneutics involves the shared activity of communication when 
the researcher is actively involved in speaking, hearing, listening and keeping silent. 
For Gadamer the reflexivity of the researcher and research process is essential, so 
that the researcher is attentive and critical during the actual research process, and 
there is an openness between the researcher and the participant. Therefore for 
Gadamer the previous experience and prejudices or beliefs of the researcher must be 
critically appraised and, together with those of the participants, brought into the 
hermeneutic circle to inform the final research study (Grondin 1994).
Harding (1987) also argues for the most rigorous performance of qualitative research 
in particular, with the researcher placed under scrutiny in the same way as the 
subjects of the research. Utilising this stance would mean that the reader is given 
explicit information about the researcher, and how her influence and the person she 
is has shaped the project. Writers such as Lincoln and Guba (1985) and more 
recently Marcus (1994) and Koch and Harrington (1998) have also noted the 
essential aspects of reflexivity in research. For Creswell (2003) this reflexivity 
typifies current qualitative research. He cites Mertens (2003) who, discussing the 
optimum position of the qualitative researcher, suggests that they are characterised 
by honesty and openness while also recognising that inquiry is value-laden. For both 
Creswell and Mertens the personal-self is indistinguishable from the researcher-self 
(Creswell 2003, p. 182). Koch (1999) describes the Gadamerian philosophy of 
research as a dialogue where you question and develop thoughts and connections, 
metaphorically writing in the margin, annotating and noting broad social, cultural 
and gender implications (Koch 1999, p.32). Finally, in a gloss on Gadamer, Koch 
notes that researchers will have their prejudices but that these are not obstacles,
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rather, they are the way we view the world and we take this into the research process 
(Koch 2006, p. 92).
There is a large body of literature addressing the particular moral stance that the 
researcher undertaking qualitative research for example embarking upon an 
ethnographic study would take as opposed to that observed for a quantitative study. 
Authors however argue that it is too simplistic to ascribe particular moral beliefs to a 
methodology, but rather that the researcher using any methodology, must question 
themselves about their research practice, and particularly about how they position 
themselves in relation to their participants (Morse 1994, Schwandt 2000, Silverman 
2005).
In this study there were two groups of participants: registered nurses working on the 
acute wards or in the CCU and people with cancer who were displaying the first 
signs of sepsis. For the researcher, her research relationship with the nurses was one 
that she actively reflected upon before each intervention session. The approach of the 
researcher was affected by the experience of working clinically with nurses over 
many years; they have an expertise that often goes unrecognised in the hurly burly of 
the busy clinical ward. The researcher was well known in the hospital as a clinical 
nurse consultant but did not have an operational management role with any of the 
nurses involved as participants.
Although the researcher was aware that the PCT-Q might aid the patient 
participants’ sepsis assessment, she was aware that using their data for her research 
would not benefit them. It was therefore essential to reassure the majority who were 
able to consent that their refusal would in no way adversely affect their treatment. 
The researcher does, however, recognise the difficulties in this relationship, as her 
experience is that patients are very keen to help. At the study hospital most patients 
are involved in clinical research and are very familiar with it. This may be seen as an 
advantage, in that they understand the process, or a problem in that they see it as a 
part of their care.
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5.11 Conclusion
The researcher chose a multiple methods design with a research framework 
consisting of five stages to better answer a question set in the complexity of practice. 
The design of the study with its five stages was underpinned by a theoretical 
framework derived from the literature and experience. Rolfe describes nursing as 
praxis with the nurse as practitioner involved in research as the “reflexive spiral” 
where the nurse asks questions about specific practice questions, tests hypotheses, 
changes practice and then re-evaluates the hypotheses (Rolfe 2006b, p.40). As a 
clinical practitioner, the researcher wanted to address questions that occur in practice 
and whose outcomes may in turn improve practice.
In this study, with its range of methods, there is a continuum of methodological 
perspectives, from the positivist approach used to interpret the patient PCT-Q tests to 
the interpretive or constructionist approach used in the remainder of the research. It 
is less common in nursing to use a positivist perspective, as nursing is often asking 
questions about the how of patient experience or, as in this study, the how of 
practice. Nursing, as opposed to other healthcare disciplines such as medicine, 
psychiatry or dietetics, is seeking to look at behaviour or experience from what 
Edwards (2001) describes as the “first person rather than the third person 
perspective”. Empirical research depends on observing or measuring, but in nursing 
there is much that cannot be simply observed as there are inner subjective 
interpretations not open to view.
This multiple methods study therefore used a combination of qualitative 
interviewing, quantitative survey, the PCT-Q testing with patients and the 
introduction of two interventions. The populations that participated were patients 
with cancer who were becoming acutely ill with sepsis and nurses caring for these 
patients on general wards and in the CCU.
The primary objective of the study was to diagnose patients’ sepsis at an earlier 
stage, recognising that nurses report a difficulty in convincing colleagues, an 
objective bedside test was to be introduced to improve multi-professional 
communication and therefore rescue.
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The eight secondary objectives were to:
1. Learn more about nurses’ experience of the cancer patient deteriorating with 
sepsis and any barriers to effective communication and rescue;
2. Gain an in-depth understanding on nurses awareness of sepsis and its 
assessment and management and how this could be improved, particularly 
how nurses felt they learnt optimally;
3. Explore whether nurses’ judgement about the patient developing sepsis was 
accurate and whether they could use the PCT-Q appropriately;
4. Gain an in-depth understanding from the nurses how they felt the use of the 
PCT-Q has impacted upon practice and how easy in practice it was to use;
5. Assess whether in the nurses’ hands and with cancer patients the PCT-Q was 
reliable in identifying sepsis compared to WBC, lactate, CRP and mean 
arterial pressure falls;
6. Evaluate if the use of the PCT-Q as part of clinical nursing assessment and 
communication resulted in earlier referrals and improved outcomes;
7. Compare the outcomes of patients during the study year to three previous 
years;
8. Evaluate whether the dedicated education session improved awareness and 
knowledge about the cancer patient with sepsis.
Chapters six, seven and eight illustrate how the findings from each research stage
link both to the theoretical framework and the overall and subsidiary aims, and
primary and secondary objectives.
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Chapter 6 Findings (1): qualitative data 
from interviews and questionnaires
6.1 Introduction
Over the next three chapters, the findings from each stage of the study will be 
presented in the order that the findings were generated. As described in the 
methodology in chapter five and particularly figure 5.2 (p.87) the data generated 
from the qualitative interviews was used to design the nurse questionnaire and 
therefore this will be presented first. The next data to be generated was from the 
nurse questionnaires and is presented in chapter seven. Finally, the patient data using 
the PCT-Q is presented in chapter eight.
This chapter focuses on analysis of the qualitative data collected from the pre- and 
post-intervention interviews and the final part of the pre-intervention questionnaire. 
The qualitative interviews, as discussed in chapter one and five link to the theoretical 
framework by providing further evidence about the nurses’ role in the early 
assessment of sepsis, blocks to effective communication and rescue, and the need 
therefore for an objective test. The objectives of the qualitative interviews were to 
gain an in-depth understanding of the following aspects of the nurses’ individual 
experiences of caring for a patient deteriorating with sepsis:
1. Nurses’ individual overall experience of caring for patients deteriorating with 
sepsis
2. Barriers to effective communication and rescue, and their previous 
experience of informing and mobilising the multi professional team;
3. Nurses’ awareness of sepsis and its assessment and management and how 
this could be improved, particularly how nurses felt they learnt optimally and 
could teach others;
4. How nurses felt the use of the PCT-Q impacted upon practice and how easy 
in practice it was to use.
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The post-intervention interviews were to be conducted with the same 10 nurses who 
had been previously interviewed. Two of the nurses had left the hospital, leaving 
eight post-intervention interviews. The rationale for the post intervention interviews 
was to interview the nurses post the introduction of the PCT-Q to obtain richer data 
about its introduction. Themes or questions that were generated from the analysis of 
the first transcripts were also explored. There was no intent to compare pre and post 
interviews but rather to integrate all the findings to better understand the experience 
of the nurses.
The method used to analyse the data was a constant comparative technique using 
elements from grounded theory. The principles behind this analysis were to remain 
true to the authors of the text and to provide a transparent audit trail to guide the 
reader through the findings. A process of reading the transcripts to gain a general 
overview was followed by a more detailed and critical re-reading, from which 
individual topics were identified. Following a further reading, these topics were 
amalgamated into broader categories, which were listed and examined for any inter­
relationships. Out of this process, larger themes emerged. The majority of the themes 
reflect a broad consensus across the data; there were “contrary cases” relating to 
some of the themes. There were also “leftover” themes, only expressed by one 
participant but so dominant in their testimony that they were retained as a theme. 
Each collection of data, for example all the pre-intervention interviews, were 
analysed first as an independent data set. Having analysed all three sets they were 
brought together and a final analysis of the central themes was undertaken. This 
chapter provides a summary of this analytic process.
6.2 First data set: analysis of the pre-intervention 
interview transcripts
The first data to be collected and analysed were the transcripts from the pre­
intervention qualitative interviews. Ten nurses with varying experience, education 
and years in nursing from across the hospital were interviewed and asked to describe 
their experience of the following:
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1. Personal experience of noticing the early changes that occur in the person 
with cancer as they start to develop sepsis;
2. Personal experience of mobilising the multidisciplinary team to rescue the 
patient;
3. Early thoughts about the use of a nurse-performed bedside test which helps to 
diagnose sepsis at an early stage.
The nurses’ demographics and educational characteristics are shown in table 6.1.
Table 6.1: Demographics of the 10 nurses involved in pre- and post-intervention 
qualitative interviews
No Qualified in 
nursing
Cancer nursing 
experience
Critical
Care
nursing
experience
Educational
qualifications
Sex
1 9 years 7 years 6 years RN, Oncology 
Diploma, currently 
undertaking BSc 
Critical Care nursing
F
2 5 years 2 years 0 RN, Oncology 
Diploma
F
3 13 months 6 months 0 RN F
4 3 months 3 weeks 0 RN F
5 4 years 4 years 0 RN, Oncology 
Diploma
F
6 2 years 2 years 0 RN, Oncology 
Diploma
F
7 6 years 4 years 0 RN F
8 4 years 16 months 2 years RN, Advanced 
Diploma Nursing, 
currently undertaking 
BSc Critical Care 
nursing
M
9 20 years 4 .5 years 0 RN, Oncology F
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Diploma
10 17 years 13 years 16 years RN, ENB ITU, ENB 
Teaching & assessing
M
The taped interviews were transcribed and then read through in an attempt to get an 
impression of the whole. During this first reading the researcher often made notes in 
the margins of the transcripts. Following this first read through some notes were 
made in a research notebook, for example: “The two newly registered nurses both 
mature students -  is this important, relevant or not?”; “I speak too much in some of 
the interviews -  long bits for SD”; and “glad I read the stuff about novice nurses and 
intuition -  useful in transcript four”. Having read through all 10 transcripts once, 
each was then read in a more concentrated way, making detailed notes and 
underlining passages that seemed important to the participant. The researcher used 
the guidance provided by Tesch (1990, p. 121) in clustering these topics into major, 
unique and leftover. A table was constructed with topics placed in columns; these 
topics were recalled from the second read through. The transcripts were then read 
again. The researcher was guided by the principles of qualitative analysis in the area 
of identifying important topics. If only one of the 10 nurses identified that something 
was important to her then that was not lost to the analysis. Therefore, if one nurse 
mentioned one topic several times, that topic was retained.
Table 6.2: Major topics raised by nurses
No Topic
Major
No of 
times
1 Obs / urine output / rigors 35
2 Bloods / antibiotics / u&es 15
3 Awareness of risk / treatment they have had / Hickman lines 12
4 Perseverance and follow through 12
5 Compare them to how they were previously / know the patient well 12
6 Their colour may be different / they don’t look right compared to how 
They were previously / know the patient well
11
7 Don’t engage in conversation in the same way / slight change in 
behaviour / drowsy
11
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8 Experience 10
9 Generally docs come quickly / take you seriously 9
10 Be fantastic to use something to confirm / concrete / values & 
measurements
9
11 The patient says they don’t feel right / feel needy 7
12 Frustration 7
13 Outreach team very good / very helpful 6
14 Would inform docs early. 6
15 A sense about it / there was just something not right 6
16 The higher the nurses grade the more MD team take notice 5
17 Reinforce to the nursing team that I am worried 5
18 Patients go off very quickly 5
19 Send septic screen swabs etc 4
20 Looked after lots of patients -  build up experience of when not right 4
21 Fluid resuscitation 4
22 Nursing intuition 3
23 Not just experience how you apply it and learn 3
24 New nurses scared of septic patient 3
25 Not worried about looking silly 3
26 Previous experience different not as much sepsis 2
27 PCT-Q as long as not too much work 2
28 Unique -  nurses not being able to start the rescue start a’biots / fluids 
etc until we have a docs signature
2
29 Unique -  sense that you are waiting for the patient to do something 2
30 Unique -  easier access to MDT in CCU 2
31 Quieter 2
32 Encourage nurses to act 1
33 Reflection 1
34 EWS 1
35 PGD 1
36 Leftover: comparison of data not all BP drop = sepsis 1
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37 Leftover: some patients just not good performers 1
38 Leftover: skin temperature 1
39 Leftover: vulnerable to sepsis 1
40 Leftover: full assessment 1
Having identified 40 topics from the 10 transcripts, the transcripts were read again to 
ensure no topics had been missed. The 40 topics were then reorganised and reduced 
into categories that reflected grouping of related topics. An example of this was the 
grouping together of topics 5, 6 and 7 from table 6.2 and a new category emerging 
which was broadly to do with observed changes in the patient. It appears as category 
2 in the table 6.3. The reduction of topics into categories resulted in a decrease from 
the original 40 topics to 21 categories.
Table 6.3: Amalgamation of 40 topics into 21 categories ordered by frequency 
of occurrence in interviews
No Categories No of 
times
1 Obs / urine output / full assessment / rigors / comparison of data not all BP drop 
= sepsis
37
2 Their colour may be different / they don’t look right, ask them/ know they were 
previously/ know the patient well / quieter / skin temperature / Don’t engage in 
conversation in the same way / slight change in behaviour / drowsy
25
3 Experience / looked after lots of patients -  build up experience of when not right 
/ a sense about it / there was just something not right / sense that you are waiting 
for the patient to do something
22
4 Bloods / antibiotics / u&es 15
5 Perseverance and follow through / Not worried about looking silly 15
6 Would inform docs early / generally docs come quickly / take you seriously 15
7 Awareness of risk / treatment they have had / Hickman lines / vulnerable to 
sepsis
13
8 Compare them to how they were previously / know the patient well 12
9 Be fantastic to use something to confirm / concrete / values & measurements / 
Encourage nurses to act / PCT-Q as long as not too much work
12
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10 Send septic screen swabs etc / fluid resuscitation / nurses not being able to start 
the rescue start a’biots / fluids etc until we have a docs signature / PGD
11
11 The patient says they don’t feel right / feel needy 7
12 Frustration 7
13 Outreach team very good / very helpful / EWS 7
14 Not just experience how you apply it and learn / reflection / nursing intuition 7
15 The higher the nurses grade the more MD team take notice 5
16 Reinforce to the nursing team that I am worried 5
17 Patients go off very quickly 5
18 New nurses scared of septic patient 3
19 Previous experience different not as much sepsis 2
20 Easier access to MDT in CCU 2
21 Some patients just not good performers 1
The 21 categories were then examined again to identify any interrelationships 
between categories. This further analysis revealed more interrelationships, resulting 
in the reduction of the previous 21 categories to 8, as illustrated in table 6.4.
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Table 6.4: Categories derived from the previous 21 categories
These eight categories were then examined again, together with how they appeared 
in the transcripts and with regard to the literature, and were given a thematic 
meaning label.
1 Their colour may be different / they don’t look right ask them compared 
to how they were previously / know the patient well / quieter / skin 
temperature / Don’t engage in conversation in the same way / slight 
change in behaviour / drowsy // experience / looked after lots of patients 
-  build up experience of when not right / a sense about it / there was just 
something not right / sense that you are waiting for the patient to do 
something // Compare them to how they were previously / know the 
patient well // The patient says they don’t feel right / feel needy // some 
patients just not good performers
25+22 
+12+7 
+1 
= 67
2 Obs / urine output / full assessment / rigors / comparison of data not all 
BP drop = sepsis // Bloods / antibiotics / u&es
37+15 
= 52
3 Awareness of risk / treatment they have had / Hickman lines / 
vulnerable to sepsis // patients go off very quickly
13 + 5 
= 18
4 Would inform docs early / generally docs come quickly / take you 
seriously // perseverance and follow through / Not worried about 
looking silly // reinforce to the nursing team that I am worried // the 
higher the nurses grade the more MD team take notice // Outreach team 
very good / very helpful / EWS // easier access to MDT in CCU
15 + 15 
+ 5 + 5 
+7 + 2 
= 49
5 Be fantastic to use something to confirm / concrete / values & 
measurements / Encourage nurses to act / PCT-Q as long as not too 
much work
12
6 Send septic screen swabs etc / fluid resuscitation / nurses not being able 
to start the rescue start a’biots / fluids etc until we have a docs signature 
/ PGD // Frustration
11+7 
= 18
7 Not just experience how you apply it and learn / reflection / nursing 
intuition // new nurses scared of septic patient
7 + 3 
= 10
8 Previous experience different not as much sepsis 2
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6.3 First data set: themes
6.3.1 Importance of continuity
The first theme shared by most participants concerned the way nurses recognise a 
change in the patient that is not related to measuring their biological parameters. 
This change was dependent on knowing the patients and being able to identify a 
change. A contrary case was also identified from the most junior nurse in the cohort 
(TS.04) who felt that she was too inexperienced to use anything other than overtly 
quantifiable measurements.
“I haven’t had the experience and I am only probably going on what I have 
read and this and what I know to be erm..normal..erm but I thought she was 
worse but I would not have pushed the issue if it wasn’t for the 
respirations... for me as, for me as a newly qualified nurse I that really is all 
I have to go on, measurements, and that’s all I have to go on”. (TS. 04)
“.. .because we get to know the patients quite well and we can pretty much 
tell if something is not quite right, erm and it’s kind of just looking at areas, 
erm such as redness at Hickman sites or central venous sites”. (TS. 02)
“Dunno, sometimes you just look at them and they look not quite how they 
were before, if you ’cause, sort of, the nice thing is having patients coming 
in routinely for their chemo, you know... you know what they’re like when 
they are well”. (TS. 05)
. .mmm they’re not as well as they were... just, just generally you felt that 
their demeanour was different to what it was... that they were just a little bit 
flatter in themselves, I suppose... well that all depends on your prior 
observations of patients... sometimes that can be difficult, when you come 
on and... you haven’t met the patient before”. (TS. 07)
“... it might just be a change in the person one of our patients, you will 
remember him (name) he went to CCU, he used to always come out of his 
room and give us chocolates, and the first sign that he wasn’t well was that 
he didn’t try to come out of his room”. (TS.02)
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“sometimes it can just the general... how they... how they respond to you.
If someone isn’t feeling well because they’re becoming septic, they won’t 
be feeling well... so they might be slightly distracted when you speak to 
them, tired... erm, maybe not always in as good humour as they normally 
are”. (TS.10)
6.3.2 Making a diagnosis: vital signs
The next dominant theme was nurses recognising which changes in vital signs were 
likely to mean a diagnosis of sepsis. The changes the nurses discussed are all cited as 
important signs of SIRS (Bone 1992, Dellinger 2004, 2008). Nurses discussed 
suspecting sepsis based on changes in heart rate, blood pressure, temperature, 
presence of rigors and alteration of urine output:
“.. .but you could say this patient has dropped their blood pressure... or their 
pulse is faster, or their breathing has deteriorated”. (TS. 01)
“So I guess sepsis-wise I guess you kind of do an observation, you’re 
looking at erm things like er... temperature obviously temperature’s quite 
important pulse rate and er pulse being raised... and er rigoring that’s 
usually quite a good one that gives a good indication and a drop in blood 
pressure, erm their pallor...” (TS.02)
“Um, I think probably one of the hallmarks that I’ve always looked for say 
temperatures, erm, you know, escalating temperatures... or patterns of 
temperatures. Other things that I’ve usually got worried about are usually 
say drops in blood pressure... which just seem really quite out of the blue 
and just don’t seem to... looking at just really basic like oxygenation you 
know...” (TS. 08)
“You know, spike and be septic at some point erm and the doctors said they 
would actually wait for her to spike a temperature before would start her on 
antibiotics, which at the time I thought... well from just knowing patients 
go...you know...how quickly they can become septic. I don’t know I just 
felt a bit frustrated, you know”. (TS.02)
Two nurses, both new graduates, commented on the importance of using changes in 
the patient’s cardiovascular parameters:
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. .usually they come in and you know we’re given the background on that 
patient so immediately you know the patient is septic... so the onus 
wouldn’t be on me to recognise it... their vital signs, um their temperature 
going above thirty eight. Things like that erm... and the... pulse not going 
over um maybe a hundred. Well it all depends on the individual really 
what’s not normal and what’s not for them. Whether the patient’s become 
tachycardic or maybe bradycardic and um blood pressure”. (TS 03)
6.3.3 Contacting others
The third theme was contacting others to help. This might either be senior nurses on 
the ward, doctors or the CCU outreach team. Contributing to this theme was the 
willingness of others to listen and the different professional teams or tactics the 
nurses used to get help. The changes in the patient associated with sepsis would 
result in the nurse mobilising senior members of the nursing team, doctors and the 
multidisciplinary team quickly. There was a mixed response to this with some nurses 
noting their frustration (TSOI) whilst others felt it was better in the study hospital 
(TS.07) is a perception that the doctors in the hospital respond quickly, but this may 
be dependent on the seniority of the nurse that calls them. The outreach team were 
also perceived as a useful part of the rescue team:
“ ...and I think it’s probably the most frustrating thing, as a nurse, because 
you can’t we’re so ...medical doctors are very scientific. The way they deal 
with figures and they do, you know so they can ...they can you know ..they 
like facts and they like to act on those and that’s the way it should be. But I 
think that when we are with patients all the time I think you feel and see 
more than just...just the observations you are doing with regard to 
measurement and erm I think sometimes you do take...you go to the doctors 
and erm say so and so from an observation point of view but I’m really 
worried about them ...and it is quite frustrating you almost have to wait for 
that patient to do something so you could pull them.. .’’(TS.01)
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“The doctors are pretty good actually... erm and they tend to listen to us 1 
think. I don’t know what it's like, whether it’s different hospitals, but here I 
think the doctors do rely on us to tell them. And a lot of them they come 
here and they really haven’t a clue and you have to kind of teach them the 
ways”. (TS. 05)
“I think sometimes with the doctors... they do listen to you yes, the majority 
do. I think maybe sometimes they might be... times when I feel that perhaps 
they’ve sort of sat on things and... but generally, generally I think the 
doctors are very good. I think they do listen to you”. (TS. 09)
“And I know, I think I suppose it very much depends on the nurse as well.
You know... it depends on what... How they sort of value your input 
depending on what type of person you are and whether you’ve made sense 
in the past”. (TS. 05)
“...I think here it goes better it does in other hospitals, because I do think 
that the doctors take you seriously. I do because I think in general they... 
they value nurses’ opinions in the Marsden, because we tend to be more 
qualified... you know, in that specialty. It normally goes quite well and if I 
was seriously worried about that patient, then I would express that... erm 
quite urgently”. (TS. 07)
“Yeah even now, like, as a newly qualified... if a doctor is around and 
they’re there I will tell them, but they wouldn’t be my first port of call if 
something was going wrong I would probably go to like for instance (senior 
staff nurse name) who’s on today”. (TS. 04)
“...oh yeah the outreach girls are good aren’t they. I do think that, even if 
it’s a ridiculous, you know query that they’re more than helpful... and if 
they are making a suggestion that perhaps you should have thought about 
they do it so nicely that, you know... they are very good”. (TS 07)
6.3.4 Awareness of sepsis risk in the cancer patient
The next theme was the awareness of risk about sepsis developing. Nurses talked 
about the increased risk of sepsis in people with cancer and the increased risk posed 
by a particular treatment or an indwelling catheter. Nurses were also aware that 
people with cancer who become septic deteriorate very quickly.
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“I think within, especially within the field of haemato-oncology you expect 
these patients to have some degree of bone marrow depression and I think 
any patient who has been vulnerable to this you would expect them to be 
vulnerable to infection, indeed to developing sepsis or septicaemic shock...”
(TS. 01)
“So I suppose the main thing is to make sure that we’re dealing... obviously 
sepsis happens quite quickly and so erm got to deal with it quite quickly as 
well...” (TS.02)
“I would always err on the side of sepsis, because I know that you have to 
act quickly... probably because I know how quickly the patient can 
deteriorate...” (TS. 06)
6.3.5 Introduction of a new predictive bedside test
In response to the researcher’s introduction of the PCT-Q, nurses were generally 
keen to have a tool to use to diagnose sepsis early. As can be seen in the passages 
from transcripts 02 and 10, there was a need for it to be easy to use. There was one 
contrary case in which, although the nurse was supportive of the tool, they were keen 
that “it did not stop nurses looking at their patients” (TS.10).
“And we know and like, you know, you’ve seen... the first hour is crucial to 
optimise the patient, so I think erm it would be brilliant to have something 
to maybe initiate treatment sooner...” (TS. 01)
“Sounds like a good tool, I think yeah if we’re obviously educated and 
taught how to use it. Yeah definitely. Erm but I think that with anything that 
is obviously too complicated or means too much work, it does tend to... but 
I think something like that definitely. Mmm it certainly would help probably 
new members of the staff coming onto the ward as well to erm understand 
sepsis and probably not be so afraid of it as well...” (TS. 02)
“Then that would be something we could do straight away without... having 
to, you know, wait for the doctors to come up and for them to say, yes that’s 
okay for you to do that. ‘Cause then we’ve got even more, sort of, 
something to back our argument as well with when you phone the 
doctors...” (TS. 05)
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“I definitely think it would be helpful because erm..it would be easier to ..it 
would be easier to insist and to be able to plan what’s going on for a 
start, .with the patient and act, to act quickly and to have hard evidence 
almost, to say you know this is what’s going on, rather than, there being 
erm..it being a bit wishy washy” TS.06.
“I think it would be useful... as long as it didn’t... I mean I think that any, 
any tool that could be used to set off early alarms about a patient’s 
condition... will be useful. And preventing them deteriorating and 
becoming so unwell... as long as it didn’t discount the value of what the 
nurse actually sees on examination... it doesn’t stop nurses looking at their 
patients...” (TS.10)
6.3.6 Septic screen
The fifth theme concerned collecting microbiological samples from the patient. 
Three of the nurses described taking samples of urine, blood and a septic screen for 
microbiological analysis:
“I probably take... if they had a pyrexia, I’d probably take some blood 
cultures and do some extra bloods...” (TS. 09)
“Then do a full screen... if they’re producing any sputum, cultures erm... 
and then if they’ve got any wounds, swab those. And other breaks in the 
skin or stomas, that sort of thing... if they’ve got diarrhoea, send a stool 
sample”. (TS. 05)
“You would take if necessary, you would take bloods, you would send off a 
CRP... you would do a full screen...” (TS.01)
6.3.7 Clinical confidence based on experience, reflection and 
education
Nurses commented on their confidence level in recognising sepsis and mobilising 
the rescue team, and that this generally had improved over time. They also noted the 
benefit of increased knowledge, education, nursing intuition and reflection:
“.. .erm but it was very frustrating that, you know, you knew there was 
something wrong but you couldn’t obviously put it in... I wasn’t confident
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enough to erm push my case and present that case to the doctors in a sort of 
medical mode... I think I’ve learnt to give facts... and to be able to arrange 
those facts in a way where it highlights my concern, but it also gives a basis 
on... for people to go to the patient with knowledge already about what 
we’re actually looking for”. (TS. 10)
“I think general experience and learning and having sessions... on the 
diploma course... because... and the other thing as well is I’ve worked a lot 
with neutropenics in chemotherapy...” (TS. 09)
“All the time I go home and think erm... Oh I could do this differently next 
time, or I’m happy with what I did. I do that all the time. I mean 
things..some... sometimes if I feel not completely happy with things I’d 
come back and talk to someone about it and if I feel it important I’ll come 
back and talk to someone about it...” (TS.03)
6.3.8 Frustration about limitations to practice
Although this was only directly stated by one nurse (TS.02), she mentioned it several 
times.
“Erm, probably the most frustrating thing is when patients do go septic not 
you know having a, erm... I don’t know, we’ve got the guidelines in the 
protocol we obviously can’t administer any kind of therapy until we’ve got 
a doctor’s signature and... I know I was at the EBMT not so long ago, 
where one of the hospitals in Dublin have got... Patient Group Directions... 
and I er really, I thought that was a very good idea” (TS.02)
6.3.9 More patients with sepsis at this hospital
Creswell encourages the researcher to analyse material that is expected, surprising 
and addresses a larger theoretical perspective (Crewell 2003, p. 193). The researcher 
was surprised that two nurses commented that they saw more sepsis in the study 
hospital. They weren’t sure, however, if this was because they were more 
experienced or due to different patient populations or treatments.
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6.3.10 Summary of themes from first data set transcripts
Having identified the nine themes listed below in figure 6.1 the researcher then read 
through all 10 transcripts again to assess whether there were any important topics 
that were not included in the nine identified themes.
Figure 6.1: Nine themes from pre-intervention interview transcripts
1. Importance of continuity
2. Making a diagnosis: vital signs
3. Contacting others
4. Awareness of sepsis risk in the cancer patient
5. Introduction of a new predictive bedside test
6. Septic screen
7. Clinical confidence based on experience, reflection and education
8. Frustration about limitations to practice
9. More patients with sepsis at this hospital.
6.4 Second data set: analysis of the post-intervention 
interview transcripts
The same process was undertaken with the post-intervention interviews. Eight 
months later, two nurses had left and there were therefore eight post-intervention 
interviews. The demographics of the eight participants are shown in table 6.5
Table 6.5: Demographics of nurses interviewed post-intervention
No Qualified in 
nursing
Cancer
nursing
experience
Critical care
nursing
experience
Educational
Qualifications
Sex
1 9 years 7 years 6 years RN, Oncology 
Diploma, currently 
undertaking BSc 
Critical Care nursing
F
2 5 years 2 years 0 RN, Oncology 
Diploma
F
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3 13 months 6 months 0 RN F
4 3 months 3 weeks 0 RN F
5 4 years 4 years 0 RN, Oncology 
Diploma
F
7 6 years 4 years 0 RN F
8 4 years 16 months 2 years RN, Advanced 
Diploma Nursing, 
currently undertaking 
BSc Critical Care 
nursing
M
10 17 years 13 years 16 years RN, ENB ITU, ENB 
Teaching & assessing
M
These eight transcripts were read and re-read, and emerging topics were noted in a 
table. Following further examination of the transcripts these topics were reduced to 
12 topic areas (see table 6.6).
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Table 6.6: Reduction of first table of topics from the post-intervention 
interviews
1 Early observations the appearance of the patient, looks a bit different, they 
don’t feel as well as have they done but there is no clinical change. Patient 
doesn’t look right / feel right. / Just the general looking at them, sort of general 
inspection of the patient. / patients appearing not quite right / he was doing OK 
and then he became sort of generally unwell, nothing you could put your finger 
on you just sensed that there was something not quite right with him, he looked 
a little more distressed, just a bit slow to respond, / those kind of initial things 
when you look at the patient and you see that there’s something not right.
1 + 1+1 
+1+1
2 You use the SIRS guidelines like their respiratory rate, is it fast? Are they 
febrile, tachycardia, normally there are subtle changes in their HR and 
breathing. Tachycardic and respiratory wise. Vital signs, urine output, blood 
results. Rapid rising temperature, drop in blood pressure, in their boots 
sometimes so that you couldn’t record it, their temp you’d check it and it would 
be 39 and then 39.5 really quite rapid and resps go up and tachycardic. 
Temperature, respiratory rate and the pulse and blood pressure. Temp rises, low 
BP, tachycardia.
l+ l+ l+ l
+1+1
3 Sometimes you look at someone and they look fine... but their blood results 
are all up the creek. Blood results, you know sort of escalating white cell 
counts, finding they were needing a lot more colloid filling, patients appearing 
not quite right.
1+1
4 The colour change, we had one that flushed that went really red, mostly I’ve 
seen them go the other way, like pale, but we had one man that went bright red.
1
5 Asking the patient... the patient is always very aware that something is 
changed or wrong.
1
6 If they’ve spiked a temperature we have been on the ball and taken a PCT-Q as 
well. I’ve never used it myself, have seen the research nurse taking samples 
doing PCT and dialogue in handover, on the CCU course I had to do a paper on 
Sepsis and PCT came up, numerous entries by the anaesthetists and sometimes 
the values are written down on our observations charts. PCT I have probably 
used it for the last 12 months and that’s from picking up patients me and on the
1 + 1+1 
+1+1+1
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pts that the ward nurses are concerned about. PCT-Q is used and everyone 
knows about it I thinks it’s been a significant test/ the doctors have been a bit 
more proactive. Actually only the once...
7 I haven’t used the PCT-Q maybe it has been done but I honestly haven’t been 
wit a patient who has been infected. I have heard the outreach team talking 
about it; they do sometimes come and take bloods. I don’t think we have used it 
on the ward at al but I have seen people coming up to do it, and hearing the 
outreach nurses talking about other patients on the ward and having their blood 
taken for that. I haven’t but I know it was about signs of early sepsis.
1+1
8 PCT-Q it was one of the early signs of sepsis and you were trying t work out 
whether there was an accurate way of... I understand its an early indicator of 
sepsis, It’s a marker and is elevated when pts go into what we call the sepsis 
cascade and it can give us a level of this cascade, from the early stages through 
to severe sepsis and septic shock. It would give us an idea of perhaps how 
severe the septic episode is, we can use it regularly to see changes in the PCT.
1+1+1
9 Above 5 and a maximum of 10 with severe sepsis. Over 2, not sure how 
significant under 2 is. Something like 10 was indicative of say 2 or more organ 
systems being involved or something quite definitive.
1+1+1
10 Very quick and easy to use, very user-friendly, no problem at all. 1+1
11 The first thing is to be aware of what patients are at risk, you have to think 
ahead ad be proactive. Often patients may sense change before anything so 
consider what they are saying, go with the patient if they are not as chatty as 
normal then do the extra observations.
1
12 Teaching junior nurses early signs, to ask the patient how they are feeling. 1
13 Recommendations for care. 1
The thirteen topics were then used while re-reading the eight transcripts and further 
reduced to nine categories (see table 6.7).
Table 6.7: Categories of data obtained from further analysis
1 Early observations the appearance of the patient, looks a bit different, they don’t 1 +
feel as well as have they done but there is no clinical change. Patient doesn’t look 1+1
right / feel right. / Just the general looking at them, sort of general inspection of +1+1+
135 of 355
the patient. / patients appearing not quite right / he was doing OK and then he 
became sort of generally unwell, nothing you could put your finger on you just 
sensed that there was something not quite right with him, he looked a little more 
distressed, just a bit slow to respond, / those kind of initial things when you look 
at the patient and you see that there’s something not right. The colour change, we 
had one that flushed that went really red, mostly I’ve seen them go the other way, 
like pale, but we had one man that went bright red.
4
2 You use the SIRS guidelines like their respiratory rate, is it fast? Are they febrile, 
tachycardia, normally there are subtle changes in their HR and breathing. 
Tachycardic and respiratory wise. Vital signs, urine output, blood results. Rapid 
rising temperature, drop in blood pressure, in their boots sometimes so that you 
couldn’t record it, their temp you’d check it and it would be 39 and then 
39.5really quite rapid and resps go up and tachycardic. Temperature, respiratory 
rate and the pulse and blood pressure. Temp rises, low BP, tachycardia. 
Tachycardia, temperature, vital signs raised temp etc
2
3 Sometimes you look at someone and they look fine... but their blood results are 
all up the creek. Blood results, you know sort of escalating white cell counts, 
finding they were needing a lot more colloid filling, patients appearing not quite 
right.
4 Asking the patient... the patient is always very aware that something is changed 
or wrong.
5 If they’ve spiked a temperature we have been on the ball and taken a PCT-Q as 
well. I’ve never used it myself, have seen the research nurse taking samples doing 
PCT and dialogue in handover, on the CCU course I had to do a paper on Sepsis 
and PCT came up, numerous entries by the anaesthetists and sometimes the values 
are written down on our observations charts. PCT I have probably used it for the 
last 12 months and that’s from picking up patients me and on the pts that the ward 
nurses are concerned about. PCT-Q is used and everyone knows about it I thinks 
it’s been a significant test/ the doctors have been a bit more proactive. I haven’t 
used the PCT-Q maybe it has been done but I honestly haven’t been wit a patient 
who has been infected. I have heard the outreach team talking about it; they do 
sometimes come and take bloods. I don’t think we have used it on the ward at al 
but I have seen people coming up to do it, and hearing the outreach nurses talking
+6,7,8,
9,10.
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about other patients on the ward and having their blood taken for that. I haven’t 
but I know it was about signs of early sepsis. Actually only the once. .. .PCT-Q it 
was one of the early signs of sepsis and you were trying t work out whether there 
was an accurate way of... I understand it’s an early indicator of sepsis, It’s a 
marker and is elevated when pts go into what we call the sepsis cascade and it can 
give us a level of this cascade, from the early stages through to severe sepsis and 
septic shock. It would give us an idea of perhaps how severe the septic episode is, 
we can use it regularly to see changes in the PCT PCT-Q it was one of the early 
signs of sepsis and you were trying t work out whether there was an accurate way 
of... I understand its an early indicator of sepsis, It’s a marker and is elevated 
when pts go into what we call the sepsis cascade and it can give us a level of this 
cascade, from the early stages through to severe sepsis and septic shock. It would 
give us an idea of perhaps how severe the septic episode is, We can use it 
regularly to see changes in the PCT. Above 5 and a maximum of 10 with severe 
sepsis. Over 2, not sure how significant under 2 is. Something like 10 was 
indicative of say 2 or more organ systems being involved or something quite 
definitive Very quick and easy to use, very user-friendly, no problem at all.
6 The first thing is to be aware of what patients are at risk, you have to think ahead 
and be proactive. Often patients may sense change before anything so consider 
what they are saying, go with the patient if they are not as chatty as normal then 
do the extra observations.
8 Getting help, mobilising the team, the best way to get help from doctors.
9 Recommendations for care of the patient with sepsis.
6.5 Second data set: themes analysis of the post­
intervention interview transcripts
By combining and reducing the topics further, particularly the data around the use of 
the PCT-Q, the nine topic areas were reduced to seven categories. The data in these 
categories were then further examined with the transcripts again and each category 
given an overall theme.
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6.5.1 Patient does not look right
The first theme was about the early clinical signs or observations that led the nurse 
to think something was wrong. Five of the eight nurses interviewed talked about a 
general change that was difficult to quantify but led the nurse to monitor the patient 
more carefully. An example of an actual patient scenario was given by nurse 10:
“He was doing OK and then he became sort of generally unwell, clammy... 
there was nothing palpable that you could put your finger on you just sensed 
that there was something not quite right with him, he looked a little more 
distressed even though he was comfortable he was just a bit slow to 
respond...” (TS. 10)
One contrary case was noted, with the nurse (TS.03) noting that there can be times 
when there are no obvious changes in the patient and that it is their blood results that 
are the first sign of a problem:
“Sometimes you look at someone and they look fine... but their blood 
results are all up the creek...” (TS. 03)
Several nurses noted that knowing the patients helped in identifying changes, and the 
nurse who had transferred to the outpatient setting raised the difficulty of not having 
met the patient before:
“It’s a bit harder than on the wards because you’ve looked after them and 
seen them deteriorate... sometimes they come in and you’ve never met them 
before...” (TS.07)
6.5.2 Making a diagnosis
Six of the eight nurses then described the early quantifiable changes that they 
associate with the onset of the sepsis cascade. As in the pre-intervention interviews, 
these changes were mainly those cited as the changes that indicate SIRS. Two nurses 
described these changes as occurring very rapidly:
“They go quite quickly especially on BE, get like a real rapid rising 
temperature, a drop in blood pressure, in their boots sometimes so that you 
couldn’t record it, their temperature you would check it and it would be 39.0 
and then 39.5 really quite rapid.. .”(TS. 04)
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“...and overall the... with the temperature, with the blood pressure with the 
urine output, with the fluid requirements or whatever. Because this isn’t 
normal for the patient. There’s been an actual change wit them... with the 
patient’s brewing, or going along and improving and then all of a sudden 
this is started to happen...” (TS.10)
The most junior of the nurses interviewed (one year after registration) reflected that 
she was very dependent on monitoring the observations:
“Erm it’s funny ‘cause I’ve been a nurse a year and I’m still stuck on the 
obs. Sometime they’ll look a bit different and you’ll think Oh there’s 
something not quite right there, but I would still just go and do their obs and 
see what’s going on... because I haven’t got the experience behind me... I 
wouldn’t know that it was sepsis or something else...” (TS.04)
6.5.3 Ask the patient
One nurse noted that it was important to ask the patient, that they were always aware 
that something was wrong.
“The patient’s usually maybe the first one that actually indicates that there’s 
something wrong. They may not verbalise it, but initially they will probably, 
eventually say if you start to show concern, people might say: “Actually I 
don’t feel... I feel sick...” (TS. 10)
6.5.4 The use of the PCT-Q
The next area explored was the use of the PCT-Q bedside test. Before asking about 
the PCT-Q it was interesting to note that one of the nurses who worked in the blood 
and marrow transplant wards had already mentioned the use of the PCT-Q in the 
management of the early phase of sepsis:
“If they have spiked a temperature we’ve been on the ball and taken a PCT- 
Q as well...” (TS. 02)
Five of the nurses interviewed had seen the PCT-Q being used in clinical practice on 
their wards. These nurses all knew what it was for and when it was being used, even 
if they had not actually used it themselves. Of the nurses who had not seen it used, 
one said she had not looked after a septic patient but had seen the outreach team
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talking about it, one had transferred into the outpatient clinic setting, and a third had 
been off work due to sickness for the previous eight months. Of the nurses who were 
familiar with the PCT-Q being used on their units, some had used it much more than 
others. One nurse had only used it once, whereas others had used it regularly as part 
of their care. Of the nurses who used it regularly, two were based on the blood and 
marrow transplant unit and therefore nursing the most at-risk patients and one was 
an outreach nurse. The nurse on the transplant unit said the following:
“PCT-Q is used and everyone is quite aware of it and knows all the... I 
thinks it’s been a significant test... the doctors have been more proactive in 
how they treat the patient. It’s also good for us; it’s a good indication of 
er... how kind of septic, and possibly you know potentials of what could 
happen there”. (TS.02)
The same nurse also noticed that a significant PCT-Q result correlated with patients 
being admitted to high dependency care areas. The CCU outreach nurse interviewed 
was expected to have had most contact with the test, as the outreach team helped 
ward nurses ensure the test was performed. This was confirmed by her interview, 
and perhaps as expected she reflected that the change to practice had taken off 
slowly at first but then gathered pace:
“I think initially it probably wasn’t used as regularly, so we didn’t feel the 
benefits as much, but once everyone understood what the study was about it 
was used very frequently... and often when patients were unwell it did 
correspond... there were a couple of... bizarre results but apart from a few 
isolated episodes it did correlate and especially when we did repeat studies 
on the patient, the changes correlated with their symptoms...” (TS. 01)
To be useful in clinical practice any additional test needs to be easy to use. It was 
therefore important that the nurses said the PCT-Q was very quick and easy to use. 
The nurses were asked about the significance of PCT levels; four out of the five 
nurses who had used it regularly were able to discuss correctly the differing levels 
between 2 and 10, with the fifth saying she couldn’t remember. Finally it was 
interesting to note that even the nurses who had not experienced the PCT-Q had all 
heard of it and could describe the reasons for its use:
140 of 355
“It is about some changes that would show early sepsis that in patients who 
were septic but clinically it wasn’t as evident...” (TS. 07)
6.5.5 How nurses learn
Nurses were asked about what were the most important ways they learnt about and 
developed their practice. All of the nurses responded that experience was very 
important. They also cited reflection as important, actually looking after a septic 
patient and then reflecting on that when you meet another patient who is septic:
“Because once you actually see one, I mean one patient actually become 
quite ill, it always leaves you with a lasting impression of what actually 
happened with that sort of patient. What were they actually doing, it always 
leaves you with a lasting impression as to how you can actually... Oh you 
know he’s doing this I always remember that patient before he did the same 
thing...” (TS.08)
Four nurses also talked about how important education was in helping them to 
develop their clinical skills:
“I got a hell of a lot out of an essay I did on multiple myeloma... and I 
learnt so much from that...” (TS. 05)
“I think general experience and learning and having sessions ...on the 
diploma course.. .because.. .and the other thing as well is I’ve worked a lot 
with neutropenics in chemotherapy”. (TS. 09)
Four nurses reflected on the importance of learning from other more experienced 
nurses. Senior staff nurses and the outreach team were cited, and also an example of 
working with one of the teaching sisters. Nurse 10 also recommended using patient 
scenarios in clinical teaching to support nurses in a structured way:
“...erm, both by example and by actually working with patients by being 
exposed to those situations with support erm... and the nurse should be 
supported and [the clinical scenario] should be used, whenever possible, as a 
teaching tool as well...” (TS. 10)
Nurses were then asked how they teach junior nurses about identifying sepsis at an 
early stage. One of the eight nurses talked about the importance of being aware of
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which patients would be most at risk. Two of the nurses recommended talking to the 
patient about how they feel, with one nurse recommending the following:
“Go with the patient if they are not as chatty as normal then do extra 
observations”. (TS. 01)
One nurse talked about working with junior nurses on the ward and helping them, as 
she felt it was quite difficult for them to know what was important. The same nurse 
also thought that having an appropriate care plan that you could “walk the nurse 
through” might be helpful.
“So kind of go through everything with the student, really basic every 
single, sort of possible you know screening tool... I think sometimes when 
you are new you haven’t got any idea how you prioritise things”. (TS. 05)
For the nurse working in the outpatient setting her focus was very much on the 
patient knowing about the risks of chemotherapy and about the early signs of sepsis 
developing:
“erm... well the main experience we’d have with that is chemotherapy 
patients... to require them to be aware of a temperature, rigors. Normally 
we’d advise them if they’d a temperature of greater than thirty-eight or felt 
unwell to get in touch. Then at that point they’d be admitted for some 
treatment”. (TS. 07)
6.5.6 Contacting others to help
The next part of the interviews concentrated on nurses getting an effective 
multidisciplinary response if concerned about a patient. One nurse used a technique 
that he termed “planting”:
“I think probably planting which is very very subtle ways of going up to 
doctors and saying: “look you know, what do you think your opinion is 
about... I’ve just seen this and I’ve seen this, what do you think?” It’s 
probably something which I call planting, whereas being quite 
confrontational with doctors... so what you’re doing is actually really 
getting them to... it’s almost like a lead on... an encouragement come and
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have a look, rather than being very obvious and confrontational about it”.
(TS. 08)
Another nurse (TS.10) said he felt that it was important nurses know that they are 
“empowered” at this hospital and their opinion matters. He also suggested that there 
is a way to talk to doctors that will get their attention more successfully:
“When they go to get in touch with the doctor to have the accurate bullet 
points of what has happened with the patients. So they’re able to liaise with 
the doctors or with the multidisciplinary team... so that they get a quick 
response to what is happening to the patient... To be a professional to have 
it all with them when they do go to them”. (TS. 10)
“ I think I’ve leamt to give facts...very strong definitive facts .. .and to be 
able to arrange those facts in a way where it highlights my concern, but it 
also gives a basis on.. .people to walk into the .. .go to the patient with 
knowledge already about what we’re actually looking for”.(TS.10)
The other nurses all talked about using the CCU outreach team, the site nurse 
practitioner or more senior nurses on the ward to ensure that they got a quick 
response.
6.5.7 Practice improvement
In the final section, the nurses were asked if there was anything they would 
recommend to improve the early diagnosis and treatment of cancer patients who 
were deteriorating. Only one of the nurses couldn’t think of anything to recommend 
and she felt that, compared to a general hospital, everything in the current hospital 
was done very efficiently. The other seven nurses made different suggestions which 
are listed in table 6.8
Table 6.8: Suggestions made by seven nurses regarding possible practice 
improvement
Transcript
/Nurse
Suggestion / recommendation
TS.01 For some nursing teams to be able to take more responsibility for the acute 
monitoring of a patient who is deteriorating, and to increase acute care
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skills training for some wards
TS. 02 Patient Group Directions (PGD): if the nurse had a PGD for antibiotics 
they could give the drug as soon as sepsis was identified, and therefore 
reduce the delay to starting treatment
TS. 04 * If you are a more junior nurse to ask for help in a particular way that will 
mean people are less likely to delay and more likely to come immediately 
to help you
TS. 05 Work already ongoing to link up the Early Warning System (EWS) with 
the observation chart and possibly in the future to be linked with the new 
Transitional Care Unit as many acute patients will be admitted through 
there
TS. 07 To increase the education and empowerment of patients and relatives to 
get help as soon as they are starting to feel unwell and not to delay being 
seen by a hospital
TS. 08 The EWS and linking that with education and “planting” from the 
Outreach nurses
TS. 10 Nurse education and practice in how to present their patients perhaps 
linked with the EWS
*Nurse 04 recounted a scenario that she had learnt from and, as a result, had changed 
her practice:
“With one patient I didn’t have any backing, I’m sorry its going to sound 
like I am having a go at everyone it was just before handover... I went into 
this patient, it was the one who went red. I hadn’t seen that before I didn’t 
know what was going on, his temperature was shooting up and his blood 
pressure was coming down.... he wasn’t feeling well, I wasn’t happy with 
him, in fact it was the first sepsis I had seen on the ward. I went in to the 
staff room to let the nurses know... and no one, in fact one of them said, “oh 
he always looks like that”, I’m like no he really doesn’t look well, so no one 
was really I think cause they see it quite a lot they were quite blase about 
it... they weren’t necessarily thinking that I haven’t got the experience to 
deal with it. I think I had already phoned the doctor and he had said to keep 
an eye on him... I went back to the patient... his temperature had gone up 
again... blood pressure was still the same really really low, so I went back
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and phoned the doctor again and said please can you come... and then one 
of the F grades came... she didn’t sort of take over, but she helped me with 
him... After that that woke me up ‘cause I realised that you’re not always 
going to get help unless you actually specifically ask for it. So after that I 
wouldn’t go in there and say: “I’m a bit worried about so and so”. I’d say:
“Can you come and help me””. (TS.04)
6.5.8 Summary of themes from second data set
The seven themes from the post-intervention interviews are shown in figure 6.2.
Figure 6.2: Themes from the post-intervention interviews
1. Patient does not look right
2. Making a diagnosis
3. Ask the patient
4. The use of the PCT-Q
5. How nurses learn
6. Contacting others to help
7. Practice improvement
6.6 The third data set: analysis of the qualitative data 
from the pre-intervention questionnaires
The next data to be analysed were the qualitative texts from the pre-intervention 
questionnaires, of which 177 were completed. Of these, 75 nurses chose to complete 
question 15, which asked for a free text answer (see appendix 10). The preceding 
question 14, which required a “yes/ no” answer, was as follows:
“Have you ever had the experience of thinking that a patient was 
deteriorating but finding it difficult to convince other nurses/doctors or other 
health care professionals?”
This was then followed by the last question, question 15:
If you have had any such experience please could you give an example 
below:
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The texts from these 75 questionnaires, which ranged in length between one sentence 
and a short paragraph, were analysed in the same way as described previously. After 
the first reading of these 75 answers 18 topics were identified. The topics are shown 
in table 6.9 in order of the frequency raised.
Table 6.9: Topics from pre-intervention questionnaires
No Theme No of 
times 
raised
1 Times when nurse concerned that patient exhibiting signs of sepsis but 
difficult to convince medical colleagues
17
2 Description of what happens to the patient in the early stages of sepsis 15
3 Gut feeling, nurse intuition, know the patient not right 8
4 Haematology patients singled out as at risk or being the one that 
developed sepsis
8
5 The patient who first verbalises that there is something wrong 7
6 Bad memories -  reflections on times when sepsis not recognised earlier 
enough, or difficult to get help and the patient died
6
7 Patients who had few hard signs but were unwell, but the nurse could not 
convince doctors or nurses to act quickly enough
5
8 Either a nurse or doctor did not want the nurse to refer the patient to CCU 
or outreach and then later the patient deteriorates
3
9 A junior nurse unable to mobilise rescue but helped in this by senior 
nurses, outreach or senior ward nurses
3
10 Not many changes therefore difficult to convince medical or nursing team 2
11 Very few early signs but patients clearly deteriorating 2
12 Earlier intervention may be more beneficial to the patient 2
13 Team members all cooperative and coordinated response 1
14 Junior nurse could not convince colleagues 1
15 The need to encourage doctors to listen to nurses 1
16 Delays in transfer to CCU 1
17 Difficulty in convincing specialised colleagues that sepsis may be an 
issue in patients with cerebral metastases
1
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18 Only senior nurses allowed to use EWS (in previous hospital)
The texts were then read again and the topics amalgamated, with the number 
reducing to 11 (see table 6.10):
Table 6.10: Topics from pre-intervention questionnaires reduced on second 
reading
1 Times when nurse concerned that patient exhibiting signs of sepsis but 
difficult to convince medical colleagues. Sometimes in the early stage pts 
few clinical signs but unwell and nurse could not convince doctor or nurse 
to act quickly. Junior nurse found it difficult to convince colleagues that 
patient was deteriorating. Earlier intervention would be beneficial for the 
patient. The need to encourage doctors to listen to nurses.
17 + 5
+ 2 +
2
+ 1 + 
2+1 = 
29
2 Description of what happens to the patient in the early stages of sepsis 15
3 Gut feeling, nurse intuition, know the patient not right 8
4 Haematology patients singled out as at risk or being the one that developed 
sepsis
8
5 The patient who first verbalises that there is something wrong 7
6 Bad memories -  reflections on times when sepsis not recognised earlier 
enough, or difficult to get help and the patient died
6
7 Either a nurse or doctor did not want to allow referral or transfer to CCU 
and then later the patient deteriorates
3 + 1 
= 4
8 Junior nurses felt unable to initiate rescue but helped in this by senior 
nurses from the ward or outreach team
3
9 Team members all cooperative and coordinated response 1
10 Difficulty in convincing specialised colleagues that sepsis may be an issue 
in pts with cerebral mets
1
11 Only senior nurses allowed to use EWS in previous hospital 1
These eleven topics were then re-examined for any interconnecting themes, which 
resulted in a further reduction to six clusters.
5. Twenty-nine nurses described finding it difficult in clinical practice to 
convince either their senior nursing colleagues or medical staff to intervene
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quickly. There was a general recognition that the nurse recognised that the 
patient was unwell but, because there was as yet little physical change, it was 
difficult to convince colleagues. There was also a plea for doctors to listen to 
nurses. Three nurses described reflecting back and remembering when they 
were junior nurses feeling unable to effectively mobilise help, but gave 
examples of senior nurses (for example the “PART team” (Patient at Risk 
Team) or experienced nurses on the bone marrow transplant unit) who were 
able to help them.
“Has been many cannot remember one specific incident, feel that sometimes 
when patients are starting to deteriorate the medical team sits on them too 
long”. (Q.12)
“The patient looked and felt unwell. He had an increasing tachycardia, 
respiratory rate and was hypotensive 90/50 but had a temperature of 36 
degrees Celsius and so the SHO didn’t think he was developing sepsis and 
did not want to start antibiotics”. (TS.21)
“Doctors often want to “watch and wait” instead of respond early”. (Q.142)
“When difficult to convince doctor got Patient At Risk Team (PART) 
nurses involved (team of experienced ITU nurses, that are around to support 
nursing team) of whom did ABGs and convince doctors that patient needed 
to be in a more suitable environment”. (Q.27)
2. There were fifteen responses where nurses used this question to describe the 
patient’s condition when developing the early signs of sepsis. These answers provide 
descriptions of the changes in cardiovascular, respiratory and urological changes and 
the changes that nurses notice before parameters change, with the following cited: 
“sweaty”, “pallor”, “restlessness”, “lethargy” and seeming “unwell”. Eight different 
nurses described using nursing intuition, gut feeling and knowing that the patient 
“not right”. Several nurses noted that they noted a change because they knew the 
patient well.
“I was working for surgical ward one patient was suddenly collapsed.
Sweating ++, tachycardic, BP was low temp it was 40 degrees Celsius, 
patient looks pale, patient was confused”. (Q. 28)
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“Too many to give actual specific, but general picture of raise respiratory 
rate, pyrexia, low BP, decreasing urine output”. (Q.56)
“Gut feelings, prior to septic episode patient observations generally slight 
increase in resps, small drop in saturation reported to doctors then patient 
rapidly deteriorate two hours later”. (Q.67)
“The experienced practitioner has “intuition”. Sepsis may be “brewing” but 
clinical signs not yet present”. (Q.15)
“When you have been looking after the same patient for a few days, you 
know how they are. When there is something “just not right” nurses 
intuition”. (Q.41)
2. Eight nurses also gave examples of the haematological patients that had 
developed sepsis.
“Haematology patient leukaemia neutropenic” (Q.76)
“A haematology patient with neutropenia was in my care being treated with 
antibiotics for sepsis. She became gradually more unwell but took a long 
time to show physical indicators typical to severe sepsis...” (Q.71)
3. Seven nurses noted that it was the patient themselves who first raised the 
alarm that there was something wrong.
“Patient was restless and kept saying that something was wrong but obs 
were stable”. (Q.50)
“Mr.X. said he “felt unwell/strange” observations tachy pyrexia approx 
37.3-37.5 BP up patient looked unwell...” (Q.15)
4. Six nurses reflected on times when early intervention had not occurred or 
where it was difficult to get people to help or to be transferred to the CCU and 
the patient had died.
“Elderly lady on medical ward who was deteriorating she was more 
confused and seemed more listless her vital signs were only slightly worse 
and her temperatures only 37.8 degrees Celsius. It took several hours to get
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a doctor he still didn’t take it seriously she did eventually start antibiotics 
that 24 hours later and she died a week later”. (Q. 131)
“When I was fairly newly qualified I looked after a patient on an admissions 
ward who became septic and went into DIC -  they subsequently died. I felt 
from early on that the patient deteriorating but could not quantify the and I 
could not persuade the HO to review the patient. Neither he nor I realised 
the sped with which these patients deteriorate”. (Q.158)
5. Finally there were three nurses who described three different subjects: one 
felt she worked in an area where there was a good coordinated response; a 
second worked in an area where sepsis is unusual and felt she needed to 
highlight the risk; and finally a nurse said the only nurses allowed to use the 
Early Warning System and refer to the CCU teams were senior nurses on the 
ward.
“In this set-up the team members have been quite cooperative when it 
comes to issues regarding deteriorating in patient’s condition and necessary 
measures”. (Q. 104)
“Patients with Ca cervix and brain mets. My colleagues kept relating 
temperatures with brain mets and not with sepsis”. (Q.43)
“At time “emergency warning system” under discussion and only nurse 
practitioners were to assess using it. Patient deteriorated — this was not at 
this trust and early in my career”. (Q.52)
On a further reading of these six clusters, the following five key themes were 
generated from the data:
1. There is difficulty in getting help from doctors, but help from senior 
nurses.
2. Early changes are either measurable or less tangible.
3. Haematology patients are at greater risk from sepsis.
4. It is the patient who first raises the alarm.
5. Reflections on times when failure to get help resulted in a patient’s 
death.
150 of 355
There were three leftover topics, that were important to individual nurses but did not 
seem to fit into an overall theme:
6. A description of a good coordinated response.
7. Highlighting the risk of sepsis in a ward where it is rarely seen.
8. In a previous hospital only senior nurses allowed to use MEWS and 
contact outreach.
6.7 Analysis of the three data sets combined
Having analysed the three data sets, the key themes were brought together for further 
examination:
First data set
1. Importance of continuity
2. Making a diagnosis: vital signs
3. Contacting others
4. Awareness of sepsis risk in the cancer patient
5. Introduction of a new predictive bedside test
6. Septic screen
7. Clinical confidence based on experience, reflection and education
8. Frustration about limitations to practice (leftover)
9. More patients with sepsis at this hospital (leftover)
Second data set
1. Patient does not look right
2. Making a diagnosis
3. Ask the patient
4. The use of the PCT-Q
5. How nurses learn
6. Contacting others to help
7. Practice improvement
Third data set
1. Difficulty in getting help from doctors but helped by senior nurses
2. Early changes either measurable or less tangible
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3. Haematology patients at greater risk from sepsis
4. It is the patient who first raises the alarm
5. Reflections on times when failure to get help resulted in a patient’s death
6. Description o f a good coordinated response (leftover)
7. Highlighting risk o f  sepsis in a ward where it is rarely seen (leftover)
8. Only senior nurses allowed to use M EW S and contact outreach (leftover)
These themes were placed into a table to make it easier to identify interrelated 
themes. W here connections were identified, the them es were highlighted by a colour 
pen as illustrated in table 6.11.
Table 6.11: Interrelated themes highlighted
No Theme from 1s( cohort o f data Theme from 2nd cohort o f data Theme from 3 rd cohort o f data
1 HIHHHHHHHi Difficulty in getting help from 
doctors but helped by senior 
nurses.
2 M aking a diagnosis: vital signs "]Making a diagnosis
UHMIIHMI
3 Contacting others Ask the patient Haematology patients at greater 
risk from sepsis.
4 Awareness o f sepsis risk in the 
cancer patient
~ff?he use of the PC T-<f It is the patient who first raises the 
alarm.
5 Introduction of a new 
p redictive bedside
H H H H I Reflections on times when failure 
to
get help resulted in a patient’s 
death.
6 |Septic sc ree | Contacting others to help
7
h b h h h h
HUHI
Practice improvement.
Leftovers Leftovers Leftovers
Frustration about limitations to 
practice.
As a junior nurse learning from a 
difficult experience to ask for 
help in a particular way that will 
have a more immediate effect.
Description o f  a good coordinated 
response
More patients with sepsis at this 
hospital.
Highlighting risk of sepsis in a 
ward where it is rarely seen
Only senior nurses allowed to use 
MEWS and contact outreach
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This highlighting of related themes resulted in a reduction from 19 major themes to 
eight, as shown in table 6.12.
Table 6. 2: Key themes from all data sources
No Theme
1 Knowing the patient: the importance of nursing continuity: recognition of 
early changes either measurable or less tangible
2 Making a diagnosis of sepsis: using vital signs, urine output, septic screen and 
the PCT-Q
3 Contacting others to help: difficulty in persuading doctors at an early stage but 
senior nurses able to help, one example of a good coordinated response
4 Asking the patient: they always know something is wrong and are often the 
first to raise the alarm
5 Being aware of (the risk of) sepsis: even on wards that rarely see it, and that 
haematology patients are more at risk
6 Nurses learning: develop confidence using reflection, experience and education 
and how they teach others
7 Reflecting on failure: failure to get help early resulted in a patient’s death.
8 Improving practice
6.8 Integration of the three qualitative data sets
The three sets of qualitative data obtained from the two sets of interviews and the 
pre-intervention questionnaire were all analysed independently using a constant 
comparative technique informed by grounded theory. Important topics were 
identified by reading and re-reading the transcripts. Topics were identified either 
because they were mentioned by several nurses or were cited by only one nurse but 
were central to that account. For each data set, the topics were then reduced to 
broader categories by amalgamating several topics. Several themes were identified 
on re-reading the data by using these categories and looking for interrelated 
connections. For each data set a group of seven to nine themes was identified. For
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each data set leftover themes were also recorded. The three sets of themes were then 
placed in a table and interconnections identified using a coloured highlighter. The 
final result was a distillation of 21 themes into eight overarching themes across all 
the qualitative data. These eight themes are shown above in table 6.12. The 
importance of these themes and their links to nursing theory, literature and clinical 
experience will be discussed in chapters nine and ten.
6.9 Conclusion
The overall aim of the study was to improve the early diagnosis of sepsis and 
communication with the multi-professional team by introducing a dedicated 
education session and an objective test. The objectives of the qualitative interviews 
were to gain an in-depth understanding of the following aspects of the nurses’ 
individual experiences of caring for a patient deteriorating with sepsis:
The nurses’ experience of barriers to effective communication with and mobilising 
the multi-professional team; nurses’ awareness of sepsis its assessment and 
management and how this could be improved; and finally their thoughts about the 
introduction of the PCT-Q and their experience of using it to aid communication and 
mobilisation of the team. As can be seen from table 6.12 above these objectives were 
achieved. These findings also support the theory as described in chapter one: that 
nurses intuit subtle change and want to act, and that there is a need to improve 
communication and multi-professional rescue with the nurses substantiating the 
evidence that “packaging” of information is necessary, thus the introduction of the 
objective tool the PCT-Q to aid communication inter and between professionals.
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Chapter 7 Findings (2): nurse questionnaire 
data
7.1 Introduction
The next data to be analysed were the pre- and post-intervention questionnaires. The 
nurse questionnaire survey links to the theoretical framework by testing the nurses’ 
knowledge of sepsis pre and post the educational intervention. This part of the study 
was therefore designed to raise the awareness of sepsis during the study and to 
increase nurses’ knowledge about sepsis and the PCT-Q. The questionnaires were 
the same except that the first included an invitation in question 15 to describe a 
clinical scenario when a patient was deteriorating. The first questionnaire was 
completed by 177 nurses. These questionnaires were completed during the first 10- 
15 minutes of the teaching session. The post-intervention questionnaires were sent to 
every nurse who had received the teaching session but only 85 of these were 
returned. Of the original 177, 32 nurses had left the trust and were not able to receive 
a questionnaire. This left 145 nurses. A reminder letter was sent but only 85 were 
returned. This was a 58.6% return of the post-intervention questionnaires. As there 
was only a limited response to the post-intervention questionnaire it was important to 
compare the nurses who did respond the second time with those who did not, to 
ascertain whether there was a major systematic difference between the two groups. 
The differences are summarised below in table 7.1 but, as demonstrated, there is no 
significant difference and the reasons for non response are therefore presumed to be 
due to chance rather than any more systematic difference. For the rest of the data in 
this chapter, the important assessment is the within person/group change in the 85 
nurses who completed both questionnaires.
7.2 Demographics
The first section of the questionnaire consisted of demographic information. In both 
questionnaires the population of nurses was well distributed across all wards on both 
sites of the trust, with more nurses from the acute areas such as CCU (36 nurses
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(20.3%) answering the first and 21 (24.7%) the second) and the bone marrow 
transplant unit (30 nurses (16.9%) answering the first and 16 (18.8%) the second).
Table 7.1: Which ward was the nurse from?
Questionnaire 1 Questionnaire 2
Ward Frequency %
CCU 36 20.3
Haemato-
oncology
30 16.9
GI and GU & 
Neuro
17 9.6
Private Patients 16 9.0
Breast 14 7.9
MDU & OPD 12 6.8
Sarcoma,
Haem-onc
11 6.2
Drug
Development
9 5.0
Palliative Care 8 4,5
Gynae-onc 6 3.4
CCU Outreach 5 2.8
Elsewhere 5 2.8
Night Sister 4 2.2
Rehabilitation 3 1.7
Head & Neck 1 .56
Total 177 100.
0
Ward Frequency %
CCU 21 24.7
Haemato-
oncology
16 18.8
GI, GU, & 
Neuro
4 4.7
Private
Patients
8 9.4
Breast 4 4.7
MDU & OPD 6 7.0
Sarcoma,
Haem-onc
6 7.0
Drug
Development
5 5.9
Palliative care 4 4.7
Gynae-onc 0 0
CCU
Outreach
5 5.9
Elsewhere 2 2.3
Night Sister 2 2.3
Rehabilitation 1 1.2
Head & Neck 1 1.2
Total 85 100.0
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7.3 Experience working with cancer patients
Question one asked how long each nurse had worked with cancer patients. As can be 
seen from the pie charts below, the greatest number of nurses in both samples had 
worked with cancer patients for two to four years (40% in the first questionnaire and 
34.12% in the second). Post intervention there were more nurses who had only 
worked one to two years, but also more nurses who had worked with cancer patients 
for five to ten years.
Table 7.2: Cross tabulation of pre and post experience
Pre: How long have 
you worked with 
cancer patients?
Post: How long have you 
worked with cancer patients?
N Valid 177 85
Missing 0 92
Pre: How long have you worked with cancer patients?
Frequency Percent Cumulative Percent
less than 1 year 39 22.0 22.0
2-4 years 72 40.7 62.7
5-10 years 39 22.0 84.7
more than 10 
years
21 11.9 96.6
1-2 years 6 3.4 100.0
Total 111 100.0
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Post: How long have you worked with cancer patients?
Frequency Percent Valid Percent
Cum ulative
Percent
Valid less than 1 year 12 6.8 14.1 14.1
2 -4  years 29 16.4 34.1 48.2
5 -10  years 26 14.7 30.6 78.8
more than 10 years 11 6.2 12.9 91.8
1 -2  years 7 4.0 8.2 100.0
Total 85 48.0 100.0
Missing System 92 52.0
Total 177 100.0
Figure 7.1: Length of time working with cancer patients: numbers represent 
frequencies
Pre-How long have you worked with cancer patien ts? Post-How long have you worked with cancer pa tien ts?
■  less T-im 1 /ear
■  2-4 years 
H S - 10 years
|  nx*e than 1C years 
□  *-2 years
7.4 Post-registration cancer qualifications
Question two asked nurses if  they had any post-registration cancer qualification. 
They were asked for a yes or no answer. There was a greater num ber o f  nurses in the 
second sample that had a cancer qualification (64.71%  versus 57.39%  in the first 
sample).
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Table 7.3 Post-registration cancer qualifications
Pre: Post-reg 
qualifications Post: Post-reg qualifications in cancer
N Valid 177 85
Missing 0 92
Pre: Post-reg qualifications
Frequency Percent Cumulative Percent
Valid yes 101 57.1 57.1
no 75 42.4 99.4
99.00 1 .6 100.0
Total 177 100.0
Post: Post-reg qualifications in cancer
Frequency Percent
Valid
Percent
Cumulative
Percent
Valid yes 55 31.1 64.7 64.7
no 30 16.9 35.3 100.0
Total 85 48.0 100.0
Missing System 92 52.0
Total 177 100.0
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Figure 7.2: Post-registration qualifications in cancer
P o st-P o s t reg Q ualifications in C ancer
Pre-Post reg Qualifications
7.5 Types o f  post-registration qualification
Nurses were asked to record their various post-registration cancer nursing 
qualifications.
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Table 7.4: Have you undertaken any post-registration education? 
Questionnaire 1 Questionnaire 2
Course Frequency %
None other 128 72.3
Haemato-
oncology
module
11 6.2
Foundations of 
cancer module
16 9.0
2-3 cancer 
modules
6
1 &2 1 .6
Cert in cont 
prof dev
1 .6
Dip in cancer 1 .6
Short courses 5 2.8
Chemotherapy 3 1.7
BSc nursing 2 1.1
MSc Advanced 
Nursing
2 1.1
Missing 1 .6
Total 177 100.0
Course Frequency %
None other 59 69.4
Haemato-
oncology
module
2 2.4
Foundations of 
cancer module
9 10.6
2-3 cancer 
modules
6 7.0
1 &2 1 1.2
Cert in cont 
prof dev
2 2.4
Dip in cancer 1 1.2
Short courses 5 5.9
Chemotherapy 2 2.4
Critical Care 
Module
2 2.4
Total 85 100
7.6 How up to date was nurses’ knowledge?
The next section of questions addressed nurses’ knowledge regarding the sepsis 
syndrome. The first asked whether they felt their knowledge could be improved. A 
majority felt that their knowledge could be improved (131 nurses, 74%, n=177, 1 
nurse did not answer this question) while 39 nurses felt that their knowledge was not 
up to date and six nurses felt that it was up to date.
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Table 7.5: Do you feel your knowledge is up to date regarding the sepsis 
syndrome?
Questionnaire 1 Questionnaire 2
Variable Frequency % Cumulative
%
No 39 22
.0
22.2
yes 6 3.
4
25.6
Could be 131 74 100.0
improved .0
Total 176 99
.4
Missing 1 0.
6
Total 177 10
0.
0
Variable Frequency % Cumulative
%
No 6 7.
1
7.1
Yes 17 2
0.
0
27.1
Could be 62 7 100.0
improved 2.
9
Total
Missing
Total 85 1
0
0.
0
This is an interesting set of answers, (perhaps as might be expected), with slightly 
more nurses in the second sample being more experienced and more qualified (39% 
of the first sample said that their knowledge was not up to date while only 6% said 
so in the second sample). It is tempting to wonder whether the second sample 
reflects the fact that these nurses had received the teaching intervention. Post­
intervention, 20% of nurses versus 6% in the same group pre-intervention answered 
yes, that their knowledge was up to date. As can be seen below in table 7.6, this 
change did reach statistical significance.
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Table 7.6: Crosstabulation
Pre: Do you feel your knowledge is up to date regarding the sepsis syndrome? * Post: Do 
you feel your knowledge is up to date regarding the sepsis syndrome? Crosstabulation
Post: Do you feel your knowledge 
is up to date regarding the sepsis 
syndrome? Total
No Yes
could be 
improved
Pre: Do you feel 
your knowledge is 
up to date 
regarding the 
sepsis syndrome?
no Count
1 3 7 11
% of Total 1.2% 3.6% 8.3% 13.1%
yes Count 0 0 2 2
% of Total 0.0% 0.0% 2.4% 2.4%
could be improved Count 5 13 53 71
% of Total 6.0% 15.5% 63.1% 84.5%
Total Count 6 16 62 84
% of Total 7.1% 19.0% 73.8% 100.0%
Chi-Square Tests
Value df
Asymp. Sig. (2- 
sided)
McNemar-Bowker Test 11.400 3 .010
N of Valid Cases 84
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7.7 Different stages of the sepsis syndrome
Question four asked nurses to describe the different stages of the sepsis syndrome. 
Table 7.7: Standard definitions
Pre: Describe standard definitions for different parts of sepsis cascade
Frequency % Cumulative %
Valid 1 correct 22 12.4 21.4
2 correct 5 2.8 26.2
3 correct 10 5.6 35.9
4 correct 2 1.1 37.9
nil 26 14.7 63.1
don't know 25 14.1 87.4
don't understand/don't 
know what this means
13 7.3 100.0
Total 103 58.2
Missing 99.00 74 41.8
Total 177 100.0
Post: Describe standard definitions for different parts of sepsis cascade
Frequency % Cumulative %
Valid 1 correct 6 3.4 9.7
2 correct 11 6.2 27.4
3 correct 7 4.0 38.7
4 correct 16 9.0 64.5
5 correct 6 3.4 74.2
nil 13 7.3 95.2
don't know 1 .6 96.8
don't understand/don't 
know what this means
2 1.1 100.0
Total 62 35.0
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Missing missing 23 13.0
System 92 52.0
Total 115 65.0
Total 177 100.0
Table 7.8: Change in number of correct definitions
N Valid 43
Missing 134
Change in number of correct definitions
Frequency % Valid % Cumulative %
Valid Decrease 5 2.8 11.6 11.6
No change 12 6.8 27.9 39.5
Increase 26 14.7 60.5 100.0
Total 43 24.3 100.0
Missing System 134 75.7
Total 177 100.0
These stages are well described in the literature and have been the standard 
definitions used since 1992 (Bone et al 1992). This question proved to be very 
difficult for nurses to answer; with 74 nurses (41.8%) not answering the question and 
13 nurses (7.3%) writing that they didn’t know what the question meant. Of the 
nurses that did answer this question, only two got the four stages correct. Ten got 
three stages, five got two stages correct and twenty-two got one stage correct. There 
was an increase in knowledge post intervention, with 14.7% of nurses’ knowledge 
increasing (see table7.7).
7.8 Average mortality rate in healthy adults
Question five asked nurses to provide the average mortality rate for severe sepsis in 
healthy adults. Only 20 nurses (11.3%) answered this question correctly in the first
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questionnaire. In the second questionnaire the number increased to 28 (32.9%) but 
remained small. The change does reach statistical significance.
Table 7.9: What is the mortality rate for severe sepsis in previously healthy 
adults?
Questionnaire 1 Questionnaire 2
Variable Frequency % Cumulative
%
Correct
35-45%
28 32.9 38.9
incorrect 44 51.8 100.0
Total 72 84.7
missing 13 15.3
Total 85 100.0
Variable Frequency % Cumulative
%
Correct
35-45%
20 11.3 11.3
incorrect 157 88.7 100.0
Total 177 100.0
Again, crosstabulating both results and using McNemar to compare the two sets of 
data, there is a statistically significant difference (p<.001) with a greater percentage 
of nurses after the intervention being able to answer this question correctly (6.9% in 
the first versus 38.9% in the second), for nurses who answered both questionnaires. 
It is important to note that although the knowledge acquisition improved there were 
still 51.9% of the nurses after the teaching that got this answer wrong.
Table 7.10: Crosstabulation
Pre: What is the mortality rate for severe sepsis in previously healthy adults * Post: What 
is the mortality rate for severe sepsis in previously healthy adults Crosstabulation
Post: What is the mortality 
rate for severe sepsis in 
previously healthy adults Total
35-45% Incorrect
Pre: What is the 
mortality rate for severe 
sepsis in previously 
healthy adults
35—45% Count
2 3 5
% of Total 2.8% 4.2% 6.9%
incorrect Count 26 41 67
% of Total 36.1% 56.9% 93.1%
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Total Count 28 44 72
% of Total 38.9% 61.1% 100.0%
Chi-Square Tests
Exact Sig. 
Value (2-sided) 
McNemar Test .000(a)
N of Valid Cases 72
a Binomial distribution used.
7.9 Average mortality rate with sepsis
Question six asked nurses to provide the average mortality rate for the person with 
cancer who develops severe sepsis. In the first questionnaire, the question was 
answered by all nurses except one but answered incorrectly by a majority (168 or 
94.9%). In the second questionnaire, as shown below, more nurses were correct but 
70.6% were still wrong, with 15.3% not answering this question. The improvement 
is statistically significant (p= 0.035). The correct answer is between 55% and 65%.
7.11: Average mortality rate for person with cancer who develops sepsis 
Questionnaire 1 Questionnaire 2
Variable Frequency % Cumulative
%
Correct
55-65%
8 4.5 4.5
Incorrect 168 94.9 100.0
Total 176 99.4
Missing 1 .6
Total 177 100.0
Variable Frequency % Cumulative
%
Correct
55-65%
12 14.1 16.7
incorrect 60 70.6 100.0
Total 72 84.7
Missing 13 15.3
Total 85 100.0
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Table 7.12: Crosstabulation
Pre: What is the mortality rate for severe sepsis in cancer patients * Post: What is the 
mortality rate for severe sepsis in cancer patients Crosstabulation
Post: What is the 
mortality rate for 
severe sepsis in adults 
with cancer Total
55-65% incorrect 55-65%
Pre: What is the 
mortality rate for severe 
sepsis in people with 
cancer
55-65% 0 3 3 (4%)
incorrect
12 56 68 (96%)
Total 12(17%) 59 (83%) 71
Chi-Square Tests
Exact Sig.
Value (2-sided)
McNemar Test .035(a)
N of Valid Cases 71
a Binomial distribution used.
7.10 Early signs of sepsis
The next section of the questionnaire concentrated on the early diagnosis of sepsis. 
Question seven asked nurses to describe the early signs of sepsis, listing as many as 
possible. In total 15 variables were listed as shown in table 7.13, with the frequency 
with which they were mentioned by nurses. The two sets of answers are very similar 
with few noticeable differences, but there is an important difference with 
tachypnoea. In the first questionnaire only 28.2% of the nurses (50) identified that 
tachypnoea is an important early sign of sepsis, whereas in the post-intervention 
questionnaire 60% (51) of nurses identified tachypnoea (and of these 51,31 had not
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identified tachypnoea pre-intervention). The major clinical signs such as pyrexia, 
hypotension and tachycardia were answered equally well in both samples.
Table 7.13: Listing early signs of sepsis
Questionnaire 1 Questionnaire 2
No Variable No of
nurses
that
specified
this
variable
% of
nurses
that
specified
this
variable
1. Pyrexia 170 96%
2. Hypotension 140 79.1%
3. Tachycardia 135 76.3%
4. Oliguria/Anuria 56 31.6%
5. Tachypnoea 50 28.2%
6. Drop in Oxygen 
saturations
38 21.5%
7. Raised white cell 
count
35 19.8%
8. Hypothermia 29 16.4%
9. Malaise 27 15.3%
10. Clammy 22 12.4%
11. Rigors 20 11.3%
12. Altered
consciousness
20 11.3%
13. Raised CRP 14 7.9%
14. Vasoconstriction 9 5.1%
15. Vasodilation 7 4.0%
No Variable No of
nurses
that
specified
this
variable
% of
nurses
that
specified
this
variable
1. Pyrexia 77 90.6%
2. Hypotension 66 77.6%
3. Tachycardia 71 83.5%
4. Oliguria/Anuria 27 31.8%
5. Tachypnoea 51 60%
6. Drop in Oxygen 
saturations
15 17.6%
7. Raised white cell 
count
21 24.7%
8. Hypothermia 25 29.4%
9. Malaise 8 9.4%
10. Clammy 11 12.9%
11. Rigors 8 9.4%
12. Altered
consciousness
20 23.5%
13. Raised CRP 5 5.9%
14. Vasoconstriction 6 7.1%
15. Vasodilation 7 8.2%
Table 7.14: Crosstabulation
Pre and Post: Describe early signs of sepsis developing -  Tachypnoea Crosstabulation
Post: Describe early signs of sepsis 
developing -  Tachypnoea Total
yes no yes
Pre: Describe early signs of 
sepsis developing -  Tachypnoea
yes
20 9 29
no 31 23 54
Total 51 32 83
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p-value from McNemars test = 0.001
7.11 Immunological and blood indicators
Question eight asked nurses to list three immunological/blood indicators of sepsis. In 
sample one, 154 nurses answered this question with 23 nurses not answering. In 
sample two, 81 of the nurses answered with only 4 missing. Overall the two sets of 
answers are not significantly different; however there are more correct answers in 
questionnaire two than in one if you look at those nurses being able to provide more 
than three indicators, as shown below in the frequency tables.
7.15: List the immunological predictors of sepsis 
Questionnaire 1 Questionnaire 2
Variable Frequency % Cumulative
%
0 right 19 10.7 12.3
1 right 60 33.9 51.3
2 right 54 30.5 86.4
3 right 20 11.3 99.4
4 right 1 .6 100.0
Total 154 87.0
missing 23 13.0
Total 177 100.
0
Variable Frequency % Cumulative
%
0 right 3 3.5 3.7
1 right 20 23.5 28.4
2 right 28 32.9 63.0
3 right 28 32.9 97.5
4 right 2 2.4 100.0
Total 81 95.3
missing 4 4.7
Total 85 100.
0
The following table lists the indicators noted and the frequency with which they 
were noted:
Table 7.16: Blood indicators listed
Questionnaire 1 Questionnaire 2
No Indicator of No of % of No Indicator of No of % of
sepsis nurses nurses sepsis nurses nurses
who listed who who who
the listed listed the listed the
variable the variable variable
variable
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1 White blood 
cells / 
neutrophil 
count
68 80%
2 CRP 51 60%
3 PCT 34 40%
4 Erythrocyte 
Sedimentation 
Rate (ESR)
5 5.9%
1 White blood cells / 
neutrophil count
105 59.3%
2 CRP 74 41.8%
3 PCT 23 13%
4 Erythrocyte 
Sedimentation 
Rate (ESR)
5 2.8%
As can be seen from the frequency tables, more nurses in the second questionnaire 
raised all four indicators, in particular WBC and PCT.
Table 7.17: Crosstabulation
Pre: List three immunological/blood indicators of sepsis and severe sepsis * Post: List 
three immunological/blood indicators of sepsis and severe sepsis Crosstabulation
Count
Post: List three immunological/blood indicators 
of sepsis and severe sepsis Total
0 right 1 right 2 right 3 right 4 right 0 right
Pre: List three 
immunological/blood 
indicators of sepsis 
and severe sepsis
0 right
0 2 4 0 0 6
1 right 2 6 7 7 0 22
2 right 1 7 10 16 0 34
3 right 0 2 3 1 1 7
4 right 0 0 0 0 0 0
Total 3 17 24 24 1 69
Chi-Square Tests
Value df
Asymp. Sig. 
(2-sided)
McNemar-Bowker Test 14.473 6 .025
N of Valid Cases 69
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7.12 Making a difference to morbidity and mortality rates
Question nine asked nurses to indicate whether they thought identifying sepsis early 
made a difference to morbidity and mortality rates. As can be seen in the table 
below, a majority of nurses felt early identification did make a difference with no 
statistical difference between the two questionnaires.
Table 7.18: Does identifying sepsis early make any difference to morbidity and 
mortality rates?
Questionnaire 1 Questionnaire 2
Variable Frequency % Cumulative
%
Variable Frequency % Cumulative
%
Yes 174 98.3 98.3 Yes 84 98.8 98.8
No 1 0.6 98.9 No 1 1.2 100.0
Not sure 2 1.1 100.0 Not sure
Total 177 100.0 Total 85 100.0
Table 7.19: Crosstabulation
Pre: Do you think that identifying sepsis at an early stage makes any difference to 
mortality and morbidity * Post: Do you think that identifying sepsis at an early stage 
makes any difference to mortality and morbidity Crosstabulation
Post: Do you think that 
identifying sepsis at an 
early stage makes any 
difference to mortality 
and morbidity Total
yes No yes
Pre: Do you think that 
identifying sepsis at an 
early stage makes any 
difference to mortality 
and morbidity
yes 82 1 83
no 1 0 1
not sure
1 0 1
Total 84 1 85
Chi-Square Tests
Value df Asymp. Sig. (2-sided)
McNemar-Bowker Test •(a)
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N o f  Valid Cases 85
a Computed only for a PxP table, where P must be greater than 1.
7.13 Awareness of CRP and procalcitonin tests
Question ten asked nurses whether they had heard of CRP and procalcitonin blood 
tests.
Table 7.20: CRP and procalcitonin tests
Questionnaire 1 Questionnaire 2
Variable Frequency % Valid % Cumulative
%
Variable Frequency % Valid % Cumulative
%
PCT Yes 100 56.5 56.5 56.5 PCT Yes 81 95.3 95.3 95.3
PCT No 50 28.2 28.2 84.7 PCT No
CRP 27 15.3 15.3 100.0 CRP 4 4.7 4.7 100.0
Total 177 100.
0
100.0 Total 85 100.0
Table 7.21: Crosstabulation
Pre: Have you heard of PCT and CRP * Post: Have you heard of PCT and CRP 
Crosstabulation
Count
Post: Have you heard of 
PCT and CRP Total
Yes crp yes
Pre: Have you 
heard of PCT 
and CRP
yes
49 2 51
no 16 1 17
crp 16 1 17
Total 81 4 85
Chi-Square Tests
Value df
Asymp. Sig. (2- 
sided)
McNemar-Bowker Test .(a)
N of Valid Cases 85
a Computed only for a PxP table, where P must be greater than 1.
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As can be seen from the frequency tables above, (and perhaps as to be expected 
given the practical application using PCT in the study), the difference between the 
two sets of answers is statistically significant. In the first questionnaire, 100 nurses 
(56.5%) of nurses had heard of PCT and in the second 81 nurses (95.3%).
7.14 Knowledge of using the PCT-Q
Question 11 asked nurses if they knew how to use the PCT-Q test and, as is 
illustrated below, only 11 nurses before the study knew how to use the PCT-Q.
Table 7.22: How to use the PCT-Q
Questionnaire 1 Questionnaire 2
Variable Frequency % Valid % Cumula­
tive %
Variable Frequency % Valid % Cumula­
tive %
No 165 93.2 93.2 93.2 No 35 41.2 41.2 41.2
Yes 11 6.2 6.2 99.4 Yes 48 56.5 56.5 97.6
Not sure 1 0.6 0.6 100.0 Not sure 1 1.2 1.2 98.8
Total 177 100.
0
100.0 Total 85 100.0 100.0
Table 7.23: Crosstabulation
Pre-Do you know how to use the PCT-Q * Post-Do you know how to use the PCT-Q 
Crosstabulation
Post: Do you know how to use the PCT-Q Total
no Yes not sure forgotten No
Pre: Do you know how 
to use the PCT-Q
no
32 47 1 0 80
yes 3 1 0 1 5
Total 35 48 1 1 85
Chi-Square Tests
Value df
Asymp: Sig. (2- 
sided)
McNemar-Bowker Test .(a)
N of Valid Cases 85
a Computed only for a PxP table, where P must be greater than 1.
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As can be seen from the frequency tables above, there is a statistically significant 
difference with 165 nurses (93.2%) of nurses in the first questionnaire not knowing 
how to use the PCT-Q and 35 (41.2%) in the second sample.
7.15 Contacting healthcare professionals
The final section of the questionnaire concentrated on the care of the patient once 
sepsis has been diagnosed. Question 12 asked the nurses to list which healthcare 
professionals (HCP) they would contact if one of their patients was developing 
sepsis. As can be seen from the frequency tables below, the major differences are:
1. Contacting the CCU outreach team, with 106 nurses (59.9%) contacting them 
in the first questionnaire and 64 (75.3%) in the second;
2. Contacting the medical team, with 102 nurses (57.6%) contacting them in the 
first questionnaire and 81 nurses (95.3%) in the second; and
3. In the first questionnaire eight nurses (4.5%) would contact the CCU and in 
the second sample 13 nurses (15.3%).
Table 7.24: How many HCPs contacted
Pre: How many contacted? If one of your patients was developing the early signs of sepsis 
who would you contact? * Post: How many contacted? If one of your patients was 
developing the early signs of sepsis who would you contact? Crosstabulation
Post: How many contacted? If one of your patients was 
developing the early signs of sepsis who would you contact? Total
1 2 3 4 5 6 1
Pre: How many 
contacted? If one of 
your patients was 
developing the early 
signs of sepsis who 
would you contact?
1
0 4 4 3 1 1 13
2 3 13 11 6 2 0 35
3 0 12 7 3 4 0 26
4 0 3 2 0 0 0 5
5 0 2 1 1 0 0 4
Total 3 34 25 13 7 1 83
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Chi-Square Tests
Value df
Asymp. Sig. (2- 
sided)
McNemar-Bowker Test 13.186 11 .281
N of Valid Cases 83
Post-intervention change in number of people 
contacted if patient showing early signs Frequency Percent
Fewer than pre-intervention 24 28.9%
Same as pre-intervention 20 24.1%
More than pre-intervention 39 47.0%
Total 83 100.0%
Table 7.25: Which HCPs would you contact if your patient was developing 
sepsis?
Questionnaire 1 Questionnaire 2
No Member of 
staff
Numbers 
of nurses 
who cited 
this group
% of 
nurses 
who cited 
this group
1. CCU outreach 
nurse
64 75.3%
2. Medical team 81 95.3%
3. Nurse in 
charge
44 51.8%
4. Senior house 
officer (SHO)
27 31.8%
5. Oncology
specialist
registrar
18 21.2%
6. Anaesthetist 13 15.3%
7. Critical Care 
Unit
13 15.3%
No Member of 
staff
Numbers 
of nurses 
who cited 
this group
% of 
nurses 
who cited 
this group
1 CCU outreach 
nurse
106 59.9%
2. Medical team 102 57.6%
3 Nurse in 
charge
91 51.4%
4 Senior house 
officer (SHO)
84 47.5%
5 Oncology
specialist
registrar
39 22%
6 Anaesthetist 24 13.6%
7 Critical Care 
Unit
8 4.5%
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7.16 Experience of nursing patients with severe sepsis
Question 13 asked nurses whether they had nursed a patient who had developed 
severe sepsis. A majority of nurses (145 or 81.9%) answered positively, 23 (13%) 
had not nursed a patient with sepsis and 8 (4.5%) were not sure. In the second 
sample the answers were very similar, with 71 nurses answering positively (83.5%), 
11 (12.9%) had not and 3 nurses (3.5%) were not sure. There was no significant 
change between the pre- and post-intervention answers.
Table 7.26: Have you nursed a patient who has developed severe sepsis? 
Questionnaire 1 Questionnaire 2
Variable Frequency % Valid
%
Cumul­
ative %
Yes 145 81.9 81.9 81.9
No 23 13.0 13.0 94.9
Not sure 8 4.5 4.5 99.4
Missing 1 .6 .6 100.0
Total 177 100.
0
Variable Frequenc
y
% Valid
%
Cumul­
ative %
Yes 71 83.5 83.5 83.5
No 11 12.9 12.9 96.5
Not sure 3 3.5 3.5 100.0
Missing
Total 85 100.
0
100.0
Table 7.27: Crosstabulation
Pre: Have you nursed a person with cancer who has developed severe sepsis? * Post: Have 
you nursed a person with cancer who has developed severe sepsis? Crosstabulation
Post: Have you nursed a person with 
cancer who has developed severe 
sepsis?
Totalyes No NOT SURE
Pre: Have you nursed 
a person with cancer 
who has developed 
severe sepsis?
yes Count 62 9 3 74
% of Total 72.9% 10.6% 3.5% 87.1%
no Count 5 1 0 6
% of Total 5.9% 1.2% .0% 7.1%
NOT SURE Count 4 1 0 5
% of Total 4.7% 1.2% .0% 5.9%
Total Count 71 11 3 85
% of Total 83.5% 12.9% 3.5% 100.0%
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Chi-Square Tests
Value df
Asymp. Sig. 
(2-sided)
McNemar-Bowker Test 2.286 3 .515
N of Valid Cases 85
7.17 Problems convincing others
Finally, question 14 asked the nurses whether they had ever experienced a time when 
they thought that a patient was deteriorating but had had problems convincing 
others. As is illustrated clearly with the frequency tables below, the nurses were very 
closely divided with 83 (46.9%) of nurses having had difficulty convincing others 
and 91 nurses (51.4%) who had not. Three nurses did not answer this question.
Table 7.28: Have you had a time when a patient was deteriorating but you 
found it difficult to convince others?
Questionnaire 1 Questionnaire 2
Variable Frequency % Valid
%
Cumul - 
ative %
Variable Frequency % Valid
%
Cumul - 
ative %
Yes 83 46.9 46.9 46.9 Yes 55 64.
7
64.7 64.7
No 91 51.4 51.4 98.3 No 29 34.
1
34.1 98.8
Missing 3 1.7 1.7 100.0 Missing 1 1.2 1.2 100.0
Total 177 100.0 100.0 Total 85 10
0.0
100.0
Table 7.29: Crosstabulation
Pre: Have you ever had the experience of thinking that a patient was deteriorating but 
finding it difficult to convince other nurses/doctor or other HCPs? * Post: Have you ever 
had the experience of thinking that a patient was deteriorating but finding it difficult to 
convince other nurses/doctor or other HCPs? Crosstabulation
Post: Have you ever had the experience of thinking 
that a patient was deteriorating but finding it difficult 
to convince other nurses/ doctor or other HCPs? Total
yes no not sure Yes
Pre: Have you ever had yes 31 15 0 46
178 of 355
the experience of 
thinking that a patient 
was deteriorating but 
finding it difficult to 
convince other nurses/ 
doctor or other HCPs?
no 22 14 1 37
Total 52 29 1 85
Chi-Square Tests
Value df
Asymp. Sig. 
(2-sided)
McNemar-Bowker Test 2.324 2 .313
N of Valid Cases 83
Although there was a higher percentage of nurses in the second questionnaire that 
answered yes (64.7 % as compared to 46.9%), the change between pre- and post­
intervention answers was not statistically significant.
7.18 Conclusion
The questionnaire survey achieved the aims reflected in the secondary research 
objectives to the extent that the researcher did reach nurses across the trust on all 
wards and on all shifts and therefore improved the awareness of sepsis and the PCT- 
Q. The PCT-Q was used 416 times in 320 patients and there is evidence therefore 
that nurses were alert to the possibility of sepsis, although there was no historical 
data for comparison. The educational intervention and questionnaire survey were 
also designed to measure improvement in knowledge and this was achieved in some 
areas. There were five answers demonstrating an improvement that is statistically 
significant between pre- and post-intervention questionnaires:
1. The mortality rate for severe sepsis in previously healthy adults;
2. The mortality rate for severe sepsis in patients with cancer;
3. The nurse’s knowledge of PCT and CRP;
4. How to use the PCT-Q;
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5. Which HCPs would you contact if your patient was developing sepsis?
There were four areas where an improvement was demonstrated but did not reach 
statistical significance:
1. List the different stages of the sepsis syndrome;
2. Tachypnoea as an early sign of sepsis;
3. List three indicators of sepsis;
4. A time when a patient was deteriorating but difficult to convince others.
There were three questions that were used to gain demographic detail about the 
sample and are therefore not useful in comparing knowledge acquisition. The 
demographic data did illustrate that there was no significant difference between the 
two samples. Therefore the total number of questions that could be used to test 
knowledge on the sepsis syndrome is 14 -  3 = 11.
Across the trust, 177 nurses received a dedicated teaching session on sepsis that was 
based on the latest evidence. Ten of these sessions were provided to nurses who 
mainly work at night and had received less formal education. The sessions also gave 
many nurses the opportunity to informally discuss problems and their 
recommendations for practice, which have since been implemented across the trust 
(see chapter nine, section 9.22).
The researcher is aware, however, that providing a teaching session may not mean an 
increase in knowledge or practice improvement. The questionnaires were used as a 
device to allow individual nurses to compare their own learning over time and for 
the researcher to compare anonymised knowledge acquisition.
Looking at the 11 questions that could be used to test knowledge acquisition, nine 
showed an improvement with five reaching statistical significance. Finally, 177 
nurses were introduced to the PCT-Q and taught how to use it in readiness for the 
patient part of the study
There was also a demonstrable improvement in knowledge after eight months. The 
limitations, however, are that there were four questions in the second questionnaire 
that showed only small improvement and there was only a 58.6% return of that
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questionnaire, despite a reminder letter. Finally, the questionnaires only assessed one 
dimension of knowledge acquisition and may not correlate with an improvement in
practice.
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Chapter 8 Findings (3): patient data and use 
of the PCT-Q to assess early sepsis
8.1 Introduction
This chapter provides the findings of using the PCT-Q in patients who were thought 
to be developing sepsis. This patient part of the study links to the theoretical 
framework and aims by exploring the nurses’ ability to assess deterioration due to 
sepsis and intuit subtle change, even in the absence of overt clinical signs. Croce’s 
model of intuition is used to explain the way nurses’ are affected by a change in the 
patient, and then go on to analyse and communicate the change to others. To aid in 
this assessment an objective test was introduced the PCT-Q. In this chapter further 
findings are provided about the ability of nurses to use an objective test and its effect 
on mobilising the multi-professional team to improve early rescue. This study was 
not designed to test the validity and reliability of the PCT-Q, (previously 
comprehensively demonstrated as described in chapter two), but as the PCT-Q has 
not previously been used by ward and CCU nurses its reliability in their hands was 
compared with the markers currently used in the hospital. Finally because the patient 
data on episode and hospital outcome was collected data in the study year was to be 
compared to the three previous years.
As described in chapter three, the sepsis cascade has been defined as having four 
stages from the earliest SIRS with subtle or no obvious change, to sepsis, the next 
stage where there may be few signs and other causes of an acute inflammatory event 
are excluded, through to severe sepsis and septic shock and the last stage of Multi- 
Organ Dysfunction Syndrome (MODS) when the patient is critically ill requiring all 
support. The aim of this study was to diagnose a greater proportion of people with 
cancer at the early stages: SIRS or sepsis.
As described in chapter five any patients who a nurse felt were deteriorating and 
exhibiting signs of SIRS or sepsis were asked for consent to take blood to measure 
their PCT-Q and use their data in the research study. Over the study period, 
approximately 12 months, a total of 320 patients were recruited. There were however
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416 sepsis episodes, as several patients had more than one episode. To be included 
as a separate sepsis episode the patient had to have recovered from the first, and the 
two events needed to be separated by at least seven days. Patient characteristics are 
shown in the frequency tables below:
Table 8.1: Gender of patients recruited into the study
Gender Frequency Percent
Male 176 55.0%
Female 144 45.0%
Total 320 100.0%
Table 8.2: Gender of patients in whole data set including repeat episodes
Gender Frequency Percent
Male 233 56.0%
Female 183 43.9%
Total 416 100.0%
Table 8.3: Distribution of patient population by age
Histogram
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C0)
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age (continuous)
Mean =54.5831 
Std. Dev. =15. 
36245
As can be seen from the table above, the mean age o f  the patients recruited into the 
study was 54.6 years.
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Table 8.4: Distribution of patient population by type of cancer
Category Diagnosis Frequency Percent
Haemato-oncology Acute Leukaemia 88 21.2
Lymphoma 78 42.8
Myeloma 47 11.3
Chronic Leukaemia 9 2.2
Myelofibrosis/myeloproliferative
disorder
3 0.7
Gastro-intestinal Upper GI 45 10.8
Lower GI 15 3.6
Carcinoid 1 0.2
Solid Tumours Urology 26 6.3
Breast 25 6.0
Gynaecology 21 5.0
Head & Neck 15 3.6
Sarcoma 12 2.9
Neuro-oncology 7 1.7
Multiple primary 7 1.7
Thyroid 2 0.5
Melanoma 1 0.2
Unknown primary Unknown 2 0.5
Total 416 100%
As expected, the highest proportion of patients recruited into the study was those 
with the greatest risk of sepsis: patients with haematological cancer. Leukaemia 
represents the largest group (96 patients or 23.4%); lymphoma 78 patients (18.8%); 
and myeloma 47 patients (11.3%). The haematological cancers therefore represent 
222 patients (n=320) or 53.5% of the whole sample. Of the patients with solid 
tumours, the largest proportion in the sample are those patients with upper 
gastrointestinal cancer (upper GI) at 45 patients (10.8%). Patients with upper GI 
cancer tend to be older and to have co morbid conditions such as ischaemic heart 
disease, chronic pulmonary disease and diabetes, and are at greater risk of 
developing sepsis.
184 of 355
Table 8.5: Distribution of patient population by cancer treatment
Cancer Treatment Frequency Percent
Chemotherapy 186 44.7
Allogeneic transplant 46 11.8
Autologous transplant 44 10.6
Surgery 89 21.4
Chemo/radiotherapy 7 1.7
Chemo/surgery 5 1.2
Chemo/radio/surgery 5 1.2
Endocrine therapy 3 0.7
Interferon therapy 1 0.2
Nil for last 3 months 23 5.5
Total 416 100.0
As described in chapter three, several factors predispose patients to developing 
sepsis. Some are patient characteristics such as age, cancer diagnosis and the 
presence or absence of comorbid conditions. There are also treatment-related factors, 
and in table 8.5 above it is clear that the largest group of associated treatment is 
chemotherapy, with 186 patients (n=320) or 44.7% having received chemotherapy. 
Perhaps surprisingly, patients having surgery and those who have had a blood or 
marrow transplant have a similar incidence to those who had surgery (89 patients or 
21.4%) and those who had a transplant (90 patients). This may be explained by the 
fact that many of the patients who have had surgery are from the upper GI group 
who are older, have co morbid conditions and receive chemotherapy prior to surgery.
8.2 Stage of the sepsis syndrome at diagnosis
Data from the 420 sepsis episodes was explored firstly for the stage of the sepsis 
syndrome at which the patient was referred and assessed. Table 8.6 and figure 8.1 
illustrate the stage of the sepsis syndrome at diagnosis.
Table 8.6: The stage of the sepsis syndrome at diagnosis
Sepsis Criteria Frequency Percent
PCT-Q not appropriate 11 2.6
SIRS 163 39.2
Sepsis 112 26.9
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Septic Shock 23 5.5
Multi-organ Dysfunction syndrome (MODS) 22 5.3
total 413 99.3
missing 3 0.7
Total 416 100.0
Figure 8.1: The stage of the sepsis syndrome at diagnosis
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The frequency table and bar chart above illustrate that most patients in the study 
were identified at the earliest two stages o f  the syndrom e, with 163 patients (n=420) 
or 39.2% satisfying the SIRS criteria and 112 patients (26.9%) identified at the 
sepsis stage. There is no physical difference between SIRS and sepsis; the definition 
sepsis is used when everything that may have caused the change in the patient’s 
condition (for example bleeding or pancreatitis) has been eliminated and the 
deterioration is thought to be due to infection. Therefore, accum ulatively, 66.1%  o f 
the patient episodes were identified at an early stage before the severe sepsis and 
m ulti-organ stages. For clarity o f  illustration, all further data was therefore 
reclassified into early or late sepsis: “early” including SIRS and sepsis and “ late” 
including severe sepsis, septic shock and M ODS. Table 8.7 uses crosstabulation to 
examine the possible relationship between early and late diagnosis and the stage o f 
sepsis at diagnosis.
PCT-Q not Severe Sepsis Septic Shock Multi-O rgan
Dysfunction
Syndrome
S e p s is  Criteria
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Table 8.7: Sepsis Endpoint Early Sepsis Crosstabulation
EarlySepsis Total
No Yes
Sepsis Endpoint SIRS 0 167 167
Sepsis 0 108 108
Severe Sepsis 126 0 126
Total 126 275 401
% within Sepsis Endpoint 31.4% 68.6% 100.0%
95% confidence interval for 
percentage
(63.8%, 73.1%)
Table 8.8 provides information on the immediate interventions needed by patients 
during the sepsis episode lasting 12-72 hours. As illustrated, only 9.6% (40, n=416) 
of patients required no further acute care intervention, although a further six patients 
(1.4%) were able to be discharged from the CCU or Step Up unit, and nine patients 
were discharged from outreach. The highest percentage of patients needed further 
interventions with 180 patients (43.7%) requiring ongoing review by the CCOT. 
There were 56 patients (13.4%) identified as needing an intervention or escalation in 
their care; they were transferred from the rehabilitation unit to the ward (one 
patient), to theatre (one patient), from the ward to the Step Up or CCU (54 patients). 
There were 115 patients (27.6%) identified as still needing to remain in the CCU or 
Step Up Unit.
8.3 Outcome of the sepsis episode
Table 8.8: Outcome of sepsis episode
Intervention Frequency Percent
Observe and monitor 40 9.6
Outreach team review 180 43.3
Remaining in CCU/Step Up 115 27.6
Admission to Step Up/CCU 41 9.9
Transfer from Step Up to CCU 13 3.1
Discharged from Outreach 9 2.2
Discharged from Step Up/CCU 6 1.4
Care goals reviewed not for acute care 5 1.2
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To theatre for drainage of septic collection 1 0.2
Transfer to ward from Rehabilitation Unit 1 0.2
Withdrawal o f treatment 1 0.2
Missing 3 0.7
Total 416 100.0
Table 8.9: Hospital outcome for all patients recruited to the study
Outcome of hospital stay Frequency Percent
Survived to leave hospital 297 71.4
Died in CCU (18 severe sepsis) 44 10.6
Died in hospital ward -  cancer 32 7.7
Died in hospital ward -  acute (14 non sepsis, 1 severe sepsis) illness 15 3.6
Died in CCU -  cancer 12 2.9
Died in Step Up -  critical illness (1 severe sepsis) 9 2.0
Died in another hospital 4 0.9
Discharged to another hospital/hospice 4 0.9
Total 416 100.0
As can be seen from table 8.9, a majority of patients survived to leave hospital (297 
or 71.4%). There were four patients discharged to another hospital and one to a 
hospice (0.18%). Of the 115 patients (27.6%) who died, 47 died directly as a result 
of their disease (11.3%) and 68 (16.3%) as the result of a critical illness. Another 20 
(4.8%) deaths were due to sepsis: most on the CCU (18), one on a general ward and 
one on the Step Up Unit.
8.4 Physiological parameters as an assessment of sepsis
The next data to be analysed were the alterations to the patient’s physiological 
parameters as a result of sepsis. In the analysis of the questionnaires the nurses cited 
a high temperature as one of the most important indications of sepsis. The sepsis 
literature, however, and particularly the definitions of SIRS and sepsis, indicates that 
there may be a high or low temperature. In table 8.10 the temperature findings of the 
patients are correlated with the stage of the sepsis syndrome. Patients were 
categorised into low (<36), normal (36 to <38) and high (>=38) temperature groups
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and a chi-squared test was used to explore the link between tem perature and sepsis 
stage. As can be seen from the results, there is no statistically significant correlation 
between sepsis and temperature.
Figure 8.2: Temperature frequencies
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Table 8.10: Correlation of temperature with SIRS/Sepsis
E a rly  S ep s is T o ta l
L ate
d ia g n o sis
E arly
d ia g n o sis L ate  d ia g n o sis
T e m p  C o n tin u o u s Low Count 2 5 7
% within EarlySepsis 1.6% 1.8% 1.8%
Normal Count 24 52 76
% within EarlySepsis 19.2% 19.1% 19.1%
High Count 99 211 311
% within EarlySepsis 72.6% 78.7% 78.9%
Total Count 125 268 393
% within EarlySepsis 100.0% 100.0% 100.0%
p-value from Chi-squared test=0.981
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Table 8.11: Correlation of MAP with SIRS/Sepsis
Early Sepsis Total
Late
diagnosis
Early
diagnosis Late diagnosis
Map Continuous Low Count 76 104 180
% within EarlySepsis 60.8% 38.7% 45.7%
High Count 49 165 214
% within EarlySepsis 39.2% 61.3% 54.3%
Total Count 125 269 394
% within EarlySepsis 100.0% 100.0% 100.0%
PO.OOl (chi-squared)
The mean arterial pressure (MAP) was then correlated with the stage of the sepsis 
syndrome. MAP was grouped into low/high/normal and a Chi-squared test used to 
check for relationship with sepsis stage at diagnosis (see table 8.11). A low MAP has 
a statistically significant correlation (pO.OOl) with the late stages of sepsis. This is 
to be expected, as a characteristic of increasing sepsis is the release of anaphyltoxins 
such as Bradykinin, which have a profound vasodilation effect and rapidly lower the 
blood pressure.
8.5 Ordinal regression analysis of the blood predictors of 
sepsis and MAP
The main aim of this study was to improve the early detection of patients who were 
deteriorating from sepsis. As explained in the methods chapter in the hospital, before 
this study, CRP and WBC were the most commonly used indicators, with the critical 
care team also using lactate measurements. Procalcitonin (PCT) had not previously 
been used and neither had the PCT-Q -  the bedside test. It was essential therefore to 
be able to compare the blood tests and their reliability and specificity at predicting 
sepsis. The aim was to confirm that, in cancer patients, the results of diagnostic tests 
including PCT-Q were a useful predictor of sepsis stage at diagnosis. The first 
indicator to be assessed was the Mean Arterial Pressure (MAP), which was included 
as a categorical predictive variable with values of low (<70) and high (>70).
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Table 8.12: Crosstabulation of MAP by sepsis stage
Sepsis Endpoint Total
SIRS (1) Sepsis (2) Severe Sepsis (3)
MAP Low <=70 (N) 53 51 76 180
(% of MAP 
low) 29% 28% 42%
High >70 (N) 110 55 49 214
(% of MAP 
high) 51% 26% 23%
All
episodes
(N)
163 106 125 394
(% of all 
episodes) 41% 27% 32%
Model fitting 
information
-2 Log 
Likelihood Change in -2 Log likelihood df Sig.
Null model 45.091
MAP model 21.660 23.431 1 .000
Parameter estimates Category Odds ratio Sig- 95% confidence interval
MAP Low 2.50 <0.001 1.72 3.64
High 1
The hypothesis being tested here was that the null model is as good at predicting 
sepsis stage as the model using MAP. This highly significant result (p=0.000) shows 
that MAP is a good predictor of sepsis stage. The null model is one where no 
predictive variables are used, so all episodes are assumed to carry the same risk for 
sepsis stage. The quoted odds ratio is for the relative odds of and increase in sepsis 
stage by one category for low versus high MAP. This model assumes that the odds 
ratio is the same for SIRS: sepsis/severe sepsis as it is for SIRS/sepsis: severe sepsis. 
That is, that the risk increase is the same for each step of sepsis severity. The model 
fitting process showed that MAP was a significant predictor of sepsis stage, with low 
MAP associated with an increased risk of later-stage sepsis (OR 2.5) compared to 
high MAP.
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The next indicator to be assessed was the white blood cells (WBC). The WBC data 
was grouped into low (<4), normal (4.1 -  11.9) and high (>12).
Table 8.13: Crosstabulation of WBC by sepsis stage
Sepsis Endpoint Total
SIRS Sepsis
Severe
Sepsis
WBC Low N 46 83 83 212
% of WBC low 22% 39% 39%
Normal N 65 12 15 92
% of WBC normal 71% 13% 16%
High N 55 13 28 96
% of WBC high 57% 14% 29%
Total N 166 108 126 400
% of total 42% 27% 32%
Model Fitting 
Information
-2 Log 
Likelihood Chi-Square df Sig.
Null model 111.87
WBC model 53.51 58.36 2 0.000
Parameter
estimates Category Odds ratio Sig. 95% confidence interval
WBC Low 5.98 0.000 3.59 9.97
Normal 1
High 2.03 0.016 1.14 3.63
WBC was a significant predictor of sepsis stage, with both low and high WBC 
carrying an increased risk of late-stage sepsis. The risk was greatest in patients with 
low WBC (OR 5.98).
The next predictor to be assessed was lactate, which was divided by the median 
value of 1.4 into low (< 1.4) and high (>1.4):
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Table 8.14: Crosstabulation of lactate by sepsis stage
Sepsis Endpoint Total
SIRS Sepsis
Severe
Sepsis
Lactate Low<1.4 N 87 45 54 186
% of low 47% 24% 29%
High>1.4 N 55 40 59 154
% of high 36% 26% 38%
Total N 142 85 113 340
% of all 42% 25% 33%
Model Fitting 
Information
-2 Log 
Likelihood Chi-Square df Sig.
Null model 25.91
Lactate model 21.18 4.73 1 0.030
Parameter
estimates Category Odds ratio Sig. 95% confidence interval
Lactate Low<=l .4 1
High>1.4 1.55 0.030 1.04 2.31
Lactate is also a statistically significant predictor of sepsis, with high lactate carrying 
a small but significant increase in risk of later stage sepsis (OR 1.5).
The lactate level significant for predicting severe sepsis in the literature is >4 
(Bakker and Jansen 2007, Trezeciak et al 2007, Robson and Daniels 2008). 
Therefore a further analysis was conducted, recategorising lactate values <4 or >4 
(with the highest value in the study being 7.5c 1).
Table 8.15: Crosstabulation of lactate using <4 or >4 values
Sepsis Endpoint Total
SIRS Sepsis
Severe
Sepsis
Lactate Low < 4 N 139 75 95 309
% of low 45% 24% 31%
High > 4 N 3 10 18 31
% of high 10% 32% 58%
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Total N 142 85 113 3 4 0
% o f  all 42% 25% 33%
Model Fitting 
Information
-2 Log 
Likelihood Chi-Square df Sig.
Null model 36.18
Lactate model 21.71 14.47 1 0.000
Parameter estimates Category Odds ratio Sig.
95% confidence 
interval
Lactate Low < 4 1
High > 4 3.75 0.000 1.79 7.84
A high lactate >4 was seen to be a statistically significant indicator (p=0.000) of 
sepsis.
CRP was classified according to the median as low (<168) or high (>168).
Table 8.16: Crosstabulation of CRP by sepsis stage
Sepsis Endpoint Total
SIRS Sepsis Severe Sepsis
CRP Low N 69 47 44 160
% of low 43% 29% 28%
High N 62 49 56 167
% of high 37% 29% 34%
Total N 131 96 100 327
% of all 40% 29% 31%
Model Fitting 
Information
-2 Log 
Likelihood Chi-Square df Sig.
Null model 22.80
CRP 21.11 1.68 1 0.194
Parameter Odds
estimates Category ratio Sig. 95% confidence interval
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CRP L ow 1
H igh 1.30 0 .1 9 5 0 .8 7 1.95
Although high CRP was apparently associated with later stage sepsis (OR 1.3) the 
link was not significant (p=0.2)
PCT was classified as either positive or negative.
Table 8.17: Crosstabulation of PCT by sepsis stage
Sepsis Endpoint Total
SIRS Sepsis
Severe
Sepsis
PCT Positive N 77 59 89 225
% of positive 34% 26% 40%
Negative N 90 49 37 176
% of negative 51% 28% 21%
Total 167 108 126 401
42% 27% 31%
Model Fitting 
Information
-2 Log 
Likelihood Chi-Square df Sig.
Null model 39.75
PCT 22.64 17.11 1 0.000
Parameter
estimates Category Odds ratio Sig. 95% confidence interval
PCT Positive 2.18 0.000 1.50 3.16
Negative 1
PCT is significantly correlated with sepsis, with a positive PCT reading giving a two 
times greater odds of developing later stage sepsis.
Of the five indicators, CRP is the only one that does not reach statistical 
significance. Of the other four, the one indicating the highest risk is a low WBC, at 
six times the risk, then low MAP, positive PCT and high WBC all carry a similar
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level of risk with odds ratios of 2.5, 2.2 and 2.0 respectively, and finally the lowest 
risk increase is given by high lactate with an odds ratio of 1.5.
To compare the four indicators with each other statistically, a multivariate ordinal 
regression analysis was then performed, as shown below in tables 8.18 and 8.19. 
Backwards model selection was used, with initially all four variables being included 
in the model, and a reduced model with one variable omitted in turn evaluated in 
comparison to the full model.
Table 8.18: Model fitting information
Model Fitting Information
-2 Log 
Likelihood
Chi-
Square df Sig.
MAP, PCT, Lactate and WBC (Full model) 132.52
MAP, Lactate, WBC (PCT omitted) 96.06 36.46 1 <0.001
WBC, MAP, PCT (Lactate omitted) 109.95 22.57 1 <0.001
Lactate, PCT, MAP (WBC omitted) 60.31 72.22 2 <0.001
Lactate, PCT, WBC (MAP omitted) 91.91 40.62 1 <0.001
All four terms remained significant, as the removal of any one term resulted in a 
significant decrease in model fit.
Table 8.19: Multivariate Model
Parameter Estimates Odds ratio Sig. 95% Confidence Interval
PCT Positive 1.84 0.007 1.186 2.864
Negative 1
Lactate Low<=4 1
High>4 2.97 0.006 1.356 6.493
WBC Low 5.39 0.000 3.050 9.528
Normal 1
High 1.80 0.066 0.962 3.378
MAP Low 2.17 0.000 1.406 3.358
High 1
Parameter estimates from the multivariate model remained comparable to those 
obtained from univariate regression, with the exception of high WBC for which the 
odds ratio, although of similar magnitude (1.8 compared to 2.0 from univariate 
regression), was no longer significant compared to normal WBC.
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8.6 Conclusion
The aims of the PCT-Q arm of the study were to assess if the PCT-Q was used 
appropriately and whether its use meant that sepsis was diagnosed at an early stage. 
The findings demonstrate that the nurses were using the PCT-Q appropriately the 
majority of the time (398, n=416). The performance of the PCT-Q was also assessed 
against the markers previously used in the host hospital. Finally patient outcome data 
was compared from the study year with three previous years. Analysis of the patient 
data revealed that 66% patients were identified at an early stage of their sepsis. The 
patients at the greatest risk of sepsis were those with a diagnosis of haematological 
cancer. The greatest proportion of patients (71.3%) were overseen by the CCU 
outreach team and survived to leave hospital. Of those who were admitted to the 
CCU or Step Up, 65 patients died of their critical illness. A further 20 patients died 
of severe sepsis 18 on CCU, one on Step Up and one on the ward. Of the 
physiological parameters that correlated most significantly with the development of 
sepsis, the MAP was most significantly correlated. Of the blood indicators of sepsis, 
CRP, previously the most commonly used indicator by general ward teams, was the 
least specific and reliable. Conversely, a low WBC, a high lactate and a high PCT all 
reached statistical significance when correlated with sepsis. Unexpectedly in one 
case the PCT-Q was requested by a patient. This young patient had been diagnosed 
with sepsis twice with the PCT-Q and suffered severe sepsis requiring mechanical 
ventilation and haemofiltration. Having recovered from both of these episodes and 
back on the ward she again felt ill and requested the PCT-Q. Her procalcitonin level 
was very low and her MEWS score was low, she visibly relaxed and went on to be 
discharged from hospital two weeks later.
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Chapter 9 Discussion
9.1 Introduction
In this chapter the findings from the three data sets are discussed. They are presented 
in the same order as the research was undertaken and the findings are related to the 
theoretical framework that informed the whole study. The qualitative data from both 
sets of interviews and the questionnaire, the quantitative data from the questionnaire, 
and the PCT-Q data are discussed in that order. The data are discussed as they relate 
to the overall aims of the study, the literature and to clinical practice. As discussed in 
chapter five data integration in a multiple methods study can be regarded as 
problematic. In this study however the only data to be combined are the qualitative 
findings from the two interviews and the questionnaires (chapter six, section 6.7 and 
6 .8).
9.2 The interview and questionnaire qualitative data
The aims of the qualitative part of the research were twofold. First, to gain an 
understanding of the experiences of ward and CCU nurses as they care for and 
recognise the cancer patient developing early sepsis and, secondly, to understand 
their experiences in mobilising the multidisciplinary team. The only other published 
research relating to the former is a study investigating the experience of nurses 
caring for newborns with sepsis (Rubarth 2003). Research studies directly relating to 
the second aim are also limited, the most important being Cioffi’s (2000) study 
looking at 32 nurses’ experience of calling the Medical Emergency Team (MET) in 
Australia (2000,a,b). A small number of studies investigating critical care outreach 
are also relevant (Ryan et al 2004, McBride et al 2005, Jones et al 2006).
The data from the two sets of interviews and the free text from the questionnaires 
were initially analysed separately (see chapters six and seven), but there were clear 
themes that were common to all three data sets. Some of these themes have been
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discussed in chapter six, but the major overarching themes that ran throughout the 
qualitative data were:
1. Knowing the patient: the importance of nursing continuity
2. Making a diagnosis of sepsis
3. Contacting others to help
4. Asking the patient
5. Being aware of (the risk of) sepsis
6. Nurses learning
7. Reflecting on failure
8. Improving practice.
9.3 Key themes for practice
The themes identified during this study are key enablers for nurses to use with 
confidence, to believe in their assessments and effectively manage care.
9.3.1 Knowing the patient: the importance of nursing continuity
One of the key themes to come out of the qualitative data was the importance of the 
nurse being able to distinguish early changes in the patient as they began to 
deteriorate. In many instances they attributed this ability to the fact that they knew 
the patient well. They had got to know the patient as a person and therefore noticed 
quickly when the person had changed their behaviour, demeanour or appearance. 
Patients most at risk from sepsis, for example those with haematological cancer or 
those with solid tumours who have received multimodality treatment, will have been 
in hospital for weeks or returned several times for successive cycles of treatment. 
The nurses gave several examples of patients’ behaviour changing. For example:
“...it might just be a change in the person one of our patients, you will 
remember him (name) he went to CCU, he used to always come out of his 
room and give us chocolates, and the first sign that he wasn’t well was that 
he didn’t try to come out of his room”. (TS.02)
These changes in behaviour lead the nurse to take action, such as a closer 
examination of the patient. Observation is thus linked to critical thinking and action.
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In acute care it could be argued that this is one of the most important qualities or 
skills for a nurse to develop. For patients who are at risk of developing a life- 
threatening infection or a haemorrhage it is important that the nurse, who is the 
healthcare professional most often with the patient, notices any small changes in 
their demeanour, behaviour or appearance. It is often the nurse who will start and 
coordinate the whole process of rescue. Eventually changes in the patient developing 
sepsis will become obvious, but the imperative is to discover patients earlier and get 
help mobilised effectively. The evidence described in chapter three shows that, the 
earlier the person with sepsis is treated, the greater their chance of survival. 
Recognition of subtle changes in the person that herald deterioration is an essential 
part of nursing care.
9.3.2 Knowing the patient: the literature
Knowing patients as individuals and knowing how they usually behave is an 
important part of the nurse-patient relationship. For this skill and knowledge to be 
embedded in clinical practice the nurse needs to recognise the need to get to “know” 
the patient as a person, and the organisation needs to promote continuity of nursing. 
Liaschenko and colleagues (1999) describe getting to know the patient as a person as 
essential knowledge that nurses bring to the clinical arena:
“Person knowledge is a potent reminder that the life being lived is the life of the 
recipient of care”. (Liaschenko et al 1999, p. 39).
An important aspect of the data provided by the nurses in the study is the 
individuality of behavioural change, so that the nurse is not saying that all 
patients who go quiet or exhibit a particular type of behaviour are in danger; 
rather they are reflecting on the individual change in a particular patient.
Getting to know a patient in this way requires that the nurse actively and 
consciously develops a therapeutic relationship with the patient.
For Morse and colleagues (2006), for the relationship to be therapeutic the key 
characteristic is:
“the engagement, the identification of the nurse with the patient”. (Morse et al 2006, 
p. 85). They propose a model for nurse-patient engagement that is linked with
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nursing actions; they acknowledge that engagement in “first level responses” with 
the patient requires more energy but assert that this is more rewarding for both 
patient and nurse. To have an insight into how an individual person is experiencing 
their cancer and interpreting their illness, nurses need to recognise that this 
experience is an individual and dynamic phenomenon (O’Connor et al 1995). 
Nightingale (1859) in the chapter “Observation of the sick” in her Notes on Nursing 
directs nurses to appreciate the difference between individual patients:
“Again the nurse must distinguish between the idiosyncrasies of patients.
One likes to suffer out all his suffering alone, to be as little looked after as 
possible. Another likes to be perpetually made much of and pitied, and to 
have some one always by him. Both these peculiarities might be observed 
and indulged much more than they are”. (Nightingale 1859, p.25).
There are common themes that emerge in working with cancer patients or reading 
the lay literature, but it cannot be assumed that a particular patient will interpret their 
experience in a standard way. The way for a nurse to gain this understanding is to 
listen to how the person is interpreting his or her own experience. This means that 
the nurse must actively ask and then listen and learn from the patient. As nurses, we 
need to be aware that the expert on how it feels to have this diagnosis, to be 
undergoing treatment at this time, is the patient.
This finding of the importance of nurse expertise and continuity is an important 
factor in planning appropriate services for patients with a life-threatening condition. 
As was reflected upon by one of the outpatient nurses in this study, not knowing the 
patient makes change recognition more difficult. The retention of expert clinical 
nurses at the bedside is therefore a key contribution to safe and effective patient care.
9.4 Asking the patient (they always know if there is 
something wrong)
The next key theme, which links with getting to know the patient as a person, is the 
nurses' view that the patient always knows if there is something wrong. This may be 
particularly true when dealing with the “expert patient”, as many cancer patients
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receiving acute care become experienced in their care. Again, knowing the patient 
and being intelligently sensitive to their experience, their current emotional state and 
their needs is essential. Especially in acute care, the patient is often attuned to the 
subtle variations of their clinical condition. Cioffi (2000a), in her study looking at 
why nurses called the Medical Emergency Team (MET) in two hospitals in 
Australia, included patients’ recognition of their own deterioration as one of the four 
main reasons that nurses alerted the MET. The nurses interviewed in her study 
commented that the patients reported feeling “different” or “worse than a previous 
day” (Cioffi 2000a, p. 264). The nurses in Cioffi’s study also reported that patients 
sometimes voiced feeling a sense of doom or fear.
Paradoxically, there are also times when a cancer patient, either consciously or 
unwittingly, does not act upon their physical deterioration. Patients may stay at home 
without contacting the hospital when their symptoms such as oral toxicity or severe 
diarrhoea have reached life-threatening levels. In clinical practice talking to patients 
about these times, some did not want to trouble the hospital while others were 
desperate to avoid or delay more hospitalisation. Clinical care is seldom about 
absolutes but about finding a way to work through the muddle and complexity of 
practice while acknowledging the individuality of each patient, their family and each 
nurse in practice. Rolfe describes clinical practice as “a series of unique encounters, 
each of which is different from all others” (Rolfe 2006b, p. 39).
For many patients undergoing major cancer treatment, there has been a substantial 
threat to personal control and safety and they are therefore exquisitely aware of a 
deterioration or change and will often voice this change to the nurses at the bedside.
“The patients usually maybe the first one that actually indicates that 
there’s something wrong. They may not verbalise it, but initially they 
will probably, eventually say if you start to show concern, people 
might say: “Actually I don’t feel... I feel sick...”” (TS. 10)
This experienced clinical nurse indicated that it is not just a matter of 
respecting that the patient will know, but giving the patient time to vocalise 
how they are feeling. All nurses have probably been guilty on a busy clinical
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day of saying to patients or colleagues, “how are you feeling, are you okay?” 
and not listening or allowing time for a reply.
Nightingale has this advice for nurses when speaking to patients:
“Always sit down when a sick person is talking business to you, show no signs of 
hurry, give complete attention and full consideration if your advice is wanted, and go 
away the moment the subject is ended” (Nightingale 1859, p. 28).
The end of this statement by Nightingale is interesting and perhaps reflects changing 
attitudes to practice over the intervening years. Sometimes it is following a silence or 
a seeming end to an exchange that the researcher has experienced the patient starting 
to voice their fears.
9.5 Making a diagnosis of sepsis
All of the nurses interviewed (10) and 15 of those answering the free text question in 
the survey (n=85) included assessing the vital signs in their experience of working 
with the cancer patient developing sepsis. It is notable that more nurses (23) cited a 
raised temperature than any other sign. This is interesting because, although it is an 
important warning sign in infection it is of less use as a prediction of sepsis, as 
illustrated by the quantitative patient data analysis in this study.
Nurse interview 21 and 2 demonstrates that it is not only nurses who can erroneously 
rely on a change in temperature:
“The patient looked and felt unwell. He had an increasing tachycardia, 
respiratory rate and was hypotensive 90/50 but had a temperature of 36 
degrees Celsius and so the SHO didn’t think he was developing sepsis and 
did not want to start antibiotics”. (TS. 21)
“You know, spike and be septic at some point erm and the doctors said they 
would actually wait for her to spike a temperature before would start her on 
antibiotics, which at the time I thought... well from just knowing patients 
go... you know... how quickly they can become septic. I don’t know I just 
felt a bit frustrated, you know”. (TS.02)
203 of 355
It is encouraging that many nurses (19) also mentioned a drop in blood pressure, as 
this is an important sign of sepsis as illustrated by patient data from this study.
Finally, there were fewer nurses (11) who mentioned changes in respiratory rate as 
an important predictor of sepsis. This finding was reflected in the questionnaire 
findings and is a concern, as an increase in respiratory rate is a important indicator of 
rapid deterioration (Goldhill et al 1999, Subbe et al 2003). Chellel and colleagues 
confirmed many CCU outreach teams’ findings that the charting of physiological 
observations is poor and that respiratory rate recording is often missed (Chellel et al 
2002, DH 2003, Ryan et al 2004, McBride et al 2005).
9.6 Contacting others to help
The lack of effective communication between teams, anecdotally and reflected in the 
literature, is a barrier to treatment of patients as they deteriorate on the ward 
(Brennan et al 1991, McQuillan et al 1998, Goldhill et al 1999, Hillman et al 2001, 
Goldhill 2005, Hillman et al 2005, Tourangeau et al 2006). Nurses were therefore 
asked about their experience of convincing others and mobilising the 
multidisciplinary team. Five issues emerged in response to this question:
1. There were sometimes difficulties with convincing doctors to act quickly;
2. In this specialist cancer hospital there was the feeling among nurses that the 
doctors did listen and also learnt from experienced cancer nurses on the 
wards;
3. Senior clinical nurses did not always listen to the more junior nurse on the 
ward;
4. Nurses and doctors do not share the same language and this sometimes 
creates difficulties;
5. Ward nurses get around the difficulties in communication by using more 
senior or specialist nurses such as the Outreach or Patient at Risk Team 
(PART).
Thirty-five (n=85) nurses reflected on difficulties with convincing medical 
colleagues to act quickly.
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Several nurses reflected back to a time when they were more junior:
“When I was fairly newly qualified I looked after a patient on an admissions 
ward who became septic and went into DIC -  they subsequently died. I felt 
from early on that the patient deteriorating but could not quantify the... and 
I could not persuade the HO to review the patient. Neither he nor I realised 
the speed with which these patients deteriorate”. (Q.158)
“When difficult to convince doctor got PART nurses involved (team of 
experienced ITU nurses, that are around to support nursing team) of whom 
did ABGs and convince doctors that patient needed to be in a more suitable 
environment ITU”. (Q.27)
In many instances these nurses will be liaising with the most junior clinical doctor 
who, because of alterations to clinical training, may be less clinically prepared than 
previously (Goldhill 2005). There is also perhaps a characteristic among junior 
doctors to try to manage the patient themselves without recourse to other teams and 
specialists (Brennan et al 1991, McQuillan et al 1998, Goldhill et al 1999, Hillman 
et al 2001, Goldhill 2005).
“.. .and I think it’s probably the most frustrating thing, as a nurse, because 
you can’t... we’re so... medical doctors are veiy scientific. The way they 
deal with figures and they do, you know so they can... they can you 
know... they like facts and they like to act on those and that’s the way it 
should be. But I think that when we are with patients all the time I think you 
feel and see more than just... just the observations you are doing with 
regard to measurement and erm I think sometimes you do take... you go to 
the doctors and erm say so and so from an observation point of view but I’m 
really worried about them... and it is quite frustrating you almost have to 
wait for that patient to do something so you could then pull them...”
(TS.01)
In contrast to the literature and the questionnaire data, the majority of the nurses 
interviewed did not recall problems in collaboration with their clinical colleagues.
“I think here it goes better than it does in other hospitals, because I do think 
that the doctors take you seriously. I do because I think in general they... 
they value nurses’ opinions in the , because we tend to be more
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qualified... you know, in that specialty. It normally goes quite well and if I 
was seriously worried about that patient, then I would express that... erm 
quite urgently”. (TS. 07)
It is possible, however, that, because a majority of the nurses interviewed were fairly 
senior clinical nurses (average of seven years qualified) and had worked with cancer 
patients for an average of 3.8 years, they had devised a way in practice of ensuring 
effective communication. The nurses answering the questionnaire came from a much 
more diverse group, with 39 nurses having been qualified less than a year and their 
mean experience of working with cancer patients 2.3 years. The most junior nurse 
interviewed reflected that she had found it difficult sometimes to get senior clinical 
nurses to help. She had used this experience and reflected on a way to improve the 
response to her call for help:
“With one patient I didn’t have any backing, I’m sorry its going to sound 
like I am having a go at everyone it was just before handover... I went into 
this patient, it was the one who went red. I hadn’t seen that before I didn’t 
know what was going on, his temperature was shooting up and his blood 
pressure was coming down... he wasn’t feeling well, I wasn’t happy with 
him, in fact it was the first sepsis I had seen on the ward. I went in to the 
staff room to let the nurses know... and no one, in fact one of them said, “oh 
he always looks like that”, I’m like no he really doesn’t look well, so no one 
was really I think cause they see it quite a lot they were quite blase about 
it... .they weren’t necessarily thinking that I haven’t got the experience to 
deal with it. I think I had already phoned the doctor and he had said to keep 
an eye on him... I went back to the patient... his temperature had gone up 
again... blood pressure was still the same really really low, so I went back 
and phoned the doctor again and said please can you come... and then one 
of the F grades came... she didn’t sort of take over, but she helped me with 
him... After that that woke me up ‘cause I realised that you’re not always 
going to get help unless you actually specifically ask for it. So after that I 
wouldn’t go in there and say: “I’m a bit worried about so and so. I’d say: 
can you come and help me””. (TS.04)
This nurse graphically demonstrates two important issues in obtaining timely and 
effective help: first, the complacency of nurses who have worked in a high-risk
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setting for a number of years, and secondly the importance of “framing” information 
or communication in a way to get an active response.
Having recognised deterioration quickly it is essential that there is an effective and 
timely response including a thorough assessment and effective communication with 
the team. Studies have demonstrated that there are deficits in medical and nursing 
patient assessment and effective, timely communication about change (McQuillan et 
al 1998, McGloin et al 1999, Chellel et al 2002, DH 2003, Ryan et al 2004, 
McBride et al 2005).
Nurses in this study recognised a need to quantify evidence to convince the doctor of 
deterioration:
“When they go to get in touch with the doctor to have the accurate bullet 
points of what has happened with the patients. So they’re able to liaise with 
the doctors”. (TS.10)
“I think probably planting... which is a very subtle way of going up to 
doctors and saying look you know, what do you think your opinion is 
about... I’ve just seen this and I’ve seen this, what do you think? ...it’s an 
encouragement, come and have a look. Rather than being very, very obvious 
and very, very confrontational about it”. (TS 08)
“I think I’ve leamt to give facts... very strong definitive facts... and to be 
able to arrange those facts in a way where it highlights my concern, but it 
also gives a basis on... people to walk into the... go to the patient with 
knowledge already about what we’re actually looking for”. (TS. 10)
Andrews and Waterman (2005) provide two reasons for this: first, that busy doctors 
need to prioritise which patients to see, and secondly that precise information makes 
it easier to determine treatment. Several authors connect the inability of nurses to 
objectively present deterioration as being linked to a lack of applied physiological 
knowledge (Clarke 1995, Jordan and Reid 1997, Prowse and Lynne 2000, Clancy et 
al 2002, Clarke and Aiken 2003). In addition to greater applied physiology 
knowledge, the nurses in this study indicated a need to learn to present or package 
their data to medical colleagues in a particular way. They discussed presenting 
factual evidence in bullet points, in a more scientific way. The Early Warning Score
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(EWS) or Modified Early Warning Score (MEWS) provide nurses with a way of 
identifying and monitoring at-risk patients (Goldhill and McNarry 2004, Andrews 
and Waterman 2005, Ridley 2005). These models or packages of information fulfil 
some of the functions that nurses felt were important, but they do not address the 
issues of confidence or ability to influence colleagues or as the nurse interviewed 
described it, “planting” (TS 08).
9.7 Improving practice: use of the PCT-Q
Of the 85 nurses who returned their post-intervention questionnaire, 48 (56.5%) said 
they knew how to use the PCT-Q compared to 6.2% (11 nurses) in the pre­
intervention questionnaire.
Nurses were asked in the post-intervention interviews and questionnaires about their 
experience of using the PCT-Q. All nurses who had used the PCT-Q felt that it was 
useful in practice and easy to use.
The CCU outreach nurses would have used the PCT-Q most, and one of this team 
was represented in the interview sample:
“I think initially it probably wasn’t used as regularly, so we didn’t feel the 
benefits as much, but once everyone understood what the study was about it 
was used very frequently... and often when patients were unwell it did 
correspond... there were a couple of... bizarre results but apart from a few 
isolated episodes it did correlate and especially when we did repeat studies 
on the patient, the changes correlated with their symptoms”. (TS. 01)
Nurses who worked in the bone marrow transplant unit were the bedside nurses who 
had most experience of using it, and they felt that it had become integrated into their 
care:
“PCT-Q is used and everyone is quite aware of it and knows all the... I 
think it’s been a significant test... the doctors have been more proactive in 
how they treat the patient. It’s also good for us; it’s a good indication of
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er... how kind of septic, and possibly you know potentials of what could 
happen there”. (TS.02)
This comment illustrates not only that the PCT-Q had become integrated into 
nursing care, but that it had achieved one of the aims of using it that is convincing 
others to act. This response was of course very soon after the PCT-Q had been 
introduced and the researcher was concerned that over time its use and effectiveness 
might diminish. The researcher was therefore pleased to hear, two years later in 
2008, one of the haematology consultants referring to the use of the PCT-Q during 
the formal external assessment of the Blood and Marrow Transplant Unit’s European 
accreditation.
9.8 Nurses learning
During the pre-and post-intervention interviews, the ten and then eight nurses were 
asked about how they leamt in clinical practice and especially about the care of 
cancer patients developing sepsis. All ten nurses cited experience, reflecting on that 
experience and remembering particular patients who had deteriorated:
“Because once you actually see one, I mean one patient actually became 
quite ill, it always leaves you with a lasting impression of what actually 
happened with that sort of patient. What were they actually doing, it always 
leaves you with a lasting impression as to how you can actually... Oh you 
know he’s doing this I always remember that patient before he did the same 
thing”. (TS.08)
“When you have been looking after the same patient for a few days, you 
know how they are. When there is something “just not right” nurses 
intuition”. (Q.41)
This theme of learning from experience and then using that leamt pattern 
intelligently with each unique patient was shown to be a core focus of nursing 
clinical development. Another factor that nurses cited in helping them to learn was 
working with others, notably the teaching sisters/charge nurses or lecturer 
practitioners and the CCU outreach team. They also mentioned studying on post- 
basic courses and even, in one case, writing an essay:
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“I got a hell of a lot out of an essay I did on multiple myeloma.... and I 
leamt so much from that”. (TS. 05)
“I think general experience and learning and having sessions... on the 
diploma course... because... and the other thing as well is I’ve worked a lot 
with neutropenics in chemotherapy”. (TS. 09)
The nurses were also asked about what they would teach others in practice. There 
was generally discussion about learning in practice, reflection, mentoring, role 
modelling, use of the MEWS and the outreach team. Several nurses discussed the 
problems of communicating with doctors and teaching nurses different ways to 
communicate
9.9 Improving practice: reflection and intuition
Reflection or “recognition behaviour” is important when patients are especially 
vulnerable to deteriorating quickly and is a necessary attribute for nurses working 
with the critically ill and in accident and emergency and coronary care. Cioffi (1997) 
describes nurses using visual memories of common and unusual events to help them 
when working in uncertain and complex environments. Benner describes this 
phenomenon as a clustering of past experiences to prepare the mind (Benner 1984). 
Muir (2004) describes nurses using pattern recognition, where each new patient or 
situation will be compared with previous circumstances that have been stored in the 
nurse’s memory and then compared for their similarity (Muir 2004, p. 52). 
Reflection on previous experience and using it to inform new clinical scenarios has 
also been termed “reflection within the moment” where the nurse consciously 
monitors herself during practice (Johns 1998, p. 14).
Nurses in this study however illustrate the importance of this recognition behaviour 
in less acute areas. Nurses working in general oncology wards experience more 
challenges in recognising the “pattern” quickly. There is a higher patient-to-nurse 
ratio and a much greater diversity of focus. On general wards nurses see less acute 
deterioration than in a CCU and therefore may be less attuned or ready to recognise 
it. There is also currently a concentration on reduction of length of stay with greater
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turnover and acuity of patients on general wards in the UK (DH 2000, Goldhill 2001, 
Ryan et al 2004, NHS Institute for Innovation and Improvement 2008).
Some nurses in the study described reflection as intuition. Intuition has been linked 
to clinical practice for many years and is cited in both the medical and the nursing 
literature. In the medical literature, Alam and Talha (2005) contrast intuition with the 
evidence-based practice movement, linking intuition with an unexamined clinical 
experience. Edwards (2004), however, in a short letter to the Lancet, exhorts medical 
colleagues not to ignore intuition but to use it in combination with evidence:
However good our medical systems are, I think the use of intuition 
and other subliminal signals to our consciousness should not be 
ignored in our efforts to make medical care as efficient and safe as 
possible. By all means go for evidence, but do not rule out intuition.
They both have their place. (Edwards, 2004, p.387)
More recently, Berwick has challenged hierarchies of evidence, using as an example 
the problems of using a randomised controlled trial to prove the efficacy of medical 
emergency teams (Hillman 2005). Berwick concludes that to effect healthcare 
improvement alternative evidence such as qualitative methods, anthropology and 
learning from experience need to be used -  and viewed as not just as important as 
the randomised controlled trial but in some cases superior (Berwick 2008, p. 1,184).
In the nursing literature, there is more research linked with critical care and intuition 
than any other branch of nursing (Pyles and Stem 1983, Smith 1988, Rew 1988, 
Rew 1990, Benner et al 1992, Polge 1995, Elcock 1997, Benner et al 1999, King and 
Macleod Clark 2002, Aitken 2003). The key finding that links these studies is 
rapidity of decision making in an uncertain situation. The nursing literature is 
divided: some authors, as in the medical literature above, criticise intuition for being 
anti-science, dependent on the individual or problematic when seen in terms of 
clinical governance or accountability (Cash 1995, Walsh 1997, Turnbull, 1999). 
Others see it as an important part of practice, with authors such as Cader et al (2005) 
arguing that nurses use a “cognitive continuum theory” using intuition, analysis or 
application of evidence depending on the situation (Cader et al 2005, p. 403). 
Donald Schon and Chris Argyris at Massachusetts Institute of Technology theorised
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that people have a mental map that they use to act in a certain circumstance. They 
also suggest that people take an action but use a different explanation if called upon 
to explain their actions (Argyris & Schon 1974). Schon went on to develop his most 
acclaimed series of works, developing critical self-reflection in practice. Like John 
Dewey (1933, p. 123) Schon saw the practitioner’s repertoire of images, ideas, 
examples and actions as essential to reflective thought:
When a practitioner makes sense of a situation he perceives to be 
unique, he sees it as something already present in his repertoire. To 
see this site as that one is not to subsume the first under a familiar 
category or rule. It is, rather, to see the unfamiliar, unique situation as 
both similar to and different from the familiar one, without at first 
being able to say similar of different with respect to what. The 
familiar situation functions as a precedent, or a metaphor, or... an 
exemplar for the unfamiliar one. (Schon 1983, p. 138)
As discussed in chapter four, the phenomenon of intuition has been described 
variously in the nursing literature but for the purposes of this study it is Croce’s 
definition of intuition that is important: that we intuit anything (static or changing) 
first at a pre-cognitive level -  we intuit the presence of something(s) before we apply 
a conceptual structure from which we identify them (Croce 1872). Therefore when 
nurses talk about intuition all they mean by this is that they have some awareness of 
something. Although they may not articulate this, they then fall victim to Dewey’s 
idea of discomfort -  something, either the presence of some subtle cue or the 
phenomenon of change -  creates discomfort which is the stimulus to action (Dewey 
1931). The ability to intuit and react appropriately is improved when the nurse 
knows the patient. Nursing continuity and commitment to the patient as a person is 
therefore essential to reduce the risk for the cancer patient developing sepsis.
Intuition is useful at times of uncertainty and rapid deterioration, but needs to be 
coupled even in the most acute situation with practical evidence-based guidelines. A 
good example of this would be the Advanced Life Support (ALS) guidelines. Many 
nurses and doctors experienced in emergency care have an intuition that a person is 
just about to have a cardiac arrest, apparently intuiting very subtle signs in the 
patient .This must be followed by the rigorous application of the ALS guidelines if
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the patient is to have a chance of survival (UKRC 2007). Nursing in acute situations 
requires decisions to be made at times of uncertainty and it seems that it is these 
unusual circumstances that are more likely to lead to the use of intuition (Benner et 
al 1999).
9.10 The questionnaire data: 177 pre-intervention 
questionnaires and 85 post-intervention
The research aims for the questionnaire part of the research were: first, to increase 
the overall awareness of the risk of sepsis and its consequences for cancer patients 
across a wide range of nurses across the trust; secondly, to increase the knowledge 
base of nurses who were caring for patients at risk from sepsis; and thirdly to 
introduce the PCT-Q across the trust.
A pre-intervention questionnaire was completed by 177 nurses (Ql). These 
questionnaires were completed at the time of the teaching session. The post­
intervention questionnaires (Q2) were sent out eight months later to every nurse who 
had received the teaching session, 18 of the nurses had left the hospital and despite 
two reminder letters only 85 questionnaires were received back. There was therefore 
a 58.6% return of Q2, Although disappointing this is still a good number as response 
rates to postal questionnaires are often as low as 28-35% (Kaplowitz et al 2004, 
Edwards et al 2009).
9.10.1 The questionnaires
The questionnaires were the same apart from an additional question in the first 
questionnaire. The questionnaires were designed to be quick to complete, with 15 
questions in the first and 14 in the second. Ql and Q2 (see appendices 10 and 11) 
were the same pre and post intervention apart from the last section. In Ql the nurses 
were asked to include a free text answer on their experience of caring for someone 
with sepsis and mobilising the multidisciplinary team. Both questionnaires had three 
sections: (a) a section on knowledge of the sepsis syndrome; (b) the serum markers 
of sepsis; and (c) sepsis and using the PCT-Q experience. The intervention was a 40-
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minute PowerPoint teaching session on the sepsis syndrome, risk factors, incidence, 
mortality rates, immunological markers and the PCT-Q (see appendix 7).
9.11 Nurse demographic information
9.11.1 Experience of working with cancer patients
In the pre-intervention sample (n=177), the mean period of time that nurses had 
worked with cancer patients was 2.33 years, and 39 nurses had less than one year’s 
experience and 21 nurses had more than ten years’ experience. In the post­
intervention sample (n=85) the mean experience was slightly higher at 2.67 years, 
while 12 nurses had less than one year’s experience and 11 more than ten years’.
9.11.2 Nursing location
In both samples the nurses were well distributed across all wards of the trust, but 
there were more nurses from the acute areas such as CCU and the bone marrow 
transplant units.
9.11.3 Post registration qualifications in cancer nursing
There were a greater number of nurses in the second sample that had a cancer 
qualification (64.71% versus 57.1%) in the first sample. The qualifications ranged 
from stand-alone diploma modules to two nurses with a Masters Science degree.
9.12 Knowledge regarding sepsis
In Ql, 39% of nurses answered that their knowledge was not up to date on the sepsis 
syndrome, compared to 6% in Q2. More than double the number of the second group 
(20% versus 6%) answered yes, that their knowledge was up to date. Nurses were 
then asked to describe the four stages of the sepsis syndrome. These stages are well 
described in the literature and have been the standard definitions used since 1992 
(Bone et al 1992, Dellinger et al 2004, 2008). This question proved to be difficult for 
nurses to answer. In Q l, 74 nurses did not answer this question and 13 wrote that 
they did not understand the question. In Q2, 23 nurses did not answer and two did 
not understand. A greater number of nurses in Q2 were able to provide more than the
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first three stages of the sepsis syndrome. In Ql only 1.1% achieved more than three, 
while in Q2 25.9% had achieved four or five stages. These were, however, small 
numbers and the difference did not reach statistical significance.
On being asked about the mortality rate for healthy people with sepsis, in Ql 20 
nurses (11.3%) answered this question correctly. In Q2 the number improved to 28 
(32.9%) and did reach statistical significance (p<.001). Although the knowledge had 
improved, 59% of answers were still wrong after the intervention. For mortality rates 
for the person with cancer, in Ql 91 nurses (71%) answered correctly with 49 
abstaining. In Q2, 53 (84%) answered correctly with 16 missing answers. The 
improvement is statistically significant, but it is disappointing that there were 16 
nurses who did not answer.
The next question asked nurses to list the early signs of sepsis. The two 
questionnaires had similar answers with one important difference: tachypnoea. In Ql 
only 28.2% of the nurses identified that tachypnoea is an important early sign of 
sepsis, whereas in Q2 60% of the nurses identified tachypnoea. This is an important 
improvement as the respiratory rate is one of the most important signs of critical 
deterioration (Goldhill et al 1999, Subbe et al 2003), but in practice it is often not 
recorded or poorly recorded (Chellel 2002, DH 2003, Ryan et al 2004, McBride et al 
2005).
The next question addressed the immunological markers of sepsis. Although there 
was an improvement in the nurses’ knowledge it did not reach statistical 
significance. With PCT, however, and perhaps unsurprisingly given its significance 
in the study, there was a statistically significant improvement in awareness (p=.001) 
and of how to use it in practice (p<.001).
The final section of the questionnaire concentrated on the care of the patient once 
sepsis had been diagnosed. Answering who they would contact, there was a 
statistically significant difference between the two groups (p=.008) with Q2 nurses 
contacting more appropriate personnel including more contact with CCU. Lastly, 
nurses were asked whether they had ever had difficulty convincing others of a 
patient’s deterioration. A higher percentage of nurses in Q2 answered yes to this
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question (64.7% compared to 46.9%) but the difference was not statistically 
significant ( p=.139).
The free text from the last question in Ql is analysed together with the other 
qualitative data (see chapter six, section 6.6).
9.13 Nurse Questionnaires: Conclusion from the findings
In conclusion, 177 nurses working on days and nights across the trust received a 
dedicated teaching session on sepsis that was based on the latest evidence.
The analysis of the 85 pre and post questionnaires revealed five areas where there 
was a statistically significant improvement in knowledge:
1. The mortality rate for severe sepsis in previously healthy adults;
2. The mortality rate for severe sepsis in patients with cancer;
3. The nurse’s knowledge of PCT and CRP;
4. How to use the PCT-Q; and
5. Which HCPs would be contacted if a patient was developing sepsis.
There were also a further four areas where an improvement was demonstrated but 
did not reach statistical significance:
7. Listing the different stages of the sepsis syndrome;
8. Tachypnoea as an early sign of sepsis;
9. Listing three indicators of sepsis; and
10. Recalling a time when a patient was deteriorating but it was difficult to 
convince others.
For the knowledge acquisition questions nine out of eleven thus showed an 
improvement with five reaching statistical significance. These included important 
practice improvement issues such as raising awareness of the dangers of sepsis in the 
cancer patient and recognising a raised respiratory rate as an important indicator of 
deterioration. Finally the questionnaires and teaching session prepared 177 nurses 
for using the PCT-Q during the patient part of the study.
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An important contribution of this part of the study was reaching nurses right across 
the trust on all wards and on all shifts. The limitations were that in four questions 
only a small improvement was demonstrated and there was only a 58.6% return of 
the second questionnaire despite a reminder letter.
9.14 Sepsis admissions and deaths during the study period 
compared to the three preceding years: study limitations
During the study year, January 2005 to February 2006, there were 20 deaths due to 
sepsis. Most were on the CCU (18), with one on a general ward and one on the Step 
Up unit. This was compared to the archival data for the previous three years:
2002: 41 deaths due to sepsis and 695 admissions (6%)
2003: 36 deaths due to sepsis and 789 admissions (5%)
2004: 26 deaths due to sepsis and 710 admissions (4%)
2005: 20 deaths due to sepsis and 651 admissions* (3%)
* study period
There are however limitations to the interpretation of this data, for the following 
reasons:
1. The CCU electronic database had not been completed accurately; therefore 
information about cause of death from previous years may not be accurate. In 
an attempt to improve the integrity of the data the researcher and the nurse 
researcher for critical care nursing went through many of the death 
certificates, but these had limited details and often only details about the 
cancer.
2. The acuity and complexity of the surgical admissions to the CCU have 
changed markedly over the last four years. In 2004, the hospital became a 
major centre for hepato-biliary and upper GI surgery and there was therefore 
a major increase in level 3 surgical patients. The haemato-oncology 
population has however remained fairly stable.
3. A major change to the configuration of the critical care service took place in 
October 2004, which resulted in all critically ill patients being cared for 
together in one large unit. There are several advantages to this
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reconfiguration and evidence that the survival figures generally have 
improved.
It is therefore not possible to conclude that the use of the PCT-Q alone has improved 
the outcome of cancer patients who develop sepsis. It is important to note, however, 
that, despite significantly more level 3 patients in the study year admitted to the 
CCU as an emergency due to sepsis 94 as opposed to 45, there were still fewer 
deaths overall from sepsis. Level 3 patients are those who require full intensive care 
support of at least one organ and often more, for example mechanical ventilation and 
renal replacement therapy. To put this into context, if the mortality rate for the 
haemato-oncology patients alone who developed sepsis is compared to the literature, 
then the survival figure of 66% is excellent (34% mortality) compared to published 
mortality rates of 65% to 85% (Groeger 1991, Chemecky and Berger 1998, 
Aisenberg et al 2004, Cone et al 2004, Scales et al 2008). Early diagnosis and 
treatment of sepsis is one of the key elements in survival for these patients and the 
data presented below demonstrates that the majority of patients who developed 
sepsis during the study were diagnosed at the early stage.
9.15 Patient Data: Use of the PCT-Q
The aim of the patient data part of the study was to investigate the use of the PCT-Q 
by ward and CCU nurses as a part of their assessment in the early recognition of 
sepsis. The validity, reliability, sensitivity and specificity of PCT as a diagnostic 
indicator for sepsis in the neutropenic and non-neutropenic adult and child has been 
demonstrated many times since its discovery in 1983 (Assicot et al 1993, Al-Nawas 
et al 1996, Rothenburger et al 1999, Delevaux et al 2003, Clec’h et al 2004, Mitaka 
et al 2005). Since its development in 1996, the validity and reliability of the rapid 
bedside test (the PCT-Q) has been established in two studies in children (Fenandez 
Lopes et al 2003, Casado-Flores et al 2006) and four in adults (Meisner et al 
2000a,b, Pinkola et al 2001, Makay et al 2003, Olah et al 2005).
This study adds new work to the data on the PCT-Q: it is the first time it has been 
used by general ward nurses; with a large sample (416); and used exclusively with 
cancer patients. In common with previous studies, the PCT-Q was compared in this
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study to the blood tests currently used in the host hospital to predict sepsis. The 
markers that were measured with the PCT-Q were CRP, WBC and lactate. The 
researcher had not originally intended to compare PCT with CRP as the superiority 
of PCT has been shown many times in robust studies (Delevaux et al 2003, Luzzani 
et al 2003, Clec’h et al 2004). On presenting the research protocol to the scientific 
peer review committee at the host hospital, medical consultants who were not 
familiar with the work on PCT were keen to continue to measure CRP. The 
researcher agreed to this as it constituted current practice and CRP is an indicator of 
a general deterioration.
An Excel spreadsheet was used to correlate the use of the PCT-Q with the individual 
patient data (see appendix 14). All relevant patient details such as gender, age, type 
of cancer and type of treatment were entered. Clinical details, especially those 
denoting the various stages of the sepsis syndrome (SIRS, sepsis, severe sepsis, 
septic shock definitions) were recorded, together with blood markers and the PCT-Q 
result. Other patient variables recorded were the microbiology and finally the patient 
episode outcome and the hospital outcome. From this database it was possible to 
extrapolate whether any PCT-Q tests had been done unnecessarily. It was also 
important to be able to assess whether there were any occasions when the PCT-Q 
was not done but should have been, or where the PCT-Q result was inaccurate. The 
general CCU and Step Up electronic database was used as the historical control to 
ascertain whether using the PCT-Q had brought forward the sepsis diagnosis.
9.15.1 Patient characteristics
There were 176 men and 141 women recruited into the study (n=317). In the 
complete sepsis episode data set that is used throughout this chapter (where some 
patients had more than one episode) there were 233 men and 183 women (n=416). 
The ages of the patients ranged from 18 to 86 with a mean of 54.5 years. Patients 
had a range of diagnoses including the common cancers breast, lung, gynaecological, 
urological and lower and upper gastrointestinal, and the rare cancers leukaemia, 
myeloma, lymphoma, neurological, head and neck, sarcoma and disseminated 
melanoma. As expected, of all cancers the haematological malignancies -  the group 
most at risk from sepsis -  were the most commonly recruited. Leukaemia 
represented the largest group with 96 patients (23.4%); lymphoma 78 patients
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(18.8%); and myeloma 47 patients (11.3%). The haematological cancers therefore 
represent 222 patients (n=416) or 53.5% of the whole sample. Of the patients with 
solid tumours, the greatest number represented in the sample were those patients 
with upper gastrointestinal cancer (upper GI): 45 patients (10.8%). Patients with 
upper GI cancer tend to be older and to have comorbid conditions such as ischeamic 
heart disease, chronic pulmonary disease and diabetes and are therefore also at 
greater risk of developing sepsis (DH 2001, Abunasra et al 2005).
There are several other factors that predispose patients to developing sepsis, for 
example age and the presence or absence of co morbid conditions (Mavrommatis et 
al 2001, Cariou et al 2002, Yamamoto et al 2002, Aird 2003, Knobl 2005). 
Treatment-related factors are also important: in this study the most common 
associated treatment was chemotherapy with 186 patients or 44.7% (n=416). 
Surprisingly, patients having surgery and those who had had a blood or marrow 
transplant were similarly sized groups: those who had surgery numbered 89 patients 
and those who had had a transplant numbered 90 patients. This may be explained by 
the fact that many of the patients who had had surgery were from the upper GI group 
as discussed above.
9.15.2 Use of the PCT-Q to improve the early recognition of 
sepsis in cancer patients
The 416 episodes were correlated with the stage of the sepsis syndrome when the 
nurse decided to use the PCT-Q. As described in the introduction there are four 
stages of the sepsis syndrome, with the first the early stage and the fourth septic 
shock and multi-organ failure requiring all critical care support:
1. Systemic Inflammatory Response Syndrome (SIRS);
2. Sepsis;
3. Severe sepsis; and
4. Septic shock and Multi Organ Dysfunction Syndrome (MODS) (Bone 
et al 1992.
An early diagnosis would mean that the PCT-Q was used when the patient had the 
characteristics of SIRS. The highest number of patients, 163 (39.2%, n=420), were 
recruited at the SIRS stage with 112 (26.9%) being recruited at the next stage
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(sepsis). The only difference between SIRS and sepsis is that at the sepsis stage all 
other causes of inflammatory change have been discounted. Therefore 66.1% of 
patients were identified at an early stage before the onset of severe haemodynamic 
instability, acidosis and multi-organ failure. It was not possible to compare this result 
directly with archival results, as comparable data had not previously been collected. 
It is however important, when the early signs of sepsis are so subtle, that a majority 
of patients in this study were diagnosed at an early stage. The evidence from the 
literature on failure to rescue, problems with monitoring and recognising critical 
illness illustrate that this is a major patient care challenge (McQuillan et al 1998, 
McGloin et al 1999, Chellel et al 2002, DH 2003, Goldhill et al 2005).
9.15.3 The correlation of the PCT-Q with sepsis compared to 
the other inflammatory markers: WBC, CRP and lactate
Procalcitonin has been evaluated in many studies for validity, reliability, sensitivity 
and specificity, both on its own and in combination with other markers. No 
published study has compared the PCT-Q with CRP, lactate and WBC when 
diagnosing sepsis. It was important to include WBC as this is a reliable and easily- 
measured marker that ward and CCU nurses are equally familiar with monitoring. It 
is also important to monitor in the cancer population, as cancer patients may have an 
abnormally low WBC due to their disease or treatment. Lactate level is monitored in 
the critically ill, with raised levels >5 mmol/1 being associated with impaired tissue 
oxygenation and a high mortality rate. Lactate levels are monitored using blood 
analysed from a venous or arterial blood gas test (Clec’h et al 2004, Fall and Szerlip 
2005). As described earlier, CRP was the test most commonly used at the trust to 
indicate a general inflammatory response. PCT had not previously been used in the 
trust and neither had the PCT-Q -  the bedside test.
The first analysis used was univariate ordinal logistic regression analysis of each 
variable:
1. WBC: Using the WBC as a categorical variable with the absolute value 
or banding it into three areas (low, normal or high), the WBC is a 
statistically significant predictor of late-stage sepsis when the WBC is 
low <1 or high >20.1. Of these two levels, the lowest (WBC <1) is the
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strongest predictor giving a six times greater odds of late-stage sepsis 
than a normal WBC count. The high WBC count (>20.1) gives two times 
the odds.
2. Lactate was also a statistically significant predictor of sepsis, with a high 
value >4 giving a four times greater risk of developing late-stage sepsis.
3. CRP does not reach statistical significance, p=0.194.
4. PCT is statistically significantly correlated with sepsis, with a high PCT 
reading of 10 or >10 giving a two times greater odds of developing late- 
sepsis. Therefore, of all the four indicators CRP was the only one that did 
not reach statistical significance. Of the other three, a low WBC indicates 
the highest odds (WBC <1 at six times the odds), a lactate level >4 gives 
four times the odds, PCT at a level of >10 gives two times the odds, and 
finally a high WBC > 20.1 gives twice the odds.
Finally, a multivariate logistic regression analysis was performed to compare the 
four indicators (including MAP) that were significant on univariate analysis with 
each other. At the final step of this analysis CRP was removed by the model 
although the four other indicators were retained.
9.15.4 Unnecessary tests
There were 11 (n=420) PCT-Q tests performed in patients who did not have and 
never developed sepsis. Therefore in 409 cases out of 420 nurses accurately 
identified the onset of sepsis, and in 66.6% of these they identified it at the early 
stage, when there would have been few obvious signs or symptoms. This is 
important as it suggests an extraordinary ability on the part of nurses to detect sepsis.
9.15.5 Patients who developed sepsis but no test was 
performed
There were 11 patients admitted either to the Step Up or CCU with sepsis who had 
not had a PCT-Q performed prior to admission. These numbers are an important part 
of the analysis as they indicate that the nurses were using the PCT-Q appropriately 
the majority of the time (398, n=416). This coupled with the previous comment 
about the 11 inappropriate tests suggests an extraordinary degree of precision or 
specificity, not only did nearly all the patients who were tested turn out to have been
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tested appropriately, but nearly all those who were not tested were also not tested 
appropriately.
9.15.6 Inaccurate PCT-Q tests
There were three (n=416) PCT-Q tests that were high (>10 ngs/ml) and the patient 
never developed sepsis. This finding replicates the work by Clec’h and colleagues 
(2004) who had six patients (n=75) in their study with high PCT-Q values without 
sepsis.
This study has been able to demonstrate that the PCT-Q used for the first time by 
ward nurses was accurate in predicting sepsis at an early stage. The nurses also used 
the PCT-Q reliably for a majority of the time, with 11 tests done erroneously and 11 
tests not performed before admission to CCU or Step Up (n=416).
9.16 The research journey, strengths and limitations to the 
study
The researcher has worked clinically for over 20 years in acute care, mainly in the 
field of critical care for adults, and for the last 15 years working with the critically ill 
person with cancer. The experience of the researcher, substantiated by the literature, 
is that the sickest patients to be admitted to a CCU are already in-patients (Hillman 
et al 2005, Sakr et al 2008). These patients are often admitted at a late stage of acute 
illness and the CCU staff, the patient and their family are then engaged in a 
desperate battle for their survival. It was this experience and a visit to Chicago to see 
the work of Dr Emmanuel Rivers, who had tried to link the emergency department 
and wards that was the inspiration to work with ward and CCU nurses to improve 
early recognition and then rescue. Having been involved in the start of CCU 
outreach teams in the UK, this was the next step. The researcher’s clinical 
experience of many years talking with ward nurses was that they had often been 
worried about patients but had not had the confidence or “tools” to convince others. 
This study was therefore designed to try and improve this area of practice by raising 
awareness of sepsis, providing an extra tool to aid in nursing assessment (one that 
would be understood and meaningful to all disciplines) and exploring nurses’
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experience and listening to their advice about the way they learnt and taught others. 
Table 9.1 (page 230) illustrates the achievements of the study in achieving the 
overall and subsidiary aims but also the limitations and therefore learning points for 
future research.
An experimental design was contemplated but rejected, as the researcher was keen to 
improve practice in all its complexity and muddle and not impose an artificial model 
that would not exist when the study had finished. The researcher was also concerned 
that a randomised controlled trial would pose major ethical challenges as the PCT-Q 
was already validated as the most useful predictive tool for sepsis. An historical 
reference was therefore chosen to evaluate the efficacy of the study: that of the 
mortality rate in the study year. The hypothesis was that early detection, coupled 
with generally raised awareness and a tool to help convince others, would translate 
into early rescue and therefore a lowered mortality rate. The mortality rate did 
improve over the study year, despite a greater number of critically ill patients, but 
one of the limitations to this study was that other variables could have contributed to 
this improvement. It would have been useful to compare stage of sepsis referral in 
the host hospital, but unfortunately detailed historical data was not available.
The other endpoints were to increase awareness and education regarding sepsis, and 
analysis of the 85 questionnaires did reveal an improvement in knowledge over the 
six to eight months. The PCT-Q behaved as expected from the literature as a reliable 
indicator of the stages of sepsis but, more meaningfully for the researcher, has 
remained as a core tool for nurses and doctors at the study hospital. The researcher 
was concerned that once the study had finished the PCT-Q would be forgotten, but it 
is now included in the assessment documentation of nurses and doctors and is used 
to follow the progress of sepsis in the CCU. Finally, the information gathered from 
the nurses in the interviews and qualitative section of the questionnaire has been 
used in formal education sessions and the mentorship of new practice educators in 
the host hospital.
The findings of the research have been discussed locally and presented at national 
and international cancer and intensive care conferences. This study has also led to 
ideas for further research which are discussed in Chapter Ten.
224 of 355
9.17 Conclusion
The experiences of 187 nurses in the qualitative part of the study illustrate the 
importance of the nurse’s recognition of the early changes of deterioration due to 
sepsis. As described in chapter three the first signs of sepsis deterioration are very 
subtle and difficult to recognise thus the importance of intuition and preparedness in 
the theoretical framework for this study. From the many descriptions and models of 
intuition the researcher has chosen Croce’s definition coupled with Dewey’s 
description of “discomfort” as a stimulus to action (Croce 1866-1952, Dewey 1932).
Subtle changes in behaviour are particularly recognisable to the nurse when he or she 
has got to know the patient as a person. Continuity of nursing is therefore an 
important part of care provision if the nurse is to recognise subtle changes in the 
person she has come to know. These qualitative and less tangible signs can be used 
in further assessment and early mobilisation of the team. Linked to the importance of 
knowing the patient as a person is listening to the patient’s own narrative of their 
experience. In both this study and those of Cioffi (2000a,b), the patient can reliably 
predict early changes and it is therefore essential that their narrative is encouraged 
and used. Both the nurses’ and patients’ oral testimonies are important indicators of 
early deterioration and can therefore be used as part of clinical assessment.
The questionnaire and the qualitative interviews demonstrated that nurses and 
doctors do not always share the same language. Nurses felt their language to be “less 
scientific” and that they needed to package their information in a particular way to 
gain the doctors’ attention. Experienced nurses, however, were able to demonstrate 
that even using qualitative assessments of their patients they were able to convince 
doctors to see the patient and initiate effective treatment quickly. When nurses are 
not confident in their pathophysiological knowledge they are less able to provide a 
quantitative account of patient deterioration. The questionnaire survey found that the 
nurses’ knowledge on sepsis was limited and that they recognised this and wanted to 
improve. In a contrary case in the interviews, a junior nurse recounted that she only 
had recourse to the patient’s observations as she did not feel that she had the 
experience to notice anything qualitative. Where there is no continuity of expert 
nursing at the bedside or the nursing resource is inexperienced or unmatched to need,
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then quantitative tools such as scoring systems can be useful tools. The PCT-Q has 
been shown in this study to be an easy-to-use, reliable and valid tool in highlighting 
the patient who is developing sepsis. This study was not designed to evaluate the use 
of the MEWS or the CCOT, but several nurses commented positively on using the 
MEWS and working with the CCOT.
When nurses discussed the way they learn in practice, intuition, experience and 
reflection were highlighted as the predominant methods, together with working with 
more senior nurses, formal education and even in one case writing an essay. The 
nurses’ empirical knowledge of sepsis did improve throughout the study, but the 
study was not designed to measure whether this improved practice. It is encouraging, 
however, that nurses’ recognition of when to use the PCT-Q was accurate in 394 
(93%) of cases (n=416) and the teaching intervention may therefore have been 
useful.
As discussed earlier, the teaching session and the interviews provided opportunities 
for the nurse researcher to work with 187 nurses across the trust. This protected time 
led directly to the development of three unexpected clinical practice developments:
1. A new observation monitoring chart was developed by two of the outreach 
nurses in liaison with the ward nurses. The background of the chart is 
coloured on areas outside physiological norms as reflected in the MEWS 
chart. Thus a low or high respiratory rate is recorded against a red 
background, indicating to the nurse who uses it that the patient is scoring 
high on the MEWS and is at risk and to contact the outreach team.
2. The MEWS posters were reprinted and laminated to replace those that had 
been lost on some wards. Several wards elected to place a copy of the MEWS 
in each patient’s bedside folder.
3. A session on the importance of the oral testimony of the bedside nurse is now 
included in the researcher’s advanced life support teaching with the SHOs on 
their six-monthly induction to the hospital.
The researcher has also noted during her clinical experience that the doctors most 
involved with the study -  those on the BMT unit and CCU -  have found the PCT-Q 
useful and have now incorporated it into their daily blood test sheets. Lastly, the
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outcome of cancer patients with sepsis during the study period improved, with only 
20 deaths in one year. As noted earlier, other factors could have contributed to this, 
but the early recognition of sepsis has been shown to improve survival. In this study 
of 416 episodes of sepsis in 320 people with cancer, ward and CCU nurses identified 
the sepsis accurately in 93% of cases. Nurses also reflected that having a semi- 
quantitative tool to “back up” their early clinical assessments translated into 
improved communication with their colleagues and therefore more immediate 
intervention.
227 of 355
Ta
bl
e 
9.1
: 
Ov
er
vie
w 
of 
th
eo
re
tic
al
 f
ra
m
ew
or
k,
 r
es
ea
rc
h 
ai
m
s, 
m
et
ho
ds
 a
nd
 
key
 
fin
di
ng
s
75
.2*0a
5
y
5b g
a  <L>
o> a
?? rH fl
fli CO
Ps
N CO
5? «» 3 > « £
C? 227 5  £ s  ,± 3  
2 & ^
T3
4 )
S3 * 2  > 2
T3
a - s
> c 
o °o ^.y <u
3  *a> o
£ £ 
4 >  0
3 .S  
^  £
<1> CO"* C
<D
>» ^H
c3-4—»
• pH
3Ocr
-*->
C/5O
O h -
t3
Co
ao%—*
75
75a>CO
1
r-r-
TSoA
•K—4i
75 on
a * 3 ts„ .a o -o0 ^  ^  • r H£  r  a  
^  <U 2 0)
c® 3  ^  3  i .5 O a"
iooo
C/5 1-rt 
4 >  g
C/5 Ha & d 2y  .  t-i
o l> 3  
t  ’T 3
o  ■■ •4 >
3
• pH
I
s - >
KAo
O h
*2 O ^f l  . H  Cfl 
®  W  Q« J> 2In 3 O Ph O' c4
o. 
S f ?  “  22 o 
3  ^
g  4>
S
•  p H
<3
ja
Q
Uata>
75v
VUA
pO
u«
V  7>
V
PS
( -1
4 )
O
9o
t - l
<2
00a
<L>
Oa
4 )
•n0)
O hXw
in
O ha>
75
'Z
a
4 >
► r H
O h
00 3
, 0 1 . 2 2
3
• p H +-► 3
0•  rH 3
s
O h
c d
|
4 )
3
3
0
7 5
’in
O h
O 00r H * 9
4 )
7 5
O
<K-I
M• p H
1
3
O
• p H
4 > ! >
4 > x> H->
0 00 O
0 a cO 0
4 >
• c
4 )
O h
0
T 3
0
0.  f—H
7 5
7 5
3*-<
0
X
w
. O■H—1
r<L>Q - l
O
' C
4 )H->
i-t 4 >
< N £ O h ’T J
«  4 >a> a>
as w 
O h O h 
4 >
4 >  CO
4> 75
4>o 00 75 Kft 75 0 0( D  4 )
4 )  4 >4 >  0 3
O h 0 3
4 )003
.2
C/5
•75 O
8-.S
V> r.
0 <L>
75  
75  ‘
75  
4 )a
4 )
o3
1
o«KHO
»  S.S 75
75 »
..H  75
0 3  75
OS <
( N
22
8 
of 
35
5
oo
C
'■aa
£
*
w 3
CO fl>
Gy  ai
£  'c y y
CN <D Oh P.
y o
•S'S
<D
<U
o  B
00 
a► H
^  &  o  G
3 o
cd °
£
&
G-lo
nd J3y  *“ 1
3
co 55 
G Oh 
H  CD 
CO
o td 
>  §  
^  .2
^  'S
>  .§>
O  co
P i  > >
3  3  o
"rt .53
•* s
SoT3 55y  ^
3  >
o  
g
3  
-3
3
hJO  
X)y
a to
o
ay
nd
CO
G 
O
§
" T ' 8o To
J  £
y  0)• G o
cO 'O
§  G 
O O
•4-*
co cO 
<D M3 o cr'C
_  CD C +-*o «
§
vr>oo
G
CD
a
<D 
>  
Ot-H
Oh
>» a_ -a
*-> —H G
■= <D w  
y  ’G  
S  <D> 3CO 2
G
CD
a
CD
E>
0  *-<
1
hGy
a
<D
CO
CD CD
£ 1  O 3
Ch•v op
y  GVh id o . T3
aO hL «-! ootin <L>n  t*
d
co o
.§ a3  uG 3^
*-H CO
O t-c 3  a)-C-* C>co s  
y  co
o  G or 3
TO 0
(D I f i
a  3
•S-spJ> CO
52 «  co o
CD - d
a .S  
a 3
I *
S y2 tx
co d
CD S-H co ’3 
H 2
§  §
IT) 'G00 g
'd .25 2 1
■ S  CO-*-» *I-H
2 3  2G 2 G
£  2 CO - -}
G 3  CD
^  a  0 0
Td
<U o
§  £  2 o
-  S  Jy o ,
*■» CO 02  u  «d  3 ft
“H a ^
°  I  S
§>S 2g  > to
”  6  3
2  G o3  •? '*"*G +5* TJ , g  O° as
G 2  O rG <D .2  ■(- > 'G
11-a1 | 1
< I I
nS
o
-G co
O
CO
CO
8o
CO
C"-
C-~
T3
CD
nd
>
o
yt-i yGhy
l-H
3
3 a
00to#G H—»COy
O Gcr
3 GC+H 0, vCO3g y
H ty yH—>
.3
pG
yL.
G
y
CO
&
G 00
59 <D
a ^CO 4"* 00 3  (D O
m aCD . 
00 <D Td O
y  g
a
co cn
CO■"Oh CO00G•CO
nd •COGhyG•a
COu-i0
3<+HO0H-> CO y•JJ30 yG3y s>y*c yy0G y 4^—>55 »1-HG t3 GhXCOH-» y GhCOy-*-> ay 3ycob Gy y O'•S-»CO3 G 1H0 G y U
§)G3 hGHPhy•T3 3Vhvo hG4—*
X 2
y
y
■5
G
O
co
G
O
co
CO
y
CO
00
G
3
ay-*->
"G
a
£
_, y
3  a 3  y
■S 3o >
co y  
coG 2
r, hG
co
• f-H f\
co y  
G h t i  y 2CO M
Td £ *
§ 3
s  B8 § 
a  ,5
G h 3
a  ay 1/3 
G ^rrt CO
o  *C
G
a ’a S ®
I  -g 
£  2
Td G
§  ’G
co► fHCO CO
O  ’
G 
00 G
I I
H  co 
CO CO 
<D (U
-H CO 
C  GO
O  cO
22
9 
of 
35
5
GA
W
a
B
d
d
o
-d
h-»o>
d<d
l i
C/3C/3CDtOC/3d 03<d-4-*
■g
CO• pH00OhO <D<dtH CO<4-1 cxCO4-* o Hd1) CO<L> U
•3
d
O
Ph
UOhco• pH43
o Oh4->(N CD 00
m VO (3• pH# V i CO1 H- d
CO ca
P 55
P d
d
• ^Ht-H
a
0  
Oh 
&
d
P
cod
COd
£
a 1
H
u
Ph
CD4=1h->
co 
CD 
to  c3 
O
VO
d ’
<4-1o
o
oo
On
m
s
•  p H
43
ub.
«<L>co<D
£
p
-6
< 4 - 1o
CDind
p  .B OT
o 24->
d -2o 3• pH C/5
O -g— D
- 5  ^  
2 O
H—» l
2  ^  
^  u
(N  P h
H
U
Oh
cdd♦ pH
C /5
dp
43
P
434-»
< 4 -H
O
a
.2
*■+->oddo
d
<D
cod
totoVh
2  d  ■5 otn o
<2 3
—i poj d-4-> • 4•a 3s «
43 
p
43
CD4->
O '
01
H
U
Ph
cd
B
ind
coin
P  . m m in •’-<
«* Oh
to <u 
P  in
3  O
d  co
d  S )
B  "co
§  £  § e3
d  OX) Oh O
1 °
O C/3
CD
o p <+h 43
d  oCD-*-» o3*3 d
o P
«  £  Lh Cu
£  •*<u -2 
*-(3 ■+-» 
d  W a  2
43
od
W
<N
OI
H
UPLh
2 1 P
IS H <D
T3 >  • pH
d  o  
P  Ph
3CO
+-»o<u pto
O
CD
434^ 4> #c (L> s * H->
OH-> T3 B 13
o B
d
• p H
d
<d
<4-H
o <Uto
, o
? "2
• ^ H
Oh
a>
43H—*
C+H
o
d
p
P h
§ • d
d
T3
D
CO
O
43 B
to
P
d
3CO
d
B o
B(U
'd t-H 'd
*-H
o CD
to
P
dCO
d
1)
a
p (U
,d
CD
Oh
o
a
2
a
1
<L>CO to-a o &
Cw/
P O
i
HCu
d <L> OX3
dd> to• p H S o  U
c3 H->
• p H 
H—» Oh CO Phd
mo
tv
Ohr-i
OH-> 'd
cd
O
CD
<D
CD
d
"-d d H-» H-> ^ H > c d 43o
fp
fl
Oo
o
H -»
in(U Qh +3  to
a i S
^3 d  
<C 43
ro 2
o
O
ao
o
o<+Ho
O
1
P
P
CO
$
M o
p HB U
S3 Ph
• i-H CD
CO 43u H—1
a S3o Po
a 1o CO
V ho d CD+ H
c3CD CO • p H
> •, d do
• ^H §d P>
a
CD
t-H
H—*o
to Oh S3
dp
C/3d
OI
H
OPh
•S
C /3
C /3
P
C /3
C/3<
23
0 
of 
35
5
<+Ho
-*—*
CD
03
ao
CD
43
■4—>
CD
5S
<D
T3)
(Z)
1  . 2  
^  43
CD f- 1
b o
.S  c/5
w go
1 3  &
CD g  
-  &
- B O
GA
. 9
' t sa•F*
Eft
&l
*
CD
03
9
S3
o
<N
^J-
<H-Ho
" 3o
C/3
CD
oo
cd
o
o \o
<N
' S  . 3
« a  co
« 3CD ^  
*2 -2
r  >>* 43
i* °
z  *oo ,< D  
CD H " 143 .'*-* S3 
t w  <D O <U, p
n°
vo S> 
• ►> X> cd 
,£3
S3•*h n3
oo
*55 g> 
Oh C
CD x 3  
oo 33
S3b-H
O
5  .
O h <D
» s
■ 5  - 3
f i  c d  
O .ts
I? 233 O 
io  cd
« S
6  2 
S  £
•I §
O <L>
S 2-H-> ”
X  CD 
<D f 3
§ iCO2  33 00 'M 
CD »-i 00 « 
bO 433 00 <« 33
MH
CO CO
o* ' 3
1 3  O h
5  w  
t i  «
a s3h +-* 3  CD
. 5  x )
*r4
cd 5  *-1O & o
r o
95
%
C
on
fid
en
ce
In
te
rv
al
2.
86
4
6.
49
3
9.
52
8
3.
37
8
3.
35
8
981*1 1.
35
6
3.
05
0
0.
96
2
1 .
1.
40
6
Si
g.
ooo
©
9000
oo©
d
9900
ooo
d
O
dd
s
ra
tio 1.
84 r-H
"
2.
97
5.
39 »-M
081
LYZ 1“H
Po
sit
iv
e
N
eg
at
iv
e T
V
£o
H-J H
ig
h>
4
Lo
w
N
or
m
al
H
ig
h
i L
ow H
ig
h
1
Pa
ra
m
et
er
Es
tim
at
es
PC
T
La
ct
at
e
W
B
C
M
A
P
oo cd oo
g *  &2  X> «
^  3 3  cd cd
^  >  
£ • 300 O
1  t i  S , j a ^
cd
CD
b fl
O
&
CD>
co t s  58.2 MC -•-* O
&  r  ^O >^ 43 O 'O oo
T )  5  g  g w g 
d 2 #
8 £  - 
"S o  
. a  c
Oh O  
<D  " 3 3  3 3
. 2  - 2  1/5 "3Oh C  O  5? •§ 43
03 ^  -*-»
c+h cd -o
c/3 O  
£  CD
2  o  
B 2  Dj
9S 2 o o c3 °
“  CD
O
S3
CD ^  2
(D
^  s  s  
^  £  £
T Jo
4=
-**
o
43
CD
43
a
<
4=
W
J -
cd
GA
(D
P h
(D
O h
O
a
§•
03
O h
. 9  g  
a t d
U  03
O h §
(D <D
r+3 S  *h
CD
b0  3h ” 3
. S o b
§ a §
03 8  ^
8 I 1 w 03 &
03 . 2  Cd
<  a ^
(N  oo . 2
CD ?> 03 CD
CL'TD
CD CD
CD 03
4 0 §
o  I
O h O
23
1 
of 
35
5
ItI
iI
I
iI!
a• P*
a
&
*
CD
c/5
CCJ
CDI-Ho£• I'H
<u+-*
Phc/5
CDX>
TJ
CD
CD
•3ODlH
C /5CJ CD 
^ T3
c3 £
CD <D
1  & 
C/5 J-H
2 2  
+* £ 
°<2 « 
- h w
I  3C3 -*—>
£3 5/5fi §
§ a fi .a
1) 52
5-L 0>
£ <2 2 •S <W £
>  <D H
bO « oi
55 C>
57'-o
(D <Us - g a
o is .2
C /5  CCJ C /5
a bDCD <D
CD X lCD w
<D<D j*  > P
OS -H
CCJ 1,
3 £O'1 O
j l  
fo o
• 'S 
2 § bfl ”<D
<H-HO
£o
CCJ
OSnd
« -S—i dd
0) CVT 
.£ TJ
*  IH_» TO (Dc] h3 Ph cd P . PC71 i C71
c / 5
a  oP P h.2 4d 
3  §D TO
s  e
CD P h
cshP <N
b0a
a
03
CD-4-*
a nd
2  <D O -rt •rt ccJ CDa  «a p 
2 £
3  S 
S ^  _cr1 m  co
Td
<D
Q
'"p"
CD,£ H—>C*Ho
£O
.a ^
55 gpH § 
CD 2
c / 5  g
P «O u
p S o J2 • ^  _
C /5
C /5  ^ P  
<D W  oo m
<D
CD
T d  bpo P o to
'S ^W (LD 'Cd • rt
•  >-h  - r t05 TO
T d  P h  
CD ^
O  H
M  /v.u  .
P h  P -
Td
(D
ID ^Jp 3
CD
s•p*
-c
CD>-es4>
C /5
OD
Cs2
£•m*
<
> o
P h ^
2 2 ^  
. tf o
C /5  * H  C »  
D  C /5  1 >« ft w 
a  <d p  g w h P <4H 2
£  0 ^  ts .22 -g 
b o  55 >
\ £  O  c /5  71 (DCD bo CO> & tia -rt P w T3 fl
<D>
S
t §on ^ O g
• § 1td ^O «»P ‘ Td
CD
C /5oc
boaT3CD
OS 'P 
.2
3  e3Td CD
232
 
of 
35
5
Chapter 10 Conclusion and implications for 
future research
10.1 Introduction
Nurses in an acute cancer setting are the healthcare professionals most in contact with the 
patient and are in a position to notice changes in the patient’s condition and alert others. 
There are blocks to recognition, monitoring and then mobilisation of an effective and timely 
rescue for the patient. Nurses are working in increasingly pressured environments, with sicker 
patients on general wards and less resource to care for them. In the cancer centre where the 
research was undertaken, there are more junior nurses working in acute areas such as the 
bone marrow transplant unit that have less experience in acute cancer care. Junior doctors 
also have less clinical experience, with reduced practice hours in their training. There is 
evidence that there are serious delays to effective care in hospitals due to problems in 
communication both within and between disciplines, cultural problems with junior 
professionals unwilling to consult senior colleagues, and nurses and doctors not recognising 
the early signs of an acute deterioration (McQuillan et al 1998, McGloin et al 1999, Goldhill 
et al 1999 Chellel et al 2002, Clarke and Aiken 2003, DH 2003, Goldhill et al 2005). It was 
against the background of increasing incidence of sepsis, reduced resource on the wards, 
evidence of ineffective care and resultant increase in admissions to CCU that the present 
study was designed.
The research study described in this thesis has demonstrated that cancer nurses can and do 
recognise sepsis, consistently and accurately, at an early stage. In the period since the study 
was completed there has been evidence that the awareness of sepsis and the use of the PCT-Q 
have increased, as teaching on the sepsis syndrome and the use of the PCT-Q have been 
embedded in the practice of the hospital. It is essential that cancer nurses are encouraged and 
supported to use this information in an effective way to mobilise the multidisciplinary team to 
effect an early rescue for the cancer patient developing sepsis. The study has also led to other 
practice developments, such as a new physiological observation chart, improved 
documentation of deterioration on general wards and increased teaching for nurses and junior 
doctors on the need for collaboration in the early rescue of the cancer patent with sepsis. 
Nurses were also able to describe the way they learn most effectively, and these
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recommendations have been built into clinical supervision and postgraduate education 
programmes in the hospital’s school of nursing. A weakness of the design was its complexity 
but also the reliance on historical data, some of which was missing, for comparison of 
mortality data. The lack of robust archival data and some changes to the delivery of critical 
care during the study period means that it cannot safely be concluded that this research 
directly led to the decrease in mortality during the study year. The overall aim of the study 
however was to raise awareness of the dangers of sepsis and improve practice in the early 
detection and rescue of the person with cancer who develops sepsis and the evidence has 
been presented that this and the other subsidiary aims were achieved.
10.2 Implications for future research
10.2.1 Related sepsis studies
Having improved the early recognition of sepsis in the person with cancer, the imperative is 
now to implement an effective early intervention algorithm for the treatment of sepsis. There 
is robust evidence for such an algorithm and the next study is introducing an evidence-based 
treatment plan to be used by all clinical staff immediately the diagnosis of sepsis is made 
(Dellinger et al 2004, 2008, Robson and Daniels 2008).
This study is being instituted in two stages: first, across the host cancer centre and then, if 
successful, in a second stage across the six hospitals in the cancer network. In the network 
stage, relevant education and introduction of the PCT-Q and early intervention algorithm will 
be introduced to nurses working in accident and emergency departments and acute wards 
with cancer patients. There are good senior nursing links across the cancer network, but the 
complexities of working across institutions necessitate a larger research team and these 
studies will therefore be part of a programme bid submitted to the Department of Health 
under the Research for Patient Benefit programme.
10.2.2 Quality of nursing studies
This study has demonstrated that temporal continuity of nursing coupled with targeted 
education and the availability of a bedside test enables nurses to recognise subtle change 
early and accurately and to respond appropriately. However the study relates only to cancer 
nurses working in a specialised setting. An important question therefore is whether these
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findings can be replicated in other clinical settings where early recognition of subtle change is 
essential for safe, effective care for example acute cardiology and acute postoperative care. 
Major questions to be asked in future research studies would include:
1. Do nurses in other clinical settings intuit change quickly and can this be 
incorporated into an effective early rescue plan?
2. Is it only trained nurses that can intuit this early change can the same practice 
be applied to non qualified support workers and assistant practitioners?
3. How can we improve nurses' confidence and multi-professional 
communication so that the nursing voice is heard more effectively in the acute 
setting?
These are of course large questions and would form the basis for a substantial programme of 
research. Reflections on the limitations to this study have also made the researcher more 
aware of the challenges described in the literature about evaluating complex interventions in 
practice and this learning will inform future work (Comer & Normand 2001).
Understanding and engagement with the patient as a person would seem to be essential if the 
nurse is to work alongside the patient nurturing and enabling them to achieve their personal 
goal for example recovery from major surgery, acute cardiac events. Even on the busiest 
ward during the most acute episodes a nurse that is fully engaged with the patient has two key 
advantages: the first is a therapeutic encounter that may be healing in itself, the second is that 
the nurse's knowledge of the patient can be used as another level of monitoring reducing the 
possibility of harm. Currently there is much concentration on tools used to enhance patient 
safety and reduce harm. These tools such as the Department of Health High Impact 
Interventions (2008) to reduce health care associated infections are important tools for the 
healthcare team. Several authors notably Linda Aiken have also demonstrated that well 
trained nurses and a good skill mix also improve care and outcomes (Aiken 2009). All of 
these are important but it seems that a vital question to answer is how nursing contributes to 
the well being of patients; whether the values held by nurses have importance in improving 
outcomes for patients.
In this study experienced well educated nurses were shown sometimes to be less safe than a 
junior nurse with little experience who had the motivation to engage and ensure a single
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patient’s safety whilst at the same time risking embarrassment in front of the team. Working 
with an acutely ill patient as they cope with ill health requires an acute concentration, 
observation and energy motivated by the wish to reduce harm and bring about a change for 
the better.
At a time when the nursing profession is criticised both by patients and the profession 
concentration on practice that is caring, based on intelligent reflection and the moral intent to 
do good is timely (Patients Association 2009, DH 2010). Research is needed to explore how 
these characteristics can be encouraged, nurtured and promoted across nursing. Nationally 
and internationally work has focused on reducing risk and improving the quality of patient 
care (IHI 2010, Patient Safety First 2010). Much of this work has been based on reducing 
systems and process errors, and using tools or algorithms to reduce risk (NPSA 2009). There 
remains a gap with research needed to explore the qualities of nursing that promote safe and 
effective care and ensure that the patient and family have a therapeutic experience. The work 
of Gallagher and colleagues (2008) has begun to address this need by replicating part of a 
study exploring patients’ perceptions of the “good nurse” (Pang et al 2007). This small pilot 
included patients from the specialist cancer centre in the sepsis study and there were shared 
resonances: suggestions that “knowing the patient” and “personalised caring” were important 
to the patients interviewed. Another finding from the Gallagher pilot was the importance of 
the organisational culture and environment, with patients identifying a difference between the 
specialist centre and other NHS hospitals. The effect of the organisational culture on the 
behaviour of nurses was also identified in the sepsis study. Future research is therefore 
needed to explore the power of good nursing to positively affect outcomes and the experience 
of care, and how this might be encouraged, nurtured and replicated outside of the specialist 
cancer setting.
10.3 Conclusion
This practice development study has made a unique contribution to nursing and has identified 
that nurses who get to know the patient as a person, and receive a dedicated education session 
can effectively recognize the subtle changes of sepsis at an early stage. Sepsis is the major 
cause of death in people undergoing acute cancer care and its incidence is increasing. To treat 
sepsis successfully it has to be diagnosed early and this finding is therefore significant. The 
study has had a lasting effect on the way that ward and CCU nurses assess the person with
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cancer who is deteriorating. Sepsis is now a major feature on all relevant undergraduate and 
postgraduate modules and is a part of the mandatory induction programme for all clinical 
disciplines. A new bedside blood test, the PCT-Q, has been successfully introduced into the 
hospital’s core assessment of the deteriorating patient. Importantly, the ward nurses identify 
the translational value of this test and its numerical value in their ability to convince others to 
take action. The evidence from 187 nurses about the way they learn and their experience of 
trying to convince senior nurses and junior doctors is regularly used in coaching, mentoring 
and induction training. Finally, the effects of the study have been to raise the awareness of 
sepsis and its early diagnosis, to give confidence to nurses that their assessments are accurate, 
especially when they know the patient well and listen to them, and that “packaging” patient 
deterioration information to produce an effective and timely multidisciplinary response has a 
positive effect on patient survival.
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Appendix 2: Table of sepsis early indicators
Abbreviation Sepsis Early Indicator 
in full
Abbreviation Sepsis Early Indicator -  in full
PCT Procalcitonin APACHE n Acute Physiology and Chronic 
Health Evaluation scoring system 
(Knaus etal 1985)
CRP C-reactive protein ESR Erythrocyte sedimentation rate
WBC White Blood Cell 
(count)
Ca (ion) Ionized calcium
SOFA Sequential Organ 
Failure Assessment 
(Vincent etal 1996)
A tm Antithrombin III
aPPT Activated partial 
thromboplastin time
TT Thromboplastin time
BPW Partial thromboplastin 
biphasic waveform
AM Adhesion molecules
TNFa Tumour Necrosis 
Factor alpha
Thromb Thrombomodulin
IL-1,2, 6, 8,10,12 Interleukin 1,2,6, 8, 
10, 12
vWF von Willebrand Factor
vWF protein Endocan -  
proteoglycan in vitro
HLA Histocompatability leukocyte 
antigen
L. Lactate PMNs Polymorphonuclear cells
WBC diff White blood cell 
differential
PRR Peak respiratory rate
E. Endotoxin PHR Peak heart rate
NT. Neopterin GCS Glasgow Coma Scale
APOE Apolilipoprotein E 
genotypes
NGCS Nadir Glasgow Coma Scale
PCT-Q Procalcitonin Quick 
test
PBC Peak blood creatinine
SAA Serum amyloid A C3a Protein complement
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Abbreviation Sepsis Early Indicator 
in full
Abbreviation Sepsis Early Indicator -  in full
SLP Silkworm larvae test LE Leukocyte elastase
T Temperature ICAM-1 Circulating intercellular adhesion 
molecule -1
HR Heart rate PECAM-1 Platelet endothelial cell adhesion 
molecule -1
RR Respiratory rate LHF Leukaemia inhibitory factor
HSP Heat Shock Protein sTNF Soluble Tumour Necrosis Factor 
receptors
SAA Serum Amyloid A MIF Macrophage Migration Inhibitory 
Factor
sTREM-1 Soluble triggering 
receptor expressed on 
myeloid cells -1
suPAR Soluble receptors urokinase -type  
plasminogen activator
MBL Mannan-binding Lectin ANP Atrial natriuretic peptide
EAA Endotoxin activity 
assay
LBP Lipoprotein binding protein
mid pro-ANP Mid pro-atrial 
natriuretic peptide
LAR Leucocyte antisedimentation rate
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Appendix 3: Nurse characteristics — participants in 
qualitative interviews
Respondent
Number
Grade
of
Nurse
Length
qualified
Ward area Date of first 
interview
Date of post­
intervention 
interview
01 G 9 years Critical Care 
Outreach Sister
6.12.04
02 E 4 years Staff Nurse 
Haemato-oncology
7.12.04
03 D 13
months
Staff Nurse General 
ward -  upper GI & 
GU medical 
oncology and 
Neuro-oncology
7.12.04
04 D 2 months Staff Nurse Private 
patient unit -  all 
cancer specialties
7.12.04
05 F 4 years Senior Staff Nurse
Gynaeoncology
ward
9.12.04
06 E 2 years Staff Nurse 
sarcoma, melanoma 
and chronic
13.12.04
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Respondent
Number
Grade
of
Nurse
Length
qualified
W ard area Date of first 
interview
Date of post­
intervention 
interview
haematology ward
07 F 6 years Senior Staff Nurse 
breast cancer ward
13.12.04
08 E 10 years Staff Nurse Critical 
Care
15.12.04
09 F 20 Senior Staff Nurse 
private patients 
OPD
17.12.04
10 H 17 years Senior Charge 
Nurse Critical Care
23.12.04
I
I}
I
i
i
i
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Appendix 4: Nurse Information Sheet -  qualitative 
interviews
The Royal Marsden NHS Foundation Trust
Sep sis Study: Protocol 2372
Nurse Information Sheet
The early identification of cancer patients who have the immunological precursors for severe 
sepsis: a tool to confirm nurses' intuition and experience
I would like to invite you to take part in a research study. Before you decide it is important 
for you to understand why the research is being done and what it will involve. Please take 
time to read the following information carefully. Ask us if there is anything that is not clear 
or if you would like more information. Take time to decide whether or not you wish to take 
part. Thank you for reading this.
What is the purpose of the study?
This study aims to improve the early diagnosis of sepsis and severe sepsis in patients who are 
receiving inpatient treatment at the Royal Marsden Hospital. As you will be aware Sepsis and 
Severe Sepsis are the cause of an increased morbidity and mortality in some cancer patients 
undergoing treatment. We know from experience and previous research that early diagnosis 
of this condition is important. This study aims to increase awareness and education about the 
sepsis syndrome, and also to provide the nurse working on the ward with a new tool that may 
help to diagnose sepsis in its early stages.
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Why am I being invited to take part?
A cohort of 10 nurses who are permanently employed at the Royal Marsden NHS Trust and 
who work on the adult acute care wards are being invited to take part in this study. Because 
the study is about the early identification of sepsis it is very important that nurses caring for 
patients at risk are involved in the study.
Do I have to take part?
It is up to you to decide whether or not to take part. If you decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form. If you decide to 
take part you are still free to change your mind or withdraw at any time and without giving a 
reason.
What will happen to me if I take part?
You will be asked to be interviewed on two occasions, once before the study intervention 
begins and one afterwards. The purpose of the qualitative interview is to ask you about your 
experience of caring for patients who develop sepsis. Following the introduction of the PCT- 
Q on all the wards a second interview will occur during which your experience of the study 
intervention will be sought. I am also interested in the way we learn as nurses and what you 
recommend for learning and teaching about sepsis in clinical practice. Your interview will be 
taped and then transcribed later. The transcripts will then be analysed using a constant 
comparative technique.
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What is the drug or procedure that is being tested?
There is no drug being tested but we are testing a kit called PCT-Q which has been used 
previously in the detection of sepsis and severe sepsis. It is a kit that measures a substance in 
the blood called Procalcitonin. Procalcitonin levels can give us a clue as to whether a patient 
is developing sepsis. The PCT-Q has been used in several studies but these have been small 
and it has not been used in the hospital ward setting before. PCT was launched in 1996 as a 
diagnostic tool for identifying severe bacterial infections and indicating complications 
secondary to systemic inflammation. PCT levels increase in cases of sepsis, septic shock and 
in severe systemic inflammatory reactions. The main stimulus for PCT induction is the 
systemic effect of lipopolysaccharide from bacterial endotoxins, and systemic fungal 
infections. Viral diseases, autoimmune diseases and local and organ related infections do not 
induce PCT. PCT can therefore be used in the differential diagnosis of bacterial infections. 
PCT can also be used to monitor patients who are at risk of infection or sepsis for the early 
detection of infectious complications; this makes its application particularly important in 
high- risk surgical and immunosuppressed patients (Meisner 2000, Fleischhack et al 2000).
The PCT-Q is used by taking a sample of blood from the patient who is suspected of 
developing sepsis, spinning the blood down in a centrifuge and then adding a drop of the 
plasma to a test strip (a bit like a blood glucose test strip). After 30 minutes the PCT-Q gives 
a measure of the procalcitonin level and an indicator of the level of sepsis. The PCT-Q 
measures the different stages of sepsis from Systemic Inflammatory Response Syndrome 
(SIRS) right through the syndrome to Severe Sepsis. This semi-quantitative test can then be 
used in your communication with the multi-disciplinary team.
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What are the possible disadvantages and risks of taking part?
The disadvantage of taking part in this study is having to be interviewed twice. Each interview 
will take about 45 minutes to one hour to complete.
What are the possible benefits of taking part?
We hope that the associated teaching sessions and the use of the new tool will augment your 
clinical practice. From clinical experience and the literature we know that there are many 
times when the clinical nurse knows that the patient is not as well but there are few clinical 
signs. It is hoped that this PCT-Q test will give nurses another tool that can be used in 
discussion with the MD team to ensure that patients with sepsis are diagnosed more qUickly.  ^
The information we get from this study may help us to treat future patients with cancer who 
are at risk of developing sepsis. Your thoughts may also help to influence future nursing and 
future patient outcomes.
What if new information becomes available?
Sometimes during the course of a research project, new information becomes available about 
the treatment/drug that is being studied. If this happens, the research nurse will tell you about 
it and discuss with you whether you want to continue in the study. If you decide to withdraw 
your research nurse will make the necessary arrangements. If you decide to continue in the 
study you will be asked to sign an updated consent form.
Will my taking part in this study be kept confidential?
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All interview transcripts will be coded so that only myself will know who has been 
interviewed. Any presentation or publication that results from this study will not therefore 
include the names of any nurses involved.
What will happen to the results of the research study?
The results of this study are likely to be available in December 2005, if you would like a 
summary of the results when available please let us know. The results will also be presented 
at conferences and as part of the education of cancer and critical care nurses, and in relevant 
cancer and critical care publications.
Who has reviewed the study?
This study has been reviewed by the Committee for Clinical Research and the Research 
Ethics Committee of the Royal Marsden NHS Trust.
Contact for the Further Information;
If you require any further information or if you have any questions about the study please 
contact any of the numbers listed below:
Shelley Dolan Nurse Consultant Cancer: Critical Care 0207 808 2351 
Natalie Pattison Nurse Researcher: Critical Care Nursing 0207 811 8054 
Sister Critical Care Outreach (Chelsea) 0207 808 2331 
Sister Critical Care Outreach (Sutton) 0208 642 6011 ext: 1427/1038
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Appendix 5: Nurse Information Sheet — pre­
intervention questionnaire
The Royal Marsden NHS Foundation Trust
S ep sis Study: Protocol 2372 
Nurse Information Sheet
The early identification of cancer patients who have the immunological precursors for 
severe sepsis: a tool to confirm nurses' intuition and experience
| I would like to invite you to take part in a research study. Before you decide it is important
j for you to understand why the research is being done and what it will involve. Please take
|
time to read the following information carefully. Ask us if there is anything that is not clear 
or if you would like more information. Take time to decide whether or not you wish to take 
part. Thank you for reading this.
What is the purpose of the study?
This study aims to improve the early diagnosis of sepsis and severe sepsis in patients who are 
receiving inpatient treatment at the Royal Marsden Hospital. As you will be aware Sepsis and 
! Severe Sepsis are the cause of an increased morbidity and mortality in some cancer patients
| undergoing treatment. We know from experience and previous research that early diagnosis
I
! of this condition is important. This study aims to increase awareness and education about the|
! sepsis syndrome, and also to provide the nurse working on the ward with a new tool that may 
help to diagnose sepsis in its early stages.
Why am I being invited to take part?
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All nurses who are permanently employed at the Royal Marsden NHS Trust and who work 
on the adult acute care wards are being invited to take part in this study. Because the study is 
about the early identification of sepsis it is very important that all nurses caring for patients at 
risk are informed about the study.
Do I have to take part?
It is up to you to decide whether or not to take part. If you decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form. If you decide to 
take part you are still free to change your mind or withdraw at any time and without giving a 
reason.
What will happen to me if I take part?
You will be asked to complete a short questionnaire exploring sepsis, its diagnosis and the 
early indicators of sepsis pre the introduction of the PCT-Q. Following the introduction of the 
PCT-Q on all the wards a second questionnaire which starts the same as the first but also
I includes a few questions on your experience of the use of the PCT-Q.
I
I
i
| What is the drug or procedure that is being tested?
There is no drug being tested but we are testing a kit called PCT-Q which has been used 
| previously in the detection of sepsis and severe sepsis. It is a kit that measures a substance in
: the blood called Procalcitonin. Procalcitonin levels can give us a clue as to whether a patient
F
is developing sepsis. The PCT-Q has been used in several studies but these have been small 
and it has not been used in the hospital ward setting before. PCT was launched in 1996 as a 
diagnostic tool for identifying severe bacterial infections and indicating complications 
secondary to systemic inflammation. PCT levels increase in cases of sepsis, septic shock and
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in severe systemic inflammatory reactions. The main stimulus for PCT induction is the 
systemic effect of lipopolysaccharide from bacterial endotoxins, and systemic fungal 
infections. Viral diseases, autoimmune diseases and local and organ related infections do not 
induce PCT. PCT can therefore be used in the differential diagnosis of bacterial infections. 
PCT can also be used to monitor patients who are at risk of infection or sepsis for the early 
detection of infectious complications; this makes its application particularly important in 
high- risk surgical and immunosuppressed patients (Meisner 2000, Fleischhack et al 2000).
The PCT-Q is used by taking a sample of blood from the patient who is suspected of 
developing sepsis, spinning the blood down in a centrifuge and then adding a drop of the 
plasma to a test strip (a bit like a blood glucose test strip). After 30 minutes the PCT-Q gives 
a measure of the procalcitonin level and an indicator of the level of sepsis. The PCT-Q 
measures the different stages of sepsis from Systemic Inflammatory Response Syndrome 
(SIRS) right through the syndrome to Severe Sepsis. This semi-quantitative test can then be 
used in your communication with the multi-disciplinary team.
What are the possible disadvantages and risks of taking part?
The disadvantage of taking part in this study is having to complete 2 short questionnaires.
What are the possible benefits of taking part?
We hope that the associated teaching sessions and the use of the new tool will augment your 
clinical practice. From clinical experience and the literature we know that there are many 
times when the clinical nurse knows that the patient is not as well but there are few clinical 
signs. It is hoped that this PCT-Q test will give nurses another tool that can be used in 
discussion with the MD team to ensure that patients with sepsis are diagnosed more quickly.
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The information we get from this study may help us to treat future patients with cancer who 
are at risk of developing sepsis.
What if new information becomes available?
Sometimes during the course of a research project, new information becomes available about 
the treatment/drug that is being studied. If this happens, the research nurse will tell you about 
it and discuss with you whether you want to continue in the study. If you decide to withdraw 
your research nurse will make the necessary arrangements. If you decide to continue in the 
study you will be asked to sign an updated consent form.
Will my taking part in this study be kept confidential?
| All completed questionnaires will be coded so that only the staff nurses administering the 
| questionnaires will know which wards and nurses have received a questionnaire. No
questionnaire will have a nurse's name on it. Any presentation or publication that results from 
this study will not therefore include the names of any nurses involved.
What will happen to the results of the research study?
The results of this study are likely to be available in December 2005, if you would like a 
summary of the results when available please let us know. The results will also be presented
[
| at conferences and as part of the education of cancer and critical care nurses, and in relevant
I cancer and critical care publications.
iI
Who has reviewed the study?
This study has been reviewed by the Committee for Clinical Research and the Research 
Ethics Committee of the Royal Marsden NHS Trust.
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Contact for the Further Information;
If you require any further information or if you have any questions about the study please 
contact any of the numbers listed below:
Shelley Dolan Nurse Consultant Cancer: Critical Care 0207 808 2351 
Natalie Pattison Nurse Researcher: Critical Care Nursing 0207 811 8054 
Sister Critical Care Outreach (Chelsea) 0207 808 2331 
Sister Critical Care Outreach (Sutton) 0208 642 6011 ext: 1427/1038
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Appendix 6: Lesson plan for formal education 
session
Royal Marsden NHS Foundation Trust 
Doctoral research -  Shelley Dolan
The early identification of cancer patients who have the immunological precursors for 
severe sepsis: a tool to confirm nurses' intuition and experience.
Lesson Plan for nurses on general wards and CCUs
By the end of this ward based teaching session the nurse will have an understanding and be 
able to discuss the following:
1. The standard definition for the sepsis cascade
2. The mortality and morbidity of sepsis and severe sepsis
3. The increase in incidence across the UK and internationally
4. The increased morbidity and mortality in people with cancer
5. The early signs of sepsis
6. The immunological indicators of sepsis and severe sepsis including WBC, CRP and 
PCT
7. The evidence that the early identification of sepsis can reduce mortality and morbidity
8. How the PCT-Q works
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9. How the PCT-Q can be used together with the nurse’s intuition and experience to 
make an early diagnosis of sepsis
10. How to use the PCT-Q.
11. Key clinical colleagues to liaise with regarding the early recognition and optimisation 
of patients with sepsis and severe sepsis
References (for Lesson Plan)
1. American College of Chest Physicians/Society of Critical Care Medicine Consensus 
Conference (1992) ‘Definitions for Sepsis and multiple organ failure, and guidelines 
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74.
2. Brun-Buisson, C., Meshaka, P., Pinton, P., Vallet, B. EPISEPSIS Study Group (2004) 
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8. Williamson, E.C., Millar, M.R., Steward, C.G., Cornish, J.M., Foot, A.B., Oakhill, A., 
Pamphilon, D.H., Reeves, B., Caul, E.O., Wamock, D.W., Marks, D.I. (1999) 
‘Infections in adults undergoing unrelated donor bone marrow transplantation’.
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9. Laupland KB, Gregson DB, Zygun DA. (2004) ‘Sepsis Severe bloodstream 
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Appendix 7: Powerpoint presentation: Educational 
intervention
The early identification of sep sis  in 
patients with cancer: Improving practice
•  Shelley Dolan
*  Nurse Consultant Cancer: Critical Care
S ep sis: A Worldwide Health Care 
Challenge
S ep sis  kills more than 1,400 people every day across 
the world.
Mortality rates from severe  sep sis are on a similar scale 
to lung, breast and colon cancer and it is one of the 
leading cau ses  of death  in the intensive care unit 
(ICU)
The 28 day mortality rate in sep sis  is similar to the 
1960s 28 day mortality rate for Myocardial Infarction -  
much international work has reduced the mortality 
from AMI and now in som e comm on cancers.
This is NOT the ca se  for Sepsis.
• •• 
•  • ••  • •The Mortality and Morbidity of 
S ep sis
Mortality rates range from 40 - 85% depending on 
the previous performance status and co-morbidity 
of the patient, and the virulence / site of the 
organism.
Mortality rates may be lower in patients who are 
previously fit and healthy than those with a 
chronic illness, malignancy or who are immune- 
compromised.
Overview of s e p s is
A major cause of morbidity and mortality
The uncontrolled systemic response to infection
Can rapidly escalate to severe sepsis causing acute 
organ dysfunction and ultimately death
Affects healthy people or people with 
pre-existing illnesses at any age
Worldwide mortality rates of 1,400 people a day.
In the Cancer Patient
•  • ••  • • •  •  •• • • •  
•  .>
•  • •  ;
R eason s for S ep sis  in Cancer 
patient continued:
• ••• ••• • •••
•  • •• •••
Many reasons for risk of Sepsis:
•  Disease
•  Immunosupression with prolonged neutropenia 
being an important risk
•  Repeated Anti-microbial therapy
•  Invasive therapy and catheters
•  Malnutrition
R epeated  blood and blood com ponent transfusions 
R epeated  hospitalisation
Multi-modality therapy -  i.e. C hem otherapy / surgery / 
radiotherapy -
C ancer = a d isease  of the older person
Older people may also have concom ittant d ise a se s  such
as  d iabetes or rheumatoid arthritis.
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C auses of the growth in 
incidence of severe sep sis
•  The ability to reverse life-threatening 
emergencies
•  Older population
•  Growing numbers of immune-compromised 
patients
•  Increased nosocomial infections
•  Increased microbiological resistance.
What is this thing called Sepsis ?
From our patient experience we know that sepsis is a 
complex syndrom e that enco m p asses a range of clinical 
conditions.
The clinical signs that we encounter are:
D ecreased m ean arterial pressure, peripheral vasodilation, 
leaky capillaries, coagulopathy and fibrinolyis.
Definitions of S ep sis
The American College of Chest Physicians / 
Society of Critical Care Medicine Consensus 
Conference Committee 1992
Defined the disease continuum of Sepsis > 
Organ Failure and Guidelines for Research 
into new therapeutic interventions.
Bone, Balk, Cerra e ta ! 1992 Chest, 101 (6) 1644-55.
What is this thing called S ep sis  ?
The most obvious starting point for us working with 
patients is that whilst there are many causes and 
presenting conditions there seems to a final 
common clinical pathway recognisable by all ITU 
nurses - that of increasing metabolic 
derangement and organ failure requiring more 
and more support.
The d isease  continuum: The d isea se  con tin u u m :S ep sis
Severe
sepsis
A non-specific clinical response including 
>2 of the following:
• Temperature >38°C or <36°C
• Heart rate >90 beats/min
• Respiratory rate >20/min
• White blood cell count >12,000/mm3 or 
<4,000/mm3 or >10% immature neutrophils
As well as infection, SIRS can also be caused by 
trauma, burns, pancreatitis and other insults
SIRS: systemic inflammatory response syndrome
D eath SIRS
s e p s i s
Death
SIRS w ith a presumed or 
confirmed infectious 
process
SIRS: systemic inflammatory response syndrome
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The disease continuum: 
severe sepsis
Sepsis with signs of at least one acute 
organ dysfunction
• Renal
• Respiratory
• Hepatic
• Haematological
• Central nervous system
• Unexplained metabolic acidosis
• Cardiovascular
SIRS: systemic inflammatory response syndrome
Septic shock 
S e v e re  s e p s is  w ith  
h y p o te n s io n  
r e fra c to ry  to  
a d e q u a te  v o lu m e  
re s u s c ita t io n
Severe sep sis:  a growing 
healthcare problem?
Proportion of admissions to ICU with severe sepsis in first 
24 hours in ICU for three consecutive years in 26 ICUs
296%
I  I  ■
Host re sp o n se  to infection 
Progression to sepsis and severe sepsis
•  •
•  • •  
•  •  
« »  - P ath ogen esis of sep si
Loss of homeostasis
4
Organ dysfunction
4
Death
E n d o th e lia l
d ys fu n c tion
O ther C oagufetion/
fac to rs  fibrinolysis
L eu co cy te  a c tiv a tio n
M icro v ascu la r 
flow
red is tr ib u tio n
0 r 9 an  T is s u e  in ju r
d y s fu n c tio n
. t
M icro v ascu la r 
c o a g u la tio n / U63th th ro m b o s is
H om eostasis
L oss of h om eostasis  
in s e p s is
Inflammation
Coagulation Fibrinolysis
Homeostasis
Endothelial dysfunctio??''0
Loss of homeostasis
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Diagnosing the patient
•  • ••  • • •
•  •
•  • ••  •  •  •  • • •  ••  •  •
with sep sis Patient history
Prior and current medical history
Investigations
•  Routine
•  Special
SIRS / 
sepsis
Immediate resuscitation/ 
supportive therapy
•  Oxygen
•  Fluids
Sym ptom s may include:
•  ‘ Feeling hot/cold/ 
shivering’
• Rigors
•  Nausea/vomiting
•  Lethargy
• Rash
However N.B. there may be 
very few symptoms
Photophobia 
Diarrhoea 
Headache 
Abdominal pain 
Infective source
Increasing evidence that early 
diagnosis and optimisation may 
reduce mortality
Rady et al (1996) Resuscitation of the critically ill in the 
ED: responses of blood pressure, heart rate, shock 
index, central venous oxygen saturation and lactate, 
Am.J.Emerg.Med, 14 (2) 218-25.
Rivers et al (2001) Early goal directed therapy in the 
treatm ent of severe sepsis and septic shock,
N.Engl. J.Med, 345 (19) 1368-77.
Vincent et al (2002) Reducing mortality in sepsis new 
directions, Crit Care Suppl 3:S1-18.
The evidence for early 
recognition
‘Early goal directed therapy has been 
shown to improve survival...for patients 
presenting with septic shock in a 
randomised controlled single centre 
study’
Dellinger, R. et al 2004 Surviving Sepsis Campaign guidelines for m anagement of severe 
sepsis and septic shock.
Critical Care Medicine. 32(3):858-873,
Critical Care M edicine^
All guidelines regarding early diagnosis and optinsption 
depend on early reo xjnition
As there can be few early signs -  what else can we 
use to raise awareness:
Teaching and raising aw areness 
Critical Care O utreach 
Inflammatory m arker m easurem ent 
Procalcitonin m easurem ent on the ward
We now have an evidence base for 
early Goal Directed Therapy:
•  ‘Central venous Pressure 8-12 mm Hg
• Mean Arterial Pressure >_65 mmHg
•  Urine output >0.5 ml/Kg/hr
•  Central venous (SVC) or mixed venous oxygen 
saturation >_70%’
So we need  to  be su re  th a t we recogn ise  it early 
Dellinger et al (2004) Surviving Sepsis Guidelines for 
management o f severe sepsis and septic shock, Crit Care 
Med, 32 (3), 858-873.
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Outreach:
B ackground e v id e n c e
•  • •  
• • • «  
•  •
• •  •  -
•  •  9 •
•  •  •
There IS a serious problem
McQuillan et al 1998, McGloin et al 1999 
Young et al 2003, J Gen Intern Med.
Physiological collapse is often predictable
Goldhill & McNarry 2003, Schein et al 1990
Prompt treatment improves outcomes
Gusto, Newby et al 1996, J Am Coll Cardiol.
Rivers et al 2001, N Engl J Med.
McGloin et al 1999, J R Coll Physicians London
Avoidable d eaths & ICU adm issions: 
our ‘b e s t’ hospital
Hospital deaths over 6 months 
2 unexpected, potentially avoidable deaths a month 
Clear signs of prior deterioration over hours / days: 
untreated BP < 80 for > 24 hours, 4- K \ I  0 2,1  BM
Vincent e ta l 2001, BMJ
Adverse events
10.8% patients experience adverse event: 
half are preventable
1/3 of adverse events lead to disability / death
McQuillan et al 1998, BMJ
Suboptimal care on wards
100 non-elective ICU admissions from wards: 
20 well-managed
• Process issues (organisation & supervision)
• Cultural issues (experience, advice-seeking)
• Education issues (knowledge, urgency)
McQuillan etaU19981
-  E f f e c t s  o f  s u b - o p t im a l  c a r e
00 □  Good c a re  C l S u b s tan d a rd  care .
48% I
35%
ICU m o rta lity Hospital m o rta lity
poor management of:
Airway 
Breathing 
Circulation 
Oxygen therapy 
Monitoring
Also: failures of communication & teamwork
M cQ uillan et al 1998, BM J
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Critical Care throughout 
the patient journey
Pre-hospital
=> Em ergency Room
=> ICU / HDU / W ard
=> Operating Room
=> Recovery / ICU / HDU 
=> Ward
=> Home
.
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CRITICAL CARE UNIT 
EARLY WARNING SCORING SYSTEM
P U T R B A C h  a E R V T C t A Y A Ik A B L t O N . 1 I ■ I I
In flam m atory M arkers in sen
•  • •  
R S S *
In d ic a to r o f In flam m atio n  or  
in fec tion
A ction A u th o rs  & D ates  Si 
stud ies
e s e t r c h
•  •
C-reactive protein Acute - p h a s e  reac tan t 
b iochem ical m arker of 
inflam m ation & infection
Engel e t al 1998, M eisner et al 
1999, F le ischhack  et al 2000
T um our N ecrosis  Factor 
(TNFa)
M acrophage  / m onocyte  
derived cy tokine m ed ia te s  an  
acu te  p h a s e  reaction
Suffredini e t al 1999, F leischhack  
et a I 2000
Interleukin 6  (IL6) 
Interleukin 8 (IL8)
M acrophage  / m onocyte  
derived  cytokines m ed ia te s  an 
acu te  p h a s e  reaction
Lotz 1995, d e  W erra  et al 1997. 
Engel e t al 1998
PMN E la s ta se Proteolytic en zy m e -  
biochem ical m arker for 
granulocyte  stim ulation
P e te rs  e t al 1991. Ishlkaw a et al 
1998
W hite Blood Cell C ount 
(WBC)
Norm al 5-10
Inflammatory marker in se p s is  -  
Procalcitonin (PCT)
•  • •
•  • • * >  
•  •
•  •  •  o
•  •  •  •
•  •  •
Of all markers studied over the last 10 years PCT has 
demonstrated the greatest specificity & reliability in the 
detection, differentiation and prediction of the 
development of infection, sepsis and severe sepsis.
PCT has been studied since 1996 in the neutropeanic and 
non neutropaenic patient.
C a rsm  e t  a l 1997, d e  W erra  e t  a l 1997, C h ie sa  e t  a l 1998, M im o z  e t  a l 1998, 
M e is n e r  1999, O b e rb o ffe r  1999, F le is h h a c k  e t  al 2 0 00 , K u s e  e t  a l 2 0 00 , 
R a u  e t  al 2 0 0 0
What is Procalcitonin (PCT)?
PCT is a 116 amino acid with a sequence identical to that 
of the prohormone of calcitonin. In the normal healthy 
person under normal metabolic conditions hormonally 
active calcitonin is produced and secreted in the C-cells 
of the thyroid gland following specific intracellular 
proteolytic interaction of the prohormone PCT.
In severe infections intact PCT is found in the blood.
PCT
•  • •  -
•  • • <  •  • •
In health plasma PCT levels are usually below 
the detection limit.
PCT concentrations above 0.5ng/ml indicate an 
acute infection + a systemic inflammatory 
reaction
High PCT concentrations from 10ng/ml - > 1000 
ng/ml are found in patients with sepsis and 
severe sepsis.
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Importantly PCT levels rise quickly 
following infection and stay high for 
24-48
•  PCT level increases after 
2-3 hrs post infection
• Levels then rise rapidly 
achieving a peak at 6-12 
hrs
•  PCT levels then remain at 
a plateau for 24-48 hrs
•  Then start to fall.
Thus PCT levels can be used:
•  To aid early diagnosis of infection
• BUT also to monitor the course of sepsis 
-  especially important in the person with 
cancer -  a peripheral blood test much 
less invasive than returning to theatre, 
even journeying to a CT scan or having 
repeated bronchealveolar lavage.
The rapid test PCT-Q
The PCT-Q is a semi-quantitative test that provides 
a PCT concentration but also groups the results 
according to the sepsis syndrome banding.
During this study
“ 00 0 M
m
PCT-Q used by ward based nurses, critical care outreach 
team and nurses in critical care.
Each nurse on the above areas also receives a teaching 
session with pre and post test to raise their knowledge 
and awareness of the importance of recognising the 
signs of sepsis early 
Study to enroll 400 patients and 200 nurses
Data Collection:
PCT finding -  collated with other important markers of 
sepsis e.g. CRP, lactate, BP etc. & importantly nurse’s 
intuition.
Nurse’s teaching sessions and pre and post test results 
20 qualitative interviews with nurses re their experience 
of the use of the PCT -Q  to aid their decision making 
and interventions.
Study end points:
•  To increase numbers of patients with severe 
sepsis identified early -  compare with historical 
data (problematic ?)
•  To increase numbers of patients -  receiving early 
goal directed therapy
•  To increase nurses -satisfaction with decision 
making and communication with MD team.
•  To decrease mortality from severe sepsis
•  ??To raise awareness of sepsis and the early 
signs of sepsis at an early stage.
267 o f 355
Conclusion
•  • ••  • •
•  •
•  •  B 
» • • •
•  •  •
The sepsis syndrome is a complicated 
immunological syndrome that affects 
homeostasis and causes multi-organ failure. The 
incidence is rising and the mortality rates in 
people with cancer are still too high.
It may be that use of the PCT-Q coupled with 
increased awareness and teaching may improve 
rapid access to acute care and optimisation.
A request: \  , SurvivingSepsis
Internationally to raise the awareness of the Surviving 
Sepsis Campaign -supported by:
American Association Critical Care Nurses. American College Chest 
Physicians, American College of Emergency Physicians, American 
Thoracic Society, Australian & New Zealand Intensive Care 
society, European Society of Clinical Microbiology and Infectious 
Diseases, European Society of Intensive Care Medicine, European 
Respiratory Society. International Sepsis Forum, Society of Critical 
Care Medicine, Surgical Infection Society
Click onto: 
www. surviving sepsis.com
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Appendix 8: Summary guide for PCT-Q testing kits
The sample can be taken in either a red top (for serum) or green top/EDTA (for 
plasma). Ideally the sample should be centrifuged within one hour of being 
taken. Please note time it was taken and write the hospital number onto the test.
- Place sample in centrifuge, counter the weight of the sample on the 
opposite spindle with a same-sized tube filled with water/saline to the 
same amount as sample.
- Set temp on centrifuge to 25°C. (At Sutton, you may need to spin it 
empty for a few minutes to warm up machine, as they are often set at 
4°C.) Centrifuge at 5000 rpm (max machines will do in Sutton is 4000) 
for 15 mins.
- Pipette 6 drops onto PCT-Q test in the bottom hole. Pipette should be 
filled to line, without bubbles. Tilt slightly when pipetting.
- Leave for 30 mins (max. 45) at room temperature.
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- Read test results in conjunction with reference card.
Control
band
Test
band
B. Negatively valid C. Positively validA. Not valid
- Test A is invalid
- Test B negatively valid (procalicitonin <0.5 ng/ml)
- Test C positively valid
Check intensity of band colour with colour blocks on reference card. A positive 
should be followed up 12-24 hourly and clinical measures taken.
N.B.
A follow-up comparing one test with one from the day before is not valid. The 
colour may change within a few hours (red to violet). It may also happen that a 
test which is negative after 30 mins may turn slightly in colour after a few 
hours, the result after 30 mins is valid in this case.
Hb <5g/dl affects accuracy.
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Any queries please call Natalie Pattison, Nurse Researcher: Critical Care 
Nursing on ext: 8054, or Shelley Dolan, Nurse Consultant Cancer: Critical
Care ext: 2351
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Appendix 9a: Nurse Consent form: Qualitative 
Interviews
CONSENT FORM
Early identification of sepsis in patient with cancer (Nurse consent)
Protocol Number: 2372 
Please initial box
I confirm that I have read and understand the information sheet for the 
above study and have had the opportunity to ask questions.
I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my 
employment or legal rights being affected
I agree to take part in the above study.
Name of Patient Date Signature
Name of Person taking consent Date Signature
(if different from researcher)
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Researcher Date Signature
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Appendix: 9b Nurse Consent form: Questionnaires
CONSENT FORM
Early identification of sepsis in patient with cancer (Nurse consent)
Protocol Number: 2372 
Please initial box
I confirm that I have read and understand the information sheet for the 
above study and have had the opportunity to ask questions.
I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my 
employment or legal rights being affected 
I agree to take part in the above study.
Name of Patient Date Signature
Name of Person taking consent Date Signature
(if different from researcher)
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Researcher Date Signature
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Appendix 10: Pre-intervention questionnaire
Ward 
Nurse No. 
Date
Royal Marsden NHS Foundation Trust 
Doctoral research -  Shelley Dolan
The early identification of cancer patients who have the immunological precursors for 
severe sepsis: a tool to confirm nurses' intuition and experience.
I Questionnaire for Nurses
ij
I
\ Pre-test questionnaire
i
1. How long have you worked with cancer patients? (please circle answer)
Less than 1 year 2-4 years 5-10 years more than 10 years
2. Have you undertaken any post-registration education in cancer nursing? (please 
circle answer)
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ENB 237 type course Diploma in cancer BSc in cancer
MSc Cancer Other -  please give details...
3. Do you feel your knowledge is up to date regarding the sepsis syndrome? (please 
circle answer)
No Yes Could be improved
4. Please describe the standard definitions for the different parts of the sepsis cascade
5. What is the mortality rate for severe sepsis in previously healthy adults?
6. What is the mortality rate for severe sepsis in people with cancer?
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7. Please describe the early signs of sepsis developing
I 8. Please list three immunological / blood indicators of sepsis and severe sepsis
I
!
9. Do you think that identifying sepsis at an early stage makes any difference to 
morbidity and mortality rates? (please circle answer)
Yes No Not sure
10. Have you heard of CRP and Procalcitonin blood tests? (please circle answer)
Yes No
11. Do you know how to use the PCT-Q? (please circle answer)
No Yes
12. If one of your patients was developing the early signs of severe sepsis who would you 
contact? (please list personnel below)
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13. Have you nursed a person with cancer who has developed severe sepsis? (please circle
answer)
Yes No Not sure
14. Have you ever had the experience of thinking that a patient was deteriorating but 
finding it difficult to convince other nurses /doctor or other health care 
professionals?
No Yes
15. If you have had any such experience please could you give an example below:
Thank you very much for completing this questionnaire
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Appendix 11: Post-intervention questionnaire
Royal Marsden NHS Foundation Trust 
Doctoral research -  Shelley Dolan
The early identification of cancer patients who have the immunological precursors for severe 
sepsis: a tool to confirm nurses' intuition and experience.
| Questionnaire for Nurses
[t
Post-test questionnaire
1. How long have you worked with cancer patients? (please circle answer)
Less than 1 year 2-4 years 5-10 years more than 10 years
2. Have you undertaken any post-registration education in cancer nursing? (please circleif
I answer)
; ENB 237 type course Diploma in cancer BSc in cancer
j
I MSc Cancer Other -  please give details...
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3. Do you feel your knowledge is up to date regarding the sepsis syndrome? (please circle
answer)
No Yes Could be improved
4. Please describe the standard definitions for the different parts of the sepsis cascade
5. What is the mortality rate for severe sepsis in previously healthy adults?
6. What is the mortality rate for severe sepsis in people with cancer?
I
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7. Please describe the early signs of sepsis developing
8. Please list three immunological I blood indicators of sepsis and severe sepsis
9. Do you think that identifying sepsis at an early stage makes any difference to morbidity and 
mortality rates? (please circle answer)
Yes No Not sure
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10. Have you heard of CRP and Procalcitonin blood tests? (please circle answer)
Yes No
11. Do you know how to use the PCT-Q? (please circle answer)
No Yes
12. If one of your patients was developing the early signs of severe sepsis who would you 
contact? (please list personnel below)
13. Have you nursed a person with cancer who has developed severe sepsis? (please circle 
answer)
Yes No Not sure
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14. Have you ever had the experience of thinking that a patient was deteriorating but finding it 
difficult to convince other nurses /doctor or other health care professionals?
No Yes
Thank you very much for completing this questionnaire
285 of 355
Appendix 12 : Patient Information Sheet (PIS)
THE ROYAL MARSDEN FOUNDATION NHS TRUST
Sepsis Study: Protocol Number 2372 
PATIENT INFORMATION SHEET
The early identification of sepsis and severe sepsis in patients with cancer
(
i
|
!
I would like to invite you to take part in a research study. Before you decide it is important 
for you to understand why the research is being done and what it will involve. Please take 
time to read the following information carefully and discuss it with friends, relatives and your 
GP if you wish. Ask us if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part. Thank you for reading 
this.
What is the purpose of the study?
This study aims to improve the diagnosis of sepsis and severe sepsis in patients who are
I receiving inpatient treatment at the Royal Marsden Hospital. Sepsis and Severe Sepsis are
i
| conditions where an infection starting somewhere in the body starts to have an effect on theI
I rest of the body causing trouble for the lungs, heart, kidneys or other areas. You may have
[
I heard this condition called Septicaemia or Septic Shock. We know from experience and
|
previous research that early diagnosis of this condition is important. This study is hoping to
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help nurses on your ward to recognise this condition earlier and therefore hope to improve 
patient care.
Why am I being invited to take part?
You are due to be admitted to the Royal Marsden for treatment of your cancer or are already 
receiving treatment on a ward at the Royal Marsden Hospital. Your doctors and nurses in the 
clinic will have explained that cancer and its treatment: chemotherapy, radiotherapy and 
surgery can make your body temporarily more susceptible to an infection. The aim of this 
| study is to ask all patients, who because of their cancer or its treatment may be more likely to 
develop an infection, and then sepsis, to allow a sample of their blood to be tested.
Do I have to take part?
It is up to you to decide whether or not to take part. If you decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form. If you decide to 
take part you are still free to change your mind or withdraw at any time and without giving a 
reason. This will not affect the standard of treatment or care you receive.
What will happen to me if I take part?
i
| During your stay in the ward if you develop a temperature or any of the other early signs of 
sepsis: faster pulse, lower blood pressure, faster breathing or lowered urine output, we would 
like to take an extra blood test from you. One of the nurses will take the blood from you
i
i either from your central line your Hickman line or your arterial line, or directly from your
I vein. We will need about 10 mis of your blood about 2 teaspoonful. You will probably needI
blood taken for other reasons and we will take this blood at the same time. Depending on
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your condition we might ask to do this blood test once, twice or three times during your stay 
in hospital.
What do I have to do?
Agree to have a blood test if you display any of the early signs of sepsis.
What is the drug or procedure that is being tested?
There is no drug being tested but we are testing a kit called PCT-Q which has been used
j  previously in the detection of sepsis and severe sepsis. It is a kit that measures a substance in
!
I
i  the blood called Procalcitonin. Procalcitonin levels can give us a clue as to whether a patient 
is developing sepsis. The PCT-Q has been used in several studies but these have been small 
and it has not been used in the hospital ward setting before.
What are the possible disadvantages and risks of taking part?
The disadvantage of taking part in this study is having the extra blood tests taken.
What are the possible benefits of taking part?
We hope that the PCT-Q and the information gained will help you. However, this cannot be 
guaranteed. The information we get from this study may help us to treat future patients with
[
I cancer who are at risk of developing sepsis.
I[
[I
! ;
i
I What if new information becomes available?
i
j
Sometimes during the course of a research project, new information becomes available about 
the treatment/drug that is being studied. If this happens, your research nurse will tell you 
about it and discuss with you whether you want to continue in the study. If you decide to
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withdraw your research nurse will make arrangements for your care to continue. If you 
decide to continue in the study you will be asked to sign an updated consent form.
Also, on receiving new information your research nurse might consider it to be in your best 
interests to withdraw you from the study. He/she will explain the reasons and arrange for 
your care to continue.
| Will my taking part in this study be kept confidential?
| All information which is collected about you during the course of the research will be kept
I
strictly confidential. Any information about you which leaves the hospital will have your 
name and address removed. Any presentation or publication that results from this study will 
have your name and address removed. Your GP with your agreement will also be informed of 
your participation in this study.
What will happen to the results of the research study?
The results of this study are likely to be available in December 2005, if you would like a 
summary of the results when available please let us know. The results will also be presented 
at conferences and as part of the education of cancer nurses, and in relevant cancer
I
| publications.
j
Iij
! Who has reviewed the study?
i  This study has been reviewed by the Committee for Clinical Research and the Research 
| Ethics Committee of the Royal Marsden NHS Trust.
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Contact for the Further Information;
If you require any further information or if you have any questions about the study please 
contact any of the numbers listed below:
Natalie Pattison Nurse Researcher: Critical Care Nursing 0207 811 8054
Shelley Dolan Nurse Consultant 0207 808 2351
Sister Critical Care Outreach (Chelsea) 0207 808 2331
Sister Critical Care Outreach (Sutton) 0208 642 6011 ext: 1427/1038
Date given to patient:____________________________
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Appendix 13: Patient consent form
CONSENT FORM
Early identification of sepsis in patient with cancer (Patient consent)
I Protocol Number: 2372
[
i
i Please initial box
I confirm that I have read and understand the information sheet for the 
above study and have had the opportunity to ask questions.
I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my medical 
care or legal rights being affected
i
i|
; I understand that information from my medical notes may be reviewed
i
| by the study team. I give my permission for this team to look at my 
clinical notes.
I agree to take part in the above study.
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Name of Patient Date Signature
Name of Person taking consent Date Signature
(if different from researcher)
Researcher Date Signature
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Appendix 15: Transcript from the post-intervention 
qualitative interviews
THE ROYAL MARSDEN NHS TRUST
Sepsis Study 
Study Protocol Number 
Interviewee: 10 
Po&t-mtervention interviews
—  l£Uc
IjM IS P IT*- '*
-Uu.Ve
pc-CTir*
UOt
Date 14/1205
\  C O  ‘"V i C S D ^ t c - .
’ < r v
SO finally I shcnild have said its all confidential yew are given a number 
and the tapes are destroyed alter they ve been transcribed Ok
10 Yes
SO Thank you very much for the Erm first of all I just want to ask since , 
since you've been working on the unit, probably since you came back have 
you had the experience of looking alter somebody erm.. who you ve thought 
are they're going to develop sepsis’  Or anybody who you know kind of was 
alnght and then is going off and then you the* that could be sepsis
10 Not since Ive come back
SO Right So ngM rt would be reflecting back erm «s there anyone you 
can think of when you retted back and. I dont know 4 could be anyone on 
the unit or on a ward or whatever, who was going along alright and then 
maybe developed some changes ’
10 Urn probably a patient who came back and who was with us for a few 
days after having an oesophagogastreclomy
SD Right
10 Whose name I can t remember
SD: And you shouldn t say anyway so that's alright! (laughing)
10 And he was toodimg along okay, chest drains were coming out and urn.
up to srt and then he became sod of generaty unwell. ciammy Respeatory- 
w*se he was going off J here was nothing palpable vou rpould put voyr firmer 
on in itia lly  ?ou jusl M W M  there w a s  something n o :  c-1e right with ~ ~ He 
jusi looked a irme W  more distressed even though hc was comfortable he was 
just a little bit sow  to respond when you spoke to him
SD: Right nght
\ ©
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10 .. those kind of initial things where you ook at the patient and you see
tnat thorn's not somethings . something's not ghl
SD Yeah Brilliant, thank you Erm have you had a chance to use the 
PCT Q’
10: I haven !, no
SU No that s fine Erm and the reas and er why ao you think you haven i 
used rt’
1C I think because it's because I ve been off sic* for quite a ong period of 
tkne,
SD That's fine that s fine I dont want to put any words in your mouth but I 
presumed that was why Erm, do you think you understand what ft is or why 
we woukt be using it?
10 I understand its j n  indica te , an eartyjugn ©t sepsis, but as forJthP
actual mecha- cs t j  m not totally ’
SD Okay That's fine Do you erm it's probably a slightly unfair question
because you've been back such a short time But have you heard people 
talking about the measurement of it n  the unit when they've been talking 
about ,n the unit when they 've been talking about patients’
10 I haven t, no
SD No. that s tine Erm finai queston aoout the PCT Q Do you 
remember which level of PCT-Q is a k«od of worrrsome level?
[{MMM*]
SD It's absci
10 No (laughs)
SD Abso&ufoty That s fme 10 Cause the other questions are not about
the PCT-Q
10 Right
SD and its ocmptetety understandable cause you ve not been around 
Erm. okay I m now gomg to leave the PCT Q questions and I ve just got one 
two, three, four, five questions
10 Okay
(SD
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SO eirn about the early recognition of sepsis generally Qbviou-sly, in 
your role you re a lot about coacmng arc teaching junior staff
10 Yes
SD If yov were coaching or teaching a junior staff member about how to 
recognise the early signs of sepsis I hunting abcut the early stages - SIRS 
sort o# stage what would you say to them you k^ow would, should make 
them think about it?
10; When they're doing their checks of the pabeni you know
SD Yes
10 observe the patients colour rvow the patient a  breathing, how the 
patent responding If they are in pain , if they are not in pain cause that might 
be a sign of sops s cause they've actually got a especially if 1hey are 
surgica: patients cause they ve got a wound
SD Ye* yes
10 Erm once they ve done the dnp, the srm the assessment of the 
patients to look at the patient s v tai signs the* blood pressure heart rate emi 
their temperature if tnere s an underlying a sort of slow nse in temperature
SD Yes yes
10 fcrm if they're clammy, if their flud requirements are going up if their
urine outputs varying at ail. if its  going down.
SD Yes yes
10 Emv I Hunk tHai a
SD Yes. that's great Thank you its  a sort of leadership question, but erm, 
If you were talking to teaching the same nurse who might either be on a unit 
or on the ward
10 Mmhmrr
SO And you were trying to tell her how to mobilise help around So, you 
know you know how to effect help around I don t mean in an arrest situation, 
more in the early stage how do you how would you tell the nurse (laughing | 
to talk to say doctors or senior nurses to get them to pay attention to you
SD Yeah
©
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10 That they that their v<xce v»4l be heard 
SO: Yes
10 And that sr>outd be done maybe at induction when they come to work 
here.
SD Yes yes
10: That they are not lust a number but that their view and their perception
of what irhappening with the patient is very important
SD Yes
10: So we shood st>fl ernpower thid&ttJWOi'King here
SD Yes
10: Ana emt again if they nave concerns about the patient, that those are
real concerns and that they should be able to act on them so it's be*ig able to 
assess the palieru and being able tc get accurate information to the other 
nurses on duty Maybe the F grade who is on m-charge When they gp to get 
mtouch with the docJy, ty h ^ j j  tM  Jfifaiiate bu *4 w ufts Qf what has 
happened with the paterts. So they’re able to lia se with the doctors or wth 
the other members of the mufb^liscipftnary team’
SD Yes
10 'When tney re getting n  touch with the outreach to be able to have all 
the information on the patient them ready to give us
SD Yes
10 So that they get a quick response to what is happening wrth the patient
SD Yeah bnlfcanl Thank you Erm, (laughs) Erm no that s bntbant E m il
suppose I just want to push you one more bit on that because you are very 
experienced nurse
10 Mmhrrtm
SD: You ve got all th a t mftxmation to g e th er and all that kmd of stuff Mow
do you actually say 4s doctors how do you talk to ihem you know what s the 
kind of way you do it to make 4 work?
10 You woukj talk to the doctors erm I concerned about this patient They 
look tta tfaa.- ' " .......     *
SD: Yep
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10. You know and you* would give a descnpton of now tne palienl
'V looked and say that there's wen slight but marked changes in the
patient s condition
SD Yes. yes
w.th the to lute. with I t *  bood pressure with the 
>r whatever Because this isn'tfluid requ
>ng and improving and then all of a sudden this is
SD y^
10 So there’s been a marked [pause] 
SD deterioration?
10: Deterioration [bothj
not to just go to Ihe doctor I think that this Is happening 
SD Absolutely, absolutely
10 To be a professional 1o have it all with them when they do go them
SD Fantastic, arm is it when you re speaking to somebody about sepsis 
Ihe nurse or whatever is there, do yoe think the pabent ever knows that 
tnere s something wrong7 Do you thank n  your experience has the patient
ever had any inking7
10 T h e  narK > nts u su a lly  m a y tw  th e  f r e t  n n e  th a t  a c h  tally inrlirflton  th a t
there's something wrong 
SD Right, nght
10 They may not verbalise it. but inrbatty they w>» probably, eventually aav 
if you staff to shfltt.SflOMIlL-PedPki might say Actually | don’t,flwil 7 7 5
liCk,
SD Right, yes
10 And it s usually a feefang of  tost unweknesjs
SO: Yes
tO that they feel a change has happened They feet cold and slavery
SO Yes
©
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10 You know they mght want to pul another bed acket on . .
SD Yes yes
'■0: Or something, another ptanket cause they re tee ng unwea Ihcy feel a
cjenctafmataisr
SD Right, brilliant Thank you 10 In a cancer hospital is there anything er 
that you In.nk we could do to improve the early diagnosis of sepsis? Is there 
anything else that we could do, do you think?
[pause]
10 Erm I think that nurse education is important and nirses knowing how 
to present their patients that rf they are concerned about a patent tha! those 
concerns are relevant to the patent s care
SD: Yes
10 And that should not just tr>ey should be empowered to be able to sorl 
of say to people that I'm this is important and you maybe need to have some 
form of indicator* either a how chart., or an ca-y warning chart
SD Yeah yeah
10 That says if this happens, this happens then you should contact and I 
th«rvk with in© outieach (whispers) what s it called?
SD Outreach team Oh erm the early warning system
10 The early warning system the nurses know that they should get 
touch b u f f just gives 1hem a SffleM  more
SD Yeah
10 they je el encouraged X»y because fl's actually there and they can 
actually quote numbers and say that Ihis is needed
SD Yeah brilliant Thankyou very much Penultimate question 
10 Penultimate
SD Erm, yeah how have you (both laugh) m if you think back on your 
career how have you learnt wh*1 you have learnt, do you think? What's you 
know if I’m looking at how nurses, how best to help nurses team? How have 
you learnt what you've leamt?
10 By example iboth laugh) Errr^bcth by example and by acluarty 
working with patients by being exposed to those situations with sup*»iTerm
299 of 355
and alao obviously throug n ire rttuclu ng ind tore structured
k:,i i; ;• VHOrtmjrtt t
SD Yes
10 I think in the critical care uml rt is a wore structured learning 
environment and >1 « Doth formal ana -formal And r  those environments 
there should always be an opportunity for funror nurses to be able tg be 
exposed to a patent **x j is undetqcmq ’.hia_dieaaf- situatim EircJhe 
nutses should be supported and 4 should be used wherever possible, as a 
teaching tool as well—
SD Yes yes
10 which i$ a dreadful way to talk aoout a patent..
SD No. but yeah
10 the nurses these »itua(QOS_sttuuld be utilised wherever possible So
that nurses can be taught
SD Yes yes Yeah Thank you Finally is there anything eae you d Ifce to 
add about the early diagnosis of sepsis?
10 We* just that I'm so*ry that I missed out on the
SD: PCT-Q7
10 PCT Erm but I m very interested to hoar I’ll bo very interested to hear 
the results of the study (both uiughi
SO Thank you so much
10 Thank you so much for involving me
SD Thank you very much for being pad of it
END
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Glossary
Acquired immunity -  immunity acquired by infection or vaccination.
Acute Graft versus Host Disease (AGvHD) -  a complication of allogenic blood or marrow 
transplant that occurs in the first 100 days following transplant, when transplanted cells 
mount an immunological attack on the host.
Adenocarcinoma -  cancer that originates from epithelial or glandular tissue.
Allogeneic Transplant -  blood or marrow transplant from another person.
Anastomotic leak -  is a serious complication of a leak at the site of a surgical join or 
anastomosis. In Gastro-intestinal surgery this leak can be associated with sepsis and a critical 
illness.
Antibody -  or immunoglobulin (Ig) is a protein in the blood that is used by the immune 
system to identify and neutralize foreign organisms such as bacteria or viruses.
Antigen -  a substance that prompts generation of antibodies and an immune response.
Anti-inflammatory mediators -  substances released to control the process of inflammation.
Antimicrobial proteins -  are important components of the innate immune system.
Autologous Transplant -  blood or marrow transplant from the self.
Apoptosis -  the process of programmed cell death involving a series of biochemical events.
B cell -  lymphocyte that has a major role in the humoral immune response making antibodies 
against antigens.
Basophil -  the least common of the white blood cell involved in the immune system and in 
allergic reactions.
Blasts -  immature blood cells that in large numbers can be an indicator of disease such as 
leukaemia.
Calcitonin -  a 32- amino acid linear polypeptide hormone produced primarily by the 
parafollicular cells of the thyroid.
Cancer -  a class of diseases where cells grow in an uncontrolled way, invade and destroy 
other tissues and can metastasise locally or to distant sites.
Carcinogenesis -  the process by which normal cells are transformed into cancer cells.
Cell cycle or cell division cycle -  the process that takes place in a cell that leads to its division 
and replication.
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Central-venous Access Device (CVAD) -  small flexible plastic tubes inserted into large veins 
for the delivery of fluids and medicines.
Chemokine -  small cytokine or protein secreted by cells. Some chemokines are pro- 
inflammatory and are used to direct cells of the immune system to the site of an infection.
Chemotactic (chemotaxis) -  the phenomenon by which cells and bacteria direct their 
movements according to chemicals in their environment.
Chemotherapy -  chemical treatment of disease in this study cancer.
Cluster Designation system (CD) -  a system of defining the cell surface molecule on an 
immune cell.
Co-morbid -  the presence of one or more diseases in addition to the primary disease.
j  Complement system -  the biochemical system that helps to clear pathogens from the host. It is 
I part of the innate immune system.
C-reactive protein (CRP) -  is a protein produced by the liver and fat cells and is found in the 
blood as a response to inflammation (an acute phase protein).
Critical Care Unit (CCU) -  a specialised unit in a hospital that provides intensive care.
Critical Care Outreach Team (CCOT) -  a multi-professional or nursing team taking critical 
care skills onto the wards external to critical care.
Cytokine -  is a signalling molecule that is used extensively in cellular communication. 
Cytokines are critical to the development and functioning of the immune system.
Deoxyribonucleic acid (DNA) -  a nucleic acid that contains all the genetic instructions used 
in the development and functioning of all living organisms.
Electrocardiogram (ECG) -  the recording of the electrical activity of the heart over time 
using skin electrodes.
Empirical -  data or information produced by experiment, experience or observation.
Endothelium -  the thin layer of cells that line the interior surface of the blood vessels.
Endotoxin -  a toxin associated with certain bacteria. Endotoxin forms a structural component 
of the bacteria and is released when the bacteria is lysed.
Eosinophil -  a white blood cell that is responsible for combating infection and parasites in the 
immune system.
Epidemiology -  the study of factors that affect the health and illness of populations.
Epiphyses -  the rounded end of a long bone that is filled with red bone marrow.
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Epistemology -  the theory of knowledge, how we know what we know.
Epithelial cells -  line the cavities and surfaces of structures throughout the body. Epithelial 
cells express adhesion molecules such as immunoglobulins which are essential in the immune 
system.
Erythrocytes -  red blood cells the most common blood cell. They contain haemoglobin which 
has an affinity for oxygen.
Failure to Rescue -  failure of health care professionals to respond in a timely or effective 
manner to acute patient deterioration.
Gel filtration chromatography -  a process that separates molecules of different size such as 
proteins, peptides and oligonucleotides.
Glycoprotein -  a protein that contains oligosaccharide chains that are important in cell cell 
interactions.
Granulocyte colony-stimulating factor (G-CSF) -  is a growth factor to produce granulocytes 
and stem cells.
Haematological cancer -  a cancer that affects the cells of the blood or lymphatic system. 
Haematopoiesis -  the formation of blood cell components.
Hemostatic balance -  the complex process that causes the blood to clot, includes primary and 
secondary hemostasis.
Hepa filtration -  removes 99% of airborne particles measuring 0.3 micrometers in diameter. 
Hepafilters are used in bone marrow transplant units to protect transplant recipients.
Heuristics -  an adjective for methods that help with problem solving which lead to learning 
and discovery. These methods typically use experimentation or trial and error, heuristic 
methods are “rules of thumb” or educated guesses, intuition.
Human Immunodeficiency Virus ( HIV) -  a retrovirus that can lead to Acquired 
Immunodeficiency Syndrome (AIDS) that causes the immune system to fail.
Immunochromatic -  a rapid dipstick type test to test the presence of a chemical substance for 
example procalcitonin in the PCT-Q.
Immunology -  the physiological functioning of the immune system in health and illness.
Immunoneutralisation - the neutralisation of various aspects of the immune system in an 
effort to moderate or prevent severe sepsis.
Immunosupression -  reduction of the activation or efficacy of the immune system as a result 
of cancer or the treatment of cancer.
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Immune System -  processes that protect the host from disease by identifying and killing 
pathogens and cancer cells.
Infection -  the detrimental colonisation of a host by a foreign organism.
Inflammation -  the complex biological response of vascular tissues to harmful stimuli such as 
pathogens, infection, damaged cells or irritants.
Innate immunity -  the cells and mechanisms that protect the host from infection in a generic 
way.
Intuitive- humanist -  a type of decision making that is based on intuition and is more likely to 
be used by the expert than the novice.
Lactate -  lactic acid which is constantly produced from pyruvate by the action of the enzyme 
lactate dehydrogenase (LDH) during metabolism and exercise.
Lactate Dehydrogenase (LDH) -  an enzyme that converts pyruvate to lactic acid in low 
oxygen states. LDH is abundant in red blood cells and a high level can indicate haemolysis 
but also the breakdown of other cells.
Leukaemia -  cancer of the blood or bone marrow.
Leukocyte -  another term for the family of white blood cells.
Logistic regression analysis -  a statistical process used to predict the probability of the 
occurrence of an event by fitting data to a logistic curve.
Lymphocytes -  a type of white blood cell important in the immune system.
Macromolecules -  a large molecule usually in the field of biochemistry.
Macrophage -  white blood cells within the tissues which are involved in phagocytosis and 
therefore an important part of the immune system.
Mean Arterial Pressure (MAP) -  at normal resting heart rates the MAP is twice the diastolic 
Pressure + systolic pressure then the total divided by three. At high heart rates the MAP is 
closer to the arithmetic mean of the systolic and diastolic pressures. In Critical Care Units 
cardiac monitors display the MAP continuously.
Megakaryocyte -  a blood marrow cell responsible for the production of platelets which are 
involved in the clotting of the blood.
Meningitis -  inflammation of the three meninges which form the protective membrane 
covering the brain and spinal cord. This can be caused by infection, disease and some drugs.
Modified Early Warning Score (MEWS) -  a simple physiological scoring system to be used at 
the bedside to detect deterioration.
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Monoclonal antibody -  monospecific antibodies that are identical because they are produced 
by one type of immune cells.
Morbidity -  disease or sickness due to any cause, often used as a measure of incidence of 
disease in contrast to mortality.
Multi-Organ Dysfunction Syndrome (MODS) -  altered organ function in a patient which 
requires medical intervention.
Myeloid cell line -  is one of two groups of stem cells produced in the bone marrow that 
differentiates into several types of blood cells including: megakaryocyes, erythrocytes, 
macrophages, neutrophils, eosinophils, basophils.
Myelosupression -  the bone marrow is suppressed as a result of cancer or treatment for cancer 
and results in less red and while blood cells and platelets bring produced.
Natural Killer Cells (NK) -  a type of cytotoxic lymphocyte that play an important role in the 
rejection of tumours and cells infected by viruses. NK cells are an important part of the innate 
immune system.
Neuroendocrine cells -  cells that receive neuronal input and then release hormones to the 
blood.
Neutrophil -  the most abundant white blood cell which has a very important role in the 
immune system.
Non-Hodgkins Lymphoma -  a cancer that starts in the lymphatic system and affects B cell or 
T cell lymphocytes but most commonly B cell.
Null model -  null model or null hypothesis is a statistical method or computer simulation used 
to test a hypothesis. The null hypothesis (H0) specifies the value of the parameter to be tested 
the null hypothesis will then be contrasted by another hypothesis.
Oesophagogastrectomy -  large surgical procedure to remove the lower oesophagus and 
proximal stomach for the treatment of cancer.
Pancreatitis -  inflammation of the pancreas which in its acute form can cause a critical 
illness.
Pancytopenia -  a condition where the red and white blood cells and platelets are reduced due 
to disease such as cancer or treatment for the disease.
Paradigm -a  philosophical or theoretical framework.
Parafollicular cells -  also called C cells are in the thyroid and produce and secrete 
Calcitonin.
Pathogen -  an infectious agent that causes disease or illness of the host.
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Patient At Risk Team (PART) -  a multi-professional or nursing team taking critical care skills 
onto the wards external to critical care.
PCT-Q -  rapid bedside test for measuring serum procalcitonin.
Perineum -  the surface region in males and females between the symphysis pubis and the 
coccyx.
Periodonteum -  the layer of connective tissue around the teeth.
Phagocytosis -  a cellular process used to engulf and remove dead cells and bacteria from the 
host.
Platelet -  or thrombocytes are small anuclear cells which play a fundamental role in 
hemostasis and are a source of growth factors.
Pluripotent stem cell -  a stem cell that has the potential to differentiate into any of the three 
germ layers (endoderm, mesoderm or ectoderm).
Pneumonitis -  inflammation of the lung tissue which can be caused by many irritants such as 
infection or chemotherapy or radiotherapy.
Polymorphonuclear cells -  these are granulocytes which are white blood cells characterised 
by the granules in their cytoplasm. There are three types Neutrophils, Basophils and 
Eosinophils with neutrophils being the most abundant.
Praxis -  the process by which a skill, theory or lesson is enacted or practiced.
Procalcitonin (PCT) - is a 116 amino acid protein which is a predictor of sepsis.
Procoagulant -  the precursor of any of the substances needed for coagulation (clotting) of the 
blood or an agent that promotes coagulation.
Pro-inflammatory mediators -  When harmful bacteria or other irritants attack the host pro- 
inflammatory mediators are released to initiate the inflammatory process.
Radiotherapy -  the use of ionising radiation for the treatment of cancer.
Reflexivity -  a subjective process of self-consciousness inquiry used in qualitative research 
methods.
Ribonucleic acid -  a single strand of nucleotide units. RNA is central to the synthesis of 
proteins.
Septic screen -  specimens of skin flora, blood, urine, faecal or wound drainage collected and 
sent for microbiological culture to assess the cause of an infection and sepsis.
Septic Shock -  critical medical condition resulting from reduced tissue perfusion and oxygen 
delivery as the result of sepsis and infection.
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Serum lactate -  high lactate levels are present in the blood in septic shock and severe sepsis 
probably as a result of anaerobic metabolism due to hypoperfusion. Serum lactate is typically 
measured in a blood gas analyser in a Critical Care Unit.
Squamous cell -  a cell of the squamous epithelium that is characterised by its flat scale like 
cells.
Staphylococcal Toxic Shock Syndrome -  a rare critical illness caused by a bacterial toxin.
Systemic Inflammatory Response Syndrome (SIRS) - is an inflammatory state of the whole 
body with no proven infection.
Systematic Positivism -  a philosophy developed from Comte by Herbert Spencer (1820-1903) 
that all knowledge is attainable by scientific inquiry.
T cell -  belong to the group of white blood cells called lymphocytes. Tcells play a major role 
in cell- mediated immunity.
Tachypnoea -  rapid breathing may be caused by the need to excrete carbon dioxide or another 
gas such as carbon monoxide.
Targeted Therapies -  cancer therapy that targets drugs against specific targeted molecules 
which govern carcinogenesis and tumour growth.
Teratoma -  a tumour which is histologically based on the germ cell most often found in the 
ovary or testis.
Tertiary referral centre -  a hospital that receives referrals for specialist treatment from 
general hospitals or General Practitioners.
Total body irradiation -  irradiation of the whole body (shielding the lungs) in preparation for 
a blood or marrow transplant for haematological cancer.
Vasomotor tone -  the constant level of nervous stimulation to the muscles in the walls of 
blood vessels.
Veno-Occlusive Disease (VOD) -  a disease following high dose induction chemotherapy prior 
to blood or marrow transplantation where the small veins in the liver are blocked.
Vital signs -  measures of physiological statistics monitored by health care professionals to 
assess body functions, for example, heart rate, respiratory rate, temperature and blood 
pressure.
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